| 1 | Carcinoma of the Œsophagus perforating into the Trachea at the Bifurcation; Report of a Case and Demonstration of Specimen. (Forster HV) Proc R Soc Med 1922;15(Laryngol Sect):17-8 |
| 1 | Clinical course related to preoperative and postoperative pulmonary function in patients with bronchogenic carcinoma. (Boushy SF, Billig DM, North LB, Helgason AH) Chest 1971 Apr;59(4):383-91 151 Citations |
| 1 | The effects of bleomycin on Ehrlich ascites carcinoma in suspension culture. (Eells JT, Farrell LD, Fontenelle LJ) Proc West Pharmacol Soc 1977;20:199-203 |
| 1 | Distraction rod stabilization in the treatment of metastatic carcinoma. (Cusick JF, Larson SJ, Walsh PR, Steiner RE) J Neurosurg 1983 Nov;59(5):861-6 18 Citations |
| 1 | Mucoepidermoid carcinoma of the bronchus in a 4-year-old child. A high-grade variant with lymph node metastasis. (Seo IS, Warren J, Mirkin LD, Weisman SJ, Grosfeld JL) Cancer 1984 Apr 01;53(7):1600-4 62 Citations |
| 1 | A case report of leptomeningeal involvement of pancreatic carcinoma following whole body hyperthermia (Neville AJ, Robins IH, Longo WL) Cancer Journal 1986;1(3):132-134 |
| 1 | Trisomy 12 correlates with elevated expression of p21 ras in a human adenosquamous carcinoma of the lung. (Liang JC, Kurzrock R, Gutterman JU, Gallick GE) Cancer Genet Cytogenet 1986 Oct;23(2):183-8 29 Citations |
| 1 | Pharyngeal carcinoma and natural killer cell activity. (Schantz SP, Campbell BH, Guillamondegui OM) Am J Surg 1986 Oct;152(4):467-74 38 Citations |
| 1 | Osteonecrosis, fractures, and protrusio acetabuli secondary to x-irradiation therapy for prostatic carcinoma. (Csuka M, Brewer BJ, Lynch KL, McCarty DJ) J Rheumatol 1987 Feb;14(1):165-70 27 Citations |
| 1 | Phase II studies of recombinant human interferon gamma in metastatic renal cell carcinoma. (Quesada JR, Kurzrock R, Sherwin SA, Gutterman JU) J Biol Response Mod 1987 Feb;6(1):20-7 78 Citations |
| 1 | Eccrine porocarcinoma. (Matloub HS, Cunningham MW, Yousif NJ, Sanger JR, Romano JA, Choi HY) Ann Plast Surg 1988 Apr;20(4):351-5 28 Citations |
| 1 | [Cell strains of A431 epidermoid carcinoma with altered epidermal growth factor reception]. (Gudkova DA, Sorokin AB) Tsitologiia 1989 Mar;31(3):319-23 1 Citation |
| 1 | [Isolation and characteristics of monoclonal antibodies to the external domain of the EGF receptor in human A431 epidermoid carcinoma]. (Sorokin AB, Nesterov AM, Sorkin AD, Ignatova TN, Galaktionov KI) Tsitologiia 1989 May;31(5):549-55 5 Citations |
| 1 | Determination of intracellular reduced glutathione and glutathione related enzyme activities in cisplatin-sensitive and resistant experimental ovarian carcinoma cell lines. (Chen G, Frei E, Zeller WJ) Cancer Lett 1989 Aug;46(3):207-11 22 Citations |
| 1 | Evidence for the metabolism of tumor promoter organic hydroperoxides into free radicals by human carcinoma skin keratinocytes: an ESR-spin trapping study. (Athar M, Mukhtar H, Bickers DR, Khan IU, Kalyanaraman B) Carcinogenesis 1989 Aug;10(8):1499-503 57 Citations |
| 1 | Small cell undifferentiated carcinoma of the maxillary sinus: technical considerations for radiation therapy. (Janjan NA, Campbell B, Wilson JF, Zellmer D) Med Dosim 1989 Dec;14(4):273-6 7 Citations |
| 1 | [The ligand-dependent phosphorylation of epidermal growth factor receptors and the production of a secreted form of the receptor by cell strains of A-431 epidermoid carcinoma]. (Sorokin AB, Gudkova DA, Kudriavtseva NV, Nikol'skiĭ NN) Tsitologiia 1990;32(10):1026-30 |
| 1 | Activation of M3 muscarinic acetylcholine receptors inhibits voltage-dependent calcium influx in small cell lung carcinoma. (Williams CL, Lennon VA) J Biol Chem 1990 Jan 25;265(3):1443-7 33 Citations |
| 1 | Radiation therapy for squamous cell carcinomas of the oral cavity and oropharynx: a review of recent techniques. (Janjan NA, Campbell B, Wilson JF, Toohill R) Cancer Treat Rev 1990 Mar;17(1):89-101 2 Citations |
| 1 | DNA content in nasopharyngeal carcinoma. (Cheng DS, Campbell BH, Clowry LJ, Hopwood LE, Murray KJ, Toohill RJ, Hoffmann RG) Am J Otolaryngol 1990;11(6):393-7 10 Citations |
| 1 | Extended surgical resection for adenocarcinoma of the pancreas (Evans DB, Skibber JM, Ames FC, Rich TA) Cancer Bulletin 1991;43(3):279-282 5 Citations |
| 1 | Orbital metastasis as the presenting sign of adenocarcinoma of the breast. (Glazer LC, Harris GJ, Simons KB) Ophthalmic Plast Reconstr Surg 1991;7(4):252-5 30 Citations |
| 1 | Basal cell carcinoma of the lower leg occurring in association with chronic venous stasis. (Gosain A, Sanger JR, Yousif NJ, Matloub HS) Ann Plast Surg 1991 Mar;26(3):279-83 22 Citations |
| 1 | Measurement of skin dose in primary irradiation of maxillary sinus carcinoma. (Janjan NA, Zellmer D, Gillin M, Kengchon W, Campbell B) Med Dosim 1991 Mar;16(1):33-6 3 Citations |
| 1 | Adenocarcinoma of the pancreas: current management of resectable and locally advanced disease. (Evans DB, Rich TA, Byrd DR, Ames FC) South Med J 1991 May;84(5):566-70 24 Citations |
| 1 | Activation of muscarinic acetylcholine receptors inhibits cell cycle progression of small cell lung carcinoma. (Williams CL, Lennon VA) Cell Regul 1991 May;2(5):373-81 44 Citations |
| 1 | Oncocytic adrenal cortical carcinoma. (el-Naggar AK, Evans DB, Mackay B) Ultrastruct Pathol 1991;15(4-5):549-56 82 Citations |
| 1 | Concentration of Tc-99m MDP in ovarian carcinoma and its soft tissue metastases. (Beres RA, Patel N, Krasnow AZ, Isitman AT, Hellman RS, Veluvolu P, Patillo RS, Collier BD) Clin Nucl Med 1991 Aug;16(8):550-2 20 Citations |
| 1 | Hepatocellular carcinoma in hemophilia. (Colombo M, Mannucci PM, Brettler DB, Girolami A, Lian EC, Rodeghiero F, Scharrer I, Smith PS, White GC 2nd) Am J Hematol 1991 Aug;37(4):243-6 68 Citations |
| 1 | Preoperative chemoradiotherapy for adenocarcinoma of the pancreas. Rationale and technique. (Evans DB, Byrd DR, Mansfield PF) Am J Clin Oncol 1991 Aug;14(4):359-64 17 Citations |
| 1 | DNA flow cytometry of sebaceous cell carcinomas of the ocular adnexa: introduction to the technique in the evaluation of periocular tumors. (Sakol PJ, Simons KB, McFadden PW, Harris GJ, Massaro BM, Koethe S) Ophthalmic Plast Reconstr Surg 1992;8(2):77-87 4 Citations |
| 1 | Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: report on Intergroup Study 0034. (Laramore GE, Scott CB, al-Sarraf M, Haselow RE, Ervin TJ, Wheeler R, Jacobs JR, Schuller DE, Gahbauer RA, Schwade JG) Int J Radiat Oncol Biol Phys 1992;23(4):705-13 369 Citations |
| 1 | Human cell line from an adenocarcinoma of the ampulla of Vater. (Frazier ML, Brown N, Pathak S, Mackay B, Cleary K, Olive M, Byrd DR, Evans DB, Levin B) In Vitro Cell Dev Biol 1992 Mar;28A(3 Pt 1):149-53 7 Citations |
| 1 | Cytotoxicity of Clostridium difficile toxin A for human colonic and pancreatic carcinoma cell lines. (Kushnaryov VM, Redlich PN, Sedmak JJ, Lyerly DM, Wilkins TD, Grossberg SE) Cancer Res 1992 Sep 15;52(18):5096-9 12 Citations |
| 1 | Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas. (Evans DB, Rich TA, Byrd DR, Cleary KR, Connelly JH, Levin B, Charnsangavej C, Fenoglio CJ, Ames FC) Arch Surg 1992 Nov;127(11):1335-9 649 Citations |
| 1 | Carcinomas of Bartholin's gland. Histogenesis and the etiological role of human papillomavirus. (Felix JC, Cote RJ, Kramer EE, Saigo P, Goldman GH) Am J Pathol 1993 Mar;142(3):925-33 44 Citations |
| 3 | Hyperbaric oxygen therapy and squamous cell carcinoma cell line growth. (Sklizovic D, Sanger JR, Kindwall EP, Fink JG, Grunert BK, Campbell BH) Head Neck 1993;15(3):236-40 17 Citations |
| 1 | Regulation of E-cadherin-mediated adhesion by muscarinic acetylcholine receptors in small cell lung carcinoma. (Williams CL, Hayes VY, Hummel AM, Tarara JE, Halsey TJ) J Cell Biol 1993 May;121(3):643-54 96 Citations |
| 1 | In situ localization of parathyroid hormone-like protein and mRNA in intraepithelial neoplasia and invasive carcinoma of the uterine cervix. (Liapis H, Crouch EC, Roby J, Rader JS) Hum Pathol 1993 Oct;24(10):1058-66 11 Citations |
| 1 | Granulocyte-macrophage colony-stimulating factor as a cause of paraneoplastic leukaemoid reaction in advanced transitional cell carcinoma. (Wetzler M, Estrov Z, Talpaz M, Markowitz A, Gutterman JU, Kurzrock R) J Intern Med 1993 Oct;234(4):417-20 44 Citations |
| 1 | Retinoic acid induction of major histocompatibility complex class I genes in NTera-2 embryonal carcinoma cells involves induction of NF-kappa B (p50-p65) and retinoic acid receptor beta-retinoid X receptor beta heterodimers. (Segars JH, Nagata T, Bours V, Medin JA, Franzoso G, Blanco JC, Drew PD, Becker KG, An J, Tang T) Mol Cell Biol 1993 Oct;13(10):6157-69 69 Citations |
| 1 | Isolated splenic metastases from colon carcinoma. (Thomas SM, Fitzgerald JB, Pollock RE, Evans DB) Eur J Surg Oncol 1993 Oct;19(5):485-90 45 Citations |
| 1 | Preoperative and postoperative combination chemotherapy for potentially resectable gastric carcinoma. (Ajani JA, Mayer RJ, Ota DM, Steele GD, Evans D, Roh M, Sugarbaker DJ, Dumas P, Gray C, Vena DA) J Natl Cancer Inst 1993 Nov 17;85(22):1839-44 124 Citations |
| 1 | Nonfunctioning islet cell carcinoma of the pancreas. (Evans DB, Skibber JM, Lee JE, Cleary KR, Ajani JA, Gagel RF, Sellin RV, Fenoglio CJ, Merrell RC, Hickey RC) Surgery 1993 Dec;114(6):1175-81; discussion 1181-2 104 Citations |
| 1 | Is a surgical resection leaving positive margins of benefit to the patient with locally advanced squamous cell carcinoma of the head and neck: a comparative study using the intergroup study 0034 and the Radiation Therapy Oncology Group head and neck database. (Laramore GE, Scott CB, Schuller DE, Haselow RE, Ervin TJ, Wheeler R, al-Sarraf M, Gahbauer RA, Jacobs JR, Schwade JG) Int J Radiat Oncol Biol Phys 1993 Dec 01;27(5):1011-6 31 Citations |
| 1 | Early mutational activation of the c-Ki-ras oncogene in endometrial carcinoma. (Duggan BD, Felix JC, Muderspach LI, Tsao JL, Shibata DK) Cancer Res 1994 Mar 15;54(6):1604-7 82 Citations |
| 1 | Adenocarcinoma of the lung associated with eosinophilia and hidebound skin. (Henry DW, Rosenthal A, McCarty DJ) J Rheumatol 1994 May;21(5):972-3 |
| 1 | [Pain assessment and therapy in bronchial carcinoma]. (Radbruch L, Zech D, Grond S, Jung H, Meuser T) Chirurg 1994 Aug;65(8):696-701 4 Citations |
| 1 | Microsatellite instability in sporadic endometrial carcinoma. (Duggan BD, Felix JC, Muderspach LI, Tourgeman D, Zheng J, Shibata D) J Natl Cancer Inst 1994 Aug 17;86(16):1216-21 192 Citations |
| 1 | Basal cell carcinoma of the penis: case report and review of the literature. (Kim ED, Kroft S, Dalton DP) J Urol 1994 Nov;152(5 Pt 1):1557-9 12 Citations |
| 1 | Resection for cure of carcinoma of the colon directly invading the duodenum or pancreatic head. (Curley SA, Evans DB, Ames FC) J Am Coll Surg 1994 Nov;179(5):587-92 66 Citations |
| 1 | Preoperative chemoradiotherapy, pancreaticoduodenectomy, and external- beam intraoperative radiotherapy for pancreatic adenocarcinoma: The M.D. Anderson experience (Leach SD, Rich TA, Abbruzzese JL, Lee JE, Cleary KR, Katz RL, Charnsangavej C, Ames FC, Buchholz DJ, Fenoglio CJ, Stanford P, Evans DB) Cancer Bulletin 1994;46(6):518-524 3 Citations |
| 1 | Indeterminate fine-needle aspiration biopsy of the thyroid: identification of subgroups at high risk for invasive carcinoma. (Tyler DS, Winchester DJ, Caraway NP, Hickey RC, Evans DB) Surgery 1994 Dec;116(6):1054-60 128 Citations |
| 1 | Preoperative chemoradiation for adenocarcinoma of the pancreas: M.D. Anderson experience (Evans DB, Abbruzzese JL, Lee JE, Leach SD, Charnsangavej C, Cleary KR, Buchholz DJ, Rich TA) Seminars in Surgical Oncology March/April 1995;11(2):132-140 10 Citations |
| 1 | Cisplatin, 5-fluorouracil, and leucovorin in the therapy of adenocarcinomas of the pancreas (Jones DV, Sugarman SM, Markowitz AB, Levin B, Abbruzzese JL, Evans DB, Charnsangavej C, Smith R, Patt YZ) Oncology Reports 1995;2(6):1121-1123 |
| 1 | Laser-Induced FLuorescence in the Detection of Esophageal Carcinoma (Wang KK, Gutta K, Laukka MA, Densmore J) Proc SPIE Proc. SPIE 2324, Optical Biopsy and Fluorescence Spectroscopy and Imaging, 14 (January 4, 1995); doi:10.1117/12.198731 |
| 1 | Abnormalities in the PRAD1 (CYCLIN D1/BCL-1) oncogene are frequent in cervical and vulvar squamous cell carcinoma cell lines. (Kurzrock R, Ku S, Talpaz M) Cancer 1995 Jan 15;75(2):584-90 58 Citations |
| 1 | Heuristically derived tumor burden score as a prognostic factor for stage IIIB carcinoma of the cervix. (Arthur D, Kaufman N, Schmidt-Ullrich R, Kavanagh B, Simpson P, Hill M, Ali M) Int J Radiat Oncol Biol Phys 1995 Feb 15;31(4):743-51 15 Citations |
| 1 | Central mucoepidermoid carcinoma of the mandible. (Freije JE, Campbell BH, Yousif NJ, Clowry LJ Jr) Otolaryngol Head Neck Surg 1995 Mar;112(3):453-6 24 Citations |
| 1 | Endogenous human renin expression and promoter activity in CALU-6, a pulmonary carcinoma cell line. (Lang JA, Yang G, Kern JA, Sigmund CD) Hypertension 1995 Apr;25(4 Pt 2):704-10 40 Citations |
| 3 | Case report: renal phosphate wasting, syndrome of inappropriate antidiuretic hormone, and ectopic corticotropin production in small cell carcinoma. (Shaker JL, Brickner RC, Divgi AB, Raff H, Findling JW) Am J Med Sci 1995 Jul;310(1):38-41 16 Citations |
| 1 | RET proto-oncogene mutations in multiple endocrine neoplasia type 2 and medullary thyroid carcinoma. (Cote GJ, Wohllk N, Evans D, Goepfert H, Gagel RF) Baillieres Clin Endocrinol Metab 1995 Jul;9(3):609-30 33 Citations |
| 1 | Primary squamous cell carcinoma of the breast: sensitivity to cisplatinum-based chemotherapy. (Dejager D, Redlich PN, Dayer AM, Davis HL, Komorowski RA) J Surg Oncol 1995 Jul;59(3):199-203 67 Citations |
| 1 | Monoclonal antibodies against EGFRvIII are tumor specific and react with breast and lung carcinomas and malignant gliomas. (Wikstrand CJ, Hale LP, Batra SK, Hill ML, Humphrey PA, Kurpad SN, McLendon RE, Moscatello D, Pegram CN, Reist CJ) Cancer Res 1995 Jul 15;55(14):3140-8 472 Citations |
| 1 | Functional gastric impairment in carcinoma of the pancreas. (Sikora SS, Mital BR, Prasad KR, Das BK, Kaushik SP) Br J Surg 1995 Aug;82(8):1112-3 17 Citations |
| 1 | Significance of peritoneal cytology in patients with potentially resectable adenocarcinoma of the pancreatic head. (Leach SD, Rose JA, Lowy AM, Lee JE, Charnsangavej C, Abbruzzese JL, Katz RL, Evans DB) Surgery 1995 Sep;118(3):472-8 92 Citations |
| 1 | X chromosome inactivation and microsatellite instability in early and advanced bilateral ovarian carcinomas. (Park TW, Felix JC, Wright TC Jr) Cancer Res 1995 Nov 01;55(21):4793-6 29 Citations |
| 1 | Preoperative chemoradiation for adenocarcinoma of the pancreas: excessive toxicity of prophylactic hepatic irradiation. (Evans DB, Abbruzzese JL, Cleary KR, Buchholz DJ, Fenoglio CJ, Collier C, Rich TA) Int J Radiat Oncol Biol Phys 1995 Nov 01;33(4):913-8 32 Citations |
| 1 | Laser-induced fluorescence in the detection of esophageal carcinoma (Wang KK, Gutta K, Laukka MA, Densmore J) Proceedings of SPIE - The International Society for Optical Engineering 1995;2324:14-18 10 Citations |
| 1 | Surgical management, DNA content, and patient survival in adrenal cortical carcinoma. (Lee JE, Berger DH, el-Naggar AK, Hickey RC, Vassilopoulou-Sellin R, Gagel RF, Burgess MA, Evans DB) Surgery 1995 Dec;118(6):1090-8 104 Citations |
| 1 | Inhibition of voltage-gated Ca2+ channel activity in small cell lung carcinoma by the Ca2+/calmodulin-dependent protein kinase inhibitor KN-62 (1-[N,O-bis(5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenylpiperaz ine) . (Williams CL, Porter RA, Phelps SH) Biochem Pharmacol 1995 Dec 22;50(12):1979-85 14 Citations |
| 1 | WAF1/Cip1 gene polymorphism and expression in carcinomas of the breast, ovary and endometrium (Lukas J, Niu N, Saffarinazari B, Felix J, Jones L, Hall FL, Press MF) Journal of Investigative Medicine 1996;44(1) |
| 1 | Preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for adenocarcinoma of the pancreatic head. (Staley CA, Lee JE, Cleary KR, Abbruzzese JL, Fenoglio CJ, Rich TA, Evans DB) Am J Surg 1996 Jan;171(1):118-24; discussion 124-5 225 Citations |
| 1 | Patterns of recurrence following hysterectomy and radiation for cervical carcinoma: Relationship to residual disease and brachytherapy techniques (Lattanzi J, Erickson B) International Journal of Gynecological Cancer 1996;6(5):396-404 1 Citation |
| 1 | Pancreatic adenocarcinoma cell line, MDAPanc-28, with features of both acinar and ductal cells. (Frazier ML, Fernández E, de Llorens R, Brown NM, Pathak S, Cleary KR, Abbruzzese JL, Berry K, Olive M, Le Maistre A, Evans DB) Int J Pancreatol 1996 Feb;19(1):31-8 30 Citations |
| 1 | Rationale for en bloc vein resection in the treatment of pancreatic adenocarcinoma adherent to the superior mesenteric-portal vein confluence. Pancreatic Tumor Study Group. (Fuhrman GM, Leach SD, Staley CA, Cusack JC, Charnsangavej C, Cleary KR, El-Naggar AK, Fenoglio CJ, Lee JE, Evans DB) Ann Surg 1996 Feb;223(2):154-62 373 Citations |
| 1 | Annular constriction of the rectum secondary to transitional cell carcinoma of the bladder. (Langenstroer P, Zacharias A, Almagro U, Dewire D) Urology 1996 Mar;47(3):442-4 21 Citations |
| 1 | Application of genetic screening information to the management of medullary thyroid carcinoma and multiple endocrine neoplasia type 2. (Wohllk N, Cote GJ, Evans DB, Goepfert H, Ordonez NG, Gagel RF) Endocrinol Metab Clin North Am 1996 Mar;25(1):1-25 60 Citations |
| 1 | Expression of Ca2+/calmodulin-dependent protein kinase types II and IV, and reduced DNA synthesis due to the Ca2+/calmodulin-dependent protein kinase inhibitor KN-62 (1-[N,O-bis(5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenyl piperazine) in small cell lung carcinoma. (Williams CL, Phelps SH, Porter RA) Biochem Pharmacol 1996 Mar 08;51(5):707-15 44 Citations |
| 1 | Vascular involvement in pancreatic adenocarcinoma: reassessment by thin-section CT. (Loyer EM, David CL, Dubrow RA, Evans DB, Charnsangavej C) Abdom Imaging 1996;21(3):202-6 139 Citations |
| 1 | Inverted papilloma associated with squamous cell carcinoma and adenocarcinoma: case report and review of the literature. (Kerschner JE, Futran ND, Chaney V) Am J Otolaryngol 1996;17(4):257-9 11 Citations |
| 1 | Association of gastric adenocarcinoma with the HLA class II gene DQB10301. (Lee JE, Lowy AM, Thompson WA, Lu M, Loflin PT, Skibber JM, Evans DB, Curley SA, Mansfield PF, Reveille JD) Gastroenterology 1996 Aug;111(2):426-32 79 Citations |
| 1 | Relevance of RET proto-oncogene mutations in sporadic medullary thyroid carcinoma. (Wohllk N, Cote GJ, Bugalho MM, Ordonez N, Evans DB, Goepfert H, Khorana S, Schultz P, Richards CS, Gagel RF) J Clin Endocrinol Metab 1996 Oct;81(10):3740-5 191 Citations |
| 1 | Cutaneous keratocyst in naevoid basal cell carcinoma syndrome. (Baselga E, Dzwierzynski WW, Neuburg M, Troy JL, Esterly NB) Br J Dermatol 1996 Nov;135(5):810-2 26 Citations |
| 1 | Reoperative pancreaticoduodenectomy for periampullary carcinoma. (Robinson EK, Lee JE, Lowy AM, Fenoglio CJ, Pisters PW, Evans DB) Am J Surg 1996 Nov;172(5):432-7; discussion 437-8 32 Citations |
| 3 | Carcinoma of the larynx in patients with gastroesophageal reflux. (Freije JE, Beatty TW, Campbell BH, Woodson BT, Schultz CJ, Toohill RJ) Am J Otolaryngol 1996;17(6):386-90 109 Citations |
| 1 | Adenocarcinoma of the pancreas: recent controversies, current management, and future therapies (Evans DB, Staley CA, Lee JE, Pisters PWT, Abbruzzese JL) GI Cancer 1996;1(3):149-161 18 Citations |
| 1 | bcl-2 and p53 expression in resectable pancreatic adenocarcinomas: association with clinical outcome. (Sinicrope FA, Evans DB, Leach SD, Cleary KR, Fenoglio CJ, Lee JJ, Abbruzzese JL) Clin Cancer Res 1996 Dec;2(12):2015-22 56 Citations |
| 1 | Medullary thyroid carcinoma. (Evans DB, Burgess MA, Goepfert H, Gagel RF) Curr Ther Endocrinol Metab 1997;6:127-32 13 Citations |
| 1 | Advances in the diagnosis and treatment of adenocarcinoma of the pancreas. (Evans DB, Lee JE, Pisters PW, Charnsangavej C, Ellis LM, Chiao PJ, Lenzi R, Abbruzzese JL) Cancer Treat Res 1997;90:109-25 31 Citations |
| 1 | WAF1/Cip1 gene polymorphism and expression in carcinomas of the breast, ovary, and endometrium. (Lukas J, Groshen S, Saffari B, Niu N, Reles A, Wen WH, Felix J, Jones LA, Hall FL, Press MF) Am J Pathol 1997 Jan;150(1):167-75 83 Citations |
| 1 | Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas. (Spitz FR, Abbruzzese JL, Lee JE, Pisters PW, Lowy AM, Fenoglio CJ, Cleary KR, Janjan NA, Goswitz MS, Rich TA, Evans DB) J Clin Oncol 1997 Mar;15(3):928-37 508 Citations |
| 1 | Expression of alpha(v)beta3 integrin is less frequent in ovarian epithelial tumors of low malignant potential in contrast to ovarian carcinomas. (Liapis H, Adler LM, Wick MR, Rader JS) Hum Pathol 1997 Apr;28(4):443-9 103 Citations |
| 1 | Regulation of cadherin-mediated adhesion by the small GTP-binding protein Rho in small cell lung carcinoma cells. (Tokman MG, Porter RA, Williams CL) Cancer Res 1997 May 01;57(9):1785-93 35 Citations |
| 1 | Multimodality therapy for adenocarcinoma of the pancreas: The M.D. Anderson experience (Evans DB, Pisters PWT, Lee JE) Problems in General Surgery June 1997;14(2):117-124 2 Citations |
| 3 | The role of dental prostheses in alveolar ridge squamous carcinomas. (Campbell BH, Mark DH, Soneson EA, Freije JE, Schultz CJ) Arch Otolaryngol Head Neck Surg 1997 Oct;123(10):1112-5 8 Citations |
| 1 | Induction of p21waf1 expression and growth inhibition by transforming growth factor beta involve the tumor suppressor gene DPC4 in human pancreatic adenocarcinoma cells. (Grau AM, Zhang L, Wang W, Ruan S, Evans DB, Abbruzzese JL, Zhang W, Chiao PJ) Cancer Res 1997 Sep 15;57(18):3929-34 147 Citations |
| 1 | Nicotinic acetylcholine receptors of muscle and neuronal (alpha7) types coexpressed in a small cell lung carcinoma. (Sciamanna MA, Griesmann GE, Williams CL, Lennon VA) J Neurochem 1997 Dec;69(6):2302-11 47 Citations |
| 1 | Neoadjuvant chemoradiation for extrahepatic cholangiocarcinoma. (McMasters KM, Tuttle TM, Leach SD, Rich T, Cleary KR, Evans DB, Curley SA) Am J Surg 1997 Dec;174(6):605-8; discussion 608-9 204 Citations |
| 1 | Neoadjuvant chemoradiation for adenocarcinoma of the pancreas. (Miller AR, Robinson EK, Lee JE, Pisters PW, Chiao PJ, Lenzi RL, Abbruzzese JL, Evans DB) Surg Oncol Clin N Am 1998 Jan;7(1):183-97 20 Citations |
| 1 | Interleukin-1 increases expression of the LYT-10 (NFkappaB2) proto-oncogene/transcription factor in renal cell carcinoma lines. (Kurzrock R, Estrov Z, Ku S, Leonard M, Talpaz M) J Lab Clin Med 1998 Mar;131(3):261-8 5 Citations |
| 1 | Loss of heterozygosity in clinical stage IB cervical carcinoma: relationship with clinical and histopathologic features. (Huettner PC, Gerhard DS, Li L, Gersell DJ, Dunnigan K, Kamarasova T, Rader JS) Hum Pathol 1998 Apr;29(4):364-70 38 Citations |
| 1 | Vessel counts and vascular endothelial growth factor expression in pancreatic adenocarcinoma. (Ellis LM, Takahashi Y, Fenoglio CJ, Cleary KR, Bucana CD, Evans DB) Eur J Cancer 1998 Feb;34(3):337-40 162 Citations |
| 1 | Survival following pancreaticoduodenectomy with resection of the superior mesenteric-portal vein confluence for adenocarcinoma of the pancreatic head. (Leach SD, Lee JE, Charnsangavej C, Cleary KR, Lowy AM, Fenoglio CJ, Pisters PW, Evans DB) Br J Surg 1998 May;85(5):611-7 297 Citations |
| 1 | Parity, age at first birth and the risk of carcinoma in situ of the breast. (Lambe M, Hsieh CC, Tsaih SW, Ekbom A, Trichopoulos D, Adami HO) Int J Cancer 1998 Jul 29;77(3):330-2 38 Citations |
| 1 | Epidermal growth factor receptor expression in primary cultured human colorectal carcinoma cells. (Tong WM, Ellinger A, Sheinin Y, Cross HS) Br J Cancer 1998 Jun;77(11):1792-8 52 Citations |
| 1 | Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas. (Miller AR, Pisters PW, Lee JE, Janjan NA, Abbruzzese JL, Evans DB) Hepatogastroenterology 1998;45(21):624-33 9 Citations |
| 1 | Carcinoma of the breast in males: a multiinstitutional survey. (Donegan WL, Redlich PN, Lang PJ, Gall MT) Cancer 1998 Aug 01;83(3):498-509 203 Citations |
| 1 | Regulation of integrin-mediated adhesion by muscarinic acetylcholine receptors and protein kinase C in small cell lung carcinoma. (Quigley RL, Shafer SH, Williams CL) Chest 1998 Sep;114(3):839-46 27 Citations |
| 1 | Activation of protein kinase Calpha couples cell volume to membrane Cl- permeability in HTC hepatoma and Mz-ChA-1 cholangiocarcinoma cells. (Roman RM, Bodily KO, Wang Y, Raymond JR, Fitz JG) Hepatology 1998 Oct;28(4):1073-80 50 Citations |
| 1 | Neoadjuvant chemoradiation for adenocarcinoma of the pancreas. (Breslin TM, Janjan NA, Lee JE, Pisters PW, Wolff RA, Abbruzzese JL, Evans DB) Front Biosci 1998 Nov 01;3:E193-203 22 Citations |
| 1 | Reduced DNA synthesis and cell viability in small cell lung carcinoma by treatment with cyclic AMP phosphodiesterase inhibitors. (Shafer SH, Phelps SH, Williams CL) Biochem Pharmacol 1998 Nov 01;56(9):1229-36 46 Citations |
| 1 | p53 immunostaining as a significant adjunct diagnostic method for uterine surface carcinoma: precursor of uterine papillary serous carcinoma. (Zheng W, Khurana R, Farahmand S, Wang Y, Zhang ZF, Felix JC) Am J Surg Pathol 1998 Dec;22(12):1463-73 88 Citations |
| 1 | Rapid-fractionation preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for resectable pancreatic adenocarcinoma. (Pisters PW, Abbruzzese JL, Janjan NA, Cleary KR, Charnsangavej C, Goswitz MS, Rich TA, Raijman I, Wolff RA, Lenzi R, Lee JE, Evans DB) J Clin Oncol 1998 Dec;16(12):3843-50 229 Citations |
| 1 | Overexpression of the tumor suppressor gene Smad4/DPC4 induces p21waf1 expression and growth inhibition in human carcinoma cells. (Hunt KK, Fleming JB, Abramian A, Zhang L, Evans DB, Chiao PJ) Cancer Res 1998 Dec 15;58(24):5656-61 50 Citations |
| 1 | Hepatocellular carcinoma after renal transplantation in the absence of cirrhosis or viral hepatitis: a case series. (Saeian K, Franco J, Komorowski RA, Adams MB) Liver Transpl Surg 1999 Jan;5(1):46-9 19 Citations |
| 1 | Preoperative chemoradiation strategies for localized adenocarcinoma of the pancreas. (Evans DB, Pisters PW, Lee JE, Bold RJ, Charnsangavej C, Janjan NA, Wolff RA, Abbruzzese JL) J Hepatobiliary Pancreat Surg 1998;5(3):242-50 42 Citations |
| 1 | The surgical treatment of medullary thyroid carcinoma. (Evans DB, Fleming JB, Lee JE, Cote G, Gagel RF) Semin Surg Oncol 1999;16(1):50-63 57 Citations |
| 1 | Endostatin: yeast production, mutants, and antitumor effect in renal cell carcinoma. (Dhanabal M, Ramchandran R, Volk R, Stillman IE, Lombardo M, Iruela-Arispe ML, Simons M, Sukhatme VP) Cancer Res 1999 Jan 01;59(1):189-97 260 Citations |
| 1 | Relative expression of E-cadherin and type IV collagenase genes predicts disease outcome in patients with resectable pancreatic carcinoma. (Kuniyasu H, Ellis LM, Evans DB, Abbruzzese JL, Fenoglio CJ, Bucana CD, Cleary KR, Tahara E, Fidler IJ) Clin Cancer Res 1999 Jan;5(1):25-33 117 Citations |
| 1 | The nuclear factor-kappa B RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells. (Wang W, Abbruzzese JL, Evans DB, Larry L, Cleary KR, Chiao PJ) Clin Cancer Res 1999 Jan;5(1):119-27 652 Citations |
| 1 | Differences in patterns of TP53 and KRAS2 mutations in a large series of endometrial carcinomas with or without microsatellite instability. (Swisher EM, Peiffer-Schneider S, Mutch DG, Herzog TJ, Rader JS, Elbendary A, Goodfellow PJ) Cancer 1999 Jan 01;85(1):119-26 38 Citations |
| 1 | Biochemical characterization of in vivo alkylating agent resistance of a murine EMT-6 mammary carcinoma. Implication for systemic involvement in the resistance phenotype. (Chen G, Teicher BA, Frei E 3rd) Cancer Biochem Biophys 1998 Jun;16(1-2):139-55 9 Citations |
| 1 | The American brachytherapy society survey of brachytherapy practice for carcinoma of the cervix in the United States. (Nag S, Orton C, Young D, Erickson B) Gynecol Oncol 1999 Apr;73(1):111-8 81 Citations |
| 1 | Epidermal growth factor receptor blockade with C225 modulates proliferation, apoptosis, and radiosensitivity in squamous cell carcinomas of the head and neck. (Huang SM, Bock JM, Harari PM) Cancer Res 1999 Apr 15;59(8):1935-40 709 Citations |
| 1 | Lymphoscintigraphy with sentinel lymph node biopsy in cutaneous Merkel cell carcinoma. (Sian KU, Wagner JD, Sood R, Park HM, Havlik R, Coleman JJ) Ann Plast Surg 1999 Jun;42(6):679-82 42 Citations |
| 1 | Overexpression of urokinase-type plasminogen activator in pancreatic adenocarcinoma is regulated by constitutively activated RelA. (Wang W, Abbruzzese JL, Evans DB, Chiao PJ) Oncogene 1999 Aug 12;18(32):4554-63 150 Citations |
| 1 | Subglottic carcinoma: review of a series and characterization of its patterns of spread. (Strome SE, Robey TC, Devaney KO, Krause CJ, Hogikyan ND) Ear Nose Throat J 1999 Aug;78(8):622-4, 626, 628, passim 24 Citations |
| 1 | Lack of effect of tumor size on the prognosis of carcinoma of the uterine cervix Stage IB and IIA treated with preoperative irradiation and surgery. (Grigsby PW, Perez CA, Chao KS, Elbendary A, Herzog TJ, Rader JS, Mutch DG) Int J Radiat Oncol Biol Phys 1999 Oct 01;45(3):645-51 23 Citations |
| 1 | Surgical strategy for the treatment of medullary thyroid carcinoma. (Fleming JB, Lee JE, Bouvet M, Schultz PN, Sherman SI, Sellin RV, Friend KE, Burgess MA, Cote GJ, Gagel RF, Evans DB) Ann Surg 1999 Nov;230(5):697-707 136 Citations |
| 1 | Enhanced staging and all chemotherapy preoperatively in patients with potentially resectable gastric carcinoma. (Ajani JA, Mansfield PF, Lynch PM, Pisters PW, Feig B, Dumas P, Evans DB, Raijman I, Hargraves K, Curley S, Ota DM) J Clin Oncol 1999 Aug;17(8):2403-11 91 Citations |
| 1 | Modulation of tumor cell proliferation and apoptosis by polyamine depletion in cells of head and neck squamous cell carcinomas. (Bock JM, Pickart MA, Pink JJ, Harari PM) Radiat Res 1999 Dec;152(6):604-10 9 Citations |
| 1 | Periocular deep cutaneous basal cell carcinoma. (Garcia GH, Neuburg M, Troy JL, Harris GJ, Gonnering RS) Ophthalmic Plast Reconstr Surg 1999 Nov;15(6):393-5 3 Citations |
| 1 | A single-visit cervical carcinoma prevention program offered at an inner city church: A pilot project. (Holschneider CH, Felix JC, Satmary W, Johnson MT, Sandweiss LM, Montz FJ) Cancer 1999 Dec 15;86(12):2659-67 31 Citations |
| 1 | Evaluation of gemcitabine in patients with squamous cell carcinoma of the cervix: a Phase II study of the gynecologic oncology group. (Schilder RJ, Blessing JA, Morgan M, Mangan CE, Rader JS) Gynecol Oncol 2000 Feb;76(2):204-7 83 Citations |
| 1 | Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. (Pignon JP, Bourhis J, Domenge C, Designé L) Lancet 2000 Mar 18;355(9208):949-55 2336 Citations |
| 1 | Are there several types of colorectal carcinomas? Correlations with genetic data. (Martin L, Assem M, Piard F) Eur J Cancer Prev 1999 Dec;8 Suppl 1:S13-20 20 Citations |
| 1 | Epidermal growth factor receptor blockade with C225 plus gemcitabine results in regression of human pancreatic carcinoma growing orthotopically in nude mice by antiangiogenic mechanisms. (Bruns CJ, Harbison MT, Davis DW, Portera CA, Tsan R, McConkey DJ, Evans DB, Abbruzzese JL, Hicklin DJ, Radinsky R) Clin Cancer Res 2000 May;6(5):1936-48 427 Citations |
| 1 | Small cell lung carcinoma exhibits greater phospholipase C-beta1 expression and edelfosine resistance compared with non-small cell lung carcinoma. (Strassheim D, Shafer SH, Phelps SH, Williams CL) Cancer Res 2000 May 15;60(10):2730-6 47 Citations |
| 1 | Current approaches and future strategies for pancreatic carcinoma. (Wolff RA, Chiao P, Lenzi R, Pisters PW, Lee JE, Janjan NA, Crane CH, Evans DB, Abbruzzese JL) Invest New Drugs 2000 Feb;18(1):43-56 36 Citations |
| 1 | The detection of telomerase activity in patients with adenocarcinoma of the pancreas by fine needle aspiration. (Pearson AS, Chiao P, Zhang L, Zhang W, Larry L, Katz RL, Evans DB, Abbruzzese JL) Int J Oncol 2000 Aug;17(2):381-5 38 Citations |
| 1 | The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the cervix. (Nag S, Erickson B, Thomadsen B, Orton C, Demanes JD, Petereit D) Int J Radiat Oncol Biol Phys 2000 Aug 01;48(1):201-11 427 Citations |
| 1 | Human papillomavirus infection in "young" versus "old" patients with squamous cell carcinoma of the head and neck. (Sisk EA, Bradford CR, Jacob A, Yian CH, Staton KM, Tang G, Harris MO, Carey TE, Lancaster WD, Gregoire L) Head Neck 2000 Oct;22(7):649-57 47 Citations |
| 1 | The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the endometrium. (Nag S, Erickson B, Parikh S, Gupta N, Varia M, Glasgow G) Int J Radiat Oncol Biol Phys 2000 Oct 01;48(3):779-90 219 Citations |
| 1 | Relation between appropriateness of primary therapy for early-stage breast carcinoma and increased use of breast-conserving surgery. (Nattinger AB, Hoffmann RG, Kneusel RT, Schapira MM) Lancet 2000 Sep 30;356(9236):1148-53 158 Citations |
| 1 | Clinical significance of microsatellite instability in endometrial carcinoma. (Basil JB, Goodfellow PJ, Rader JS, Mutch DG, Herzog TJ) Cancer 2000 Oct 15;89(8):1758-64 113 Citations |
| 1 | In situ mRNA hybridization analysis and immunolocalization of the vitamin D receptor in normal and carcinomatous human colonic mucosa: relation to epidermal growth factor receptor expression. (Sheinin Y, Kaserer K, Wrba F, Wenzl E, Kriwanek S, Peterlik M, Cross HS) Virchows Arch 2000 Nov;437(5):501-7 56 Citations |
| 2 | Selective irradiation for the treatment of recurrent ovarian carcinoma involving the vagina or rectum. (Firat S, Erickson B) Gynecol Oncol 2001 Feb;80(2):213-20 29 Citations |
| 1 | Radiation therapy for carcinoma of the cervix with biopsy-proven positive para-aortic lymph nodes. (Grigsby PW, Perez CA, Chao KS, Herzog T, Mutch DG, Rader J) Int J Radiat Oncol Biol Phys 2001 Mar 01;49(3):733-8 62 Citations |
| 1 | Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: treatment variables and survival duration. (Breslin TM, Hess KR, Harbison DB, Jean ME, Cleary KR, Dackiw AP, Wolff RA, Abbruzzese JL, Janjan NA, Crane CH, Vauthey JN, Lee JE, Pisters PW, Evans DB) Ann Surg Oncol 2001 Mar;8(2):123-32 327 Citations |
| 1 | Re: Surgery for ductal adenocarcinoma of the pancreatic head. (Pisters PW, Evans DB, Leung DH, Brennan MF) World J Surg 2001 Apr;25(4):533-4 15 Citations |
| 1 | Pathology forum: quiz case 2. Mucoepidermoid carcinoma (intermediate grade) of the trachea. (Blumin JH, Golsorkhi AA, Feinberg GM, Berke GS) Arch Otolaryngol Head Neck Surg 2001 May;127(5):595, 597-8 |
| 1 | Preoperative chemoradiation for resectable and locally advanced adenocarcinoma of the pancreas. (Evans DB) J Gastrointest Surg 2001;5(1):2-5 18 Citations |
| 1 | Loss of heterozygosity at 11q23.3 in vasculoinvasive and metastatic squamous cell carcinoma of the cervix. (O'sullivan MJ, Rader JS, Gerhard DS, Li Y, Trinkaus KM, Gersell DJ, Huettner PC) Hum Pathol 2001 May;32(5):475-8 17 Citations |
| 1 | High-dose intra-arterial cisplatin boost with hyperfractionated radiation therapy for advanced squamous cell carcinoma of the head and neck. (Regine WF, Valentino J, Arnold SM, Haydon RC, Sloan D, Kenady D, Strottmann J, Pulmano C, Mohiuddin M) J Clin Oncol 2001 Jul 15;19(14):3333-9 30 Citations |
| 1 | Phase I trial of gemcitabine combined with radiation for the treatment of locally advanced pancreatic adenocarcinoma. (Wolff RA, Evans DB, Gravel DM, Lenzi R, Pisters PW, Lee JE, Janjan NA, Charnsangavej C, Abbruzzese JL) Clin Cancer Res 2001 Aug;7(8):2246-53 187 Citations |
| 1 | Using MR angiography for surgical planning in pelvic kidney renal cell carcinoma. (Kocak M, Sudakoff GS, Erickson S, Begun F, Datta M) AJR Am J Roentgenol 2001 Sep;177(3):659-60 17 Citations |
| 1 | Antigenic characterization of medullary carcinoma of the breast: HLA-DR expression in lymph node positive cases. (Lazzaro B, Anderson AE, Kajdacsy-Balla A, Hessner MJ) Appl Immunohistochem Mol Morphol 2001 Sep;9(3):234-41 24 Citations |
| 1 | Adrenal cortical carcinoma. (Dackiw AP, Lee JE, Gagel RF, Evans DB) World J Surg 2001 Jul;25(7):914-26 293 Citations |
| 1 | Intravesical valrubicin in the treatment of carcinoma in situ of the bladder. (Kuznetsov DD, Alsikafi NF, O'Connor RC, Steinberg GD) Expert Opin Pharmacother 2001 Jun;2(6):1009-13 22 Citations |
| 2 | In vivo proton (H1) magnetic resonance spectroscopy for cervical carcinoma. (Allen JR, Prost RW, Griffith OW, Erickson SJ, Erickson BA) Am J Clin Oncol 2001 Oct;24(5):522-9 47 Citations |
| 2 | Hepatocellular carcinoma: multimodality management. (Christians KK, Pitt HA, Rilling WS, Franco J, Quiroz FA, Adams MB, Wallace JR, Quebbeman EJ) Surgery 2001 Oct;130(4):554-9; discussion 559-60 25 Citations |
| 1 | Nonfunctioning islet cell carcinoma of the pancreas: survival results in a contemporary series of 163 patients. (Solorzano CC, Lee JE, Pisters PW, Vauthey JN, Ayers GD, Jean ME, Gagel RF, Ajani JA, Wolff RA, Evans DB) Surgery 2001 Dec;130(6):1078-85 225 Citations |
| 1 | Myofibroblasts are responsible for the desmoplastic reaction surrounding human pancreatic carcinomas (Yen TWF, Aardal NP, Bronner MP, Thorning DR, Savard CE, Lee SP, Bell RH) Surgery 2002;131(2):129-134 118 Citations |
| 1 | The American Brachytherapy Society recommendations for low-dose-rate brachytherapy for carcinoma of the cervix. (Nag S, Chao C, Erickson B, Fowler J, Gupta N, Martinez A, Thomadsen B, American Brachytherapy Society) Int J Radiat Oncol Biol Phys 2002 Jan 01;52(1):33-48 124 Citations |
| 1 | Epinephrine inhibits invasion of oral squamous carcinoma cells by modulating intracellular cAMP. (Yamanaka Y, Mammoto T, Kirita T, Mukai M, Mashimo T, Sugimura M, Kishi Y, Nakamura H) Cancer Lett 2002 Feb 25;176(2):143-8 29 Citations |
| 1 | Phase II trial of pyrazoloacridine in patients with persistent or recurrent endometrial carcinoma: a Gynecologic Oncology Group Study. (Plaxe SC, Blessing JA, Husseinzadeh N, Webster KD, Rader JS, Dunton CJ) Gynecol Oncol 2002 Feb;84(2):241-4 19 Citations |
| 1 | Autocrine interleukin-6 production in renal cell carcinoma: evidence for the involvement of p53. (Angelo LS, Talpaz M, Kurzrock R) Cancer Res 2002 Feb 01;62(3):932-40 87 Citations |
| 1 | Myofibroblasts are responsible for the desmoplastic reaction surrounding human pancreatic carcinomas. (Yen TW, Aardal NP, Bronner MP, Thorning DR, Savard CE, Lee SP, Bell RH Jr) Surgery 2002 Feb;131(2):129-34 118 Citations |
| 1 | Localized adenocarcinoma of the pancreas: the rationale for preoperative chemoradiation. (Wayne JD, Abdalla EK, Wolff RA, Crane CH, Pisters PW, Evans DB) Oncologist 2002;7(1):34-45 80 Citations |
| 1 | Recurrent giant cell carcinoma of the bladder. (O'Connor RC, Hollowell CM, Laven BA, Yang XJ, Steinberg GD, Zagaja GP) J Urol 2002 Apr;167(4):1784 30 Citations |
| 1 | Randomized trial of cisplatin and ifosfamide with or without bleomycin in squamous carcinoma of the cervix: a gynecologic oncology group study. (Bloss JD, Blessing JA, Behrens BC, Mannel RS, Rader JS, Sood AK, Markman M, Benda J) J Clin Oncol 2002 Apr 01;20(7):1832-7 120 Citations |
| 1 | Preoperative paclitaxel and concurrent rapid-fractionation radiation for resectable pancreatic adenocarcinoma: toxicities, histologic response rates, and event-free outcome. (Pisters PW, Wolff RA, Janjan NA, Cleary KR, Charnsangavej C, Crane CN, Lenzi R, Vauthey JN, Lee JE, Abbruzzese JL, Evans DB) J Clin Oncol 2002 May 15;20(10):2537-44 188 Citations |
| 1 | Fluid management and postoperative respiratory disturbances in patients with transthoracic esophagectomy for carcinoma. (Kita T, Mammoto T, Kishi Y) J Clin Anesth 2002 Jun;14(4):252-6 97 Citations |
| 1 | MSI in endometrial carcinoma: absence of MLH1 promoter methylation is associated with increased familial risk for cancers. (Whelan AJ, Babb S, Mutch DG, Rader J, Herzog TJ, Todd C, Ivanovich JL, Goodfellow PJ) Int J Cancer 2002 Jun 10;99(5):697-704 36 Citations |
| 1 | Ribosomal DNA methylation in patients with endometrial carcinoma: an independent prognostic marker. (Powell MA, Mutch DG, Rader JS, Herzog TJ, Huang TH, Goodfellow PJ) Cancer 2002 Jun 01;94(11):2941-52 55 Citations |
| 1 | Phase III study of gemcitabine in combination with fluorouracil versus gemcitabine alone in patients with advanced pancreatic carcinoma: Eastern Cooperative Oncology Group Trial E2297. (Berlin JD, Catalano P, Thomas JP, Kugler JW, Haller DG, Benson AB 3rd) J Clin Oncol 2002 Aug 01;20(15):3270-5 722 Citations |
| 1 | Human papillomavirus and p53 mutational status as prognostic factors in head and neck carcinoma. (Sisk EA, Soltys SG, Zhu S, Fisher SG, Carey TE, Bradford CR) Head Neck 2002 Sep;24(9):841-9 102 Citations |
| 1 | Adenoid cystic carcinoma of the lacrimal gland: is there a cure...yet? (Bartley GB, Harris GJ) Ophthalmic Plast Reconstr Surg 2002 Sep;18(5):315-8 35 Citations |
| 1 | Hepatocellular carcinoma: obligation and opportunity for interventional radiology. (Geschwind JF, Rilling WS) J Vasc Interv Radiol 2002 Sep;13(9 Pt 2):S167 1 Citation |
| 1 | Role of antiviral therapy in the prevention of hepatocellular carcinoma. (Franco J, Saeian K) J Vasc Interv Radiol 2002 Sep;13(9 Pt 2):S191-6 10 Citations |
| 1 | Multidisciplinary management of hepatocellular carcinoma. (Rilling WS, Drooz A) J Vasc Interv Radiol 2002 Sep;13(9 Pt 2):S259-63 31 Citations |
| 1 | ESPAC-1 trial of adjuvant therapy for resectable adenocarcinoma of the pancreas. (Evans DB, Hess KR, Pisters PW) Ann Surg 2002 Nov;236(5):694; author reply 694-6 28 Citations |
| 1 | Primary peritoneal carcinoma presenting as adenocarcinoma on a Pap smear. A case report. (Wright JD, Horowitz NS, Rader JS) J Reprod Med 2002 Nov;47(11):933-5 7 Citations |
| 1 | Growth effects of raloxifene, estradiol, medroxy-progesterone acetate, and progesterone on human endometrial adenocarcinoma cells. (Boostanfar R, Amezcua CA, Tourgeman DE, Roy S, Felix JC, Stanczyk FZ) Fertil Steril 2003 Jan;79(1):223-5 7 Citations |
| 1 | Phase I study of concomitant gemcitabine and IMRT for patients with unresectable adenocarcinoma of the pancreatic head. (Crane CH, Antolak JA, Rosen II, Forster KM, Evans DB, Janjan NA, Charnsangavej C, Pisters PW, Lenzi R, Papagikos MA, Wolff RA) Int J Gastrointest Cancer 2001;30(3):123-32 57 Citations |
| 1 | The small GTPase RhoA has greater expression in small cell lung carcinoma than in non-small cell lung carcinoma and contributes to their unique morphologies. (Varker KA, Phelps SH, King MM, Williams CL) Int J Oncol 2003 Mar;22(3):671-81 18 Citations |
| 1 | A phase II study of concomitant hyperfractionated radiation therapy and double dose intra-arterial cisplatin for squamous cell carcinoma of the head and neck. (Regine WF, Valentino J, Arnold SM, Sloan D, Kenady D, Strottmann J, Mohiuddin M) Technol Cancer Res Treat 2002 Apr;1(2):133-40 2 Citations |
| 1 | Muscarinic signaling in carcinoma cells. (Williams CL) Life Sci 2003 Mar 28;72(18-19):2173-82 29 Citations |
| 1 | Administration of optimal biological dose and schedule of interferon alpha combined with gemcitabine induces apoptosis in tumor-associated endothelial cells and reduces growth of human pancreatic carcinoma implanted orthotopically in nude mice. (Solorzano CC, Hwang R, Baker CH, Bucana CD, Pisters PW, Evans DB, Killion JJ, Fidler IJ) Clin Cancer Res 2003 May;9(5):1858-67 38 Citations |
| 2 | External auditory canal eccrine spiradenocarcinoma: a case report and review of literature. (Meyer TK, Rhee JS, Smith MM, Cruz MJ, Osipov VO, Wackym PA) Head Neck 2003 Jun;25(6):505-10 23 Citations |
| 1 | Epidermal growth factor receptor-independent constitutive activation of STAT3 in head and neck squamous cell carcinoma is mediated by the autocrine/paracrine stimulation of the interleukin 6/gp130 cytokine system. (Sriuranpong V, Park JI, Amornphimoltham P, Patel V, Nelkin BD, Gutkind JS) Cancer Res 2003 Jun 01;63(11):2948-56 251 Citations |
| 1 | Frequent HOXA11 and THBS2 promoter methylation, and a methylator phenotype in endometrial adenocarcinoma. (Whitcomb BP, Mutch DG, Herzog TJ, Rader JS, Gibb RK, Goodfellow PJ) Clin Cancer Res 2003 Jun;9(6):2277-87 99 Citations |
| 1 | Giant renal cell carcinoma directly invading the heart. (Schena S, Gilleran J, Chernoff A, Massad MG) Eur J Cardiothorac Surg 2003 Jun;23(6):1054-5 |
| 1 | Non-small and small cell lung carcinoma cell lines exhibit cell type-specific sensitivity to edelfosine-induced cell death and different cell line-specific responses to edelfosine treatment. (Shafer SH, Williams CL) Int J Oncol 2003 Aug;23(2):389-400 20 Citations |
| 2 | High-dose whole abdominal and pelvic irradiation for treatment of ovarian carcinoma: long-term toxicity and outcomes. (Firat S, Murray K, Erickson B) Int J Radiat Oncol Biol Phys 2003 Sep 01;57(1):201-7 40 Citations |
| 1 | Expression and regulation of the novel vascular endothelial growth factor receptor neuropilin-1 by epidermal growth factor in human pancreatic carcinoma. (Parikh AA, Liu WB, Fan F, Stoeltzing O, Reinmuth N, Bruns CJ, Bucana CD, Evans DB, Ellis LM) Cancer 2003 Aug 15;98(4):720-9 101 Citations |
| 1 | Adenocarcinoma of the rete testis presenting in an undescended testicle. (Perry BB, Outman JE, Olsen LT, Damjanov I, Langenstroer P, Thrasher JB) J Urol 2003 Oct;170(4 Pt 1):1304 3 Citations |
| 1 | CEP-701 and CEP-751 inhibit constitutively activated RET tyrosine kinase activity and block medullary thyroid carcinoma cell growth. (Strock CJ, Park JI, Rosen M, Dionne C, Ruggeri B, Jones-Bolin S, Denmeade SR, Ball DW, Nelkin BD) Cancer Res 2003 Sep 01;63(17):5559-63 92 Citations |
| 1 | Androgen dependent regulation of bacillus Calmette-Guerin induced interleukin-6 expression in human transitional carcinoma cell lines. (Chen F, Langenstroer P, Zhang G, Iwamoto Y, See W) J Urol 2003 Nov;170(5):2009-13 44 Citations |
| 1 | Intraoperative margin assessment reduces reexcision rates in patients with ductal carcinoma in situ treated with breast-conserving surgery. (Chagpar A, Yen T, Sahin A, Hunt KK, Whitman GJ, Ames FC, Ross MI, Meric-Bernstam F, Babiera GV, Singletary SE, Kuerer HM) Am J Surg 2003 Oct;186(4):371-7 116 Citations |
| 1 | Epstein-Barr virus detected in a head and neck squamous cell carcinoma cell line derived from an immunocompromised patient. (Sisk EA, Bradford CR, Carey TE, Paulino A, Robertson E) Arch Otolaryngol Head Neck Surg 2003 Oct;129(10):1115-24 13 Citations |
| 1 | A randomized phase II evaluation of bryostatin-1 (NSC #339555) in persistent or recurrent squamous cell carcinoma of the cervix: A Gynecologic Oncology Group Study. (Armstrong DK, Blessing JA, Rader J, Sorosky JI, Gynecologic Oncology Group Study) Invest New Drugs 2003 Nov;21(4):453-7 20 Citations |
| 1 | GLUT1 immunoreaction patterns reliably distinguish hemangioblastoma from metastatic renal cell carcinoma. (North PE, Mizeracki A, Mihm MC Jr, Mrak RE) Clin Neuropathol 2000;19(3):131-7 27 Citations |
| 1 | Efficacy of targeted FasL in nasopharyngeal carcinoma. (Li JH, Shi W, Chia M, Sanchez-Sweatman O, Siatskas C, Huang D, Busson P, Klamut H, Yeh WC, Richardson C, O'Sullivan B, Gullane P, Neligan P, Medin J, Liu FF) Mol Ther 2003 Dec;8(6):964-73 27 Citations |
| 2 | Medullary thyroid carcinoma: results of a standardized surgical approach in a contemporary series of 80 consecutive patients. (Yen TW, Shapiro SE, Gagel RF, Sherman SI, Lee JE, Evans DB) Surgery 2003 Dec;134(6):890-9; discussion 899-901 71 Citations |
| 1 | A unique collision tumor in breast: invasive ductal carcinoma and mucosa-associated lymphoid tissue lymphoma. (Susnik B, Jordi Rowe J, Redlich PN, Chitambar C, Chang CC, Kampalath B) Arch Pathol Lab Med 2004 Jan;128(1):99-101 29 Citations |
| 1 | Inhibition of platelet-derived growth factor receptor phosphorylation by STI571 (Gleevec) reduces growth and metastasis of human pancreatic carcinoma in an orthotopic nude mouse model. (Hwang RF, Yokoi K, Bucana CD, Tsan R, Killion JJ, Evans DB, Fidler IJ) Clin Cancer Res 2003 Dec 15;9(17):6534-44 154 Citations |
| 1 | Increased risk for hereditary nonpolyposis colorectal cancer-associated synchronous and metachronous malignancies in patients with microsatellite instability-positive endometrial carcinoma lacking MLH1 promoter methylation. (Buttin BM, Powell MA, Mutch DG, Rader JS, Herzog TJ, Gibb RK, Huettner P, Edmonston TB, Goodfellow PJ) Clin Cancer Res 2004 Jan 15;10(2):481-90 44 Citations |
| 1 | A Phase I trial of preoperative eniluracil plus 5-fluorouracil and radiation for locally advanced or unresectable adenocarcinoma of the rectum and colon. (Czito BG, Hong TJ, Cohen DP, Tyler DS, Lee CG, Anscher MS, Ludwig KA, Seigler HF, Mantyh C, Morse MA, Lockhart AC, Petros WP, Honeycutt W, Spector NL, Ertel PJ, Mangum SG, Hurwitz HI) Int J Radiat Oncol Biol Phys 2004 Mar 01;58(3):779-85 7 Citations |
| 1 | Physician recommendations regarding tamoxifen and patient utilization of tamoxifen after surgery for ductal carcinoma in situ. (Yen TW, Hunt KK, Mirza NQ, Thomas ES, Singletary SE, Babiera GV, Meric-Bernstam F, Buchholz TA, Feig BW, Ross MI, Ames FC, Theriault RL, Kuerer HM) Cancer 2004 Mar 01;100(5):942-9 48 Citations |
| 2 | CT-guided high-dose-rate dose prescription for cervical carcinoma: the importance of uterine wall thickness. (Mai J, Rownd J, Erickson B) Brachytherapy 2002;1(1):27-35 16 Citations |
| 1 | Gastric carcinoma. (Phan AT, Ajani JA) Curr Oncol Rep 2004 May;6(3):192-8 9 Citations |
| 2 | Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. (Cooper JS, Pajak TF, Forastiere AA, Jacobs J, Campbell BH, Saxman SB, Kish JA, Kim HE, Cmelak AJ, Rotman M, Machtay M, Ensley JF, Chao KS, Schultz CJ, Lee N, Fu KK, Radiation Therapy Oncology Group 9501/Intergroup) N Engl J Med 2004 May 06;350(19):1937-44 2737 Citations |
| 1 | Posttherapy [18F] fluorodeoxyglucose positron emission tomography in carcinoma of the cervix: response and outcome. (Grigsby PW, Siegel BA, Dehdashti F, Rader J, Zoberi I) J Clin Oncol 2004 Jun 01;22(11):2167-71 210 Citations |
| 1 | Squamous cell carcinoma in a chronically rejected renal allograft. (Schena S, Bogetti D, Setty S, Kadkol S, Bruno A, Testa G, Panaro F, Benedetti E, Sankary H) Am J Transplant 2004 Jul;4(7):1208-11 19 Citations |
| 1 | Phase II study of gemcitabine in combination with docetaxel in patients with advanced pancreatic carcinoma (E1298). A trial of the eastern cooperative oncology group. (Shepard RC, Levy DE, Berlin JD, Stuart K, Harris JE, Aviles V, Thomas JP, Benson AB 3rd) Oncology 2004;66(4):303-9 34 Citations |
| 1 | Overexpression of synuclein-gamma in pancreatic adenocarcinoma. (Li Z, Sclabas GM, Peng B, Hess KR, Abbruzzese JL, Evans DB, Chiao PJ) Cancer 2004 Jul 01;101(1):58-65 66 Citations |
| 1 | A novel point mutation of the RET protooncogene involving the second intracellular tyrosine kinase domain in a family with medullary thyroid carcinoma. (Jimenez C, Dang GT, Schultz PN, El-Naggar A, Shapiro S, Barnes EA, Evans DB, Vassilopoulou-Sellin R, Gagel RF, Cote GJ, Hoff AO) J Clin Endocrinol Metab 2004 Jul;89(7):3521-6 40 Citations |
| 1 | Renal infarction secondary to infiltrative transitional cell carcinoma. (Castle EP, Blackford T, Langenstroer P) J Urol 2004 Aug;172(2):477 |
| 1 | Preliminary results of Radiation Therapy Oncology Group 97-03: a randomized phase ii trial of concurrent radiation and chemotherapy for advanced squamous cell carcinomas of the head and neck. (Garden AS, Harris J, Vokes EE, Forastiere AA, Ridge JA, Jones C, Horwitz EM, Glisson BS, Nabell L, Cooper JS, Demas W, Gore E) J Clin Oncol 2004 Jul 15;22(14):2856-64 168 Citations |
| 1 | Parathyroid carcinoma: a 22-year experience. (Busaidy NL, Jimenez C, Habra MA, Schultz PN, El-Naggar AK, Clayman GL, Asper JA, Diaz EM Jr, Evans DB, Gagel RF, Garden A, Hoff AO, Lee JE, Morrison WH, Rosenthal DI, Sherman SI, Sturgis EM, Waguespack SG, Weber RS, Wirfel K, Vassilopoulou-Sellin R) Head Neck 2004 Aug;26(8):716-26 244 Citations |
| 1 | Pheochromocytoma and medullary thyroid carcinoma: a new genotype-phenotype correlation of the RET protooncogene 891 germline mutation. (Jimenez C, Habra MA, Huang SC, El-Naggar A, Shapiro SE, Evans DB, Cote G, Gagel RF) J Clin Endocrinol Metab 2004 Aug;89(8):4142-5 37 Citations |
| 1 | Infectivity enhanced adenoviral-mediated mda-7/IL-24 gene therapy for ovarian carcinoma. (Leath CA 3rd, Kataram M, Bhagavatula P, Gopalkrishnan RV, Dent P, Fisher PB, Pereboev A, Carey D, Lebedeva IV, Haisma HJ, Alvarez RD, Curiel DT, Mahasreshti PJ) Gynecol Oncol 2004 Aug;94(2):352-62 26 Citations |
| 1 | Patterns of radiotherapy practice for patients with carcinoma of the uterine cervix: a patterns of care study. (Eifel PJ, Moughan J, Erickson B, Iarocci T, Grant D, Owen J) Int J Radiat Oncol Biol Phys 2004 Nov 15;60(4):1144-53 120 Citations |
| 1 | Proposed guidelines for image-based intracavitary brachytherapy for cervical carcinoma: report from Image-Guided Brachytherapy Working Group. (Nag S, Cardenes H, Chang S, Das IJ, Erickson B, Ibbott GS, Lowenstein J, Roll J, Thomadsen B, Varia M, Image-Guided Brachytherapy Working Group) Int J Radiat Oncol Biol Phys 2004 Nov 15;60(4):1160-72 200 Citations |
| 1 | Cytokines in pancreatic carcinoma: correlation with phenotypic characteristics and prognosis. (Ebrahimi B, Tucker SL, Li D, Abbruzzese JL, Kurzrock R) Cancer 2004 Dec 15;101(12):2727-36 281 Citations |
| 1 | Cervical carcinoma in the elderly: an analysis of patterns of care and outcome. (Wright JD, Gibb RK, Geevarghese S, Powell MA, Herzog TJ, Mutch DG, Grigsby PW, Gao F, Trinkaus KM, Rader JS) Cancer 2005 Jan 01;103(1):85-91 83 Citations |
| 1 | Protein phosphatase-2A maintains focal adhesion complexes in keratinocytes and the loss of this regulation in squamous cell carcinomas. (Romashko AA, Young MR) Clin Exp Metastasis 2004;21(4):371-9 16 Citations |
| 1 | Use of tamoxifen after surgery for ductal carcinoma in situ (Yen TWF, Kuerer HM) Breast Diseases December 2004;15(3):227-231 |
| 1 | Fluorouracil, doxorubicin, and streptozocin in the treatment of patients with locally advanced and metastatic pancreatic endocrine carcinomas. (Kouvaraki MA, Ajani JA, Hoff P, Wolff R, Evans DB, Lozano R, Yao JC) J Clin Oncol 2004 Dec 01;22(23):4762-71 521 Citations |
| 1 | IFI16 is an essential mediator of growth inhibition, but not differentiation, induced by the leukemia inhibitory factor/JAK/STAT pathway in medullary thyroid carcinoma cells. (Kim EJ, Park JI, Nelkin BD) J Biol Chem 2005 Feb 11;280(6):4913-20 49 Citations |
| 1 | Interleukin-1beta can mediate growth arrest and differentiation via the leukemia inhibitory factor/JAK/STAT pathway in medullary thyroid carcinoma cells. (Park JI, Strock CJ, Ball DW, Nelkin BD) Cytokine 2005 Feb 07;29(3):125-34 28 Citations |
| 1 | Preventable reoperations for persistent and recurrent papillary thyroid carcinoma. (Kouvaraki MA, Lee JE, Shapiro SE, Sherman SI, Evans DB) Surgery 2004 Dec;136(6):1183-91 85 Citations |
| 1 | Cervix carcinoma, concurrent chemoradiotherapy, and salvage of isolated paraaortic lymph node recurrence. (Singh AK, Grigsby PW, Rader JS, Mutch DG, Powell MA) Int J Radiat Oncol Biol Phys 2005 Feb 01;61(2):450-5 68 Citations |
| 1 | HIF-1alpha, STAT3, CBP/p300 and Ref-1/APE are components of a transcriptional complex that regulates Src-dependent hypoxia-induced expression of VEGF in pancreatic and prostate carcinomas. (Gray MJ, Zhang J, Ellis LM, Semenza GL, Evans DB, Watowich SS, Gallick GE) Oncogene 2005 Apr 28;24(19):3110-20 346 Citations |
| 1 | Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ. (Yen TW, Hunt KK, Ross MI, Mirza NQ, Babiera GV, Meric-Bernstam F, Singletary SE, Symmans WF, Giordano SH, Feig BW, Ames FC, Kuerer HM) J Am Coll Surg 2005 Apr;200(4):516-26 264 Citations |
| 1 | Combined-modality treatment for operable pancreatic adenocarcinoma. (Pisters PW, Wolff RA, Crane CH, Evans DB) Oncology (Williston Park) 2005 Mar;19(3):393-404, 409; discussion 409-10, 412-6 24 Citations |
| 1 | Nuclear factor kappa B activation is a potential target for preventing pancreatic carcinoma by aspirin. (Sclabas GM, Uwagawa T, Schmidt C, Hess KR, Evans DB, Abbruzzese JL, Chiao PJ) Cancer 2005 Jun 15;103(12):2485-90 68 Citations |
| 1 | Neuropilin-1 suppresses tumorigenic properties in a human pancreatic adenocarcinoma cell line lacking neuropilin-1 coreceptors. (Gray MJ, Wey JS, Belcheva A, McCarty MF, Trevino JG, Evans DB, Ellis LM, Gallick GE) Cancer Res 2005 May 01;65(9):3664-70 83 Citations |
| 1 | Human papillomavirus type and tobacco use as predictors of survival in early stage cervical carcinoma. (Wright JD, Li J, Gerhard DS, Zhang Z, Huettner PC, Powell MA, Gibb RK, Herzog TJ, Mutch DG, Trinkaus KM, Rader JS) Gynecol Oncol 2005 Jul;98(1):84-91 24 Citations |
| 1 | Radiation dose considerations in the palliative treatment of locally advanced adenocarcinoma of the pancreas. (Wong AA, Delclos ME, Wolff RA, Evans DB, Abbruzzese JL, Tamm EP, Xiong HQ, Ho L, Crane CH, Pancreatic Tumor Study Group) Am J Clin Oncol 2005 Jun;28(3):227-33 14 Citations |
| 1 | Tumor suppressor activity and epigenetic inactivation of hepatocyte growth factor activator inhibitor type 2/SPINT2 in papillary and clear cell renal cell carcinoma. (Morris MR, Gentle D, Abdulrahman M, Maina EN, Gupta K, Banks RE, Wiesener MS, Kishida T, Yao M, Teh B, Latif F, Maher ER) Cancer Res 2005 Jun 01;65(11):4598-606 106 Citations |
| 1 | FDG-PET evaluation of vaginal carcinoma. (Lamoreaux WT, Grigsby PW, Dehdashti F, Zoberi I, Powell MA, Gibb RK, Rader JS, Mutch DG, Siegel BA) Int J Radiat Oncol Biol Phys 2005 Jul 01;62(3):733-7 89 Citations |
| 1 | Progression of liver pathology in patients undergoing the Fontan procedure: Chronic passive congestion, cardiac cirrhosis, hepatic adenoma, and hepatocellular carcinoma. (Ghaferi AA, Hutchins GM) J Thorac Cardiovasc Surg 2005 Jun;129(6):1348-52 294 Citations |
| 1 | Vascular endothelial growth factor receptor-1 promotes migration and invasion in pancreatic carcinoma cell lines. (Wey JS, Fan F, Gray MJ, Bauer TW, McCarty MF, Somcio R, Liu W, Evans DB, Wu Y, Hicklin DJ, Ellis LM) Cancer 2005 Jul 15;104(2):427-38 188 Citations |
| 1 | Chromophobe renal cell carcinoma in a pediatric living-related kidney transplant recipient. (Greco AJ, Baluarte JH, Meyers KE, Sellers MT, Suchi M, Biegel JA, Kaplan BS) Am J Kidney Dis 2005 Jun;45(6):e105-8 22 Citations |
| 1 | Bronchioloalveolar carcinoma and adenocarcinoma of the lung: A morphogenetic journey (Ioachimescu OC, Mehta AC) Journal of Bronchology July 2005;12(3):174-180 1 Citation |
| 1 | Surgical management of thyroid carcinoma. (Kouvaraki MA, Shapiro SE, Lee JE, Evans DB, Perrier ND) J Natl Compr Canc Netw 2005 May;3(3):458-66 18 Citations |
| 1 | Effect of mifepristone on proliferation and apoptosis of Ishikawa endometrial adenocarcinoma cells. (Li A, Felix JC, Minoo P, Amezcua CA, Jain JK) Fertil Steril 2005 Jul;84(1):202-11 38 Citations |
| 1 | Eccrine porocarcinoma of the scrotum. (Evans J, Datta MW, Goolsby M, Langenstroer P) Can J Urol 2005 Jun;12(3):2722-3 7 Citations |
| 2 | Patterns of brachytherapy practice for patients with carcinoma of the cervix (1996-1999): a patterns of care study. (Erickson B, Eifel P, Moughan J, Rownd J, Iarocci T, Owen J) Int J Radiat Oncol Biol Phys 2005 Nov 15;63(4):1083-92 66 Citations |
| 1 | A phase II trial of gemcitabine, 5-fluorouracil and leucovorin in advanced esophageal carcinoma. (Morgan-Meadows S, Mulkerin D, Berlin JD, Kim K, Bailey H, Saphner T, Jumonville A, Hansen R, Ahuja H, McFarland T, Thomas JP) Oncology 2005;69(2):130-4 16 Citations |
| 1 | Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice. (Bauer TW, Liu W, Fan F, Camp ER, Yang A, Somcio RJ, Bucana CD, Callahan J, Parry GC, Evans DB, Boyd DD, Mazar AP, Ellis LM) Cancer Res 2005 Sep 01;65(17):7775-81 135 Citations |
| 1 | Outcome of partial hepatectomy for large (> 10 cm) hepatocellular carcinoma. (Liau KH, Ruo L, Shia J, Padela A, Gonen M, Jarnagin WR, Fong Y, D'Angelica MI, Blumgart LH, DeMatteo RP) Cancer 2005 Nov 01;104(9):1948-55 112 Citations |
| 1 | Preoperative lymph node staging of early-stage cervical carcinoma by [18F]-fluoro-2-deoxy-D-glucose-positron emission tomography. (Wright JD, Dehdashti F, Herzog TJ, Mutch DG, Huettner PC, Rader JS, Gibb RK, Powell MA, Gao F, Siegel BA, Grigsby PW) Cancer 2005 Dec 01;104(11):2484-91 156 Citations |
| 1 | A phase II study of external beam radiotherapy combined with permanent source brachytherapy for intermediate-risk, clinically localized adenocarcinoma of the prostate: preliminary results of RTOG P-0019. (Lee WR, DeSilvio M, Lawton C, Gillin M, Morton G, Firat S, Baikadi M, Kuettel M, Greven K, Sandler H) Int J Radiat Oncol Biol Phys 2006 Mar 01;64(3):804-9 34 Citations |
| 1 | Downstaging hepatocellular carcinoma prior to liver transplantation. (Gamblin TC, Geller DA) Liver Transpl 2005 Dec;11(12):1466-8 15 Citations |
| 1 | From cystic pulmonary airway malformation, to bronchioloalveolar carcinoma and adenocarcinoma of the lung. (Ioachimescu OC, Mehta AC) Eur Respir J 2005 Dec;26(6):1181-7 91 Citations |
| 1 | Selective arterial chemoembolization for hepatic metastases from medullary thyroid carcinoma. (Lorenz K, Brauckhoff M, Behrmann C, Sekulla C, Ukkat J, Brauckhoff K, Gimm O, Dralle H) Surgery 2005 Dec;138(6):986-93; discussion 993 51 Citations |
| 1 | Laparoscopic resection of adrenal cortical carcinoma: a cautionary note. (Gonzalez RJ, Shapiro S, Sarlis N, Vassilopoulou-Sellin R, Perrier ND, Evans DB, Lee JE) Surgery 2005 Dec;138(6):1078-85; discussion 1085-6 193 Citations |
| 1 | Frequency and effect of adjuvant radiation therapy among women with stage I endometrial adenocarcinoma. (Lee CM, Szabo A, Shrieve DC, Macdonald OK, Gaffney DK) JAMA 2006 Jan 25;295(4):389-97 114 Citations |
| 1 | Multicenter phase II trial of S-1 plus cisplatin in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma. (Ajani JA, Lee FC, Singh DA, Haller DG, Lenz HJ, Benson AB 3rd, Yanagihara R, Phan AT, Yao JC, Strumberg D) J Clin Oncol 2006 Feb 01;24(4):663-7 93 Citations |
| 1 | Silencing of epithelial CXCL12 expression by DNA hypermethylation promotes colonic carcinoma metastasis. (Wendt MK, Johanesen PA, Kang-Decker N, Binion DG, Shah V, Dwinell MB) Oncogene 2006 Aug 17;25(36):4986-97 130 Citations |
| 4 | Initial experience of FDG-PET/CT guided IMRT of head-and-neck carcinoma. (Wang D, Schultz CJ, Jursinic PA, Bialkowski M, Zhu XR, Brown WD, Rand SD, Michel MA, Campbell BH, Wong S, Li XA, Wilson JF) Int J Radiat Oncol Biol Phys 2006 May 01;65(1):143-51 127 Citations |
| 1 | Classification and risk stratification of invasive breast carcinomas using a real-time quantitative RT-PCR assay. (Perreard L, Fan C, Quackenbush JF, Mullins M, Gauthier NP, Nelson E, Mone M, Hansen H, Buys SS, Rasmussen K, Orrico AR, Dreher D, Walters R, Parker J, Hu Z, He X, Palazzo JP, Olopade OI, Szabo A, Perou CM, Bernard PS) Breast Cancer Res 2006;8(2):R23 166 Citations |
| 1 | Identification of chromosomal alterations important in the development of cervical intraepithelial neoplasia and invasive carcinoma using alignment of DNA microarray data. (Fitzpatrick MA, Funk MC, Gius D, Huettner PC, Zhang Z, Bidder M, Ma D, Powell MA, Rader JS) Gynecol Oncol 2006 Nov;103(2):458-62 18 Citations |
| 1 | The role of ultrasound in the surgical management of patients diagnosed with ductal carcinoma in situ of the breast. (Khakpour N, Zager JS, Yen T, Stephens T, Kuerer HM, Singletary ES, Ross MI, Hunt KK, Babiera GV) Breast J 2006;12(3):212-5 3 Citations |
| 1 | Frequency and effect of adjuvant radiation therapy among women with stage I endometrial adenocarcinoma: Commentary (Lee CM, Szabo A, Shrieve DC, MacDonald OK, Gaffney DK) Obstetrical and Gynecological Survey June 2006;61(6):382-384 |
| 1 | Bevacizumab combination therapy in recurrent, platinum-refractory, epithelial ovarian carcinoma: A retrospective analysis. (Wright JD, Hagemann A, Rader JS, Viviano D, Gibb RK, Norris L, Mutch DG, Powell MA) Cancer 2006 Jul 01;107(1):83-9 123 Citations |
| 1 | Signet-ring cell carcinoma of the urinary bladder mimicking retroperitoneal fibrosis. (Iqbal MA, Lawatsch EJ, Coyle DJ, Rowe JJ, Li R, Dua KS, Kochar MS) WMJ 2006 May;105(3):55-8 6 Citations |
| 1 | Frequency and effect of adjuvant radiation therapy in stage I endometrial adenocarcinoma (Lee CM, Szabo A, Shrieve DC, Macdonald OK, Gaffney DK) American Journal of Oncology Review July 2006;5(7):417-420 |
| 1 | Src activation of Stat3 is an independent requirement from NF-kappaB activation for constitutive IL-8 expression in human pancreatic adenocarcinoma cells. (Trevino JG, Gray MJ, Nawrocki ST, Summy JM, Lesslie DP, Evans DB, Sawyer TK, Shakespeare WC, Watowich SS, Chiao PJ, McConkey DJ, Gallick GE) Angiogenesis 2006;9(2):101-10 43 Citations |
| 2 | Reduced expression of 15-lipoxygenase 2 in human head and neck carcinomas. (Wang D, Chen S, Feng Y, Yang Q, Campbell BH, Tang X, Campbell WB) Tumour Biol 2006;27(5):261-73 14 Citations |
| 1 | Adrenocortical carcinoma. (Rodgers SE, Evans DB, Lee JE, Perrier ND) Surg Oncol Clin N Am 2006 Jul;15(3):535-53 25 Citations |
| 1 | Regulatory role of c-Met in insulin-like growth factor-I receptor-mediated migration and invasion of human pancreatic carcinoma cells. (Bauer TW, Somcio RJ, Fan F, Liu W, Johnson M, Lesslie DP, Evans DB, Gallick GE, Ellis LM) Mol Cancer Ther 2006 Jul;5(7):1676-82 92 Citations |
| 1 | Squamous cell carcinoma arising in a pediatric intra- and paravertebral teratoma. (Jarzembowski JA, Ruiz RE) Pediatr Dev Pathol 2006;9(4):328-31 2 Citations |
| 1 | Potential role of Jun activation domain-binding protein 1 as a negative regulator of p27kip1 in pancreatic adenocarcinoma. (Kouvaraki MA, Korapati AL, Rassidakis GZ, Tian L, Zhang Q, Chiao P, Ho L, Evans DB, Claret FX) Cancer Res 2006 Sep 01;66(17):8581-9 55 Citations |
| 1 | 3-33 Sentinel Lymph Node Biopsy for Ductal Carcinoma in Situ: An Evolving Approach at the University of Florida (Yen TWF) Breast Diseases October 2006;17(3):258 |
| 1 | Adjuvant therapy for renal cell carcinoma. (Jacobsohn KM, Wood CG) Semin Oncol 2006 Oct;33(5):576-82 38 Citations |
| 1 | Late disease recurrence in patients diagnosed with and treated for differentiated thyroid carcinoma (Fareau GG, Vassilopoulou-Sellin R) Endocrinologist November 2006;16(6):329-334 1 Citation |
| 1 | Prognostic factors in patients with unresectable locally advanced pancreatic adenocarcinoma treated with chemoradiation. (Krishnan S, Rana V, Janjan NA, Abbruzzese JL, Gould MS, Das P, Delclos ME, Palla S, Guha S, Varadhachary G, Evans DB, Wolff RA, Crane CH) Cancer 2006 Dec 01;107(11):2589-96 76 Citations |
| 1 | Extended safety and efficacy data on S-1 plus cisplatin in patients with untreated, advanced gastric carcinoma in a multicenter phase II study. (Lenz HJ, Lee FC, Haller DG, Singh D, Benson AB 3rd, Strumberg D, Yanagihara R, Yao JC, Phan AT, Ajani JA) Cancer 2007 Jan 01;109(1):33-40 55 Citations |
| 1 | Late Disease Recurrence in Patients Diagnosed with and Treated for Differentiated Thyroid Carcinoma ( Fareau GG, Vassilopoulou-Sellin R) The Endocrinologist Fareau GG, Vassilopoulou-Sellin R. 2006; 16(6):329-34 |
| 1 | Comparison of high-dose-rate and low-dose-rate brachytherapy in the treatment of endometrial carcinoma. (Fayed A, Mutch DG, Rader JS, Gibb RK, Powell MA, Wright JD, Elnaqa I, Zoberi I, Grigsby PW) Int J Radiat Oncol Biol Phys 2007 Feb 01;67(2):480-4 33 Citations |
| 1 | Differential activity of sulindac metabolites against squamous cell carcinoma of the head and neck is mediated by p21waf1/cip1 induction and cell cycle inhibition. (Bock JM, Menon SG, Goswami PC, Sinclair LL, Bedford NS, Jackson RE, Trask DK) Cancer Biol Ther 2007 Jan;6(1):30-9 11 Citations |
| 1 | Comparison of percutaneous and surgical approaches for radiofrequency ablation of small and medium hepatocellular carcinoma - Invited critique (DeVera ME, Marsh JW, Gamblin TC) Archives of Surgery December 2007;142(12):1143 |
| 1 | Novel clinical trial designs for treatment of ductal carcinoma in situ of the breast with trastuzumab (herceptin). (Gonzalez RJ, Buzdar AU, Fraser Symmans W, Yen TW, Broglio KR, Lucci A, Esteva FJ, Yin G, Kuerer HM) Breast J 2007;13(1):72-5 24 Citations |
| 1 | Immunocytochemical study of the expression of mesothelin in fine-needle aspiration biopsy specimens of pancreatic adenocarcinoma. (Baruch AC, Wang H, Staerkel GA, Evans DB, Hwang RF, Krishnamurthy S) Diagn Cytopathol 2007 Mar;35(3):143-7 23 Citations |
| 1 | Intrahepatic portal hypertension secondary to metastatic carcinoma of the prostate. (Attila T, Datta MW, Sudakoff G, Abu-Hajir M, Massey BT) WMJ 2007 Feb;106(1):34-6 6 Citations |
| 1 | Arterial variants in pancreatic adenocarcinoma. (Balachandran A, Darden DL, Tamm EP, Faria SC, Evans DB, Charnsangavej C) Abdom Imaging 2008;33(2):214-21 35 Citations |
| 1 | Diverse roles of 2-arachidonoylglycerol in invasion of prostate carcinoma cells: Location, hydrolysis and 12-lipoxygenase metabolism. (Endsley MP, Aggarwal N, Isbell MA, Wheelock CE, Hammock BD, Falck JR, Campbell WB, Nithipatikom K) Int J Cancer 2007 Sep 01;121(5):984-91 45 Citations |
| 1 | Pilot study of regional, hepatic intra-arterial paclitaxel in patients with breast carcinoma metastatic to the liver. (Camacho LH, Kurzrock R, Cheung A, Barber DF, Gupta S, Madoff DC, Wallace MJ, Kim EE, Curley SA, Hortobagyi GN, Mavligit G) Cancer 2007 Jun 01;109(11):2190-6 32 Citations |
| 1 | Microsatellite instability and epigenetic inactivation of MLH1 and outcome of patients with endometrial carcinomas of the endometrioid type. (Zighelboim I, Goodfellow PJ, Gao F, Gibb RK, Powell MA, Rader JS, Mutch DG) J Clin Oncol 2007 May 20;25(15):2042-8 178 Citations |
| 1 | Adrenal cortical carcinoma--review of current knowledge and treatment practices. (Phan AT) Hematol Oncol Clin North Am 2007 Jun;21(3):489-507; viii-ix 39 Citations |
| 1 | Depression, immunity, and survival in patients with hepatobiliary carcinoma. (Steel JL, Geller DA, Gamblin TC, Olek MC, Carr BI) J Clin Oncol 2007 Jun 10;25(17):2397-405 134 Citations |
| 1 | Impact of randomized clinical trial results in the national comprehensive cancer network on the use of tamoxifen after breast surgery for ductal carcinoma in situ. (Yen TW, Kuerer HM, Ottesen RA, Rouse L, Niland JC, Edge SB, Theriault RL, Weeks JC) J Clin Oncol 2007 Aug 01;25(22):3251-8 45 Citations |
| 1 | Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. (Raut CP, Tseng JF, Sun CC, Wang H, Wolff RA, Crane CH, Hwang R, Vauthey JN, Abdalla EK, Lee JE, Pisters PW, Evans DB) Ann Surg 2007 Jul;246(1):52-60 515 Citations |
| 1 | Ki-67 and coagulative tumor necrosis are independent predictors of poor outcome for patients with clear cell renal cell carcinoma and not surrogates for each other. (Tollefson MK, Thompson RH, Sheinin Y, Lohse CM, Cheville JC, Leibovich BC, Kwon ED) Cancer 2007 Aug 15;110(4):783-90 63 Citations |
| 1 | Epigenetic silencing of CXCL12 increases the metastatic potential of mammary carcinoma cells. (Wendt MK, Cooper AN, Dwinell MB) Oncogene 2008 Feb 28;27(10):1461-71 108 Citations |
| 1 | Large hepatocellular carcinoma: time to stop preoperative biopsy. (Young AL, Malik HZ, Abu-Hilal M, Guthrie JA, Wyatt J, Prasad KR, Toogood GJ, Lodge JP) J Am Coll Surg 2007 Sep;205(3):453-62 38 Citations |
| 1 | Final report of RTOG 9610, a multi-institutional trial of reirradiation and chemotherapy for unresectable recurrent squamous cell carcinoma of the head and neck. (Spencer SA, Harris J, Wheeler RH, Machtay M, Schultz C, Spanos W, Rotman M, Meredith R, Ang KK) Head Neck 2008 Mar;30(3):281-8 294 Citations |
| 2 | Primary mediastinal embryonal carcinoma masquerading as chronic pancreatitis. (Kaikobad M, Cheng YC, Choi H, Teves D) WMJ 2007 Jul;106(4):225-8 2 Citations |
| 1 | Descriptive nomograms of adjuvant radiotherapy use and patterns of care analysis for stage I and II endometrial adenocarcinoma: A surveillance, epidemiology, and end results population study. (Lee CM, Szabo A, Shrieve DC, Macdonald OK, Tward JD, Skidmore TB, Gaffney DK) Cancer 2007 Nov 01;110(9):2092-100 29 Citations |
| 1 | Treatment of unresectable cholangiocarcinoma with gemcitabine-based transcatheter arterial chemoembolization (TACE): a single-institution experience. (Gusani NJ, Balaa FK, Steel JL, Geller DA, Marsh JW, Zajko AB, Carr BI, Gamblin TC) J Gastrointest Surg 2008 Jan;12(1):129-37 121 Citations |
| 1 | Population-based study of islet cell carcinoma. (Yao JC, Eisner MP, Leary C, Dagohoy C, Phan A, Rashid A, Hassan M, Evans DB) Ann Surg Oncol 2007 Dec;14(12):3492-500 278 Citations |
| 1 | 3-41 Role of Sentinel Lymph Node Biopsy in Ductal Carcinoma-in-situ Treated by Mastectomy (Yen TWF) Breast Diseases October 2007;18(3):284 |
| 1 | Radiation therapy is associated with improved survival in patients with pancreatic adenocarcinoma: results of a study from the Surveillance, Epidemiology, and End Results (SEER) registry data. (Hazard L, Tward JD, Szabo A, Shrieve DC) Cancer 2007 Nov 15;110(10):2191-201 72 Citations |
| 1 | Colonic adenocarcinoma in a 13-year-old with cystic fibrosis. (Ibele AR, Koplin SA, Slaughenhoupt BL, Kryger JV, Friedl A, Lund DP) J Pediatr Surg 2007 Oct;42(10):E1-3 12 Citations |
| 1 | Case report: percutaneous management of transitional-cell carcinoma of the upper urinary tract using the bipolar resectoscope. (Storm DW, Fulmer BR) J Endourol 2007 Sep;21(9):1011-3 9 Citations |
| 1 | Carbonic anhydrase IX is not an independent predictor of outcome for patients with clear cell renal cell carcinoma. (Leibovich BC, Sheinin Y, Lohse CM, Thompson RH, Cheville JC, Zavada J, Kwon ED) J Clin Oncol 2007 Oct 20;25(30):4757-64 164 Citations |
| 1 | Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Protocol 9911. (Langer CJ, Harris J, Horwitz EM, Nicolaou N, Kies M, Curran W, Wong S, Ang K) J Clin Oncol 2007 Oct 20;25(30):4800-5 301 Citations |
| 1 | Diagnostic challenges in adrenocortical carcinoma: recommendations for surveillance after surgical resection of selected adrenal nodules. (Fareau GG, Vassilopoulou-Sellin R) Endocr Pract 2007 Oct;13(6):636-41 5 Citations |
| 1 | SmgGDS regulates cell proliferation, migration, and NF-kappaB transcriptional activity in non-small cell lung carcinoma. (Tew GW, Lorimer EL, Berg TJ, Zhi H, Li R, Williams CL) J Biol Chem 2008 Jan 11;283(2):963-76 59 Citations |
| 1 | Thyroid function test abnormalities in patients with metastatic renal cell carcinoma treated with sorafenib. (Tamaskar I, Bukowski R, Elson P, Ioachimescu AG, Wood L, Dreicer R, Mekhail T, Garcia J, Rini BI) Ann Oncol 2008 Feb;19(2):265-8 128 Citations |
| 1 | Oncological efficacy and safety of nephron-sparing surgery for selected patients with locally advanced renal cell carcinoma. (Margulis V, Tamboli P, Jacobsohn KM, Swanson DA, Wood CG) BJU Int 2007 Dec;100(6):1235-9 56 Citations |
| 1 | Endometrial carcinoma expresses an increased cathepsin B/D ratio. (Bradley WH, Lima PH, Rodgers L, Blomquist CH, Downs LS) Gynecol Oncol 2008 Jan;108(1):84-9 8 Citations |
| 1 | Role of adjuvant chemoradiation therapy in adenocarcinomas of the ampulla of vater. (Krishnan S, Rana V, Evans DB, Varadhachary G, Das P, Bhatia S, Delclos ME, Janjan NA, Wolff RA, Crane CH, Pisters PW) Int J Radiat Oncol Biol Phys 2008 Mar 01;70(3):735-43 66 Citations |
| 1 | [New developments in staging and prognosis of bronchopulmonary carcinoma. Part I: Epidemiology and diagnostic investigations]. (Ioachimescu O, Corlan E) Pneumologia 2007;56(3):129-36 |
| 1 | False-negative PET scan with bronchioloalveolar carcinoma: an important diagnostic caveat. (Awab A, Hamadani M, Peyton M, Brown B) Am J Med Sci 2007 Oct;334(4):311-3 9 Citations |
| 1 | Surgery for hilar cholangiocarcinoma: the Leeds experience. (Hidalgo E, Asthana S, Nishio H, Wyatt J, Toogood GJ, Prasad KR, Lodge JP) Eur J Surg Oncol 2008 Jul;34(7):787-94 118 Citations |
| 1 | Intraperitoneal gemcitabine pharmacokinetics: a pilot and pharmacokinetic study in patients with advanced adenocarcinoma of the pancreas. (Gamblin TC, Egorin MJ, Zuhowski EG, Lagattuta TF, Herscher LL, Russo A, Libutti SK, Alexander HR, Dedrick RL, Bartlett DL) Cancer Chemother Pharmacol 2008 Sep;62(4):647-53 18 Citations |
| 2 | Response to mitotane predicts outcome in patients with recurrent adrenal cortical carcinoma. (Gonzalez RJ, Tamm EP, Ng C, Phan AT, Vassilopoulou-Sellin R, Perrier ND, Evans DB, Lee JE) Surgery 2007 Dec;142(6):867-75; discussion 867-75 77 Citations |
| 1 | Total laparoscopic pancreaticoduodenectomy and reconstruction for a cholangiocarcinoma of the bile duct. (Menon KV, Hayden JD, Prasad KR, Verbeke CS) J Laparoendosc Adv Surg Tech A 2007 Dec;17(6):775-80 14 Citations |
| 1 | Use of tamoxifen after breast surgery for ductal carcinoma in situ (Yen TWF) American Journal of Hematology/ Oncology January 2008;7(1):23-25 |
| 1 | Right hemihepatectomy for metastatic cloacogenic carcinoma using the staple technique (Balaa FK, Gamblin TC, Heckman JT, Geller DA) Annals of Surgical Oncology January 2008;15(1):233-234 |
| 1 | Pseudomembranous supraglottitis with airway compromise in a patient with recurrent tonsillar carcinoma. (Klein TG, Parkins DG, Gandhi SD, Iqbal Z, Schmeling WT, Pagel PS) Can J Anaesth 2008 Jan;55(1):42-6 |
| 1 | Paraneoplastic cerebellar degeneration in ovarian carcinoma: case report with review of immune modulation. (Bradley WH, Dottino PR, Rahaman J) Int J Gynecol Cancer 2008;18(6):1364-7 15 Citations |
| 1 | External validation of IMP3 expression as an independent prognostic marker for metastatic progression and death for patients with clear cell renal cell carcinoma. (Hoffmann NE, Sheinin Y, Lohse CM, Parker AS, Leibovich BC, Jiang Z, Kwon ED) Cancer 2008 Apr 01;112(7):1471-9 119 Citations |
| 6 | Clinical outcomes of patients receiving integrated PET/CT-guided radiotherapy for head and neck carcinoma. (Vernon MR, Maheshwari M, Schultz CJ, Michel MA, Wong SJ, Campbell BH, Massey BL, Wilson JF, Wang D) Int J Radiat Oncol Biol Phys 2008 Mar 01;70(3):678-84 81 Citations |
| 1 | Targeted glycoproteomic identification of biomarkers for human breast carcinoma. (Abbott KL, Aoki K, Lim JM, Porterfield M, Johnson R, O'Regan RM, Wells L, Tiemeyer M, Pierce M) J Proteome Res 2008 Apr;7(4):1470-80 88 Citations |
| 1 | Tumor-node-metastasis staging of pancreatic adenocarcinoma. (Katz MH, Hwang R, Fleming JB, Evans DB) CA Cancer J Clin 2008;58(2):111-25 104 Citations |
| 1 | Biologic study of the effects of octreotide-LAR on growth hormone in unresectable and metastatic hepatocellular carcinoma. (Attia S, Holen KD, Thomas JP, Richie K, Dzelak T, Teeter K, Warren D, Bilger A, Fine J, Eickhoff J, Drinkwater N, Mulkerin D, Morgan-Meadows S) Clin Adv Hematol Oncol 2008 Jan;6(1):44-54 5 Citations |
| 1 | Impact of systemic inflammation on outcome following resection for intrahepatic cholangiocarcinoma. (Gomez D, Morris-Stiff G, Toogood GJ, Lodge JP, Prasad KR) J Surg Oncol 2008 May 01;97(6):513-8 150 Citations |
| 1 | Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after curative resection for hepatocellular carcinoma. (Gomez D, Farid S, Malik HZ, Young AL, Toogood GJ, Lodge JP, Prasad KR) World J Surg 2008 Aug;32(8):1757-62 356 Citations |
| 1 | Modulation of cellular invasion by VEGF-C expression in squamous cell carcinoma of the head and neck. (Bock JM, Sinclair LL, Bedford NS, Jackson RE, Lee JH, Trask DK) Arch Otolaryngol Head Neck Surg 2008 Apr;134(4):355-62 23 Citations |
| 1 | Unresectable hepatocellular carcinoma with a solitary metastasis to the mandible. (Li R, Walvekar RR, Nalesnik MA, Gamblin TC) Am Surg 2008 Apr;74(4):346-9 14 Citations |
| 1 | Prognostic value of health-related quality of life on survival in patients diagnosed with hepatocarcinoma carcinoma. (Steel JL, Carr BI, Goodman J, Dew MA, Geller DA, Gamblin TC) J Clin Oncol 2008 May 20;26(15_suppl):4643 |
| 1 | Systemic chemotherapy for adrenocortical carcinoma: comparative responses to conventional first-line therapies. (Fareau GG, Lopez A, Stava C, Vassilopoulou-Sellin R) Anticancer Drugs 2008 Jul;19(6):637-44 13 Citations |
| 1 | Comparison of digital image analysis versus visual assessment to assess survivin expression as an independent predictor of survival for patients with clear cell renal cell carcinoma. (Parker AS, Lohse CM, Leibovich BC, Cheville JC, Sheinin YM, Kwon ED) Hum Pathol 2008 Aug;39(8):1176-84 14 Citations |
| 1 | Multiple squamous cell carcinomas of the skin after therapy with sorafenib combined with tipifarnib. (Hong DS, Reddy SB, Prieto VG, Wright JJ, Tannir NM, Cohen PR, Diwan AH, Evans HL, Kurzrock R) Arch Dermatol 2008 Jun;144(6):779-82 45 Citations |
| 1 | Constitutive CXCL12 expression induces anoikis in colorectal carcinoma cells. (Wendt MK, Drury LJ, Vongsa RA, Dwinell MB) Gastroenterology 2008 Aug;135(2):508-17 45 Citations |
| 1 | Adjuvant therapy for adenocarcinoma of the pancreas: analysis of reported trials and recommendations for future progress. (Wolff RA, Varadhachary GR, Evans DB) Ann Surg Oncol 2008 Oct;15(10):2773-86 51 Citations |
| 2 | Esophageal adenocarcinoma: pseudo-nutcracker esophagus. (Lawal A, Antonik S, Dua K, Massey BT) Dysphagia 2009 Jun;24(2):234-7 1 Citation |
| 1 | Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head. (Varadhachary GR, Wolff RA, Crane CH, Sun CC, Lee JE, Pisters PW, Vauthey JN, Abdalla E, Wang H, Staerkel GA, Lee JH, Ross WA, Tamm EP, Bhosale PR, Krishnan S, Das P, Ho L, Xiong H, Abbruzzese JL, Evans DB) J Clin Oncol 2008 Jul 20;26(21):3487-95 425 Citations |
| 1 | Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head. (Evans DB, Varadhachary GR, Crane CH, Sun CC, Lee JE, Pisters PW, Vauthey JN, Wang H, Cleary KR, Staerkel GA, Charnsangavej C, Lano EA, Ho L, Lenzi R, Abbruzzese JL, Wolff RA) J Clin Oncol 2008 Jul 20;26(21):3496-502 665 Citations |
| 1 | Medullary thyroid carcinoma without marked elevation of calcitonin: a diagnostic and surveillance dilemma. (Wang TS, Ocal IT, Sosa JA, Cox H, Roman S) Thyroid 2008 Aug;18(8):889-94 43 Citations |
| 1 | T-cell coregulatory molecule expression in urothelial cell carcinoma: clinicopathologic correlations and association with survival. (Boorjian SA, Sheinin Y, Crispen PL, Farmer SA, Lohse CM, Kuntz SM, Leibovich BC, Kwon ED, Frank I) Clin Cancer Res 2008 Aug 01;14(15):4800-8 244 Citations |
| 1 | Bridging locoregional therapy for hepatocellular carcinoma prior to liver transplantation. (Heckman JT, Devera MB, Marsh JW, Fontes P, Amesur NB, Holloway SE, Nalesnik M, Geller DA, Steel JL, Gamblin TC) Ann Surg Oncol 2008 Nov;15(11):3169-77 115 Citations |
| 1 | Tumor cell and tumor vasculature expression of B7-H3 predict survival in clear cell renal cell carcinoma. (Crispen PL, Sheinin Y, Roth TJ, Lohse CM, Kuntz SM, Frigola X, Thompson RH, Boorjian SA, Dong H, Leibovich BC, Blute ML, Kwon ED) Clin Cancer Res 2008 Aug 15;14(16):5150-7 236 Citations |
| 1 | Extrahepatic bile duct adenocarcinoma: patients at high-risk for local recurrence treated with surgery and adjuvant chemoradiation have an equivalent overall survival to patients with standard-risk treated with surgery alone. (Borghero Y, Crane CH, Szklaruk J, Oyarzo M, Curley S, Pisters PW, Evans D, Abdalla EK, Thomas MB, Das P, Wistuba II, Krishnan S, Vauthey JN) Ann Surg Oncol 2008 Nov;15(11):3147-56 86 Citations |
| 1 | Renal cell carcinoma in two patients with crossed fused ectopic kidneys. (Davis CM, Rao MV, Flanigan RC, Quek ML) Urol Int 2008;81(3):370-2 9 Citations |
| 1 | Portal vein arterialization as a salvage procedure during left hepatic trisectionectomy for hilar cholangiocarcinoma. (Young AL, Prasad KR, Adair R, Abu Hilal M, Guthrie JA, Lodge JP) J Am Coll Surg 2008 Nov;207(5):e1-6 27 Citations |
| 1 | SmgGDS is up-regulated in prostate carcinoma and promotes tumour phenotypes in prostate cancer cells. (Zhi H, Yang XJ, Kuhnmuench J, Berg T, Thill R, Yang H, See WA, Becker CG, Williams CL, Li R) J Pathol 2009 Feb;217(3):389-97 22 Citations |
| 1 | Expression of MAP4K4 is associated with worse prognosis in patients with stage II pancreatic ductal adenocarcinoma. (Liang JJ, Wang H, Rashid A, Tan TH, Hwang RF, Hamilton SR, Abbruzzese JL, Evans DB, Wang H) Clin Cancer Res 2008 Nov 01;14(21):7043-9 93 Citations |
| 1 | Margin status following pancreaticoduodenectomy for pancreatic adenocarcinoma: Implications of R status (Raut CP, Varadhachary G, Wang H, Tamm EP, Fleming JB, Evans DB) Diseases of the Pancreas: Current Surgical Therapy 2008:611-623 2 Citations |
| 1 | Fibroinflammatory biliary stricture: a rare bile duct lesion masquerading as cholangiocarcinoma. (Gamblin TC, Krasinskas AM, Slivka AS, Tublin ME, Demetris J, Shue E, Caro S, Marsh JW, James Moser A) J Gastrointest Surg 2009 Apr;13(4):713-21 14 Citations |
| 1 | Surgical management of hepatocellular carcinoma: is the jury still out? (Morris-Stiff G, Gomez D, de Liguori Carino N, Prasad KR) Surg Oncol 2009 Dec;18(4):298-321 56 Citations |
| 1 | Increased expression of CD44s in conventional renal cell carcinomas with renal vein or vena cava thrombosis. a retrospective evaluation of the expression of CD44s by immunohistochemical analysis in conventional RCC patients and in conventional RCC patients with renal vein or vena cava thrombosis. (Altinel M, Arpali E, Turhan N, Gonenc F, Yazicioglu A) Urol Int 2008;81(4):452-5 6 Citations |
| 1 | Preoperative therapy for patients with resectable adenocarcinoma of the pancreatic head (Varadhachary GR, Crane CH, Evans DB) American Journal of Hematology/ Oncology January 2009;8(1) |
| 2 | Bacille-Calmette Guèrin induces caspase-independent cell death in urothelial carcinoma cells together with release of the necrosis-associated chemokine high molecular group box protein 1. (See WA, Zhang G, Chen F, Cao Y, Langenstroer P, Sandlow J) BJU Int 2009 Jun;103(12):1714-20 31 Citations |
| 1 | [New data in staging and prognosis of bronchopulmonary carcinoma. Part II: volumetric analysis of pulmonary nodules]. (Ioachimescu O, Corlan E) Pneumologia 2008;57(4):209-14, 216-20 |
| 1 | Long-term survival after multidisciplinary management of resected pancreatic adenocarcinoma. (Katz MH, Wang H, Fleming JB, Sun CC, Hwang RF, Wolff RA, Varadhachary G, Abbruzzese JL, Crane CH, Krishnan S, Vauthey JN, Abdalla EK, Lee JE, Pisters PW, Evans DB) Ann Surg Oncol 2009 Apr;16(4):836-47 428 Citations |
| 1 | Erlotinib and bevacizumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck: a phase I/II study. (Cohen EE, Davis DW, Karrison TG, Seiwert TY, Wong SJ, Nattam S, Kozloff MF, Clark JI, Yan DH, Liu W, Pierce C, Dancey JE, Stenson K, Blair E, Dekker A, Vokes EE) Lancet Oncol 2009 Mar;10(3):247-57 247 Citations |
| 1 | Phase II trial of carboplatin and paclitaxel in papillary renal cell carcinoma. (Bylow KA, Atkins MB, Posadas EM, Stadler WM, McDermott DF) Clin Genitourin Cancer 2009 Jan;7(1):39-42 16 Citations |
| 1 | Recutting prostate needle core biopsies with high grade prostatic intraepithelial neoplasia increases detection of adenocarcinoma. (Rapp DE, Msezane LP, Reynolds WS, Lotan TL, Obara P, O'Connor RC, Taxy JB, Gerber GS, Zagaja GP) Can J Urol 2009 Feb;16(1):4484-9 5 Citations |
| 1 | Current role of surgery in treatment of early stage hepatocellular carcinoma: resection versus liver transplantation. (Yi NJ, Suh KS, Kim T, Kim J, Shin WY, Lee KU) Oncology 2008;75 Suppl 1:124-8 24 Citations |
| 1 | Longitudinal oncology registry of head and neck carcinoma (LORHAN): initial supportive care findings. (Murphy BA, Chen A, Curran WJ Jr, Garden AS, Harari PM, Wong SJ, Ang KK) Support Care Cancer 2009 Nov;17(11):1393-401 11 Citations |
| 1 | Influence of obesity on cancer-related outcomes after pancreatectomy to treat pancreatic adenocarcinoma. (Fleming JB, Gonzalez RJ, Petzel MQ, Lin E, Morris JS, Gomez H, Lee JE, Crane CH, Pisters PW, Evans DB) Arch Surg 2009 Mar;144(3):216-21 91 Citations |
| 1 | Development and evaluation of BioScore: a biomarker panel to enhance prognostic algorithms for clear cell renal cell carcinoma. (Parker AS, Leibovich BC, Lohse CM, Sheinin Y, Kuntz SM, Eckel-Passow JE, Blute ML, Kwon ED) Cancer 2009 May 15;115(10):2092-103 100 Citations |
| 1 | Multifocality incidence and accompanying clinicopathological factors in renal cell carcinoma. (Sargin SY, Ekmekcioglu O, Arpali E, Altinel M, Voyvoda B) Urol Int 2009;82(3):324-9 9 Citations |
| 1 | Salvage transplantation for stage IVa hepatocellular carcinoma, what are the guidelines? (Goldsmith PJ, Toogood GJ, Lodge JP, Prasad KR) Clin Transplant 2009;23(5):581 1 Citation |
| 1 | Randomized double-blind phase II trial comparing gemcitabine plus LY293111 versus gemcitabine plus placebo in advanced adenocarcinoma of the pancreas. (Saif MW, Oettle H, Vervenne WL, Thomas JP, Spitzer G, Visseren-Grul C, Enas N, Richards DA) Cancer J 2009;15(4):339-43 45 Citations |
| 2 | Genetic and nongenetic covariates of pain severity in patients with adenocarcinoma of the pancreas: assessing the influence of cytokine genes. (Reyes-Gibby CC, Shete S, Yennurajalingam S, Frazier M, Bruera E, Kurzrock R, Crane CH, Abbruzzese J, Evans D, Spitz MR) J Pain Symptom Manage 2009 Dec;38(6):894-902 39 Citations |
| 1 | Pilot study of huachansu in patients with hepatocellular carcinoma, nonsmall-cell lung cancer, or pancreatic cancer. (Meng Z, Yang P, Shen Y, Bei W, Zhang Y, Ge Y, Newman RA, Cohen L, Liu L, Thornton B, Chang DZ, Liao Z, Kurzrock R) Cancer 2009 Nov 15;115(22):5309-18 257 Citations |
| 1 | Early postoperative paclitaxel followed by concurrent paclitaxel and cisplatin with radiation therapy for patients with resected high-risk head and neck squamous cell carcinoma: report of the phase II trial RTOG 0024. (Rosenthal DI, Harris J, Forastiere AA, Weber RS, Ridge JA, Myers JN, Garden AS, Kuettel MR, Sidhu K, Schultz CJ, Trotti A, Ang KK) J Clin Oncol 2009 Oct 01;27(28):4727-32 35 Citations |
| 1 | Occult fallopian tube carcinoma detected in routine pelvic washing specimens submitted for staging: another justification for pelvic washing cytology? (Jorns JM, Knoepp SM) Diagn Cytopathol 2009 Dec;37(12):923-9 8 Citations |
| 1 | Initial presentation and management of hilar and peripheral cholangiocarcinoma: is a node-positive status or potential margin-positive result a contraindication to resection? (Nguyen KT, Steel J, Vanounou T, Tsung A, Marsh JW, Geller DA, Gamblin TC) Ann Surg Oncol 2009 Dec;16(12):3308-15 30 Citations |
| 1 | Optimal treatment for hepatocellular carcinoma in the cirrhotic liver. (White SA, Manas DM, Farid SG, Prasad KR) Ann R Coll Surg Engl 2009 Oct;91(7):545-50 1 Citation |
| 1 | Down-regulation of 20-HETE synthesis and signaling inhibits renal adenocarcinoma cell proliferation and tumor growth. (Alexanian A, Rufanova VA, Miller B, Flasch A, Roman RJ, Sorokin A) Anticancer Res 2009 Oct;29(10):3819-24 48 Citations |
| 2 | Recurrence of adrenal cortical carcinoma following resection: surgery alone can achieve results equal to surgery plus mitotane. (Grubbs EG, Callender GG, Xing Y, Perrier ND, Evans DB, Phan AT, Lee JE) Ann Surg Oncol 2010 Jan;17(1):263-70 139 Citations |
| 1 | MB49 murine urothelial carcinoma: molecular and phenotypic comparison to human cell lines as a model of the direct tumor response to bacillus Calmette-Guerin. (Chen F, Zhang G, Cao Y, Hessner MJ, See WA) J Urol 2009 Dec;182(6):2932-7 23 Citations |
| 1 | Surgical treatment of hilar cholangiocarcinoma in a new era: comparison among leading Eastern and Western centers, Leeds. (Young AL, Prasad KR, Toogood GJ, Lodge JP) J Hepatobiliary Pancreat Sci 2010 Jul;17(4):497-504 57 Citations |
| 1 | Chemoradiation in locally advanced cervical carcinoma: an analysis of cisplatin dosing and other clinical prognostic factors. (Nugent EK, Case AS, Hoff JT, Zighelboim I, DeWitt LL, Trinkhaus K, Mutch DG, Thaker PH, Massad LS, Rader JS) Gynecol Oncol 2010 Mar;116(3):438-41 58 Citations |
| 1 | New metastatic lymph node ratio system reduces stage migration in patients undergoing D1 lymphadenectomy for gastric adenocarcinoma. (Maduekwe UN, Lauwers GY, Fernandez-Del-Castillo C, Berger DL, Ferguson CM, Rattner DW, Yoon SS) Ann Surg Oncol 2010 May;17(5):1267-77 56 Citations |
| 1 | Trimodality therapy without a platinum compound for localized carcinoma of the esophagus and gastroesophageal junction. (Ajani JA, Correa AM, Walsh GL, Komaki R, Lee JH, Vaporciyan AA, Rice DC, Yao JC, Maru DM, Hofstetter WL, Phan AT, Swisher SG) Cancer 2010 Apr 01;116(7):1656-63 16 Citations |
| 1 | Prognostic factors affecting survival after recurrence in adult living donor liver transplantation for hepatocellular carcinoma. (Shin WY, Suh KS, Lee HW, Kim J, Kim T, Yi NJ, Lee KU) Liver Transpl 2010 May;16(5):678-84 68 Citations |
| 1 | Extrapulmonary small cell carcinoma metastasis to the external auditory canal with facial nerve paralysis. (Rudman KL, King E, Poetker DM) Am J Otolaryngol 2011;32(4):343-5 9 Citations |
| 1 | Adult-onset hypogonadotropic hypogonadism caused by aberrant expression of aromatase in an adrenocortical adenocarcinoma. (Advani A, Johnson SJ, Nicol MR, Papacleovoulou G, Evans DB, Vaikkakara S, Mason JI, Quinton R) Endocr J 2010;57(7):651-6 6 Citations |
| 1 | Corrigendum to "Chemoradiation in locally advanced cervical carcinoma: An analysis of cisplatin dosing and other clinical prognostic factors" [Gynecol. Oncol. 116 (2010) 438-441] (DOI:10.1016/j.ygyno.2009.09.045) (Nugent EK, Case AS, Hoff JT, Zighelboim I, DeWitt LL, Trinkhaus K, Mutch DG, Thaker PH, Massad LS, Rader JS) Gynecologic Oncology July 2010;118(1):99 |
| 3 | Longitudinal quality of life assessment of patients with hepatocellular carcinoma after primary transarterial chemoembolization. (Wible BC, Rilling WS, Drescher P, Hieb RA, Saeian K, Frangakis C, Chen Y, Eastwood D, Kim HS) J Vasc Interv Radiol 2010 Jul;21(7):1024-30 39 Citations |
| 1 | High levels of nucleolar expression of nucleolin are associated with better prognosis in patients with stage II pancreatic ductal adenocarcinoma. (Peng L, Liang J, Wang H, Song X, Rashid A, Gomez HF, Corley LJ, Abbruzzese JL, Fleming JB, Evans DB, Wang H) Clin Cancer Res 2010 Jul 15;16(14):3734-42 35 Citations |
| 1 | The NANETS consensus guidelines for the diagnosis and management of poorly differentiated (high-grade) extrapulmonary neuroendocrine carcinomas. (Strosberg JR, Coppola D, Klimstra DS, Phan AT, Kulke MH, Wiseman GA, Kvols LK, North American Neuroendocrine Tumor Society (NANETS)) Pancreas 2010 Aug;39(6):799-800 284 Citations |
| 1 | Does brachytherapy improve survival in addition to external beam radiation therapy in patients with high risk stage I and II endometrial carcinoma? (Crosby MA, Tward JD, Szabo A, Lee CM, Gaffney DK) Am J Clin Oncol 2010 Aug;33(4):364-9 19 Citations |
| 1 | Clear cell change in colonic tubular adenoma and corresponding colonic clear cell adenocarcinoma is associated with an altered mucin core protein profile. (Shi C, Scudiere JR, Cornish TC, Lam-Himlin D, Park JY, Fox MR, Montgomery EA) Am J Surg Pathol 2010 Sep;34(9):1344-50 11 Citations |
| 1 | High levels of expression of human stromal cell-derived factor-1 are associated with worse prognosis in patients with stage II pancreatic ductal adenocarcinoma. (Liang JJ, Zhu S, Bruggeman R, Zaino RJ, Evans DB, Fleming JB, Gomez HF, Zander DS, Wang H) Cancer Epidemiol Biomarkers Prev 2010 Oct;19(10):2598-604 59 Citations |
| 2 | Inhibition of carcinoma cell motility by epoxyeicosatrienoic acid (EET) antagonists. (Nithipatikom K, Brody DM, Tang AT, Manthati VL, Falck JR, Williams CL, Campbell WB) Cancer Sci 2010 Dec;101(12):2629-36 42 Citations |
| 1 | CXCL12 chemokine expression and secretion regulates colorectal carcinoma cell anoikis through Bim-mediated intrinsic apoptosis. (Drury LJ, Wendt MK, Dwinell MB) PLoS One 2010 Sep 22;5(9):e12895 40 Citations |
| 1 | Overexpression of receptor tyrosine kinase Axl promotes tumor cell invasion and survival in pancreatic ductal adenocarcinoma. (Song X, Wang H, Logsdon CD, Rashid A, Fleming JB, Abbruzzese JL, Gomez HF, Evans DB, Wang H) Cancer 2011 Feb 15;117(4):734-43 125 Citations |
| 1 | Increased expression of macrophage migration inhibitory factor during progression to hypopharyngeal squamous cell carcinoma. (Cludts S, Decaestecker C, Johnson B, Lechien J, Leroy X, Kindt N, Kaltner H, André S, Gabius HJ, Saussez S) Anticancer Res 2010 Sep;30(9):3313-9 16 Citations |
| 1 | The effects of body mass index on complications and survival outcomes in patients with cervical carcinoma undergoing curative chemoradiation therapy. (Kizer NT, Thaker PH, Gao F, Zighelboim I, Powell MA, Rader JS, Mutch DG, Grigsby PW) Cancer 2011 Mar 01;117(5):948-56 79 Citations |
| 1 | Analysis of outcomes of microinvasive adenocarcinoma of the uterine cervix by treatment type. (Reynolds EA, Tierney K, Keeney GL, Felix JC, Weaver AL, Roman LD, Cliby WA) Obstet Gynecol 2010 Nov;116(5):1150-7 45 Citations |
| 1 | Higher biologically effective dose of radiotherapy is associated with improved outcomes for locally advanced non-small cell lung carcinoma treated with chemoradiation: an analysis of the Radiation Therapy Oncology Group. (Machtay M, Bae K, Movsas B, Paulus R, Gore EM, Komaki R, Albain K, Sause WT, Curran WJ) Int J Radiat Oncol Biol Phys 2012 Jan 01;82(1):425-34 248 Citations |
| 1 | Hexaminolevulinate-mediated photodynamic purging of marrow grafts with murine breast carcinoma. (Čunderlíková B, Vasovič V, Sieber F, Furre T, Borgen E, Nesland JM, Peng Q) Bone Marrow Transplant 2011 Aug;46(8):1118-27 12 Citations |
| 1 | Double-balloon enteroscopy enabled the diagnosis of duodenal adenocarcinoma in a patient with Roux-en-Y gastric bypass surgery presenting with chronic anemia. (Sourianarayanane A, Mukewar SS, Upchurch BR, Bauer TW, Sanaka MR) Gastrointest Endosc 2011 Apr;73(4):837-8 3 Citations |
| 1 | Expression of mucin (MUC) genes in mucoepidermoid carcinoma. (Shemirani N, Osipov V, Kolker A, Khampang P, Kerschner JE) Laryngoscope 2011 Jan;121(1):167-70 14 Citations |
| 1 | The effects of physiological estrogen concentration on the immune response of urothelial carcinoma cells to bacillus Calmette-Guérin. (Guise AI, Chen F, Zhang G, See W) J Urol 2011 Jan;185(1):298-304 4 Citations |
| 1 | Development of Marjolin's ulcer within one month of burn injury with synchronous primary lung squamous cell carcinoma in an elderly patient: report of a case with allelotyping. (Wooldridge AN, Griesser MJ, Scharschmidt T, Iwenofu OH) Med Oncol 2011 Dec;28 Suppl 1:S586-92 2 Citations |
| 1 | Anti-proliferative effect of a putative endocannabinoid, 2-arachidonylglyceryl ether in prostate carcinoma cells. (Nithipatikom K, Isbell MA, Endsley MP, Woodliff JE, Campbell WB) Prostaglandins Other Lipid Mediat 2011 Feb;94(1-2):34-43 42 Citations |
| 1 | Racial/ethnic disparities in access to care and survival for patients with early-stage hepatocellular carcinoma. (Mathur AK, Osborne NH, Lynch RJ, Ghaferi AA, Dimick JB, Sonnenday CJ) Arch Surg 2010 Dec;145(12):1158-63 130 Citations |
| 1 | Hepatocellular carcinoma screening, diagnosis and management in the cirrhotic patient: A western review and recommendations (Sundaram V, Chopra K, Gamblin TC) Liver Cirrhosis: Causes, Diagnosis and Treatment February 2011:83-106 |
| 1 | Microcystic adnexal carcinoma: the first reported congenital case. (Smart DR, Taintor AR, Kelly ME, Lyon VB, Segura A, Jensen JN, Drolet BA) Pediatr Dermatol 2011;28(1):35-8 12 Citations |
| 1 | An evidence-based review of the surgical treatment of gastric adenocarcinoma. (Maduekwe UN, Yoon SS) J Gastrointest Surg 2011 May;15(5):730-41 9 Citations |
| 2 | Chemoembolization of intrahepatic cholangiocarcinoma with cisplatinum, doxorubicin, mitomycin C, ethiodol, and polyvinyl alcohol: a 2-center study. (Kiefer MV, Albert M, McNally M, Robertson M, Sun W, Fraker D, Olthoff K, Christians K, Pappas S, Rilling W, Soulen MC) Cancer 2011 Apr 01;117(7):1498-505 139 Citations |
| 1 | Review article: Effects of pepsin and alginate in an animal model of squamous cell carcinoma (Allen J, Tinling SP, Johnston N, Belafsky P) Alimentary Pharmacology and Therapeutics April 2011;33(SUPPL. 1):21-28 5 Citations |
| 1 | Longitudinal Oncology Registry of Head and Neck Carcinoma (LORHAN): analysis of chemoradiation treatment approaches in the United States. (Wong SJ, Harari PM, Garden AS, Schwartz M, Bellm L, Chen A, Curran WJ, Murphy BA, Ang KK) Cancer 2011 Apr 15;117(8):1679-86 43 Citations |
| 1 | Responses to liposomal Doxorubicin, bevacizumab, and temsirolimus in metaplastic carcinoma of the breast: biologic rationale and implications for stem-cell research in breast cancer. (Moulder S, Moroney J, Helgason T, Wheler J, Booser D, Albarracin C, Morrow PK, Koenig K, Kurzrock R) J Clin Oncol 2011 Jul 01;29(19):e572-5 63 Citations |
| 1 | Monitoring response to antiangiogenic treatment and predicting outcomes in advanced hepatocellular carcinoma using image biomarkers, CT perfusion, tumor density, and tumor size (RECIST). (Jiang T, Kambadakone A, Kulkarni NM, Zhu AX, Sahani DV) Invest Radiol 2012 Jan;47(1):11-7 140 Citations |
| 1 | Rapid development of intestinal type gastric adenocarcinoma. (Oh YS, Massey BT) Case Rep Gastroenterol 2011 Apr 13;5(1):192-5 |
| 1 | [Relationship between genetic polymorphism in microRNAs precursor and genetic predisposition of hepatocellular carcinoma]. (Zhang XW, Pan SD, Feng YL, Liu JB, Dong J, Zhang YX, Chen JG, Hu ZB, Shen HB) Zhonghua Yu Fang Yi Xue Za Zhi 2011 Mar;45(3):239-43 34 Citations |
| 1 | Evolution of the surgical management of perihilar cholangiocarcinoma in a Western centre demonstrates improved survival with endoscopic biliary drainage and reduced use of blood transfusion. (Young AL, Igami T, Senda Y, Adair R, Farid S, Toogood GJ, Prasad KR, Lodge JP) HPB (Oxford) 2011 Jul;13(7):483-93 44 Citations |
| 1 | ALDH activity selectively defines an enhanced tumor-initiating cell population relative to CD133 expression in human pancreatic adenocarcinoma. (Kim MP, Fleming JB, Wang H, Abbruzzese JL, Choi W, Kopetz S, McConkey DJ, Evans DB, Gallick GE) PLoS One 2011;6(6):e20636 231 Citations |
| 1 | Survival and quality of life of patients with resected pancreatic adenocarcinoma treated with adjuvant interferon-based chemoradiation: a phase II trial. (Katz MH, Wolff R, Crane CH, Varadhachary G, Javle M, Lin E, Evans DB, Lee JE, Fleming JB, Pisters PW) Ann Surg Oncol 2011 Dec;18(13):3615-22 18 Citations |
| 1 | Integrated genomic analyses of ovarian carcinoma. (Cancer Genome Atlas Research Network) Nature 2011 Jun 29;474(7353):609-15 6247 Citations |
| 1 | Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment. (de Jong MC, Nathan H, Sotiropoulos GC, Paul A, Alexandrescu S, Marques H, Pulitano C, Barroso E, Clary BM, Aldrighetti L, Ferrone CR, Zhu AX, Bauer TW, Walters DM, Gamblin TC, Nguyen KT, Turley R, Popescu I, Hubert C, Meyer S, Schulick RD, Choti MA, Gigot JF, Mentha G, Pawlik TM) J Clin Oncol 2011 Aug 10;29(23):3140-5 637 Citations |
| 1 | Post-therapy pathologic stage and survival in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant chemoradiation. (Estrella JS, Rashid A, Fleming JB, Katz MH, Lee JE, Wolf RA, Varadhachary GR, Pisters PW, Abdalla EK, Vauthey JN, Wang H, Gomez HF, Evans DB, Abbruzzese JL, Wang H) Cancer 2012 Jan 01;118(1):268-77 75 Citations |
| 1 | Summary of candidate selection and expanded criteria for liver transplantation for hepatocellular carcinoma: a review and consensus statement. (Prasad KR, Young RS, Burra P, Zheng SS, Mazzaferro V, Moon DB, Freeman RB) Liver Transpl 2011 Oct;17 Suppl 2:S81-9 50 Citations |
| 1 | Conjunctival squamous cell carcinoma arising in immunosuppressed patients (organ transplant, human immunodeficiency virus infection). (Shields CL, Ramasubramanian A, Mellen PL, Shields JA) Ophthalmology 2011 Nov;118(11):2133-2137.e1 75 Citations |
| 1 | Salivary duct carcinoma: targeting the phosphatidylinositol 3-kinase pathway by blocking mammalian target of rapamycin with temsirolimus. (Piha-Paul SA, Cohen PR, Kurzrock R) J Clin Oncol 2011 Sep 10;29(26):e727-30 40 Citations |
| 1 | Presentation and outcomes of hepatocellular carcinoma patients at a western centre. (Kitisin K, Packiam V, Steel J, Humar A, Gamblin TC, Geller DA, Marsh JW, Tsung A) HPB (Oxford) 2011 Oct;13(10):712-22 31 Citations |
| 1 | Disposition of ultrasound sensitive polymeric drug carrier in a rat hepatocellular carcinoma model. (Cochran MC, Eisenbrey JR, Soulen MC, Schultz SM, Ouma RO, White SB, Furth EE, Wheatley MA) Acad Radiol 2011 Nov;18(11):1341-8 56 Citations |
| 1 | Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. (Kostic AD, Gevers D, Pedamallu CS, Michaud M, Duke F, Earl AM, Ojesina AI, Jung J, Bass AJ, Tabernero J, Baselga J, Liu C, Shivdasani RA, Ogino S, Birren BW, Huttenhower C, Garrett WS, Meyerson M) Genome Res 2012 Feb;22(2):292-8 1543 Citations |
| 2 | Cannabinoid receptor type 1 (CB1) activation inhibits small GTPase RhoA activity and regulates motility of prostate carcinoma cells. (Nithipatikom K, Gomez-Granados AD, Tang AT, Pfeiffer AW, Williams CL, Campbell WB) Endocrinology 2012 Jan;153(1):29-41 34 Citations |
| 3 | Continuous-course reirradiation with concurrent carboplatin and paclitaxel for locally recurrent, nonmetastatic squamous cell carcinoma of the head-and-neck. (Kharofa J, Choong N, Wang D, Firat S, Schultz C, Sadasiwan C, Wong S) Int J Radiat Oncol Biol Phys 2012 Jun 01;83(2):690-5 38 Citations |
| 1 | Hepatocellular carcinoma within a noncirrhotic, nonfibrotic, seronegative liver: surgical approaches and outcomes. (Young AL, Adair R, Prasad KR, Toogood GJ, Lodge JP) J Am Coll Surg 2012 Feb;214(2):174-83 48 Citations |
| 1 | Papillary carcinoma of the thyroid: balancing principles of oncology with emerging technology. (Evans DB) Surgery 2011 Dec;150(6):1015-22 13 Citations |
| 1 | Plasma DNA methylation of Wnt antagonists predicts recurrence of esophageal squamous cell carcinoma. (Liu JB, Qiang FL, Dong J, Cai J, Zhou SH, Shi MX, Chen KP, Hu ZB) World J Gastroenterol 2011 Nov 28;17(44):4917-21 52 Citations |
| 1 | Histologic tumor involvement of superior mesenteric vein/portal vein predicts poor prognosis in patients with stage II pancreatic adenocarcinoma treated with neoadjuvant chemoradiation. (Wang J, Estrella JS, Peng L, Rashid A, Varadhachary GR, Wang H, Lee JE, Pisters PW, Vauthey JN, Katz MH, Gomez HF, Evans DB, Abbruzzese JL, Fleming JB, Wang H) Cancer 2012 Aug 01;118(15):3801-11 58 Citations |
| 1 | SU‐C‐BRB‐03: Modeling of Radiation‐Induced Sensorineural Hearing Loss from IMRT and Chemotherapy for Nasopharyngeal Carcinoma (Tai A, Wang J, Bao Y, Chen M, li X) Medical Physics June 2012;39(6):3601 1 Citation |
| 1 | Liver Transplantation for Hepatocellular Carcinoma among African Americans in the United States. (Sourianarayanane A, Aucejo F, Miller C, Lopez R, Zein NN, McCullough AJ, Menon KV) Int J Organ Transplant Med 2012;3(2):85-91 |
| 1 | American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part II: high-dose-rate brachytherapy. (Viswanathan AN, Beriwal S, De Los Santos JF, Demanes DJ, Gaffney D, Hansen J, Jones E, Kirisits C, Thomadsen B, Erickson B, American Brachytherapy Society) Brachytherapy 2012;11(1):47-52 453 Citations |
| 1 | Long-term results of an RTOG Phase II trial (00-19) of external-beam radiation therapy combined with permanent source brachytherapy for intermediate-risk clinically localized adenocarcinoma of the prostate. (Lawton CA, Yan Y, Lee WR, Gillin M, Firat S, Baikadi M, Crook J, Kuettel M, Morton G, Sandler H) Int J Radiat Oncol Biol Phys 2012 Apr 01;82(5):e795-801 52 Citations |
| 1 | A phase II study of lapatinib in recurrent/metastatic squamous cell carcinoma of the head and neck. (de Souza JA, Davis DW, Zhang Y, Khattri A, Seiwert TY, Aktolga S, Wong SJ, Kozloff MF, Nattam S, Lingen MW, Kunnavakkam R, Stenson KM, Blair EA, Bozeman J, Dancey JE, Vokes EE, Cohen EE) Clin Cancer Res 2012 Apr 15;18(8):2336-43 104 Citations |
| 1 | Systematic review: the prognostic role of alpha-fetoprotein following liver transplantation for hepatocellular carcinoma. (Hakeem AR, Young RS, Marangoni G, Lodge JP, Prasad KR) Aliment Pharmacol Ther 2012 May;35(9):987-99 93 Citations |
| 1 | Loco-regional therapy in patients with Milan Criteria-compliant hepatocellular carcinoma and short waitlist time to transplant: an outcome analysis. (Sourianarayanane A, El-Gazzaz G, Sanabria JR, Menon KV, Quintini C, Hashimoto K, Kelly D, Eghtesad B, Miller C, Fung J, Aucejo F) HPB (Oxford) 2012 May;14(5):325-32 15 Citations |
| 1 | Erratum: Cannabinoid receptor type 1 (CB1) activation inhibits small GTPase RhoA activity and regulates motility of prostate carcinoma cells (Endocrinology (2012) 153 (29-41)) (Nithipatikom K, Gomez-Granados AD, Tang AT, Pfeiffer AW, Williams CL, Campbell WB) Endocrinology May 2012;153(5):2531 |
| 1 | Radiation therapy oncology group protocol 02-29: a phase II trial of neoadjuvant therapy with concurrent chemotherapy and full-dose radiation therapy followed by surgical resection and consolidative therapy for locally advanced non-small cell carcinoma of the lung. (Suntharalingam M, Paulus R, Edelman MJ, Krasna M, Burrows W, Gore E, Wilson LD, Choy H) Int J Radiat Oncol Biol Phys 2012 Oct 01;84(2):456-63 90 Citations |
| 1 | The role of Rac1 in the regulation of NF-κB activity, cell proliferation, and cell migration in non-small cell lung carcinoma. (Gastonguay A, Berg T, Hauser AD, Schuld N, Lorimer E, Williams CL) Cancer Biol Ther 2012 Jun;13(8):647-56 90 Citations |
| 1 | Head and neck carcinoma in the United States: first comprehensive report of the Longitudinal Oncology Registry of Head and Neck Carcinoma (LORHAN). (Ang KK, Chen A, Curran WJ Jr, Garden AS, Harari PM, Murphy BA, Wong SJ, Bellm LA, Schwartz M, Newman J, Adkins D, Hayes DN, Parvathaneni U, Brachman D, Ghabach B, Schneider CJ, Greenberg M, Anné PR) Cancer 2012 Dec 01;118(23):5783-92 56 Citations |
| 1 | Intraperitoneal and intravenous chemotherapy in peritoneal carcinomatosis. (Tsimberidou AM, Fu S, Subbiah IM, Naing A, Hong DS, Wen S, Fortier AH, Lim J, Kurzrock R) Hepatogastroenterology 2012 Jun;59(116):960-4 3 Citations |
| 1 | Diagnosis to Treatment Interval and Outcomes in Patients with Locally-Advanced Squamous Cell Carcinoma of Head and Neck in a Veteran's Affairs Medical Center (Brinkerhoff BT, Choong NW, Massey BL, Gore EM, Firat SY, et al. ) Journal of Cancer Science & Therapy J Cancer Sci Ther 2012, 4 (5): 111-115. |
| 1 | Pleural tumor seeding following percutaneous cryoablation of hepatocellular carcinoma. (Conners D, Rilling W) Semin Intervent Radiol 2011 Jun;28(2):258-60 4 Citations |
| 1 | Liver transplantation for hepatocellular carcinoma among african americans in the United States (Sourianarayanane A, Aucejo F, Miller C, Lopez R, Zein NN, McCullough AJ, Menon KVN) International Journal of Organ Transplantation Medicine 2012;3(2):85-91 1 Citation |
| 1 | Mucinous breast carcinomas lack PIK3CA and AKT1 mutations. (Kehr EL, Jorns JM, Ang D, Warrick A, Neff T, Degnin M, Lewis R, Beadling C, Corless CL, Troxell ML) Hum Pathol 2012 Dec;43(12):2207-12 36 Citations |
| 3 | Critical steps for pancreaticoduodenectomy in the setting of pancreatic adenocarcinoma. (Christians KK, Tsai S, Tolat PP, Evans DB) J Surg Oncol 2013 Jan;107(1):33-8 38 Citations |
| 4 | Dysphagia due to adenoid cystic carcinoma of the base of the tongue. (Hoekzema CR, Massey BL, Blumin JH, Hunt BC, Bock JM) Ann Otol Rhinol Laryngol 2012 Jun;121(6):402-6 3 Citations |
| 1 | Long-term follow-up of the RTOG 9501/intergroup phase III trial: postoperative concurrent radiation therapy and chemotherapy in high-risk squamous cell carcinoma of the head and neck. (Cooper JS, Zhang Q, Pajak TF, Forastiere AA, Jacobs J, Saxman SB, Kish JA, Kim HE, Cmelak AJ, Rotman M, Lustig R, Ensley JF, Thorstad W, Schultz CJ, Yom SS, Ang KK) Int J Radiat Oncol Biol Phys 2012 Dec 01;84(5):1198-205 431 Citations |
| 4 | Diagnosis to treatment interval and outcome in patients with locally-advanced squamous cell carcinoma of the head and neck in a veterans affairs medical center (Brinkerhoff BT, Choong NW, Massey BL, Gore EM, Firat SY, Wong SJ, Campbell BH, Schapira RM, Visotcky AM, Tripp PM) Journal of Cancer Science and Therapy 2012;4(5):111-115 5 Citations |
| 1 | Surgical treatment of peritoneal carcinomatosis from gastric cancer. (Turaga KK, Gamblin TC, Pappas S) Int J Surg Oncol 2012;2012:405652 6 Citations |
| 1 | The bradykinin B(2) receptor induces multiple cellular responses leading to the proliferation of human renal carcinoma cell lines. (Kramarenko II, Morinelli TA, Bunni MA, Raymond JR Sr, Garnovskaya MN) Cancer Manag Res 2012;4:195-205 10 Citations |
| 1 | The "shield sign" in two men with metastatic salivary duct carcinoma to the skin: Cutaneous metastases presenting as carcinoma hemorrhagiectoides (Cohen PR, Prieto VG, Piha-Paul SA, Kurzrock R) Journal of Clinical and Aesthetic Dermatology September 2012;5(9):27-36 12 Citations |
| 1 | Significance of serum tumor marker levels in peritoneal carcinomatosis of appendiceal origin. (Wagner PL, Austin F, Sathaiah M, Magge D, Maduekwe U, Ramalingam L, Jones HL, Holtzman MP, Ahrendt SA, Zureikat AH, Pingpank JF, Zeh HJ 3rd, Bartlett DL, Choudry HA) Ann Surg Oncol 2013 Feb;20(2):506-14 53 Citations |
| 1 | Prospective markers for early diagnosis and prognosis of sporadic pancreatic ductal adenocarcinoma. (Tobi M, Kim M, Weinstein DH, Rambus MA, Hatfield J, Adsay NV, Levi E, Evans D, Lawson MJ, Fligiel S) Dig Dis Sci 2013 Mar;58(3):744-50 16 Citations |
| 3 | Clinical regression of squamous cell carcinoma and keratoacanthomas in a patient treated with a hypomethylating agent. (Randhawa J, Wong S, Atallah E, Olasz E) Int J Dermatol 2014 Jan;53(1):e13-4 2 Citations |
| 1 | Alveolar variant of invasive lobular carcinoma in a fibroadenoma. (Butler R, Pinsky R, Jorns JM) Breast J 2012;18(6):613-4 3 Citations |
| 1 | Primary adenoid cystic carcinoma of the orbital apex. (Walsh RD, Vagefi MR, McClelland CM, Alonso-Basanta M, Newman JG, Farkas T, Tamhankar MA) Ophthalmic Plast Reconstr Surg 2013;29(1):e33-5 15 Citations |
| 1 | HMGB1 release by urothelial carcinoma cells is required for the in vivo antitumor response to Bacillus Calmette-Guérin. (Zhang G, Chen F, Cao Y, Johnson B, See WA) J Urol 2013 Apr;189(4):1541-6 7 Citations |
| 1 | Temporal patterns of selected late toxicities in patients treated with brachytherapy or brachytherapy plus external beam radiation for prostate adenocarcinoma. (Buckstein M, Kerns S, Forysthe K, Stone NN, Stock RG) BJU Int 2013 Mar;111(3 Pt B):E43-7 8 Citations |
| 1 | The "shield sign" in two men with metastatic salivary duct carcinoma to the skin: cutaneous metastases presenting as carcinoma hemorrhagiectoides. (Cohen PR, Prieto VG, Piha-Paul SA, Kurzrock R) J Clin Aesthet Dermatol 2012 Sep;5(9):27-36 |
| 2 | Novel multimodality treatment sequencing for extrahepatic (mid and distal) cholangiocarcinoma. (Turaga KK, Tsai S, Wiebe LA, Evans DB, Gamblin TC) Ann Surg Oncol 2013 Apr;20(4):1230-9 9 Citations |
| 1 | Long-term results for living donor liver transplant recipients with hepatocellular carcinoma using intraoperative blood salvage with leukocyte depletion filter. (Kim JM, Kim GS, Joh JW, Suh KS, Park JB, Ko JS, Kwon CH, Yi NJ, Gwak MS, Lee KW, Kim SJ, Lee SK) Transpl Int 2013 Jan;26(1):84-9 41 Citations |
| 1 | Small bowel intussusception secondary to metastasis of adenocarcinoma of the lung: A case report (Prakash S, Brashear C, Schmoekel N, Pacholec M, Desouches S) Journal of Surgical Radiology 2012;3(3):162-165 |
| 1 | Radiologic-histological correlation of hepatocellular carcinoma treated via pre-liver transplant locoregional therapies (El-Gazzaz G, Sourianarayanane A, Menon KVN, Sanabria J, Hashimoto K, Quintini C, Kelly D, Eghtesad B, Miller C, Fung J, Aucejo F) Hepatobiliary and Pancreatic Diseases International 2013;12(1):34-41 20 Citations |
| 2 | Management of primary hepatopancreatobiliary small cell carcinoma. (Groeschl RT, Christians KK, Turaga KK, Gamblin TC) J Surg Oncol 2013 Jun;107(7):692-5 10 Citations |
| 1 | Tumor size on abdominal MRI versus pathologic specimen in resected pancreatic adenocarcinoma: implications for radiation treatment planning. (Hall WA, Mikell JL, Mittal P, Colbert L, Prabhu RS, Kooby DA, Nickleach D, Hanley K, Sarmiento JM, Ali AN, Landry JC) Int J Radiat Oncol Biol Phys 2013 May 01;86(1):102-7 32 Citations |
| 1 | Surgical resection in hepatocellular carcinoma patients with minimal background fibrosis: a strategy in the era of organ shortage. (Groeschl RT, Clark Gamblin T, Turaga KK) Ann Surg Oncol 2013 Jun;20(6):2043-8 12 Citations |
| 1 | Genome-wide association study identifies a novel susceptibility locus at 12q23.1 for lung squamous cell carcinoma in han chinese. (Dong J, Jin G, Wu C, Guo H, Zhou B, Lv J, Lu D, Shi Y, Shu Y, Xu L, Chu M, Wang C, Zhang R, Dai J, Jiang Y, Yu D, Ma H, Zhao X, Yin Z, Yang L, Li Z, Deng Q, Cao S, Qin Z, Gong J, Sun C, Wang J, Wu W, Zhou G, Chen H, Guan P, Chen Y, Liu X, Liu L, Xu P, Han B, Bai C, Zhao Y, Zhang H, Yan Y, Liu J, Amos CI, Chen F, Tan W, Jin L, Wu T, Hu Z, Lin D, Shen H) PLoS Genet 2013;9(1):e1003190 42 Citations |
| 1 | Macrophage migration inhibitory factor in head and neck squamous cell carcinoma: clinical and experimental studies. (Kindt N, Preillon J, Kaltner H, Gabius HJ, Chevalier D, Rodriguez A, Johnson BD, Megalizzi V, Decaestecker C, Laurent G, Saussez S) J Cancer Res Clin Oncol 2013 May;139(5):727-37 34 Citations |
| 1 | Five-year outcomes of squamous cell carcinoma of the tonsil treated with radiotherapy. (Mourad WF, Hu KS, Puckett L, Hauerstock D, Shourbaji RA, Li Z, Manolidis S, Schantz S, Tran T, Jacobson A, Urken M, Culliney B, Persky M, Harrison LB) Am J Clin Oncol 2014 Feb;37(1):57-62 6 Citations |
| 1 | Biomarker-directed therapy of squamous carcinomas of the head and neck: targeting PI3K/PTEN/mTOR pathway. (Holsinger FC, Piha-Paul SA, Janku F, Hong DS, Atkins JT, Tsimberidou AM, Kurzrock R) J Clin Oncol 2013 Mar 20;31(9):e137-40 28 Citations |
| 1 | Safety and efficacy of drug-eluting bead chemoembolization for hepatocellular carcinoma: comparison of small-versus medium-size particles. (Padia SA, Shivaram G, Bastawrous S, Bhargava P, Vo NJ, Vaidya S, Valji K, Harris WP, Hippe DS, Kogut MJ) J Vasc Interv Radiol 2013 Mar;24(3):301-6 83 Citations |
| 1 | Transplantation versus resection for patients with combined hepatocellular carcinoma-cholangiocarcinoma. (Groeschl RT, Turaga KK, Gamblin TC) J Surg Oncol 2013 May;107(6):608-12 75 Citations |
| 1 | Radiologic-histological correlation of hepatocellular carcinoma treated via pre-liver transplant locoregional therapies. (El-Gazzaz G, Sourianarayanane A, Menon KV, Sanabria J, Hashimoto K, Quintini C, Kelly D, Eghtesad B, Miller C, Fung J, Aucejo F) Hepatobiliary Pancreat Dis Int 2013 Feb;12(1):34-41 |
| 1 | Targeted therapy of advanced gallbladder cancer and cholangiocarcinoma with aggressive biology: eliciting early response signals from phase 1 trials. (Subbiah IM, Subbiah V, Tsimberidou AM, Naing A, Kaseb AO, Javle M, Fu S, Hong DS, Piha-Paul S, Wheler JJ, Hess KR, Janku F, Falchook GS, Wolff RA, Kurzrock R) Oncotarget 2013 Jan;4(1):156-65 31 Citations |
| 1 | The cost-effectiveness of neoadjuvant chemoradiation is superior to a surgery-first approach in the treatment of pancreatic head adenocarcinoma. (Abbott DE, Tzeng CW, Merkow RP, Cantor SB, Chang GJ, Katz MH, Bentrem DJ, Bilimoria KY, Crane CH, Varadhachary GR, Abbruzzese JL, Wolff RA, Lee JE, Evans DB, Fleming JB) Ann Surg Oncol 2013 Dec;20 Suppl 3:S500-8 59 Citations |
| 2 | Insulin growth factor receptor (IGF-1R) antibody cixutumumab combined with the mTOR inhibitor temsirolimus in patients with metastatic adrenocortical carcinoma. (Naing A, Lorusso P, Fu S, Hong D, Chen HX, Doyle LA, Phan AT, Habra MA, Kurzrock R) Br J Cancer 2013 Mar 05;108(4):826-30 105 Citations |
| 1 | Pituitary carcinoma in situ. (Pasquel FJ, Vincentelli C, Brat DJ, Oyesiku NM, Ioachimescu AG) Endocr Pract 2013;19(3):e69-73 21 Citations |
| 1 | The effect of alkaline phosphatase and intrahepatic metastases in large hepatocellular carcinoma. (Kim JM, Kwon CH, Joh JW, Park JB, Ko JS, Lee JH, Kim SJ, Park CK) World J Surg Oncol 2013 Feb 21;11:40 55 Citations |
| 1 | Extensive cytoreductive surgery for appendiceal carcinomatosis: morbidity, mortality, and survival. (Wagner PL, Austin F, Maduekwe U, Mavanur A, Ramalingam L, Jones HL, Holtzman MP, Ahrendt SA, Zureikat AH, Pingpank JF, Zeh HJ, Bartlett DL, Choudry HA) Ann Surg Oncol 2013 Apr;20(4):1056-62 34 Citations |
| 1 | Right hemicolectomy for mucinous adenocarcinoma of the appendix: just right or too much? (Turaga KK, Pappas S, Gamblin TC) Ann Surg Oncol 2013 Apr;20(4):1063-7 55 Citations |
| 1 | Pre-liver transplant biopsy in hepatocellular carcinoma: a potential criterion for exclusion from transplantation? (Young RS, Aldiwani M, Hakeem AR, Nair A, Guthrie A, Wyatt J, Treanor D, Morris-Stiff G, Jones RL, Prasad KR) HPB (Oxford) 2013 Jun;15(6):418-27 12 Citations |
| 5 | Staging chest computed tomography and positron emission tomography in patients with pancreatic adenocarcinoma: utility or futility? (Pappas SG, Christians KK, Tolat PP, Mautz AP, Lal A, McElroy L, Gamblin TC, Turaga KK, Tsai S, Erickson B, Ritch P, Evans DB) HPB (Oxford) 2014 Jan;16(1):70-4 23 Citations |
| 1 | Recurrence after operative management of intrahepatic cholangiocarcinoma. (Hyder O, Hatzaras I, Sotiropoulos GC, Paul A, Alexandrescu S, Marques H, Pulitano C, Barroso E, Clary BM, Aldrighetti L, Ferrone CR, Zhu AX, Bauer TW, Walters DM, Groeschl R, Gamblin TC, Marsh JW, Nguyen KT, Turley R, Popescu I, Hubert C, Meyer S, Choti MA, Gigot JF, Mentha G, Pawlik TM) Surgery 2013 Jun;153(6):811-8 248 Citations |
| 1 | Mitochondria-targeted nitroxide, Mito-CP, suppresses medullary thyroid carcinoma cell survival in vitro and in vivo. (Starenki D, Park JI) J Clin Endocrinol Metab 2013 Apr;98(4):1529-40 42 Citations |
| 1 | Response to sorafenib in a pediatric patient with papillary thyroid carcinoma with diffuse nodular pulmonary disease requiring mechanical ventilation. (Iyer P, Mayer JL, Ewig JM) Thyroid 2014 Jan;24(1):169-74 22 Citations |
| 1 | Merkel cell polyomavirus and HPV-17 associated with cutaneous squamous cell carcinoma arising in a patient with melanoma treated with the BRAF inhibitor dabrafenib. (Falchook GS, Rady P, Hymes S, Nguyen HP, Tyring SK, Prieto VG, Hong DS, Kurzrock R) JAMA Dermatol 2013 Mar;149(3):322-6 28 Citations |
| 1 | Brain metastasis from oesophageal adenocarcinoma. (Nwankwo N, Mirrakhimov AE, Wind KP, Bucher N) BMJ Case Rep 2013 Apr 19;2013 1 Citation |
| 1 | C-reactive protein may be a prognostic factor in hepatocellular carcinoma with malignant portal vein invasion. (Kim JM, Kwon CH, Joh JW, Ko JS, Park JB, Lee JH, Kim SJ, Paik SW, Park CK) World J Surg Oncol 2013 Apr 23;11:92 27 Citations |
| 1 | The influence of adjuvant radiotherapy dose on overall survival in patients with resected pancreatic adenocarcinoma. (Hall WA, Colbert LE, Liu Y, Gillespie T, Lipscomb J, Hardy C, Kooby DA, Prabhu RS, Kauh J, Landry JC) Cancer 2013 Jun 15;119(12):2350-7 12 Citations |
| 1 | Tumor marker and measurement fluctuations may not reflect treatment efficacy in patients with medullary thyroid carcinoma on long-term RET inhibitor therapy. (Kurzrock R, Atkins J, Wheler J, Fu S, Naing A, Busaidy N, Hong D, Sherman S) Ann Oncol 2013 Sep;24(9):2256-61 30 Citations |
| 1 | Ultra-rare mutation in long-range enhancer predisposes to thyroid carcinoma with high penetrance. (He H, Li W, Wu D, Nagy R, Liyanarachchi S, Akagi K, Jendrzejewski J, Jiao H, Hoag K, Wen B, Srinivas M, Waidyaratne G, Wang R, Wojcicka A, Lattimer IR, Stachlewska E, Czetwertynska M, Dlugosinska J, Gierlikowski W, Ploski R, Krawczyk M, Jazdzewski K, Kere J, Symer DE, Jin V, Wang Q, de la Chapelle A) PLoS One 2013;8(5):e61920 39 Citations |
| 1 | Persistence of nondysplastic Barrett's esophagus identifies patients at lower risk for esophageal adenocarcinoma: results from a large multicenter cohort. (Gaddam S, Singh M, Balasubramanian G, Thota P, Gupta N, Wani S, Higbee AD, Mathur SC, Horwhat JD, Rastogi A, Young PE, Cash BD, Bansal A, Vargo JJ, Falk GW, Lieberman DA, Sampliner RE, Sharma P) Gastroenterology 2013 Sep;145(3):548-53.e1 72 Citations |
| 1 | Ablation for hepatocellular carcinoma: validating the 3-cm breakpoint. (Groeschl RT, Gamblin TC, Turaga KK) Ann Surg Oncol 2013 Oct;20(11):3591-5 23 Citations |
| 1 | Pronecrotic mixed lineage kinase domain-like protein expression is a prognostic biomarker in patients with early-stage resected pancreatic adenocarcinoma. (Colbert LE, Fisher SB, Hardy CW, Hall WA, Saka B, Shelton JW, Petrova AV, Warren MD, Pantazides BG, Gandhi K, Kowalski J, Kooby DA, El-Rayes BF, Staley CA 3rd, Adsay NV, Curran WJ Jr, Landry JC, Maithel SK, Yu DS) Cancer 2013 Sep 01;119(17):3148-55 106 Citations |
| 1 | The novel cancer-testis antigen A-kinase anchor protein 4 (AKAP4) is a potential target for immunotherapy of ovarian serous carcinoma. (Agarwal S, Saini S, Parashar D, Verma A, Sinha A, Jagadish N, Batra A, Suri S, Gupta A, Ansari AS, Lohiya NK, Suri A) Oncoimmunology 2013 May 01;2(5):e24270 39 Citations |
| 1 | D2 lymphadenectomy with surgical ex vivo dissection into node stations for gastric adenocarcinoma can be performed safely in Western patients and ensures optimal staging. (Schmidt B, Chang KK, Maduekwe UN, Look-Hong N, Rattner DW, Lauwers GY, Mullen JT, Yang HK, Yoon SS) Ann Surg Oncol 2013 Sep;20(9):2991-9 21 Citations |
| 1 | Noncurative gastrectomy for gastric adenocarcinoma should only be performed in highly selected patients. (Schmidt B, Look-Hong N, Maduekwe UN, Chang K, Hong TS, Kwak EL, Lauwers GY, Rattner DW, Mullen JT, Yoon SS) Ann Surg Oncol 2013 Oct;20(11):3512-8 29 Citations |
| 2 | Viral status at the time of liver transplantation for hepatocellular carcinoma: a modern predictor of longterm survival. (Groeschl RT, Hong JC, Christians KK, Turaga KK, Tsai S, Pilgrim CH, Gamblin TC) HPB (Oxford) 2013 Oct;15(10):794-802 5 Citations |
| 1 | The association between C-reactive protein (CRP) level and biochemical failure-free survival in patients after radiation therapy for nonmetastatic adenocarcinoma of the prostate. (Hall WA, Nickleach DC, Master VA, Prabhu RS, Rossi PJ, Godette K, Cooper S, Jani AB) Cancer 2013 Sep 15;119(18):3272-9 34 Citations |
| 1 | ERCC1 protein expression is associated with differential survival in oropharyngeal head and neck squamous cell carcinoma. (Patel MR, Zhao N, Ang MK, Stadler ME, Fritchie K, Weissler MC, Zanation AM, Harris SL, Funkhouser WK, Olshan AF, Shores CG, Hayes DN) Otolaryngol Head Neck Surg 2013 Oct;149(4):587-95 11 Citations |
| 1 | Human epidermal receptor 2-amplified salivary duct carcinoma: regression with dual human epidermal receptor 2 inhibition and anti-vascular endothelial growth factor combination treatment. (Falchook GS, Lippman SM, Bastida CC, Kurzrock R) Head Neck 2014 Mar;36(3):E25-7 48 Citations |
| 2 | Recombinant leukemia inhibitory factor suppresses human medullary thyroid carcinoma cell line xenografts in mice. (Starenki D, Singh NK, Jensen DR, Peterson FC, Park JI) Cancer Lett 2013 Oct 01;339(1):144-51 15 Citations |
| 1 | ACR Appropriateness Criteria® management of locoregionally advanced squamous cell carcinoma of the vulva. (Expert Panel on Radiation Oncology-Gynecology, Kidd E, Moore D, Varia MA, Gaffney DK, Elshaikh MA, Erickson B, Jhingran A, Lee LJ, Mayr NA, Puthawala AA, Rao GG, Small W Jr, Wahl AO, Wolfson AH, Yashar CM, Yuh W, Cardenes HR) Am J Clin Oncol 2013 Aug;36(4):415-22 16 Citations |
| 3 | Mitochondria-targeted antioxidant and glycolysis inhibition: synergistic therapy in hepatocellular carcinoma. (Dilip A, Cheng G, Joseph J, Kunnimalaiyaan S, Kalyanaraman B, Kunnimalaiyaan M, Gamblin TC) Anticancer Drugs 2013 Oct;24(9):881-8 27 Citations |
| 1 | Sirolimus reduces cutaneous squamous cell carcinomas in transplantation recipients. (Colegio OR, Hanlon A, Olasz EB, Carucci JA) J Clin Oncol 2013 Sep 10;31(26):3297-8 16 Citations |
| 1 | MicroRNA-31 predicts the presence of lymph node metastases and survival in patients with lung adenocarcinoma. (Meng W, Ye Z, Cui R, Perry J, Dedousi-Huebner V, Huebner A, Wang Y, Li B, Volinia S, Nakanishi H, Kim T, Suh SS, Ayers LW, Ross P, Croce CM, Chakravarti A, Jin VX, Lautenschlaeger T) Clin Cancer Res 2013 Oct 01;19(19):5423-33 101 Citations |
| 1 | Combining erlotinib and cetuximab is associated with activity in patients with non-small cell lung cancer (including squamous cell carcinomas) and wild-type EGFR or resistant mutations. (Wheler JJ, Tsimberidou AM, Falchook GS, Zinner RG, Hong DS, Fok JY, Fu S, Piha-Paul SA, Naing A, Kurzrock R) Mol Cancer Ther 2013 Oct;12(10):2167-75 33 Citations |
| 1 | Multidisciplinary approaches to intrahepatic cholangiocarcinoma. (Maithel SK, Gamblin TC, Kamel I, Corona-Villalobos CP, Thomas M, Pawlik TM) Cancer 2013 Nov 15;119(22):3929-42 110 Citations |
| 2 | EGFRvIII expression in squamous cell carcinoma of the skin. (Dziunycz PJ, Lazarova Z, Duncan N, Wong S, Neuburg M, Hofbauer GF, Olasz EB) JAMA Dermatol 2013 Oct;149(10):1240-2 10 Citations |
| 2 | Borderline resectable/locally advanced pancreatic adenocarcinoma: improvements needed in population-based registries. (Miura JT, Evans DB, Pappas SG, Gamblin TC, Turaga KK) Ann Surg Oncol 2013 Dec;20(13):4338-47 7 Citations |
| 1 | Thymoquinone inhibits cell proliferation through regulation of G1/S phase cell cycle transition in N-nitrosodiethylamine-induced experimental rat hepatocellular carcinoma. (Raghunandhakumar S, Paramasivam A, Senthilraja S, Naveenkumar C, Asokkumar S, Binuclara J, Jagan S, Anandakumar P, Devaki T) Toxicol Lett 2013 Oct 23;223(1):60-72 72 Citations |
| 1 | Loss of bacillus Calmette-Guérin viability adversely affects the direct response of urothelial carcinoma cells to bacillus Calmette-Guérin exposure. (Shah G, Zhang G, Chen F, Cao Y, Kalyanaraman B, See W) J Urol 2014 Mar;191(3):823-9 7 Citations |
| 1 | iNOS expression and NO production contribute to the direct effects of BCG on urothelial carcinoma cell biology. (Shah G, Zhang G, Chen F, Cao Y, Kalyanaraman B, See WA) Urol Oncol 2014 Jan;32(1):45.e1-9 21 Citations |
| 4 | Ciliated hepatic cyst leading to squamous cell carcinoma of the liver - A case report and review of the literature. (Wilson JM, Groeschl R, George B, Turaga KK, Patel PJ, Saeian K, Gamblin TC) Int J Surg Case Rep 2013;4(11):972-5 29 Citations |
| 1 | Targeting SRC and tubulin in mucinous ovarian carcinoma. (Liu T, Hu W, Dalton HJ, Choi HJ, Huang J, Kang Y, Pradeep S, Miyake T, Song JH, Wen Y, Lu C, Pecot CV, Bottsford-Miller J, Zand B, Jennings NB, Ivan C, Gallick GE, Baggerly KA, Hangauer DG, Coleman RL, Frumovitz M, Sood AK) Clin Cancer Res 2013 Dec 01;19(23):6532-43 36 Citations |
| 4 | Neutrophil-to-lymphocyte ratio as a predictor of outcomes for patients with hepatocellular carcinoma: a Western perspective. (Sullivan KM, Groeschl RT, Turaga KK, Tsai S, Christians KK, White SB, Rilling WS, Pilgrim CH, Gamblin TC) J Surg Oncol 2014 Feb;109(2):95-7 37 Citations |
| 1 | Neutrophil:lymphocyte ratio as a simple and novel biomarker for prediction of locoregional recurrence after chemoradiotherapy for squamous cell carcinoma of the anus. (Toh E, Wilson J, Sebag-Montefiore D, Botterill I) Colorectal Dis 2014 Mar;16(3):O90-7 32 Citations |
| 1 | Double-blind, randomized, phase 2 trial of maintenance sunitinib versus placebo after response to chemotherapy in patients with advanced urothelial carcinoma. (Grivas PD, Daignault S, Tagawa ST, Nanus DM, Stadler WM, Dreicer R, Kohli M, Petrylak DP, Vaughn DJ, Bylow KA, Wong SG, Sottnik JL, Keller ET, Al-Hawary M, Smith DC, Hussain M) Cancer 2014 Mar 01;120(5):692-701 94 Citations |
| 1 | Discrimination between adenocarcinoma and normal pancreatic ductal fluid by proteomic and glycomic analysis. (Porterfield M, Zhao P, Han H, Cunningham J, Aoki K, Von Hoff DD, Demeure MJ, Pierce JM, Tiemeyer M, Wells L) J Proteome Res 2014 Feb 07;13(2):395-407 32 Citations |
| 1 | Sperm associated antigen 9 plays an important role in bladder transitional cell carcinoma. (Kanojia D, Garg M, Saini S, Agarwal S, Parashar D, Jagadish N, Seth A, Bhatnagar A, Gupta A, Kumar R, Lohiya NK, Suri A) PLoS One 2013;8(12):e81348 35 Citations |
| 1 | Intraepithelial sebaceous carcinoma: a case report of an unusual occurrence. (Currie GP, Plaza JA, Harris GJ) Am J Dermatopathol 2014 Aug;36(8):673-6 14 Citations |
| 1 | A phase I, open-label study of trebananib combined with sorafenib or sunitinib in patients with advanced renal cell carcinoma. (Hong DS, Gordon MS, Samlowski WE, Kurzrock R, Tannir N, Friedland D, Mendelson DS, Vogelzang NJ, Rasmussen E, Wu BM, Bass MB, Zhong ZD, Friberg G, Appleman LJ) Clin Genitourin Cancer 2014 Jun;12(3):167-177.e2 23 Citations |
| 1 | Cervical conization of adenocarcinoma in situ: a predicting model of residual disease. (Tierney KE, Lin PS, Amezcua C, Matsuo K, Ye W, Felix JC, Roman LD) Am J Obstet Gynecol 2014 Apr;210(4):366.e1-366.e5 28 Citations |
| 1 | Diabetes mellitus is associated with hepatocellular carcinoma: a retrospective case-control study in hepatitis endemic area. (Zheng Z, Zhang C, Yan J, Ruan Y, Zhao X, San X, Mao Y, Sun Q, Zhang K, Fan Z) PLoS One 2013;8(12):e84776 27 Citations |
| 1 | Landscape of genomic alterations in cervical carcinomas. (Ojesina AI, Lichtenstein L, Freeman SS, Pedamallu CS, Imaz-Rosshandler I, Pugh TJ, Cherniack AD, Ambrogio L, Cibulskis K, Bertelsen B, Romero-Cordoba S, Treviño V, Vazquez-Santillan K, Guadarrama AS, Wright AA, Rosenberg MW, Duke F, Kaplan B, Wang R, Nickerson E, Walline HM, Lawrence MS, Stewart C, Carter SL, McKenna A, Rodriguez-Sanchez IP, Espinosa-Castilla M, Woie K, Bjorge L, Wik E, Halle MK, Hoivik EA, Krakstad C, Gabiño NB, Gómez-Macías GS, Valdez-Chapa LD, Garza-Rodríguez ML, Maytorena G, Vazquez J, Rodea C, Cravioto A, Cortes ML, Greulich H, Crum CP, Neuberg DS, Hidalgo-Miranda A, Escareno CR, Akslen LA, Carey TE, Vintermyr OK, Gabriel SB, Barrera-Saldaña HA, Melendez-Zajgla J, Getz G, Salvesen HB, Meyerson M) Nature 2014 Feb 20;506(7488):371-5 698 Citations |
| 1 | Chemoradiation therapy sequencing for resected pancreatic adenocarcinoma in the National Cancer Data Base. (Colbert LE, Hall WA, Nickleach D, Switchenko J, Kooby DA, Liu Y, Gillespie T, Lipscomb J, Kauh J, Landry JC) Cancer 2014 Feb 15;120(4):499-506 39 Citations |
| 1 | Transarterial therapies for the treatment of intrahepatic cholangiocarcinoma. (Zechlinski JJ, Rilling WS) Semin Intervent Radiol 2013 Mar;30(1):21-7 13 Citations |
| 3 | Chemotherapy-induced regression of an adrenocorticotropin-secreting pituitary carcinoma accompanied by secondary adrenal insufficiency. (Cornell RF, Kelly DF, Bordo G, Carroll TB, Duong HT, Kim J, Takasumi Y, Thomas JP, Wong YL, Findling JW) Case Rep Endocrinol 2013;2013:675298 |
| 1 | Palliative surgery for malignant bowel obstruction from carcinomatosis: a systematic review. (Paul Olson TJ, Pinkerton C, Brasel KJ, Schwarze ML) JAMA Surg 2014 Apr;149(4):383-92 152 Citations |
| 2 | Hypermethylation of miR-203 in endometrial carcinomas. (Huang YW, Kuo CT, Chen JH, Goodfellow PJ, Huang TH, Rader JS, Uyar DS) Gynecol Oncol 2014 May;133(2):340-5 50 Citations |
| 1 | A nomogram to predict long-term survival after resection for intrahepatic cholangiocarcinoma: an Eastern and Western experience. (Hyder O, Marques H, Pulitano C, Marsh JW, Alexandrescu S, Bauer TW, Gamblin TC, Sotiropoulos GC, Paul A, Barroso E, Clary BM, Aldrighetti L, Ferrone CR, Zhu AX, Popescu I, Gigot JF, Mentha G, Feng S, Pawlik TM) JAMA Surg 2014 May;149(5):432-8 301 Citations |
| 1 | Borderline resectable adrenal cortical carcinoma: a potential role for preoperative chemotherapy. (Bednarski BK, Habra MA, Phan A, Milton DR, Wood C, Vauthey N, Evans DB, Katz MH, Ng CS, Perrier ND, Lee JE, Grubbs EG) World J Surg 2014 Jun;38(6):1318-27 49 Citations |
| 1 | Reduced acute toxicity associated with the use of volumetric modulated arc therapy for the treatment of adenocarcinoma of the prostate. (Hall WA, Colbert L, Nickleach D, Shelton J, Marcus DM, Switchenko J, Rossi PJ, Godette K, Cooper S, Jani AB) Pract Radiat Oncol 2013;3(4):e157-64 12 Citations |
| 1 | Methylation-associated silencing of microRNA-34b in hepatocellular carcinoma cancer. (Xie K, Liu J, Chen J, Dong J, Ma H, Liu Y, Hu Z) Gene 2014 Jun 10;543(1):101-7 54 Citations |
| 1 | Pain identifies squamous cell carcinoma in organ transplant recipients: the SCOPE-ITSCC PAIN study. (Bouwes Bavinck JN, Harwood CA, Genders RE, Wisgerhof HC, Plasmeijer EI, Mitchell L, Olasz EB, Mosel DD, Pokorney MS, Serra AL, Feldmeyer L, Baumann Conzett K, Piaserico S, Belloni Fortina A, Jahn K, Geusau A, Gerritsen MJ, Seckin D, Gulec AT, Cetkovska P, Ricar J, Imko-Walczuk B, Proby CM, Hofbauer GF) Am J Transplant 2014 Mar;14(3):668-76 16 Citations |
| 1 | Single hepatocellular carcinoma ≤ 3 cm in left lateral segment: liver resection or radiofrequency ablation? (Kim JM, Kang TW, Kwon CH, Joh JW, Ko JS, Park JB, Rhim H, Lee JH, Kim SJ, Paik SW) World J Gastroenterol 2014 Apr 14;20(14):4059-65 21 Citations |
| 1 | The influence of radiation therapy dose escalation on overall survival in unresectable pancreatic adenocarcinoma. (Hall WA, Colbert LE, Nickleach D, Switchenko J, Liu Y, Gillespie T, Lipscomb J, Hardy C, Kooby DA, Prabhu RS, Kauh J, Landry JC) J Gastrointest Oncol 2014 Apr;5(2):77-85 13 Citations |
| 1 | Papillary thyroid microcarcinoma: an over-treated malignancy? (Wang TS, Goffredo P, Sosa JA, Roman SA) World J Surg 2014 Sep;38(9):2297-303 96 Citations |
| 1 | Expressions of ABCG2, CD133, and podoplanin in salivary adenoid cystic carcinoma. (Li W, Tamamura R, Wang B, Liu Q, Liu H, Liu T, Katase N, Xiao J, Nagatsuka H) Biomed Res Int 2014;2014:132349 11 Citations |
| 1 | Tumor size predicts vascular invasion and histologic grade among patients undergoing resection of intrahepatic cholangiocarcinoma. (Spolverato G, Ejaz A, Kim Y, Sotiropoulos GC, Pau A, Alexandrescu S, Marques H, Pulitano C, Barroso E, Clary BM, Aldrighetti L, Bauer TW, Walters DM, Groeschl R, Gamblin TC, Marsh W, Nguyen KT, Turley R, Popescu I, Hubert C, Meyer S, Gigot JF, Mentha G, Pawlik TM) J Gastrointest Surg 2014 Jul;18(7):1284-91 65 Citations |
| 1 | Multi-institutional analysis of recurrence and survival after hepatectomy for fibrolamellar carcinoma. (Groeschl RT, Miura JT, Wong RK, Bloomston M, Lidsky ML, Clary BM, Martin RC, Belli G, Buell JF, Gamblin TC) J Surg Oncol 2014 Sep;110(4):412-5 28 Citations |
| 1 | Genomic profiling of intrahepatic cholangiocarcinoma: refining prognosis and identifying therapeutic targets. (Zhu AX, Borger DR, Kim Y, Cosgrove D, Ejaz A, Alexandrescu S, Groeschl RT, Deshpande V, Lindberg JM, Ferrone C, Sempoux C, Yau T, Poon R, Popescu I, Bauer TW, Gamblin TC, Gigot JF, Anders RA, Pawlik TM) Ann Surg Oncol 2014 Nov;21(12):3827-34 132 Citations |
| 2 | H2O2 generation by bacillus Calmette-Guérin induces the cellular oxidative stress response required for bacillus Calmette-Guérin direct effects on urothelial carcinoma biology. (Shah G, Zielonka J, Chen F, Zhang G, Cao Y, Kalyanaraman B, See W) J Urol 2014 Oct;192(4):1238-48 22 Citations |
| 1 | Identification of novel therapeutic targets in the PI3K/AKT/mTOR pathway in hepatocellular carcinoma using targeted next generation sequencing. (Janku F, Kaseb AO, Tsimberidou AM, Wolff RA, Kurzrock R) Oncotarget 2014 May 30;5(10):3012-22 83 Citations |
| 1 | Re-excision rates of invasive ductal carcinoma with lobular features compared with invasive ductal carcinomas and invasive lobular carcinomas of the breast. (Arps DP, Jorns JM, Zhao L, Bensenhaver J, Kleer CG, Pang JC) Ann Surg Oncol 2014 Dec;21(13):4152-8 16 Citations |
| 1 | Impact of ¹⁸F-FDG PET/CT on the management of adrenocortical carcinoma: analysis of 106 patients. (Takeuchi S, Balachandran A, Habra MA, Phan AT, Bassett RL Jr, Macapinlac HA, Chuang HH) Eur J Nucl Med Mol Imaging 2014 Nov;41(11):2066-73 36 Citations |
| 1 | MK2206 inhibits hepatocellular carcinoma cellular proliferation via induction of apoptosis and cell cycle arrest. (Wilson JM, Kunnimalaiyaan S, Gamblin TC, Kunnimalaiyaan M) J Surg Res 2014 Oct;191(2):280-5 24 Citations |
| 1 | Surgical management of bowel obstruction in patients with peritoneal carcinomatosis. (Shariat-Madar B, Jayakrishnan TT, Gamblin TC, Turaga KK) J Surg Oncol 2014 Nov;110(6):666-9 45 Citations |
| 1 | Does the extent of lymphadenectomy, number of lymph nodes, positive lymph node ratio and neutrophil-lymphocyte ratio impact surgical outcome of perihilar cholangiocarcinoma? (Hakeem AR, Marangoni G, Chapman SJ, Young RS, Nair A, Hidalgo EL, Toogood GJ, Wyatt JI, Lodge PA, Prasad KR) Eur J Gastroenterol Hepatol 2014 Sep;26(9):1047-54 49 Citations |
| 1 | Comprehensive molecular characterization of gastric adenocarcinoma. (Cancer Genome Atlas Research Network) Nature 2014 Sep 11;513(7517):202-9 4968 Citations |
| 4 | Defining the role of adjuvant external beam radiotherapy on resected adenocarcinoma of the ampulla of vater. (Miura JT, Jayakrishnan TT, Amini A, Johnston FM, Tsai S, Erickson B, Quebbeman EJ, Christians KK, Evans DB, Gamblin TC, Turaga KK) J Gastrointest Surg 2014 Nov;18(11):2003-8 12 Citations |
| 1 | Endothelial-mesenchymal transition in normal human esophageal endothelial cells cocultured with esophageal adenocarcinoma cells: role of IL-1β and TGF-β2. (Nie L, Lyros O, Medda R, Jovanovic N, Schmidt JL, Otterson MF, Johnson CP, Behmaram B, Shaker R, Rafiee P) Am J Physiol Cell Physiol 2014 Nov 01;307(9):C859-77 52 Citations |
| 1 | Comparative effectiveness of hepatic artery based therapies for unresectable intrahepatic cholangiocarcinoma. (Boehm LM, Jayakrishnan TT, Miura JT, Zacharias AJ, Johnston FM, Turaga KK, Gamblin TC) J Surg Oncol 2015 Feb;111(2):213-20 148 Citations |
| 1 | Assessment and optimization of electroporation-assisted tumoral nanoparticle uptake in a nude mouse model of pancreatic ductal adenocarcinoma. (West DL, White SB, Zhang Z, Larson AC, Omary RA) Int J Nanomedicine 2014;9:4169-76 17 Citations |
| 1 | Forkhead box M1 regulates quiescence-associated radioresistance of human head and neck squamous carcinoma cells. (Eckers JC, Kalen AL, Sarsour EH, Tompkins VS, Janz S, Son JM, Doskey CM, Buettner GR, Goswami PC) Radiat Res 2014 Oct;182(4):420-9 21 Citations |
| 1 | Ductal carcinoma in situ with distorting sclerosis on core biopsy may be predictive of upstaging on excision. (Walters LL, Pang JC, Zhao L, Jorns JM) Histopathology 2015 Mar;66(4):577-86 7 Citations |
| 1 | Use of multimodal imaging in the management of tumor embolism from the inferior vena cava through the right heart in a patient with renal cell carcinoma. (Colwell EM, Gandhi SD, Iqbal Z, Rashid ZA, Pagel PS) J Cardiothorac Vasc Anesth 2014 Oct;28(5):1421-4 3 Citations |
| 1 | Estrogen receptor expression is high but is of lower intensity in tubular carcinoma than in well-differentiated invasive ductal carcinoma. (Jorns JM, Thomas DG, Healy PN, Daignault S, Vickery TL, Snider JE, Mardis ER, Davies SR, Ellis MJ, Visscher DW) Arch Pathol Lab Med 2014 Nov;138(11):1507-13 4 Citations |
| 1 | Is Hepatic Resection for Large or Multifocal Intrahepatic Cholangiocarcinoma Justified? Results from a Multi-Institutional Collaboration. (Spolverato G, Kim Y, Alexandrescu S, Popescu I, Marques HP, Aldrighetti L, Clark Gamblin T, Miura J, Maithel SK, Squires MH, Pulitano C, Sandroussi C, Mentha G, Bauer TW, Newhook T, Shen F, Poultsides GA, Wallis Marsh J, Pawlik TM) Ann Surg Oncol 2015 Jul;22(7):2218-25 81 Citations |
| 1 | Merkel Cell Carcinoma Analysis of Outcomes: A 30-Year Experience (Liang E, Brower JV, Rice SR, Buehler DG, Saha S, Kimple RJ. ) |
| 1 | Molecular aberrations, targeted therapy, and renal cell carcinoma: current state-of-the-art. (Randall JM, Millard F, Kurzrock R) Cancer Metastasis Rev 2014 Dec;33(4):1109-24 76 Citations |
| 1 | Randomized phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas in the Radiation Therapy Oncology Group 0129 trial: long-term report of efficacy and toxicity. (Nguyen-Tan PF, Zhang Q, Ang KK, Weber RS, Rosenthal DI, Soulieres D, Kim H, Silverman C, Raben A, Galloway TJ, Fortin A, Gore E, Westra WH, Chung CH, Jordan RC, Gillison ML, List M, Le QT) J Clin Oncol 2014 Dec 01;32(34):3858-66 381 Citations |
| 1 | Pseudocarcinomatous hyperplasia mimicking squamous cell carcinoma in a case of CD56-positive cytotoxic T-cell lymphoma. (Ginsberg D, Hill H, Wilson B, Plaza JA, Schieke SM) J Cutan Pathol 2015 Mar;42(3):194-198 4 Citations |
| 1 | Integrated genomic characterization of papillary thyroid carcinoma. (Cancer Genome Atlas Research Network) Cell 2014 Oct 23;159(3):676-90 2393 Citations |
| 1 | Targeted PI3K/AKT/mTOR therapy for metastatic carcinomas of the cervix: A phase I clinical experience. (Hou MM, Liu X, Wheler J, Naing A, Hong D, Coleman RL, Tsimberidou A, Janku F, Zinner R, Lu K, Kurzrock R, Fu S) Oncotarget 2014 Nov 30;5(22):11168-79 56 Citations |
| 1 | Mortalin (GRP75/HSPA9) upregulation promotes survival and proliferation of medullary thyroid carcinoma cells (Dmytro Starenki, Seung-Keun Hong, RV Lloyd, Jong-In Park) Oncogene |
| 1 | Gemcitabine transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma. (Hammond JS, Franko J, Holloway SE, Heckman JT, Orons PD, Gamblin TC) Hepatogastroenterology 2014;61(133):1339-43 12 Citations |
| 1 | Mortalin (GRP75/HSPA9) upregulation promotes survival and proliferation of medullary thyroid carcinoma cells. (Starenki D, Hong SK, Lloyd RV, Park JI) Oncogene 2015 Aug 27;34(35):4624-34 69 Citations |
| 1 | Is central lymph node dissection necessary for parathyroid carcinoma? (Hsu KT, Sippel RS, Chen H, Schneider DF) Surgery 2014 Dec;156(6):1336-41; discussion 1341 74 Citations |
| 1 | Characteristics and kinetics of cervical lymph node regression after radiation therapy for human papillomavirus-associated oropharyngeal carcinoma: quantitative image analysis of post-radiotherapy response. (Tang C, Fuller CD, Garden AS, Awan MJ, Colen RR, Morrison WH, Frank SJ, Beadle BM, Phan J, Sturgis EM, Zafereo ME, Weber RS, Rosenthal DI, Gunn GB) Oral Oncol 2015 Feb;51(2):195-201 14 Citations |
| 1 | A novel staging system for adrenocortical carcinoma better predicts survival in patients with stage I/II disease. (Asare EA, Wang TS, Winchester DP, Mallin K, Kebebew E, Sturgeon C) Surgery 2014 Dec;156(6):1378-85; discussion 1385-6 38 Citations |
| 1 | Effective use of mirtazapine for refractory pruritus associated with carcinoma en cuirasse. (Lee JJ, Girouard SD, Carlberg VM, Mostaghimi A) BMJ Support Palliat Care 2016 Mar;6(1):119-21 18 Citations |
| 1 | The Ability to Diagnose Intrahepatic Cholangiocarcinoma Definitively Using Novel Branched DNA-Enhanced Albumin RNA In Situ Hybridization Technology. (Ferrone CR, Ting DT, Shahid M, Konstantinidis IT, Sabbatino F, Goyal L, Rice-Stitt T, Mubeen A, Arora K, Bardeesey N, Miura J, Gamblin TC, Zhu AX, Borger D, Lillemoe KD, Rivera MN, Deshpande V) Ann Surg Oncol 2016 Jan;23(1):290-6 84 Citations |
| 1 | Pathology of ductal carcinoma in situ: Features and diagnostic challenges (Jorns JM, Kleer CG) Ductal Carcinoma in Situ and Microinvasive/Borderline Breast Cancer 1 January 2015:39-49 |
| 1 | Pediatric Medullary Thyroid Carcinoma. (Starenki D, Park JI) J Pediatr Oncol 2015;3(2):29-37 |
| 1 | Erratum to: The Ability to Diagnose Intrahepatic Cholangiocarcinoma Definitively Using Novel Branched DNA-Enhanced Albumin RNA In Situ Hybridization Technology. (Ferrone CR, Ting DT, Shahid M, Konstantinidis IT, Sabbatino F, Goyal L, Rice-Stitt T, Mubeen A, Arora K, Bardeesey N, Miura J, Gamblin TC, Zhu AX, Borger D, Lillemoe KD, Rivera MN, Deshpande V) Ann Surg Oncol 2015 Dec;22 Suppl 3(Suppl 3):S1604 3 Citations |
| 1 | Comprehensive genomic characterization of head and neck squamous cell carcinomas. (Cancer Genome Atlas Network) Nature 2015 Jan 29;517(7536):576-82 3107 Citations |
| 1 | Genomic aberrations in cervical adenocarcinomas in Hong Kong Chinese women. (Chung TK, Van Hummelen P, Chan PK, Cheung TH, Yim SF, Yu MY, Ducar MD, Thorner AR, MacConaill LE, Doran G, Pedamallu CS, Ojesina AI, Wong RR, Wang VW, Freeman SS, Lau TS, Kwong J, Chan LK, Fromer M, May T, Worley MJ Jr, Esselen KM, Elias KM, Lawrence M, Getz G, Smith DI, Crum CP, Meyerson M, Berkowitz RS, Wong YF) Int J Cancer 2015 Aug 15;137(4):776-83 41 Citations |
| 1 | Extensive carcinoma cuniculatum of the mandible. (Shay S, Choy W, Christensen RE, St John MA) Am J Otolaryngol 2015;36(3):446-50 11 Citations |
| 1 | Inhibition of the AKT pathway in cholangiocarcinoma by MK2206 reduces cellular viability via induction of apoptosis. (Wilson JM, Kunnimalaiyaan S, Kunnimalaiyaan M, Gamblin TC) Cancer Cell Int 2015;15(1):13 27 Citations |
| 2 | Oncocytic Adenocarcinoma of the Orbit. (Harris GJ, Paul S, Hunt BC) Ophthalmic Plast Reconstr Surg 2017;33(1):e18-e20 2 Citations |
| 1 | Identification of Unique, Heterozygous Germline Mutation, STK11 (p.F354L), in a Child with an Encapsulated Follicular Variant of Papillary Thyroid Carcinoma within Six Months of Completing Treatment for Neuroblastoma. (Buryk MA, Picarsic JL, Creary SE, Shaw PH, Simons JP, Deutsch M, Monaco SE, Nikiforov YE, Witchel SF) Pediatr Dev Pathol 2015;18(4):318-23 18 Citations |
| 1 | The Impact of Surgical Margin Status on Long-Term Outcome After Resection for Intrahepatic Cholangiocarcinoma. (Spolverato G, Yakoob MY, Kim Y, Alexandrescu S, Marques HP, Lamelas J, Aldrighetti L, Gamblin TC, Maithel SK, Pulitano C, Bauer TW, Shen F, Poultsides GA, Marsh JW, Pawlik TM) Ann Surg Oncol 2015 Nov;22(12):4020-8 143 Citations |
| 3 | Tumor profiling of gastric and esophageal carcinoma reveal different treatment options. (Miura JT, Xiu J, Thomas J, George B, Carron BR, Tsai S, Johnston FM, Turaga KK, Gamblin TC) Cancer Biol Ther 2015;16(5):764-9 20 Citations |
| 5 | Chemotherapy for Surgically Resected Intrahepatic Cholangiocarcinoma. (Miura JT, Johnston FM, Tsai S, George B, Thomas J, Eastwood D, Banerjee A, Christians KK, Turaga KK, Pawlik TM, Clark Gamblin T) Ann Surg Oncol 2015 Oct;22(11):3716-23 88 Citations |
| 1 | Erratum to: The Ability to Diagnose Intrahepatic Cholangiocarcinoma Definitively Using Novel Branched DNA-Enhanced Albumin RNA In Situ Hybridization Technology. (Ferrone CR, Ting DT, Shahid M, Konstantinidis IT, Sabbatino F, Goyal L, Rice-Stitt T, Mubeen A, Arora K, Bardeesy N, Miura J, Gamblin TC, Zhu AX, Borger D, Lillemoe KD, Rivera MN, Deshpande V) Ann Surg Oncol 2015 Dec;22 Suppl 3:S1609 |
| 1 | "Atypical Lobular Hyperplasia and Lobular Carcinoma In Situ" (Patten, C and Shah-Khan, M) Score Curriculum Website Patten, C. and Shah-Khan, M. (2015). “Atypical Lobular Hyperplasia and Lobular Carcinoma in Situ.” The Score Portal. http://portal.surgicalcore.org/modulecontent.aspx?id=131614. |
| 1 | Using diffusion-weighted MRI to predict aggressive histological features in papillary thyroid carcinoma: a novel tool for pre-operative risk stratification in thyroid cancer. (Lu Y, Moreira AL, Hatzoglou V, Stambuk HE, Gonen M, Mazaheri Y, Deasy JO, Shaha AR, Tuttle RM, Shukla-Dave A) Thyroid 2015 Jun;25(6):672-80 33 Citations |
| 1 | Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. (Wells SA Jr, Asa SL, Dralle H, Elisei R, Evans DB, Gagel RF, Lee N, Machens A, Moley JF, Pacini F, Raue F, Frank-Raue K, Robinson B, Rosenthal MS, Santoro M, Schlumberger M, Shah M, Waguespack SG, American Thyroid Association Guidelines Task Force on Medullary Thyroid Carcinoma) Thyroid 2015 Jun;25(6):567-610 1729 Citations |
| 1 | Conditional Probability of Long-term Survival After Liver Resection for Intrahepatic Cholangiocarcinoma: A Multi-institutional Analysis of 535 Patients. (Spolverato G, Kim Y, Ejaz A, Alexandrescu S, Marques H, Aldrighetti L, Gamblin TC, Pulitano C, Bauer TW, Shen F, Sandroussi C, Poultsides G, Maithel SK, Pawlik TM) JAMA Surg 2015 Jun;150(6):538-45 92 Citations |
| 1 | Obesity Early in Adulthood Increases Risk but Does Not Affect Outcomes of Hepatocellular Carcinoma. (Hassan MM, Abdel-Wahab R, Kaseb A, Shalaby A, Phan AT, El-Serag HB, Hawk E, Morris J, Singh Raghav KP, Lee JS, Vauthey JN, Bortus G, Torres HA, Amos CI, Wolff RA, Li D) Gastroenterology 2015 Jul;149(1):119-29 97 Citations |
| 1 | Plasma miRNAs as early biomarkers for detecting hepatocellular carcinoma. (Wen Y, Han J, Chen J, Dong J, Xia Y, Liu J, Jiang Y, Dai J, Lu J, Jin G, Han J, Wei Q, Shen H, Sun B, Hu Z) Int J Cancer 2015 Oct 01;137(7):1679-90 189 Citations |
| 1 | Merkel Cell Carcinoma with a Suppressor of Fused (SUFU) Mutation: Case Report and Potential Therapeutic Implications. (Cohen PR, Kurzrock R) Dermatol Ther (Heidelb) 2015 Jun;5(2):129-43 10 Citations |
| 1 | Curcumin-mediated regulation of Notch1/hairy and enhancer of split-1/survivin: molecular targeting in cholangiocarcinoma. (Koprowski S, Sokolowski K, Kunnimalaiyaan S, Gamblin TC, Kunnimalaiyaan M) J Surg Res 2015 Oct;198(2):434-40 27 Citations |
| 1 | Treatment Outcomes for T4 Oropharyngeal Squamous Cell Carcinoma. (Zenga J, Wilson M, Adkins DR, Gay HA, Haughey BH, Kallogjeri D, Michel LS, Paniello RC, Rich JT, Thorstad WL, Nussenbaum B) JAMA Otolaryngol Head Neck Surg 2015 Dec;141(12):1118-27 33 Citations |
| 1 | Readmission After Liver Resection for Intrahepatic Cholangiocarcinoma: a Multi-Institutional Analysis. (Spolverato G, Maqsood H, Vitale A, Alexandrescu S, Marques HP, Aldrighetti L, Gamblin TC, Pulitano C, Bauer TW, Shen F, Poultsides G, Maithel S, Marsh JW, Pawlik TM) J Gastrointest Surg 2015 Jul;19(7):1334-41 13 Citations |
| 1 | Impact of complications on long-term survival after resection of intrahepatic cholangiocarcinoma. (Spolverato G, Yakoob MY, Kim Y, Alexandrescu S, Marques HP, Lamelas J, Aldrighetti L, Gamblin TC, Maithel SK, Pulitano C, Bauer TW, Shen F, Poultsides GA, Marsh JW, Pawlik TM) Cancer 2015 Aug 15;121(16):2730-9 70 Citations |
| 1 | MicroRNA-135b Regulates Leucine Zipper Tumor Suppressor 1 in Cutaneous Squamous Cell Carcinoma. (Olasz EB, Seline LN, Schock AM, Duncan NE, Lopez A, Lazar J, Flister MJ, Lu Y, Liu P, Sokumbi O, Harwood CA, Proby CM, Neuburg M, Lazarova Z) PLoS One 2015;10(5):e0125412 30 Citations |
| 1 | Xanthohumol inhibits Notch signaling and induces apoptosis in hepatocellular carcinoma. (Kunnimalaiyaan S, Sokolowski KM, Balamurugan M, Gamblin TC, Kunnimalaiyaan M) PLoS One 2015;10(5):e0127464 55 Citations |
| 1 | Merkel Cell Carcinoma Analysis of Outcomes: A 30-Year Experience. (Liang E, Brower JV, Rice SR, Buehler DG, Saha S, Kimple RJ) PLoS One 2015;10(6):e0129476 51 Citations |
| 1 | Management and Outcomes of Patients with Recurrent Intrahepatic Cholangiocarcinoma Following Previous Curative-Intent Surgical Resection. (Spolverato G, Kim Y, Alexandrescu S, Marques HP, Lamelas J, Aldrighetti L, Clark Gamblin T, Maithel SK, Pulitano C, Bauer TW, Shen F, Poultsides GA, Tran TB, Wallis Marsh J, Pawlik TM) Ann Surg Oncol 2016 Jan;23(1):235-43 221 Citations |
| 3 | Local Synthesis of Pepsin in Barrett's Esophagus and the Role of Pepsin in Esophageal Adenocarcinoma. (Samuels T, Hoekzema C, Gould J, Goldblatt M, Frelich M, Bosler M, Lee SH, Johnston N) Ann Otol Rhinol Laryngol 2015 Nov;124(11):893-902 17 Citations |
| 2 | Parathyroid Carcinoma: An Update on Treatment Outcomes and Prognostic Factors from the National Cancer Data Base (NCDB). (Asare EA, Sturgeon C, Winchester DJ, Liu L, Palis B, Perrier ND, Evans DB, Winchester DP, Wang TS) Ann Surg Oncol 2015 Nov;22(12):3990-5 131 Citations |
| 2 | TU-G-BRA-06: PET-Based Treatment Response Assessement for Neoadjuvent Chemoradiation for Pancreatic Adenocarcinoma. (Dalah E, Tai A, Oshima K, Hall W, Erickson B, Li X) Med Phys 2015 Jun;42(6):3631 |
| 1 | Beyond conventional chemotherapy: Emerging molecular targeted and immunotherapy strategies in urothelial carcinoma. (Ikeda S, Hansel DE, Kurzrock R) Cancer Treat Rev 2015 Sep;41(8):699-706 13 Citations |
| 1 | Exploring response signals and targets in aggressive unresectable hepatocellular carcinoma: an analysis of targeted therapy phase 1 trials. (Subbiah IM, Falchook GS, Kaseb AO, Hess KR, Tsimberidou AM, Fu S, Subbiah V, Hong DS, Naing A, Piha-Paul SA, Akmal O, Janku F, Kurzrock R) Oncotarget 2015 Sep 29;6(29):28453-62 12 Citations |
| 1 | Green tea component epigallocatechin-3-gallate decreases expression of osteopontin via a decrease in mRNA half-life in cell lines of metastatic hepatocellular carcinoma. (Zapf MA, Kothari AN, Weber CE, Arffa ML, Wai PY, Driver J, Gupta GN, Kuo PC, Mi Z) Surgery 2015 Oct;158(4):1039-47; discussion 1047-8 14 Citations |
| 3 | Surgical resection versus ablation for hepatocellular carcinoma ≤ 3 cm: a population-based analysis. (Miura JT, Johnston FM, Tsai S, Eastwood D, Banerjee A, Christians KK, Turaga KK, Gamblin TC) HPB (Oxford) 2015 Oct;17(10):896-901 36 Citations |
| 2 | Neutrophil-lymphocyte and platelet-lymphocyte ratio as predictors of disease specific survival after resection of adrenocortical carcinoma. (Bagante F, Tran TB, Postlewait LM, Maithel SK, Wang TS, Evans DB, Hatzaras I, Shenoy R, Phay JE, Keplinger K, Fields RC, Jin LX, Weber SM, Salem A, Sicklick JK, Gad S, Yopp AC, Mansour JC, Duh QY, Seiser N, Solorzano CC, Kiernan CM, Votanopoulos KI, Levine EA, Poultsides GA, Pawlik TM) J Surg Oncol 2015 Aug;112(2):164-72 37 Citations |
| 1 | Restoration of epigenetically silenced SULF1 expression by 5-aza-2-deoxycytidine sensitizes hepatocellular carcinoma cells to chemotherapy-induced apoptosis. (Shire A, Lomberk G, Lai JP, Zou H, Tsuchiya N, Aderca I, Moser CD, Gulaid KH, Oseini A, Hu C, Warsame O, Jenkins RB, Roberts LR) Med Epigenet 2015;3(1):1-18 |
| 1 | Can hepatic resection provide a long-term cure for patients with intrahepatic cholangiocarcinoma? (Spolverato G, Vitale A, Cucchetti A, Popescu I, Marques HP, Aldrighetti L, Gamblin TC, Maithel SK, Sandroussi C, Bauer TW, Shen F, Poultsides GA, Marsh JW, Pawlik TM) Cancer 2015 Nov 15;121(22):3998-4006 155 Citations |
| 1 | The association between C-reactive protein (CRP) level and biochemical failure-free survival in patients after radiation therapy for nonmetastatic adenocarcinoma of the prostate. (Hall WA, Nickleach DC, Master VA, Prabhu RS, Rossi PJ, Godette K, Cooper S, Jani AB ) Cancer. 2013 Sep 15;119(18):3272-9 |
| 1 | Chemoradiation therapy sequencing for resected pancreatic adenocarcinoma in the National Cancer Data Base. (Colbert LE, Hall WA, Nickleach D, Switchenko J, Kooby DA, Liu Y, Gillespie T, Lipscomb J, Kauh J, Landry JC) Cancer. 2014 Feb 15;120(4):499-506 PMID: 24390739 |
| 1 | Chromodomain Helicase Binding Protein 5 (CHD5) Is Associated With Improved Overall Survival In Patients Undergoing Adjuvant Therapy For Resected Pancreatic Adenocarcinoma. (Hall WA, Hardy CW, Colbert LE, Landry JC, Fisher SB, Sarka B, Petrova AV, Pantazides BG, Maithel SK, Kowalski J, Gandhi K, Kooby D, El-Rayes BF, Staley CA, Adsay V, Yu DS.) Oncogene. ePub Nov 25, 2013. PMID: 24276239. |
| 2 | Curative Resection of Adrenocortical Carcinoma: Rates and Patterns of Postoperative Recurrence. (Amini N, Margonis GA, Kim Y, Tran TB, Postlewait LM, Maithel SK, Wang TS, Evans DB, Hatzaras I, Shenoy R, Phay JE, Keplinger K, Fields RC, Jin LX, Weber SM, Salem A, Sicklick JK, Gad S, Yopp AC, Mansour JC, Duh QY, Seiser N, Solorzano CC, Kiernan CM, Votanopoulos KI, Levine EA, Poultsides GA, Pawlik TM) Ann Surg Oncol 2016 Jan;23(1):126-33 45 Citations |
| 1 | Incidence and Risk Factors Associated with Readmission After Surgical Treatment for Adrenocortical Carcinoma. (Valero-Elizondo J, Kim Y, Prescott JD, Margonis GA, Tran TB, Postlewait LM, Maithel SK, Wang TS, Glenn JA, Hatzaras I, Shenoy R, Phay JE, Keplinger K, Fields RC, Jin LX, Weber SM, Salem A, Sicklick JK, Gad S, Yopp AC, Mansour JC, Duh QY, Seiser N, Solorzano CC, Kiernan CM, Votanopoulos KI, Levine EA, Poultsides GA, Pawlik TM) J Gastrointest Surg 2015 Dec;19(12):2154-61 2 Citations |
| 2 | Adrenocortical Carcinoma: Impact of Surgical Margin Status on Long-Term Outcomes. (Margonis GA, Kim Y, Prescott JD, Tran TB, Postlewait LM, Maithel SK, Wang TS, Evans DB, Hatzaras I, Shenoy R, Phay JE, Keplinger K, Fields RC, Jin LX, Weber SM, Salem A, Sicklick JK, Gad S, Yopp AC, Mansour JC, Duh QY, Seiser N, Solorzano CC, Kiernan CM, Votanopoulos KI, Levine EA, Poultsides GA, Pawlik TM) Ann Surg Oncol 2016 Jan;23(1):134-41 71 Citations |
| 1 | Genetic Variants That Predispose to DNA Double-Strand Breaks in Lymphocytes From a Subset of Patients With Familial Colorectal Carcinomas. (Arora S, Yan H, Cho I, Fan HY, Luo B, Gai X, Bodian DL, Vockley JG, Zhou Y, Handorf EA, Egleston BL, Andrake MD, Nicolas E, Serebriiskii IG, Yen TJ, Hall MJ, Golemis EA, Enders GH) Gastroenterology 2015 Dec;149(7):1872-1883.e9 29 Citations |
| 1 | What is the best immunosuppressant combination in terms of antitumor effect in hepatocellular carcinoma? (Lee KW, Seo YD, Oh SC, Suh SW, Jeong J, Kim H, Yi NJ, Suh KS) Hepatol Res 2016 May;46(6):593-600 8 Citations |
| 3 | Intrahepatic cholangiocarcinoma and gallbladder cancer: distinguishing molecular profiles to guide potential therapy. (Potkonjak M, Miura JT, Turaga KK, Johnston FM, Tsai S, Christians KK, Gamblin TC) HPB (Oxford) 2015 Dec;17(12):1119-23 12 Citations |
| 1 | Yes-associated protein 1 and transcriptional coactivator with PDZ-binding motif activate the mammalian target of rapamycin complex 1 pathway by regulating amino acid transporters in hepatocellular carcinoma. (Park YY, Sohn BH, Johnson RL, Kang MH, Kim SB, Shim JJ, Mangala LS, Kim JH, Yoo JE, Rodriguez-Aguayo C, Pradeep S, Hwang JE, Jang HJ, Lee HS, Rupaimoole R, Lopez-Berestein G, Jeong W, Park IS, Park YN, Sood AK, Mills GB, Lee JS) Hepatology 2016 Jan;63(1):159-72 119 Citations |
| 2 | Synchronous Tumors: Adenocarcinoma of the Esophagus and Clear Cell Renal Carcinoma. (Narra RK, Alvarez Argote J, Mesologites T, Dasanu CA) Conn Med 2015 Aug;79(7):401-4 |
| 1 | Morphologic Mimics of Invasive Lobular Carcinoma. (Ishikawa MK, Pinsky RW, Smith LB, Jorns JM) Arch Pathol Lab Med 2015 Oct;139(10):1253-7 10 Citations |
| 2 | Comparing gene expression data from formalin-fixed, paraffin embedded tissues and qPCR with that from snap-frozen tissue and microarrays for modeling outcomes of patients with ovarian carcinoma. (Bradley WH, Eng K, Le M, Mackinnon AC, Kendziorski C, Rader JS) BMC Clin Pathol 2015;15:17 9 Citations |
| 1 | Papillary Thyroid Microcarcinoma: An Over-Treated Malignancy?: Reply. (Wang TS, Goffredo P, Sosa JA, Roman SA) World J Surg 2016 Mar;40(3):766-7 1 Citation |
| 1 | Intrahepatic Cholangiocarcinoma: Prognosis of Patients Who Did Not Undergo Lymphadenectomy. (Bagante F, Gani F, Spolverato G, Xu L, Alexandrescu S, Marques HP, Lamelas J, Aldrighetti L, Gamblin TC, Maithel SK, Pulitano C, Bauer TW, Shen F, Poultsides GA, Marsh JW, Pawlik TM) J Am Coll Surg 2015 Dec;221(6):1031-40.e1-4 68 Citations |
| 1 | Selective Mitochondrial Uptake of MKT-077 Can Suppress Medullary Thyroid Carcinoma Cell Survival In Vitro and In Vivo. (Starenki D, Park JI) Endocrinol Metab (Seoul) 2015 Dec;30(4):593-603 16 Citations |
| 1 | Safety of the Use of Blood Salvage and Autotransfusion During Liver Transplantation for Hepatocellular Carcinoma. (Han S, Kim G, Ko JS, Sinn DH, Yang JD, Joh JW, Lee SK, Gwak MS) Ann Surg 2016 Aug;264(2):339-43 57 Citations |
| 1 | A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma. (Zhu P, Jin J, Liao Y, Li J, Yu XZ, Liao W, He S) Oncotarget 2015 Dec 01;6(38):41383-97 32 Citations |
| 1 | PD-L1 (B7-H1) expression and the immune tumor microenvironment in primary and metastatic breast carcinomas. (Cimino-Mathews A, Thompson E, Taube JM, Ye X, Lu Y, Meeker A, Xu H, Sharma R, Lecksell K, Cornish TC, Cuka N, Argani P, Emens LA) Hum Pathol 2016 Jan;47(1):52-63 292 Citations |
| 1 | The canonical Wnt pathway regulates the metastasis-promoting mucin MUC4 in pancreatic ductal adenocarcinoma. (Pai P, Rachagani S, Lakshmanan I, Macha MA, Sheinin Y, Smith LM, Ponnusamy MP, Batra SK) Mol Oncol 2016 Feb;10(2):224-39 30 Citations |
| 1 | Next-Generation Sequencing of Matched Primary and Metastatic Rectal Adenocarcinomas Demonstrates Minimal Mutation Gain and Concordance to Colonic Adenocarcinomas. (Crumley SM, Pepper KL, Phan AT, Olsen RJ, Schwartz MR, Portier BP) Arch Pathol Lab Med 2016 Jun;140(6):529-35 17 Citations |
| 2 | Incidence of Perioperative Complications Following Resection of Adrenocortical Carcinoma and Its Association with Long-Term Survival. (Margonis GA, Amini N, Kim Y, Tran TB, Postlewait LM, Maithel SK, Wang TS, Evans DB, Hatzaras I, Shenoy R, Phay JE, Keplinger K, Fields RC, Moses LE, Weber SM, Salem A, Sicklick JK, Gad S, Yopp AC, Mansour JC, Duh QY, Seiser N, Solorzano CC, Kiernan CM, Votanopoulos KI, Levine EA, Poultsides GA, Pawlik TM) World J Surg 2016 Mar;40(3):706-714 12 Citations |
| 1 | Utility of estrogen receptor, progesterone receptor, and HER-2/neu analysis of multiple foci in multifocal ipsilateral invasive breast carcinoma. (East EG, Pang JC, Kidwell KM, Jorns JM) Am J Clin Pathol 2015 Dec;144(6):952-9 9 Citations |
| 1 | Phase II trial of dasatinib for recurrent or metastatic c-KIT expressing adenoid cystic carcinoma and for nonadenoid cystic malignant salivary tumors. (Wong SJ, Karrison T, Hayes DN, Kies MS, Cullen KJ, Tanvetyanon T, Argiris A, Takebe N, Lim D, Saba NF, Worden FP, Gilbert J, Lenz HJ, Razak AR, Roberts JD, Vokes EE, Cohen EE) Ann Oncol 2016 Feb;27(2):318-23 77 Citations |
| 1 | Comprehensive multiplatform biomarker analysis of 350 hepatocellular carcinomas identifies potential novel therapeutic options. (Ang C, Miura JT, Gamblin TC, He R, Xiu J, Millis SZ, Gatalica Z, Reddy SK, Yee NS, Abou-Alfa GK) J Surg Oncol 2016 Jan;113(1):55-61 26 Citations |
| 1 | BRAF(V600E) Is Correlated with Recurrence of Papillary Thyroid Microcarcinoma: A Systematic Review, Multi-Institutional Primary Data Analysis, and Meta-Analysis. (Chen Y, Sadow PM, Suh H, Lee KE, Choi JY, Suh YJ, Wang TS, Lubitz CC) Thyroid 2016 Feb;26(2):248-55 91 Citations |
| 2 | Nomograms to Predict Recurrence-Free and Overall Survival After Curative Resection of Adrenocortical Carcinoma. (Kim Y, Margonis GA, Prescott JD, Tran TB, Postlewait LM, Maithel SK, Wang TS, Evans DB, Hatzaras I, Shenoy R, Phay JE, Keplinger K, Fields RC, Jin LX, Weber SM, Salem AI, Sicklick JK, Gad S, Yopp AC, Mansour JC, Duh QY, Seiser N, Solorzano CC, Kiernan CM, Votanopoulos KI, Levine EA, Poultsides GA, Pawlik TM) JAMA Surg 2016 Apr;151(4):365-73 102 Citations |
| 1 | The Dose-Response Relationship of bacillus Calmette-Guérin and Urothelial Carcinoma Cell Biology. (Shah G, Zhang G, Chen F, Cao Y, Kalyanaraman B, See WA) J Urol 2016 Jun;195(6):1903-10 12 Citations |
| 1 | Ultrasonography-guided fine-needle aspiration with concurrent small core biopsy of neck masses and lymph nodes yields adequate material for HPV testing in head and neck squamous cell carcinomas. (Allison DB, Miller JA, Coquia SF, Maleki Z) J Am Soc Cytopathol 2016;5(1):22-30 32 Citations |
| 1 | Lipiodol transarterial chemoembolization for hepatocellular carcinoma: A systematic review of efficacy and safety data. (Lencioni R, de Baere T, Soulen MC, Rilling WS, Geschwind JF) Hepatology 2016 Jul;64(1):106-16 576 Citations |
| 1 | Outcomes of Adjuvant Mitotane after Resection of Adrenocortical Carcinoma: A 13-Institution Study by the US Adrenocortical Carcinoma Group. (Postlewait LM, Ethun CG, Tran TB, Prescott JD, Pawlik TM, Wang TS, Glenn J, Hatzaras I, Shenoy R, Phay JE, Keplinger K, Fields RC, Jin LX, Weber SM, Salem A, Sicklick JK, Gad S, Yopp AC, Mansour JC, Duh QY, Seiser N, Solorzano CC, Kiernan CM, Votanopoulos KI, Levine EA, Staley CA, Poultsides GA, Maithel SK) J Am Coll Surg 2016 Apr;222(4):480-90 74 Citations |
| 1 | A bispecific protein rG7S-MICA recruits natural killer cells and enhances NKG2D-mediated immunosurveillance against hepatocellular carcinoma. (Wang T, Sun F, Xie W, Tang M, He H, Jia X, Tian X, Wang M, Zhang J) Cancer Lett 2016 Mar 28;372(2):166-78 46 Citations |
| 1 | Patterns of PD-L1 expression and CD8 T cell infiltration in gastric adenocarcinomas and associated immune stroma. (Thompson ED, Zahurak M, Murphy A, Cornish T, Cuka N, Abdelfatah E, Yang S, Duncan M, Ahuja N, Taube JM, Anders RA, Kelly RJ) Gut 2017 May;66(5):794-801 366 Citations |
| 1 | High-Grade Neuroendocrine Colorectal Carcinomas: A Retrospective Study of 100 Patients. (Conte B, George B, Overman M, Estrella J, Jiang ZQ, Mehrvarz Sarshekeh A, Ferrarotto R, Hoff PM, Rashid A, Yao JC, Kopetz S, Dasari A) Clin Colorectal Cancer 2016 Jun;15(2):e1-7 40 Citations |
| 1 | Outcomes after resection of cortisol-secreting adrenocortical carcinoma. (Margonis GA, Kim Y, Tran TB, Postlewait LM, Maithel SK, Wang TS, Glenn JA, Hatzaras I, Shenoy R, Phay JE, Keplinger K, Fields RC, Jin LX, Weber SM, Salem A, Sicklick JK, Gad S, Yopp AC, Mansour JC, Duh QY, Seiser N, Solorzano CC, Kiernan CM, Votanopoulos KI, Levine EA, Poultsides GA, Pawlik TM) Am J Surg 2016 Jun;211(6):1106-13 43 Citations |
| 1 | Role of Akt inhibition on Notch1 expression in hepatocellular carcinoma: potential role for dual targeted therapy. (Sokolowski KM, Balamurugan M, Kunnimalaiyaan S, Wilson J, Gamblin TC, Kunnimalaiyaan M) Am J Surg 2016 Apr;211(4):755-60 6 Citations |
| 1 | Conditional Survival as a Patient Centered Metric for Patients with Appendiceal Adenocarcinoma. (Sekigami Y, Rajeev R, Johnston F, Clark Gamblin T, Turaga KK) Ann Surg Oncol 2016 Jul;23(7):2295-301 3 Citations |
| 1 | Association of Compliance With Process-Related Quality Metrics and Improved Survival in Oral Cavity Squamous Cell Carcinoma. (Graboyes EM, Gross J, Kallogjeri D, Piccirillo JF, Al-Gilani M, Stadler ME, Nussenbaum B) JAMA Otolaryngol Head Neck Surg 2016 May 01;142(5):430-7 44 Citations |
| 1 | Evaluation of a post-treatment follow-up program in patients with oral squamous cell carcinoma. (Peisker A, Raschke GF, Guentsch A, Luepke P, Roshanghias K, Schultze-Mosgau S) Clin Oral Investig 2017 Jan;21(1):135-141 5 Citations |
| 1 | Cutaneous metastasis of breast adenoid cystic carcinoma to the scalp. (Little AJ, Seline AE, Swick BL, Wanat KA) J Cutan Pathol 2016 Aug;43(8):684-7 6 Citations |
| 1 | Genomic portfolio of Merkel cell carcinoma as determined by comprehensive genomic profiling: implications for targeted therapeutics. (Cohen PR, Tomson BN, Elkin SK, Marchlik E, Carter JL, Kurzrock R) Oncotarget 2016 Apr 26;7(17):23454-67 36 Citations |
| 1 | IPI59: an actionable biomarker to improve treatment response in serous ovarian carcinoma patients. (Choi J, Shuyun Y, Eng KH, Korthauer K, Rader JS, Bradley WH, Kendziorski C.) Stat in Biosci DOI: 10.1007/s12561-016-9144-1 |
| 1 | Longterm quality of life after oncologic surgery and microvascular free flap reconstruction in patients with oral squamous cell carcinoma. (Peisker A, Raschke GF, Guentsch A, Roshanghias K, Eichmann F, Schultze-Mosgau S) Med Oral Patol Oral Cir Bucal 2016 Jul 01;21(4):e420-4 20 Citations |
| 1 | Defining when to offer operative treatment for intrahepatic cholangiocarcinoma: A regret-based decision curves analysis. (Bagante F, Spolverato G, Cucchetti A, Gani F, Popescu I, Ruzzenente A, Marques HP, Aldrighetti L, Gamblin TC, Maithel SK, Sandroussi C, Bauer TW, Shen F, Poultsides GA, Marsh JW, Guglielmi A, Pawlik TM) Surgery 2016 Jul;160(1):106-117 24 Citations |
| 1 | Dual Epidermal Growth Factor Receptor and Human Epidermal Growth Factor Receptor 2 Inhibition in Squamous Cell Carcinoma of the Head and Neck; Is the Jury Still Out? (Saba NF, Wong SJ) J Clin Oncol 2016 Jun 10;34(17):2072-3 2 Citations |
| 1 | Dysregulation of WNT5A/ROR2 Signaling Characterizes the Progression of Barrett-Associated Esophageal Adenocarcinoma. (Lyros O, Nie L, Moore T, Medda R, Otterson M, Behmaram B, Mackinnon A, Gockel I, Shaker R, Rafiee P) Mol Cancer Res 2016 Jul;14(7):647-59 12 Citations |
| 1 | A multi-institutional analysis of elderly patients undergoing a liver resection for intrahepatic cholangiocarcinoma. (Vitale A, Spolverato G, Bagante F, Gani F, Popescu I, Marques HP, Aldrighetti L, Gamblin TC, Maithel SK, Sandroussi C, Bauer TW, Shen F, Poultsides GA, Marsh JW, Pawlik TM) J Surg Oncol 2016 Mar;113(4):420-6 39 Citations |
| 1 | Cholangiocarcinoma risk factors and the potential role of aspirin. (Bagante F, Gamblin TC, Pawlik TM) Hepatology 2016 Sep;64(3):708-10 12 Citations |
| 1 | Consensus Recommendations for Radiation Therapy Contouring and Treatment of Vulvar Carcinoma. (Gaffney DK, King B, Viswanathan AN, Barkati M, Beriwal S, Eifel P, Erickson B, Fyles A, Goulart J, Harkenrider M, Jhingran A, Klopp A, Koh WJ, Lim K, Petersen I, Portelance L, Small W Jr, Stewart A, Wiebe E, Wolfson A, Yashar C, Bosch W) Int J Radiat Oncol Biol Phys 2016 Jul 15;95(4):1191-200 84 Citations |
| 1 | HER2 Status in Gastroesophageal Adenocarcinomas: Correlation Between Immunohistochemistry and Fluorescence In Situ Hybridization Methodologies. (Robertson SA, Cimino-Mathews A, Cornish TC) Appl Immunohistochem Mol Morphol 2018 Jan;26(1):35-39 1 Citation |
| 1 | Parathyroid carcinoma and atypical parathyroid neoplasms in MEN1 patients; A clinico-pathologic challenge. The MD Anderson case series and review of the literature. (Christakis I, Busaidy NL, Cote GJ, Williams MD, Hyde SM, Silva Figueroa AM, Kwatampora LJ, Clarke CN, Qiu W, Lee JE, Perrier ND) Int J Surg 2016 Jul;31:10-6 47 Citations |
| 1 | Image-based detection and targeting of therapy resistance in pancreatic adenocarcinoma. (Fox RG, Lytle NK, Jaquish DV, Park FD, Ito T, Bajaj J, Koechlein CS, Zimdahl B, Yano M, Kopp J, Kritzik M, Sicklick J, Sander M, Grandgenett PM, Hollingsworth MA, Shibata S, Pizzo D, Valasek M, Sasik R, Scadeng M, Okano H, Kim Y, MacLeod AR, Lowy AM, Reya T) Nature 2016 Jun 16;534(7607):407-411 115 Citations |
| 1 | Targeting stromal microenvironment in pancreatic ductal adenocarcinoma: controversies and promises. (Mei L, Du W, Ma WW) J Gastrointest Oncol 2016 Jun;7(3):487-94 40 Citations |
| 1 | Profiling of 149 Salivary Duct Carcinomas, Carcinoma Ex Pleomorphic Adenomas, and Adenocarcinomas, Not Otherwise Specified Reveals Actionable Genomic Alterations. (Wang K, Russell JS, McDermott JD, Elvin JA, Khaira D, Johnson A, Jennings TA, Ali SM, Murray M, Marshall C, Oldham DS, Washburn D, Wong SJ, Chmielecki J, Yelensky R, Lipson D, Miller VA, Stephens PJ, Serracino HS, Ross JS, Bowles DW) Clin Cancer Res 2016 Dec 15;22(24):6061-6068 109 Citations |
| 1 | Notch Signaling Activation Is Associated with Patient Mortality and Increased FGF1-Mediated Invasion in Squamous Cell Carcinoma of the Oral Cavity. (Weaver AN, Burch MB, Cooper TS, Della Manna DL, Wei S, Ojesina AI, Rosenthal EL, Yang ES) Mol Cancer Res 2016 Sep;14(9):883-91 33 Citations |
| 1 | Higher Bilirubin Levels of Healthy Living Liver Donors Are Associated With Lower Posttransplant Hepatocellular Carcinoma Recurrence. (Han S, Yang JD, Sinn DH, Ko JS, Kim JM, Shin JC, Son HJ, Gwak MS, Joh JW, Kim GS) Transplantation 2016 Sep;100(9):1933-8 9 Citations |
| 1 | Imaging Appearance of SMARCB1 (INI1)-Deficient Sinonasal Carcinoma: A Newly Described Sinonasal Malignancy. (Shatzkes DR, Ginsberg LE, Wong M, Aiken AH, Branstetter BF 4th, Michel MA, Aygun N) AJNR Am J Neuroradiol 2016 Oct;37(10):1925-1929 |
| 1 | Surgical management of parathyroid and adrenal glands in inherited medullary thyroid carcinoma (Carr AA, Evans DB) Medullary Thyroid Cancer 20 July 2016:103-114 |
| 1 | Management of patients with metastatic medullary thyroid carcinoma: The role for systemic therapy (Fareau GG) Medullary Thyroid Cancer 20 July 2016:157-164 |
| 1 | Primary liver resection for patients with cirrhosis and hepatocellular carcinoma: the role of surgery in BCLC early (A) and intermediate stages (B). (Bell R, Pandanaboyana S, Lodge JPA, Prasad KR, Jones R, Hidalgo E) Langenbecks Arch Surg 2017 Jun;402(4):575-583 9 Citations |
| 1 | Radiation Therapy Oncology Group 9501/Intergroup. Postoperative concurrent chemotherapy and radiation therapy in high-risk squamous cell carcinoma of the head and neck. (b. Spencer SA, Harris J, Wheeler RH, Machtay M, SCHULTZ C, Spanos W, Rotman M, Meredith R, Ang KK ) N Engl J Med 350 (19): 1937-1944 |
| 1 | Final report of RTOG 9610, a multi-institutional trial of reirradiation and chemotherapy for unresectable recurrent squamous cell carcinoma of the head and neck. (b. Spencer SA, Harris J, Wheeler RH, Machtay M, SCHULTZ C, Spanos W, Rotman M, Meredith R, Ang KK) Head Neck Mar;30(3):281-8 |
| 1 | A germline mutation of HRPT2/CDC73 (70 G>T) in an adolescent female with parathyroid carcinoma: first case report and a review of the literature. (Serrano-Gonzalez M, Shay S, Austin J, Maceri DR, Pitukcheewanont P) J Pediatr Endocrinol Metab 2016 Sep 01;29(9):1005-12 19 Citations |
| 1 | Lymphadenectomy for Adrenocortical Carcinoma: Is There a Therapeutic Benefit? (Gerry JM, Tran TB, Postlewait LM, Maithel SK, Prescott JD, Wang TS, Glenn JA, Phay JE, Keplinger K, Fields RC, Jin LX, Weber SM, Salem A, Sicklick JK, Gad S, Yopp AC, Mansour JC, Duh QY, Seiser N, Solorzano CC, Kiernan CM, Votanopoulos KI, Levine EA, Hatzaras I, Shenoy R, Pawlik TM, Norton JA, Poultsides GA) Ann Surg Oncol 2016 Dec;23(Suppl 5):708-713 41 Citations |
| 1 | Oncologic outcomes of selective neck dissection in HPV-related oropharyngeal squamous cell carcinoma. (Zenga J, Jackson RS, Graboyes EM, Sinha P, Lindberg M, Martin EJ, Ma D, Thorstad WL, Rich JT, Moore EJ, Haughey BH) Laryngoscope 2017 Mar;127(3):623-630 23 Citations |
| 1 | Actual 10-year survivors following resection of adrenocortical carcinoma. (Tran TB, Postlewait LM, Maithel SK, Prescott JD, Wang TS, Glenn J, Phay JE, Keplinger K, Fields RC, Jin LX, Weber SM, Salem A, Sicklick JK, Gad S, Yopp AC, Mansour JC, Duh QY, Seiser N, Solorzano CC, Kiernan CM, Votanopoulos KI, Levine EA, Hatzaras I, Shenoy R, Pawlik TM, Norton JA, Poultsides GA) J Surg Oncol 2016 Dec;114(8):971-976 34 Citations |
| 1 | Is Radiotherapy Warranted Following Intrahepatic Cholangiocarcinoma Resection? The Impact of Surgical Margins and Lymph Node Status on Survival. (Hammad AY, Berger NG, Eastwood D, Tsai S, Turaga KK, Christian KK, Johnston FM, Pawlik TM, Gamblin TC) Ann Surg Oncol 2016 Dec;23(Suppl 5):912-920 28 Citations |
| 2 | Invasive intraductal papillary carcinoma of the bile duct masquerading as a common hepatic duct stone. (Smith ZL, Daniel KE, Pant M, Dua KS, Aburajab M) VideoGIE 2016 Dec;1(4):68-69 |
| 1 | Outcome Analysis of Treatment in Stage IIA, T3N0 Rectal Adenocarcinoma in the Veterans Health Administration (VHA). (Hall WA, Lans D, Arce-Lara C, Kelley MJ, Santana-Davila R, Marcus DM, Tsai S, Ridolfi T, Erickson BA, Gore EM) Int J Radiat Oncol Biol Phys 2016 Oct 1;96(2S):E186 |
| 1 | Outcome Analysis of Treatment in Stage IIA, T3N0 Rectal Adenocarcinoma in the Veterans Health Administration (VHA) (W.A. Hall, D. Lans, C. Arce-Lara, M.J. Kelley, R. Santana-Davila, D.M. Marcus, S. Tsai, T. Ridolfi, B.A. Erickson, E.M. Gore) International Journal of Radiation Oncology, Biology, Physics |
| 1 | The Impact of Dose on Overall Survival in Unresectable Hepatocellular Carcinoma Treated With Stereotactic Body Radiation Therapy (A.Y. Hammad
R.K. Schmid
B.A. Erickson
T.C. Gamblin
J.R. Robbins) International Journal of Radiation Oncology, Biology, Physics POSTER VIEWING ABSTRACT| VOLUME 96, ISSUE 2, SUPPLEMENT , E152, OCTOBER 01, 2016 |
| 1 | Computed Tomography Consensus Clinical Target Volume Contouring for Intensity Modulated Radiation Therapy in Intact Cervical Carcinoma (C.M. Yashar
I.A. Petersen
W.R. Bosch
K.V. Albuquerque
S. Beriwal
J.P. Chino
B.A. Erickson
J. Feddock
D.K. Gaffney
R. Iyer
A.H. Klopp
C. Kunos
J.S. Mayadev
L. Portelance
A.N. Viswanathan
A.H. Wolfson
A. Jhingran
L.K. Mell
) International Journal of Radiation Oncology, Biology, Physics ORAL SCIENTIFIC SESSION| VOLUME 96, ISSUE 2, SUPPLEMENT , S13-S14, OCTOBER 01, 2016 |
| 1 | Intensity Modulated Radiation Therapy Versus 3-Dimensional Conformal Radiation Therapy in Head and Neck Squamous Cell Carcinoma: A Pooled Analysis of NRG Oncology/RTOG 0129 and 0522 (M. Yao
Q. Zhang
C.R. Woods
P.F. Nguyen-Tan
D.I. Rosenthal
A.S. Garden
W.L. Thorstad
P.R. Anne
C.J. Schultz
J.J. Caudell
E. Filion
J.A. Ridge
C.U. Jones
H. Kim
S.S. Yom
D. Raben
J.A. Bonner
M. Machtay
J. Harris
Q.T. Le) International Journal of Radiation Oncology, Biology, Physics ORAL SCIENTIFIC SESSION| VOLUME 96, ISSUE 2, SUPPLEMENT , S116-S117, OCTOBER 01, 2016 |
| 1 | Outcome Analysis of Treatment in Stage IIA, T3N0 Rectal Adenocarcinoma in the Veterans Health Administration (VHA) (W.A. Hall, D. Lans, C. Arce-Lara, M.J. Kelley, R. Santana-Davila, D.M. Marcus, S. Tsai, T. Ridolfi, B.A. Erickson, E.M. Gore) International Journal of Radiation Oncology, Biology, Physics |
| 1 | Outcome Analysis of Treatment in Stage IIA, T3N0 Rectal Adenocarcinoma in the Veterans Health Administration (VHA) (W.A. Hall, D. Lans, C. Arce-Lara, M.J. Kelley, R. Santana-Davila, D.M. Marcus, S. Tsai, T. Ridolfi, B.A. Erickson, E.M. Gore) International Journal of Radiation Oncology, Biology, Physics |
| 1 | Radiation for Pancreatic Adenocarcinoma: An End-of-Life Treatment? Assessing Appropriate Radiation Therapy Utilization in the National Cancer Data Base (NCDB) (L.E. Colbert
K.V. Dharmarajan
J. Switchenko
C.M. Taniguchi
W.A. Hall
T.W. Gillespie
D.A. Kooby
J. Lipscomb
J.C. Landry) International Journal of Radiation Oncology, Biology, Physics EPOSTER ABSTRACT| VOLUME 96, ISSUE 2, SUPPLEMENT , S195, OCTOBER 01, 2016 |
| 1 | Quality of Life and Performance Status From a Substudy Conducted Within a Prospective Phase 3 Randomized Trial of Concurrent Standard Radiation Versus Accelerated Radiation Plus Cisplatin for Locally Advanced Head and Neck Carcinoma: NRG Oncology RTOG 0129. (Xiao C, Zhang Q, Nguyen-Tân PF, List M, Weber RS, Ang KK, Rosenthal D, Filion EJ, Kim H, Silverman C, Raben A, Galloway T, Fortin A, Gore E, Winquist E, Jones CU, Robinson W, Raben D, Le QT, Bruner D) Int J Radiat Oncol Biol Phys 2017 Mar 15;97(4):667-677 32 Citations |
| 1 | Effects of Microwave Ablation on Arterial and Venous Vasculature after Treatment of Hepatocellular Carcinoma. (Chiang J, Cristescu M, Lee MH, Moreland A, Hinshaw JL, Lee FT, Brace CL) Radiology 2016 Nov;281(2):617-624 42 Citations |
| 1 | Primary cutaneous apocrine carcinoma: 2 cases and review of the pertinent histologic findings. (Schweitzer J, Vermeesch J, Zaleski T, Iacco M, Krach K, Ghaferi J, Cotton J) JAAD Case Rep 2016 Sep;2(5):411-414 6 Citations |
| 1 | Minimally Invasive Resection of Adrenocortical Carcinoma: a Multi-Institutional Study of 201 Patients. (Lee CW, Salem AI, Schneider DF, Leverson GE, Tran TB, Poultsides GA, Postlewait LM, Maithel SK, Wang TS, Hatzaras I, Shenoy R, Phay JE, Shirley L, Fields RC, Jin LX, Pawlik TM, Prescott JD, Sicklick JK, Gad S, Yopp AC, Mansour JC, Duh QY, Seiser N, Solorzano CC, Kiernan CM, Votanopoulos KI, Levine EA, Weber SM) J Gastrointest Surg 2017 Feb;21(2):352-362 22 Citations |
| 1 | Preoperative Therapy and Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: a 25-Year Single-Institution Experience. (Cloyd JM, Katz MH, Prakash L, Varadhachary GR, Wolff RA, Shroff RT, Javle M, Fogelman D, Overman M, Crane CH, Koay EJ, Das P, Krishnan S, Minsky BD, Lee JH, Bhutani MS, Weston B, Ross W, Bhosale P, Tamm EP, Wang H, Maitra A, Kim MP, Aloia TA, Vauthey JN, Fleming JB, Abbruzzese JL, Pisters PW, Evans DB, Lee JE) J Gastrointest Surg 2017 Jan;21(1):164-174 120 Citations |
| 1 | Mucoepidermoid Carcinoma of Palatal Minor Salivary Glands with Intracranial Extension: A Case Report and Literature Review. (Dossani RH, Akbarian-Tefaghi H, Lemonnier L, Mehta V, Jacobsohn JA, Guthikonda B) J Neurol Surg Rep 2016 Oct;77(4):e156-e159 |
| 2 | Endometrial carcinoma: The perioperative and long-term outcomes of robotic surgery in the morbidly obese. (Hinshaw SJ, Gunderson S, Eastwood D, Bradley WH) J Surg Oncol 2016 Dec;114(7):884-887 14 Citations |
| 1 | Clinical Score Predicting Long-Term Survival after Repeat Resection for Recurrent Adrenocortical Carcinoma. (Tran TB, Maithel SK, Pawlik TM, Wang TS, Hatzaras I, Phay JE, Fields RC, Weber SM, Sicklick JK, Yopp AC, Duh QY, Solorzano CC, Votanopoulos KI, Poultsides GA) J Am Coll Surg 2016 Dec;223(6):794-803 20 Citations |
| 1 | Oncologic progress for the treatment of parathyroid carcinoma is needed. (Christakis I, Silva AM, Kwatampora LJ, Warneke CL, Clarke CN, Williams MD, Grubbs EG, Lee JE, Busaidy NL, Perrier ND) J Surg Oncol 2016 Nov;114(6):708-713 31 Citations |
| 1 | Intravoxel incoherent motion diffusion-weighted MRI during chemoradiation therapy to characterize and monitor treatment response in human papillomavirus head and neck squamous cell carcinoma. (Paudyal R, Oh JH, Riaz N, Venigalla P, Li J, Hatzoglou V, Leeman J, Nunez DA, Lu Y, Deasy JO, Lee N, Shukla-Dave A) J Magn Reson Imaging 2017 Apr;45(4):1013-1023 53 Citations |
| 1 | In vitro biomechanical properties, fluorescence imaging, surface-enhanced Raman spectroscopy, and photothermal therapy evaluation of luminescent functionalized CaMoO4:Eu@Au hybrid nanorods on human lung adenocarcinoma epithelial cells. (Li Q, Parchur AK, Zhou A) Sci Technol Adv Mater 2016;17(1):346-360 27 Citations |
| 1 | T-cell programming in pancreatic adenocarcinoma: a review. (Seo YD, Pillarisetty VG) Cancer Gene Ther 2017 Mar;24(3):106-113 42 Citations |
| 1 | Metastatic basal cell carcinoma with amplification of PD-L1: exceptional response to anti-PD1 therapy. (Ikeda S, Goodman AM, Cohen PR, Jensen TJ, Ellison CK, Frampton G, Miller V, Patel SP, Kurzrock R) NPJ Genom Med 2016;1:16037- 114 Citations |
| 1 | Outcomes of surgically treated human papillomavirus-related oropharyngeal squamous cell carcinoma with N3 disease. (Zenga J, Haughey BH, Jackson RS, Adkins DR, Aranake-Chrisinger J, Bhatt N, Gay HA, Kallogjeri D, Martin EJ, Moore EJ, Paniello RC, Rich JT, Thorstad WL, Nussenbaum B) Laryngoscope 2017 Sep;127(9):2033-2037 7 Citations |
| 1 | Suberoylanilide hydroxamic Acid, a histone deacetylase inhibitor, alters multiple signaling pathways in hepatocellular carcinoma cell lines. (Kunnimalaiyaan S, Sokolowski K, Gamblin TC, Kunnimalaiyaan M) Am J Surg 2017 Apr;213(4):645-651 8 Citations |
| 1 | Curative Surgical Resection of Adrenocortical Carcinoma: Determining Long-term Outcome Based on Conditional Disease-free Probability. (Kim Y, Margonis GA, Prescott JD, Tran TB, Postlewait LM, Maithel SK, Wang TS, Glenn JA, Hatzaras I, Shenoy R, Phay JE, Keplinger K, Fields RC, Jin LX, Weber SM, Salem A, Sicklick JK, Gad S, Yopp AC, Mansour JC, Duh QY, Seiser N, Solorzano CC, Kiernan CM, Votanopoulos KI, Levine EA, Poultsides GA, Pawlik TM) Ann Surg 2017 Jan;265(1):197-204 29 Citations |
| 1 | Painful skin lesions and squamous cell carcinoma predict overall mortality risk in organ transplant recipients: a cohort study. (Oh CC, Hofbauer GFL, Serra AL, Harwood CA, Mitchell L, Proby CM, Olasz EB, Mosel DD, Piaserico S, Fortina AB, Geusau A, Jahn-Bassler K, Gerritsen MJP, Seçkin D, Güleç AT, Cetkovská P, Ricar J, Imko-Walczuk B, Dębska-Ślizień A, Bouwes Bavinck JN) Br J Dermatol 2017 May;176(5):1179-1186 7 Citations |
| 1 | Association between GWAS-identified lung adenocarcinoma susceptibility loci and EGFR mutations in never-smoking Asian women, and comparison with findings from Western populations. (Seow WJ, Matsuo K, Hsiung CA, Shiraishi K, Song M, Kim HN, Wong MP, Hong YC, Hosgood HD 3rd, Wang Z, Chang IS, Wang JC, Chatterjee N, Tucker M, Wei H, Mitsudomi T, Zheng W, Kim JH, Zhou B, Caporaso NE, Albanes D, Shin MH, Chung LP, An SJ, Wang P, Zheng H, Yatabe Y, Zhang XC, Kim YT, Shu XO, Kim YC, Bassig BA, Chang J, Ho JC, Ji BT, Kubo M, Daigo Y, Ito H, Momozawa Y, Ashikawa K, Kamatani Y, Honda T, Sakamoto H, Kunitoh H, Tsuta K, Watanabe SI, Nokihara H, Miyagi Y, Nakayama H, Matsumoto S, Tsuboi M, Goto K, Yin Z, Shi J, Takahashi A, Goto A, Minamiya Y, Shimizu K, Tanaka K, Wu T, Wei F, Wong JY, Matsuda F, Su J, Kim YH, Oh IJ, Song F, Lee VH, Su WC, Chen YM, Chang GC, Chen KY, Huang MS, Yang PC, Lin HC, Xiang YB, Seow A, Park JY, Kweon SS, Chen CJ, Li H, Gao YT, Wu C, Qian B, Lu D, Liu J, Jeon HS, Hsiao CF, Sung JS, Tsai YH, Jung YJ, Guo H, Hu Z, Wang WC, Chung CC, Lawrence C, Burdett L, Yeager M, Jacobs KB, Hutchinson A, Berndt SI, He X, Wu W, Wang J, Li Y, Choi JE, Park KH, Sung SW, Liu L, Kang CH, Hu L, Chen CH, Yang TY, Xu J, Guan P, Tan W, Wang CL, Sihoe AD, Chen Y, Choi YY, Hung JY, Kim JS, Yoon HI, Cai Q, Lin CC, Park IK, Xu P, Dong J, Kim C, He Q, Perng RP, Chen CY, Vermeulen R, Wu J, Lim WY, Chen KC, Chan JK, Chu M, Li YJ, Li J, Chen H, Yu CJ, Jin L, Lo YL, Chen YH, Fraumeni JF Jr, Liu J, Yamaji T, Yang Y, Hicks B, Wyatt K, Li SA, Dai J, Ma H, Jin G, Song B, Wang Z, Cheng S, Li X, Ren Y, Cui P, Iwasaki M, Shimazu T, Tsugane S, Zhu J, Jiang G, Fei K, Wu G, Chien LH, Chen HL, Su YC, Tsai FY, Chen YS, Yu J, Stevens VL, Laird-Offringa IA, Marconett CN, Lin D, Chen K, Wu YL, Landi MT, Shen H, Rothman N, Kohno T, Chanock SJ, Lan Q) Hum Mol Genet 2017 Jan 15;26(2):454-465 65 Citations |
| 1 | Interpretation of HPV DNA in situ hybridization in HPV-related head and neck squamous cell carcinoma: an achievable task in cell block and small biopsy material. (Miller JA, Allison DB, Maleki Z) J Am Soc Cytopathol 2017;6(3):89-95 11 Citations |
| 1 | Outcomes for patients with head and neck squamous cell carcinoma presenting with N3 nodal disease. (Witek ME, Wieland AM, Chen S, Kennedy TA, Hullett CR, Liang E, Hartig GK, Kimple RJ, Harari PM) Cancers Head Neck 2017;2 |
| 1 | Integrated genomic characterization of oesophageal carcinoma. (Cancer Genome Atlas Research Network, Analysis Working Group: Asan University, BC Cancer Agency, Brigham and Women’s Hospital, Broad Institute, Brown University, Case Western Reserve University, Dana-Farber Cancer Institute, Duke University, Greater Poland Cancer Centre, Harvard Medical School, Institute for Systems Biology, KU Leuven, Mayo Clinic, Memorial Sloan Kettering Cancer Center, National Cancer Institute, Nationwide Children’s Hospital, Stanford University, University of Alabama, University of Michigan, University of North Carolina, University of Pittsburgh, University of Rochester, University of Southern California, University of Texas MD Anderson Cancer Center, University of Washington, Van Andel Research Institute, Vanderbilt University, Washington University, Genome Sequencing Center: Broad Institute, Washington University in St. Louis, Genome Characterization Centers: BC Cancer Agency, Broad Institute, Harvard Medical School, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, University of North Carolina, University of Southern California Epigenome Center, University of Texas MD Anderson Cancer Center, Van Andel Research Institute, Genome Data Analysis Centers: Broad Institute, Brown University:, Harvard Medical School, Institute for Systems Biology, Memorial Sloan Kettering Cancer Center, University of California Santa Cruz, University of Texas MD Anderson Cancer Center, Biospecimen Core Resource: International Genomics Consortium, Research Institute at Nationwide Children’s Hospital, Tissue Source Sites: Analytic Biologic Services, Asan Medical Center, Asterand Bioscience, Barretos Cancer Hospital, BioreclamationIVT, Botkin Municipal Clinic, Chonnam National University Medical School, Christiana Care Health System, Cureline, Duke University, Emory University, Erasmus University, Indiana University School of Medicine, Institute of Oncology of Moldova, International Genomics Consortium, Invidumed, Israelitisches Krankenhaus Hamburg, Keimyung University School of Medicine, Memorial Sloan Kettering Cancer Center, National Cancer Center Goyang, Ontario Tumour Bank, Peter MacCallum Cancer Centre, Pusan National University Medical School, Ribeirão Preto Medical School, St. Joseph’s Hospital &Medical Center, St. Petersburg Academic University, Tayside Tissue Bank, University of Dundee, University of Kansas Medical Center, University of Michigan, University of North Carolina at Chapel Hill, University of Pittsburgh School of Medicine, University of Texas MD Anderson Cancer Center, Disease Working Group: Duke University, Memorial Sloan Kettering Cancer Center, National Cancer Institute, University of Texas MD Anderson Cancer Center, Yonsei University College of Medicine, Data Coordination Center: CSRA Inc., Project Team: National Institutes of Health) Nature 2017 Jan 12;541(7636):169-175 1304 Citations |
| 2 | Palliative interventions for hepatocellular carcinoma patients: analysis of the National Cancer Database. (Hammad AY, Robbins JR, Turaga KK, Christians KK, Gamblin TC, Johnston FM) Ann Palliat Med 2017 Jan;6(1):26-35 19 Citations |
| 3 | Cancer cell chemokines direct chemotaxis of activated stellate cells in pancreatic ductal adenocarcinoma. (Roy I, Boyle KA, Vonderhaar EP, Zimmerman NP, Gorse E, Mackinnon AC, Hwang RF, Franco-Barraza J, Cukierman E, Tsai S, Evans DB, Dwinell MB) Lab Invest 2017 Mar;97(3):302-317 28 Citations |
| 1 | The effect of preoperative chemotherapy treatment in surgically treated intrahepatic cholangiocarcinoma patients-A multi-institutional analysis. (Buettner S, Koerkamp BG, Ejaz A, Buisman FE, Kim Y, Margonis GA, Alexandrescu S, Marques HP, Lamelas J, Aldrighetti L, Gamblin TC, Maithel SK, Pulitano C, Bauer TW, Shen F, Poultsides GA, Marsh JW, IJzermans JN, Pawlik TM) J Surg Oncol 2017 Mar;115(3):312-318 53 Citations |
| 1 | Dosage-dependent copy number gains in E2f1 and E2f3 drive hepatocellular carcinoma. (Kent LN, Bae S, Tsai SY, Tang X, Srivastava A, Koivisto C, Martin CK, Ridolfi E, Miller GC, Zorko SM, Plevris E, Hadjiyannis Y, Perez M, Nolan E, Kladney R, Westendorp B, de Bruin A, Fernandez S, Rosol TJ, Pohar KS, Pipas JM, Leone G) J Clin Invest 2017 Mar 01;127(3):830-842 89 Citations |
| 1 | Salivary MMP-9 in the detection of oral squamous cell carcinoma. (Peisker A, Raschke GF, Fahmy MD, Guentsch A, Roshanghias K, Hennings J, Schultze-Mosgau S) Med Oral Patol Oral Cir Bucal 2017 May 01;22(3):e270-275 43 Citations |
| 1 | The Hybrid Transoral-Pharyngotomy Approach to Oropharyngeal Carcinoma: Technique and Outcome. (Sinha P, Pipkorn P, Zenga J, Haughey BH) Ann Otol Rhinol Laryngol 2017 May;126(5):357-364 5 Citations |
| 2 | Considerations Regarding the Role of Stereotactic Body Radiation Therapy for Pancreatic Adenocarcinoma in the Elderly. (Hall WA, Erickson B) J Oncol Pract 2017 Mar;13(3):171-172 |
| 1 | Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles. (Farshidfar F, Zheng S, Gingras MC, Newton Y, Shih J, Robertson AG, Hinoue T, Hoadley KA, Gibb EA, Roszik J, Covington KR, Wu CC, Shinbrot E, Stransky N, Hegde A, Yang JD, Reznik E, Sadeghi S, Pedamallu CS, Ojesina AI, Hess JM, Auman JT, Rhie SK, Bowlby R, Borad MJ, Cancer Genome Atlas Network, Zhu AX, Stuart JM, Sander C, Akbani R, Cherniack AD, Deshpande V, Mounajjed T, Foo WC, Torbenson MS, Kleiner DE, Laird PW, Wheeler DA, McRee AJ, Bathe OF, Andersen JB, Bardeesy N, Roberts LR, Kwong LN) Cell Rep 2017 Mar 14;18(11):2780-2794 393 Citations |
| 1 | Biological mechanisms of immune escape and implications for immunotherapy in head and neck squamous cell carcinoma. (Moy JD, Moskovitz JM, Ferris RL) Eur J Cancer 2017 May;76:152-166 84 Citations |
| 1 | Association of HIV Status With Local Immune Response to Anal Squamous Cell Carcinoma: Implications for Immunotherapy. (Yanik EL, Kaunitz GJ, Cottrell TR, Succaria F, McMiller TL, Ascierto ML, Esandrio J, Xu H, Ogurtsova A, Cornish T, Lipson EJ, Topalian SL, Engels EA, Taube JM) JAMA Oncol 2017 Jul 01;3(7):974-978 66 Citations |
| 1 | Metaplastic Carcinoma With Extensive Chondromyxoid Differentiation Arising in Association With Microglandular Adenosis. (Muller KE, Jorns JM) Int J Surg Pathol 2017 Sep;25(6):513-514 3 Citations |
| 1 | Prognostic Scoring System to Risk Stratify Parathyroid Carcinoma. (Silva-Figueroa AM, Hess KR, Williams MD, Clarke CN, Christakis I, Graham PH, Grubbs EG, Lee JE, Busaidy NL, Perrier ND) J Am Coll Surg 2017 Mar 15 40 Citations |
| 3 | External radiation or ablation for solitary hepatocellular carcinoma: A survival analysis of the SEER database. (Berger NG, Tanious MN, Hammad AY, Miura JT, Mogal H, Clarke CN, Christians KK, Tsai S, Gamblin TC) J Surg Oncol 2017 Sep;116(3):307-312 17 Citations |
| 1 | Vandetanib and cabozantinib potentiate mitochondria-targeted agents to suppress medullary thyroid carcinoma cells. (Starenki D, Hong SK, Wu PK, Park JI) Cancer Biol Ther 2017 Jul 03;18(7):473-483 18 Citations |
| 1 | Outcomes for patients with locally advanced pancreatic adenocarcinoma treated with stereotactic body radiation therapy versus conventionally fractionated radiation. (Zhong J, Patel K, Switchenko J, Cassidy RJ, Hall WA, Gillespie T, Patel PR, Kooby D, Landry J) Cancer 2017 Sep 15;123(18):3486-3493 102 Citations |
| 1 | Immunotherapy for Head and Neck Squamous Cell Carcinoma: A Review of Current and Emerging Therapeutic Options. (Moskovitz JM, Moy J, Seiwert TY, Ferris RL) Oncologist 2017 Jun;22(6):680-693 24 Citations |
| 1 | Selective targeted delivery of doxorubicin via conjugating to anti-CD24 antibody results in enhanced antitumor potency for hepatocellular carcinoma both in vitro and in vivo. (Ma Z, He H, Sun F, Xu Y, Huang X, Ma Y, Zhao H, Wang Y, Wang M, Zhang J) J Cancer Res Clin Oncol 2017 Oct;143(10):1929-1940 31 Citations |
| 1 | Utilization and Outcomes of Nephroureterectomy for Upper Tract Urothelial Carcinoma by Surgical Approach. (Rodriguez JF, Packiam VT, Boysen WR, Johnson SC, Smith ZL, Smith ND, Shalhav AL, Steinberg GD) J Endourol 2017 Jul;31(7):661-665 52 Citations |
| 1 | Utility of Genomic Assessment of Blood-Derived Circulating Tumor DNA (ctDNA) in Patients with Advanced Lung Adenocarcinoma. (Schwaederlé MC, Patel SP, Husain H, Ikeda M, Lanman RB, Banks KC, Talasaz A, Bazhenova L, Kurzrock R) Clin Cancer Res 2017 Sep 01;23(17):5101-5111 123 Citations |
| 1 | Exceptional Response to Nivolumab and Stereotactic Body Radiation Therapy (SBRT) in Neuroendocrine Cervical Carcinoma with High Tumor Mutational Burden: Management Considerations from the Center For Personalized Cancer Therapy at UC San Diego Moores Cancer Center. (Sharabi A, Kim SS, Kato S, Sanders PD, Patel SP, Sanghvi P, Weihe E, Kurzrock R) Oncologist 2017 Jun;22(6):631-637 95 Citations |
| 1 | Radical operation for hilar cholangiocarcinoma in comparable Eastern and Western centers: Outcome analysis and prognostic factors. (Kimura N, Young AL, Toyoki Y, Wyatt JI, Toogood GJ, Hidalgo E, Prasad KR, Kudo D, Ishido K, Hakamada K, Lodge JPA) Surgery 2017 Sep;162(3):500-514 57 Citations |
| 4 | Transarterial chemoembolization in hepatocellular carcinoma with portal vein tumor thrombosis: a systematic review and meta-analysis. (Silva JP, Berger NG, Tsai S, Christians KK, Clarke CN, Mogal H, White S, Rilling W, Gamblin TC) HPB (Oxford) 2017 Aug;19(8):659-666 87 Citations |
| 1 | Molecular Profiling of Malignant Pleural Effusion in Metastatic Non-Small-Cell Lung Carcinoma. The Effect of Preanalytical Factors. (Carter J, Miller JA, Feller-Kopman D, Ettinger D, Sidransky D, Maleki Z) Ann Am Thorac Soc 2017 Jul;14(7):1169-1176 60 Citations |
| 1 | Estrogen Replacement Reduces Risk and Increases Survival Times of Women With Hepatocellular Carcinoma. (Hassan MM, Botrus G, Abdel-Wahab R, Wolff RA, Li D, Tweardy D, Phan AT, Hawk E, Javle M, Lee JS, Torres HA, Rashid A, Lenzi R, Hassabo HM, Abaza Y, Shalaby AS, Lacin S, Morris J, Patt YZ, Amos CI, Khaderi SA, Goss JA, Jalal PK, Kaseb AO) Clin Gastroenterol Hepatol 2017 Nov;15(11):1791-1799 90 Citations |
| 1 | Clinicopathologic and molecular markers in cervical carcinoma: a prospective cohort study. (Halle MK, Ojesina AI, Engerud H, Woie K, Tangen IL, Holst F, Høivik E, Kusonmano K, Haldorsen IS, Vintermyr OK, Trovik J, Bertelsen BI, Salvesen HB, Krakstad C) Am J Obstet Gynecol 2017 Oct;217(4):432.e1-432.e17 43 Citations |
| 3 | Disparities in access to care and outcomes in patients with adrenocortical carcinoma. (Hammad AY, Yen TWF, Carr AA, Evans DB, Wang TS) J Surg Res 2017 Jun 01;213:138-146 11 Citations |
| 1 | Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. (Cancer Genome Atlas Research Network. Electronic address: wheeler@bcm.edu, Cancer Genome Atlas Research Network) Cell 2017 Jun 15;169(7):1327-1341.e23 1595 Citations |
| 1 | Risk of Post-transplant Hepatocellular Carcinoma Recurrence Is Higher in Recipients of Livers From Male Than Female Living Donors. (Han S, Yang JD, Sinn DH, Kim JM, Choi GS, Jung G, Ahn JH, Kim S, Ko JS, Gwak MS, Kwon CHD, Leise MD, Gwak GY, Heimbach JK, Kim GS) Ann Surg 2018 Dec;268(6):1043-1050 22 Citations |
| 1 | Utility of Genomic Analysis In Circulating Tumor DNA from Patients with Carcinoma of Unknown Primary. (Kato S, Krishnamurthy N, Banks KC, De P, Williams K, Williams C, Leyland-Jones B, Lippman SM, Lanman RB, Kurzrock R) Cancer Res 2017 Aug 15;77(16):4238-4246 94 Citations |
| 3 | Immune Check Point Inhibition in Sarcomatoid Renal Cell Carcinoma: A New Treatment Paradigm. (Raychaudhuri R, Riese MJ, Bylow K, Burfeind J, Mackinnon AC, Tolat PP, Iczkowski KA, Kilari D) Clin Genitourin Cancer 2017 Oct;15(5):e897-e901 15 Citations |
| 1 | Impact of Pretransplant Bridging Locoregional Therapy for Patients With Hepatocellular Carcinoma Within Milan Criteria Undergoing Liver Transplantation: Analysis of 3601 Patients From the US Multicenter HCC Transplant Consortium. (Agopian VG, Harlander-Locke MP, Ruiz RM, Klintmalm GB, Senguttuvan S, Florman SS, Haydel B, Hoteit M, Levine MH, Lee DD, Taner CB, Verna EC, Halazun KJ, Abdelmessih R, Tevar AD, Humar A, Aucejo F, Chapman WC, Vachharajani N, Nguyen MH, Melcher ML, Nydam TL, Mobley C, Ghobrial RM, Amundsen B, Markmann JF, Langnas AN, Carney CA, Berumen J, Hemming AW, Sudan DL, Hong JC, Kim J, Zimmerman MA, Rana A, Kueht ML, Jones CM, Fishbein TM, Busuttil RW) Ann Surg 2017 Sep;266(3):525-535 138 Citations |
| 1 | Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles. (Farshidfar F, Zheng S, Gingras MC, Newton Y, Shih J, Robertson AG, Hinoue T, Hoadley KA, Gibb EA, Roszik J, Covington KR, Wu CC, Shinbrot E, Stransky N, Hegde A, Yang JD, Reznik E, Sadeghi S, Pedamallu CS, Ojesina AI, Hess JM, Auman JT, Rhie SK, Bowlby R, Borad MJ, Cancer Genome Atlas Network, Zhu AX, Stuart JM, Sander C, Akbani R, Cherniack AD, Deshpande V, Mounajjed T, Foo WC, Torbenson MS, Kleiner DE, Laird PW, Wheeler DA, McRee AJ, Bathe OF, Andersen JB, Bardeesy N, Roberts LR, Kwong LN) Cell Rep 2017 Jun 27;19(13):2878-2880 145 Citations |
| 1 | Vandetanib and cabozantinib potentiate mitochondria-targeted agents to suppress medullary thyroid carcinoma cells (Dmytro Starenki, Seung-Keun Hong, Pui-Kei Wu, Jong-In Park) Cancer biology & therapy |
| 1 | Performance of prognostic scores and staging systems in predicting long-term survival outcomes after surgery for intrahepatic cholangiocarcinoma. (Buettner S, Galjart B, van Vugt JLA, Bagante F, Alexandrescu S, Marques HP, Lamelas J, Aldrighetti L, Gamblin TC, Maithel SK, Pulitano C, Margonis GA, Weiss M, Bauer TW, Shen F, Poultsides GA, Marsh JW, IJzermans JNM, Groot Koerkamp B, Pawlik TM) J Surg Oncol 2017 Dec;116(8):1085-1095 44 Citations |
| 1 | Blood Transfusion and Survival for Resected Adrenocortical Carcinoma: A Study from the United States Adrenocortical Carcinoma Group. (Poorman CE, Postlewait LM, Ethun CG, Tran TB, Prescott JD, Pawlik TM, Wang TS, Glenn J, Hatzaras I, Shenoy R, Phay JE, Keplinger K, Fields RC, Jin LX, Weber SM, Salem A, Sicklick JK, Gad S, Yopp AC, Mansour JC, Duh QY, Seiser N, Solorzano CC, Kiernan CM, Votanopoulos KI, Levine EA, Staley CA, Poultsides GA, Maithel SK) Am Surg 2017 Jul 01;83(7):761-768 12 Citations |
| 3 | The prognostic utility of baseline alpha-fetoprotein for hepatocellular carcinoma patients. (Silva JP, Gorman RA, Berger NG, Tsai S, Christians KK, Clarke CN, Mogal H, Gamblin TC) J Surg Oncol 2017 Dec;116(7):831-840 30 Citations |
| 1 | A phase 2 randomised discontinuation trial of cabozantinib in patients with ovarian carcinoma. (Vergote IB, Smith DC, Berger R, Kurzrock R, Vogelzang NJ, Sella A, Wheler J, Lee Y, Foster PG, Weitzman R, Buckanovich RJ) Eur J Cancer 2017 Sep;83:229-236 30 Citations |
| 1 | Appearance of New Cutaneous Superficial Basal Cell Carcinomas during Successful Nivolumab Treatment of Refractory Metastatic Disease: Implications for Immunotherapy in Early Versus Late Disease. (Cohen PR, Kato S, Goodman AM, Ikeda S, Kurzrock R) Int J Mol Sci 2017 Jul 31;18(8) 32 Citations |
| 1 | Long-lived pancreatic ductal adenocarcinoma slice cultures enable precise study of the immune microenvironment. (Jiang X, Seo YD, Chang JH, Coveler A, Nigjeh EN, Pan S, Jalikis F, Yeung RS, Crispe IN, Pillarisetty VG) Oncoimmunology 2017;6(7):e1333210 65 Citations |
| 1 | Transoral Resection of Human Papillomavirus (HPV)-Positive Squamous Cell Carcinoma of the Oropharynx: Outcomes with and Without Adjuvant Therapy. (Jackson RS, Sinha P, Zenga J, Kallogjeri D, Suko J, Martin E, Moore EJ, Haughey BH) Ann Surg Oncol 2017 Nov;24(12):3494-3501 24 Citations |
| 1 | Unconventional MAPK-GSK-3β Pathway Behind Atypical Epithelial-Mesenchymal Transition In Hepatocellular Carcinoma. (Parveen S, Vedagiri D, Nair HG, Parthasarathy H, Harshan KH) Sci Rep 2017 Aug 18;7(1):8842 4 Citations |
| 1 | Erratum to: Transoral Resection of Human Papillomavirus (HPV)-Positive Squamous Cell Carcinoma of the Oropharynx: Outcomes with and Without Adjuvant Therapy. (Jackson RS, Sinha P, Zenga J, Kallogjeri D, Suko J, Martin E, Moore EJ, Haughey BH) Ann Surg Oncol 2017 Dec;24(Suppl 3):695 |
| 1 | The biology of Hepatocellular carcinoma: implications for genomic and immune therapies. (Khemlina G, Ikeda S, Kurzrock R) Mol Cancer 2017 Aug 30;16(1):149 325 Citations |
| 1 | Refining Patient Selection for Reirradiation of Head and Neck Squamous Carcinoma in the IMRT Era: A Multi-institution Cohort Study by the MIRI Collaborative. (Ward MC, Riaz N, Caudell JJ, Dunlap NE, Isrow D, Zakem SJ, Dault J, Awan MJ, Vargo JA, Heron DE, Higgins KA, Beitler JJ, Marcrom S, Boggs DH, Hassanzadeh C, Reddy CA, Bonner JA, Yao M, Machtay M, Siddiqui F, Trotti AM, Lee NY, Koyfman SA, Multi-Institution Reirradiation (MIRI) Collaborative) Int J Radiat Oncol Biol Phys 2018 Mar 01;100(3):586-594 113 Citations |
| 1 | Analysis of the whole transcriptome from gingivo-buccal squamous cell carcinoma reveals deregulated immune landscape and suggests targets for immunotherapy. (Singh R, De Sarkar N, Sarkar S, Roy R, Chattopadhyay E, Ray A, Biswas NK, Maitra A, Roy B) PLoS One 2017;12(9):e0183606 6 Citations |
| 1 | Engineering a high-affinity humanized anti-CD24 antibody to target hepatocellular carcinoma by a novel CDR grafting design. (Sun F, Wang T, Jiang J, Wang Y, Ma Z, Li Z, Han Y, Pan M, Cai J, Wang M, Zhang J) Oncotarget 2017 Aug 01;8(31):51238-51252 30 Citations |
| 1 | American Brachytherapy Society recurrent carcinoma of the endometrium task force patterns of care and review of the literature. (Kamrava M, Beriwal S, Erickson B, Gaffney D, Jhingran A, Klopp A, Park SJ, Viswanathan A, Yashar C, Lin L) Brachytherapy 2017;16(6):1129-1143 26 Citations |
| 1 | HPV associated oropharyngeal carcinoma: Imaging review and update on staging. (Mohit Agarwal, B Policeni, A Parihar) Educational exhibit at ASHNR 2017, Las Vegas. |
| 1 | Tumor spread through air space (STAS) is an important predictor of clinical outcome in stage IA lung adenocarcinoma. (Chen HZ, Bertino EM, He K) J Thorac Dis 2017 Aug;9(8):2283-2285 4 Citations |
| 2 | IPI59: An Actionable Biomarker to Improve Treatment Response in Serous Ovarian Carcinoma Patients. (Choi J, Ye S, Eng KH, Korthauer K, Bradley WH, Rader JS, Kendziorski C) Stat Biosci 2017 Jun;9(1):1-12 1 Citation |
| 1 | Risk of posttransplant hepatocellular carcinoma recurrence is greater in recipients with higher platelet counts in living donor liver transplantation. (Han S, Lee S, Yang JD, Leise MD, Ahn JH, Kim S, Jung K, Gwak MS, Kim GS, Ko JS) Liver Transpl 2018 Jan;24(1):44-55 28 Citations |
| 1 | Long-term survival after resection of sarcomatoid carcinoma of the pancreas: an updated experience. (Blair AB, Burkhart RA, Griffin JF, Miller JA, Weiss MJ, Cameron JL, Wolfgang CL, He J) J Surg Res 2017 Nov;219:238-243 12 Citations |
| 1 | Targeted Gene Sequencing of Gallbladder Carcinoma Identifies High-impact Somatic and Rare Germline Mutations. (Yadav S, DE Sarkar N, Kumari N, Krishnani N, Kumar A, Mittal B) Cancer Genomics Proteomics 2017;14(6):495-506 19 Citations |
| 1 | Pancreatic adenocarcinoma: cross-sectional imaging techniques. (Kulkarni NM, Hough DM, Tolat PP, Soloff EV, Kambadakone AR) Abdom Radiol (NY) 2018 Feb;43(2):253-263 19 Citations |
| 1 | Antiproliferative and apoptotic effects of xanthohumol in cholangiocarcinoma. (Walden D, Kunnimalaiyaan S, Sokolowski K, Clark TG, Kunnimalaiyaan M) Oncotarget 2017 Oct 20;8(50):88069-88078 24 Citations |
| 1 | A Novel T-Stage Classification System for Adrenocortical Carcinoma: Proposal from the US Adrenocortical Carcinoma Study Group. (Poorman CE, Ethun CG, Postlewait LM, Tran TB, Prescott JD, Pawlik TM, Wang TS, Glenn J, Hatzaras I, Shenoy R, Phay JE, Keplinger K, Fields RC, Jin LX, Weber SM, Salem A, Sicklick JK, Gad S, Yopp AC, Mansour JC, Duh QY, Seiser N, Solórzano CC, Kiernan CM, Votanopoulos KI, Levine EA, Staley CA, Poultsides GA, Maithel SK) Ann Surg Oncol 2018 Feb;25(2):520-527 15 Citations |
| 3 | Adaptive radiation dose escalation in rectal adenocarcinoma: a review. (Van Wickle JD, Paulson ES, Landry JC, Erickson BA, Hall WA) J Gastrointest Oncol 2017 Oct;8(5):902-914 19 Citations |
| 2 | Pancreatic Adenocarcinoma Therapeutic Targets Revealed by Tumor-Stroma Cross-Talk Analyses in Patient-Derived Xenografts. (Nicolle R, Blum Y, Marisa L, Loncle C, Gayet O, Moutardier V, Turrini O, Giovannini M, Bian B, Bigonnet M, Rubis M, Elarouci N, Armenoult L, Ayadi M, Duconseil P, Gasmi M, Ouaissi M, Maignan A, Lomberk G, Boher JM, Ewald J, Bories E, Garnier J, Goncalves A, Poizat F, Raoul JL, Secq V, Garcia S, Grandval P, Barraud-Blanc M, Norguet E, Gilabert M, Delpero JR, Roques J, Calvo E, Guillaumond F, Vasseur S, Urrutia R, de Reyniès A, Dusetti N, Iovanna J) Cell Rep 2017 Nov 28;21(9):2458-2470 151 Citations |
| 1 | Pleomorphic Lobular Carcinoma: A Controversially Aggressive Variant of Invasive Lobular Carcinoma of the Breast. (Abdelkader A, Jorns JM) Int J Surg Pathol 2018 Aug;26(5):434-436 4 Citations |
| 1 | Determining Risk of Barrett's Esophagus and Esophageal Adenocarcinoma Based on Epidemiologic Factors and Genetic Variants. (Dong J, Buas MF, Gharahkhani P, Kendall BJ, Onstad L, Zhao S, Anderson LA, Wu AH, Ye W, Bird NC, Bernstein L, Chow WH, Gammon MD, Liu G, Caldas C, Pharoah PD, Risch HA, Iyer PG, Reid BJ, Hardie LJ, Lagergren J, Shaheen NJ, Corley DA, Fitzgerald RC, Stomach and Oesophageal Cancer Study (SOCS) consortium, Whiteman DC, Vaughan TL, Thrift AP) Gastroenterology 2018 Apr;154(5):1273-1281.e3 68 Citations |
| 1 | Glycogen-Rich Clear Cell Carcinoma: A Rare Variant of Breast Carcinoma of Uncertain Significance. (Akagi NE, Jorns JM) Int J Surg Pathol 2018 Sep;26(6):530-531 1 Citation |
| 1 | The evolution into personalized therapies in pancreatic ductal adenocarcinoma: challenges and opportunities. (Tesfaye AA, Kamgar M, Azmi A, Philip PA) Expert Rev Anticancer Ther 2018 Feb;18(2):131-148 34 Citations |
| 1 | Immunotherapy in Head and Neck Squamous Cell Carcinoma (HNSCC) (Moy J, Ferris RL) Current Cancer Research 2018:365-396 |
| 1 | The microRNA landscape of cutaneous squamous cell carcinoma. (Konicke K, López-Luna A, Muñoz-Carrillo JL, Servín-González LS, Flores-de la Torre A, Olasz E, Lazarova Z) Drug Discov Today 2018 Apr;23(4):864-870 28 Citations |
| 2 | Final results of a multi-institutional phase II trial of reirradiation with concurrent weekly cisplatin and cetuximab for recurrent or second primary squamous cell carcinoma of the head and neck. (Awan MJ, Nedzi L, Wang D, Tumati V, Sumer B, Xie XJ, Smith I, Truelson J, Hughes R, Myers LL, Lavertu P, Wong S, Yao M) Ann Oncol 2018 Apr 01;29(4):998-1003 21 Citations |
| 1 | Oncologic outcomes of extended neck dissections in human papillomavirus-related oropharyngeal squamous cell carcinoma. (Zenga J, Pipkorn P, Graboyes EM, Martin EJ, Rich JT, Moore EJ, Haughey BH, Jackson RS) Head Neck 2018 May;40(5):955-962 2 Citations |
| 3 | The effect of prior upper abdominal surgery on outcomes after liver transplantation for hepatocellular carcinoma: An analysis of the database of the organ procurement transplant network. (Silva JP, Berger NG, Yin Z, Liu Y, Tsai S, Christians KK, Clarke CN, Mogal H, Gamblin TC) Surgery 2018 May;163(5):1028-1034 11 Citations |
| 1 | Genomic landscape of advanced basal cell carcinoma: Implications for precision treatment with targeted and immune therapies. (Goodman AM, Kato S, Cohen PR, Boichard A, Frampton G, Miller V, Stephens PJ, Daniels GA, Kurzrock R) Oncoimmunology 2018;7(3):e1404217 51 Citations |
| 1 | Combination transarterial chemoembolization and microwave ablation improves local tumor control for 3- to 5-cm hepatocellular carcinoma when compared with transarterial chemoembolization alone. (Smolock AR, Cristescu MM, Hinshaw A, Woo KM, Wells SA, Ziemlewicz TJ, Lubner MG, Dalvie PS, Louis Hinshaw J, Brace CL, Ozkan OS, Lee FT Jr, Laeseke P) Abdom Radiol (NY) 2018 Sep;43(9):2497-2504 37 Citations |
| 1 | Analysis of Tissue and Circulating Tumor DNA by Next-Generation Sequencing of Hepatocellular Carcinoma: Implications for Targeted Therapeutics. (Ikeda S, Lim JS, Kurzrock R) Mol Cancer Ther 2018 May;17(5):1114-1122 49 Citations |
| 1 | Next-Generation Sequencing of Circulating Tumor DNA Reveals Frequent Alterations in Advanced Hepatocellular Carcinoma. (Ikeda S, Tsigelny IF, Skjevik ÅA, Kono Y, Mendler M, Kuo A, Sicklick JK, Heestand G, Banks KC, Talasaz A, Lanman RB, Lippman S, Kurzrock R) Oncologist 2018 May;23(5):586-593 71 Citations |
| 1 | Immunotherapy for Head and Neck Squamous Cell Carcinoma. (Moskovitz J, Moy J, Ferris RL) Curr Oncol Rep 2018 Mar 03;20(2):22 126 Citations |
| 1 | NKG2D Immunoligand rG7S-MICA Enhances NK Cell-mediated Immunosurveillance in Colorectal Carcinoma. (Wang T, Sun F, Wang Y, Jiang J, Pan M, Yuan M, Zhang H, Du X, Hezam K, Song K, Wang M, Zhang J) J Immunother 2018 Apr;41(3):109-117 14 Citations |
| 1 | Ductal Carcinoma in situ of the breast in sclerosing adenosis encapsulated by a hamartoma: A case report. (Fukai S, Yoshida A, Akiyama F, Tsunoda H, Lefor AK, Kimura J, Sakamoto T, Suzuki K, Mizokami K) Int J Surg Case Rep 2018;45:9-12 5 Citations |
| 1 | Interactions Between Genetic Variants and Environmental Factors Affect Risk of Esophageal Adenocarcinoma and Barrett's Esophagus. (Dong J, Levine DM, Buas MF, Zhang R, Onstad L, Fitzgerald RC, Stomach and Oesophageal Cancer Study (SOCS) Consortium, Corley DA, Shaheen NJ, Lagergren J, Hardie LJ, Reid BJ, Iyer PG, Risch HA, Caldas C, Caldas I, Pharoah PD, Liu G, Gammon MD, Chow WH, Bernstein L, Bird NC, Ye W, Wu AH, Anderson LA, MacGregor S, Whiteman DC, Vaughan TL, Thrift AP) Clin Gastroenterol Hepatol 2018 Oct;16(10):1598-1606.e4 14 Citations |
| 1 | Secretory carcinoma of the parotid with adenoid cystic carcinoma cytological pattern: A cytological-pathological correlation with literature review. (Kravtsov O, Hunt B, Peterson J, Carrillo L, Bonneau P, Giorgadze T) Ann Diagn Pathol 2018 Apr;33:58-61 7 Citations |
| 1 | Invasive Mammary Carcinoma With Mixed Invasive Papillary and Glycogen Rich Clear Cell Features. (Solanki MH, Derylo AF, Jorns JM) Int J Surg Pathol 2018 Sep;26(6):569-572 3 Citations |
| 2 | Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas. (Campbell JD, Yau C, Bowlby R, Liu Y, Brennan K, Fan H, Taylor AM, Wang C, Walter V, Akbani R, Byers LA, Creighton CJ, Coarfa C, Shih J, Cherniack AD, Gevaert O, Prunello M, Shen H, Anur P, Chen J, Cheng H, Hayes DN, Bullman S, Pedamallu CS, Ojesina AI, Sadeghi S, Mungall KL, Robertson AG, Benz C, Schultz A, Kanchi RS, Gay CM, Hegde A, Diao L, Wang J, Ma W, Sumazin P, Chiu HS, Chen TW, Gunaratne P, Donehower L, Rader JS, Zuna R, Al-Ahmadie H, Lazar AJ, Flores ER, Tsai KY, Zhou JH, Rustgi AK, Drill E, Shen R, Wong CK, Cancer Genome Atlas Research Network, Stuart JM, Laird PW, Hoadley KA, Weinstein JN, Peto M, Pickering CR, Chen Z, Van Waes C) Cell Rep 2018 Apr 03;23(1):194-212.e6 240 Citations |
| 1 | Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas. (Liu Y, Sethi NS, Hinoue T, Schneider BG, Cherniack AD, Sanchez-Vega F, Seoane JA, Farshidfar F, Bowlby R, Islam M, Kim J, Chatila W, Akbani R, Kanchi RS, Rabkin CS, Willis JE, Wang KK, McCall SJ, Mishra L, Ojesina AI, Bullman S, Pedamallu CS, Lazar AJ, Sakai R, Cancer Genome Atlas Research Network, Thorsson V, Bass AJ, Laird PW) Cancer Cell 2018 Apr 09;33(4):721-735.e8 401 Citations |
| 1 | Variation in nuclear size and PD-L2 positivity correlate with aggressive chromophobe renal cell carcinoma. (Mostafa ME, Abdelkader A, Kuroda N, Pérez-Montiel D, Banerjee A, Hes O, Iczkowski KA) Ann Diagn Pathol 2018 Jun;34:31-35 1 Citation |
| 5 | Gallbladder carcinoma: An analysis of the national cancer data base to examine hispanic influence. (Liu C, Berger NG, Rein L, Tarima S, Clarke C, Mogal H, Christians KK, Tsai S, Gamblin TC) J Surg Oncol 2018 Jun;117(8):1664-1671 5 Citations |
| 1 | Sarcopenia as a predictor of post-transplant tumor recurrence after living donor liver transplantation for hepatocellular carcinoma beyond the Milan criteria. (Kim YR, Park S, Han S, Ahn JH, Kim S, Sinn DH, Jeong WK, Ko JS, Gwak MS, Kim GS) Sci Rep 2018 May 08;8(1):7157 32 Citations |
| 1 | Cancer-Associated Fibroblasts Drive Glycolysis in a Targetable Signaling Loop Implicated in Head and Neck Squamous Cell Carcinoma Progression. (Kumar D, New J, Vishwakarma V, Joshi R, Enders J, Lin F, Dasari S, Gutierrez WR, Leef G, Ponnurangam S, Chavan H, Ganaden L, Thornton MM, Dai H, Tawfik O, Straub J, Shnayder Y, Kakarala K, Tsue TT, Girod DA, Van Houten B, Anant S, Krishnamurthy P, Thomas SM) Cancer Res 2018 Jul 15;78(14):3769-3782 105 Citations |
| 2 | Papillary Carcinoma of Stensen's Duct with Intestinal Differentiation. (Mostafa ME, Abdelkader A, Scarpinato M, Stadler ME, Hunt BC, Giorgadze T) Head Neck Pathol 2019 Sep;13(3):512-515 |
| 1 | Comprehensive molecular profiling of patients with pancreatic adenocarcinoma: A single institution’s experience. (Kamgar M, Dyson G, Diab M, Tesfaye AA, Korn WM, Shields AF, Philip AP) Journal of Clinical Oncology 36, no. 15_suppl.e16236 |
| 1 | Role of Additional Organ Resection in Adrenocortical Carcinoma: Analysis of 167 Patients from the U.S. Adrenocortical Carcinoma Database. (Marincola Smith P, Kiernan CM, Tran TB, Postlewait LM, Maithel SK, Prescott J, Pawlik T, Wang TS, Glenn J, Hatzaras I, Shenoy R, Phay J, Shirley LA, Fields RC, Jin L, Weber S, Salem A, Sicklick J, Gad S, Yopp A, Mansour J, Duh QY, Seiser N, Votanopoulos K, Levine EA, Poultsides G, Solórzano CC) Ann Surg Oncol 2018 Aug;25(8):2308-2315 20 Citations |
| 1 | Percutaneous Cryoablation of Solitary, Sporadic Renal Cell Carcinoma: Outcome Analysis Based on Clear-Cell versus Papillary Subtypes. (Haddad MM, Schmit GD, Kurup AN, Schmitz JJ, Boorjian SA, Geske J, Thompson RH, Callstrom MR, Atwell TD) J Vasc Interv Radiol 2018 Aug;29(8):1122-1126 15 Citations |
| 1 | Pleomorphic Lobular Carcinoma In Situ: Imaging Features, Upgrade Rate, and Clinical Outcomes. (Savage JL, Jeffries DO, Noroozian M, Sabel MS, Jorns JM, Helvie MA) AJR Am J Roentgenol 2018 Aug;211(2):462-467 19 Citations |
| 1 | The impact of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio among patients with intrahepatic cholangiocarcinoma. (Buettner S, Spolverato G, Kimbrough CW, Alexandrescu S, Marques HP, Lamelas J, Aldrighetti L, Gamblin TC, Maithel SK, Pulitano C, Weiss M, Bauer TW, Shen F, Poultsides GA, Marsh JW, IJzermans JNM, Koerkamp BG, Pawlik TM) Surgery 2018 Sep;164(3):411-418 50 Citations |
| 1 | Incidental extensive adenocarcinoma in lungs explanted from a transplant recipient with an idiopathic pulmonary fibrosis flare-up: A clinical dilemma. (Patil PD, Sultan S, Hahn MF, Roy SB, Ross MD, Abdelrazek H, Bremner RM, Thawani N, Walia R, Panchabhai TS) Respir Med Case Rep 2018;25:45-48 3 Citations |
| 1 | Preoperative Circulating Tumor DNA in Patients with Peritoneal Carcinomatosis is an Independent Predictor of Progression-Free Survival. (Baumgartner JM, Raymond VM, Lanman RB, Tran L, Kelly KJ, Lowy AM, Kurzrock R) Ann Surg Oncol 2018 Aug;25(8):2400-2408 52 Citations |
| 1 | Response of Cutaneous Squamous Cell Carcinoma to Treatment With Cetuximab. (Berliner JG, Schulman JM, Lazarova Z, Olasz E, Arron ST) Dermatol Surg 2019 Feb;45(2):313-316 16 Citations |
| 1 | Close Margins and Adjuvant Radiotherapy in Acinic Cell Carcinoma of the Parotid Gland. (Zenga J, Parikh AS, Emerick KS, Lin DT, Faquin WC, Deschler DG) JAMA Otolaryngol Head Neck Surg 2018 Nov 01;144(11):1011-1016 33 Citations |
| 3 | PET-based Treatment Response Assessment for Neoadjuvant Chemoradiation in Pancreatic Adenocarcinoma: An Exploratory Study. (Dalah E, Tai A, Oshima K, Hall WA, Erickson B, Li XA) Transl Oncol 2018 Oct;11(5):1104-1109 20 Citations |
| 1 | A Rare Presentation of Cardiac Tamponade from Metastatic Urothelial Carcinoma of the Bladder. (Palam S, Kapoor R, Kulinski J) Case Rep Cardiol 2018;2018:6750264 |
| 1 | Characterizing parathyroid carcinomas and atypical neoplasms based on the expression of programmed death-ligand 1 expression and the presence of tumor-infiltrating lymphocytes and macrophages. (Silva-Figueroa A, Villalobos P, Williams MD, Bassett RL Jr, Clarke CN, Lee JE, Busaidy NL, Perrier ND) Surgery 2018 Nov;164(5):960-964 18 Citations |
| 4 | Does Progesterone Receptor Matter in the Risk of Recurrence for Patients With Ductal Carcinoma in Situ? (Chaudhary LN, Jawa Z, Hanif A, Szabo A, Kamaraju S, Cheng YC, Chitambar CR) WMJ 2018 Jun;117(2):62-67 5 Citations |
| 1 | Rare breast metastasis from adenoid cystic carcinoma of the submandibular gland. (Krucoff KB, Shammas RL, Stoecker M, Tolnitch LA) BMJ Case Rep 2018 Aug 01;2018 2 Citations |
| 6 | A Phase II Clinical Trial of Molecular Profiled Neoadjuvant Therapy for Localized Pancreatic Ductal Adenocarcinoma. (Tsai S, Christians KK, George B, Ritch PS, Dua K, Khan A, Mackinnon AC, Tolat P, Ahmad SA, Hall WA, Erickson BA, Evans DB) Ann Surg 2018 Oct;268(4):610-619 64 Citations |
| 7 | Patients with Oncocytic Variant Papillary Thyroid Carcinoma Have a Similar Prognosis to Matched Classical Papillary Thyroid Carcinoma Controls. (Carr AA, Yen TWF, Ortiz DI, Hunt BC, Fareau G, Massey BL, Campbell BH, Doffek KL, Evans DB, Wang TS) Thyroid 2018 Nov;28(11):1462-1467 15 Citations |
| 1 | Adjuvant and Neoadjuvant Therapy, Treatment for Advanced Disease, and Genetic Considerations for Adrenocortical Carcinoma: An Update from the SSO Endocrine and Head and Neck Disease Site Working Group. (Dickson PV, Kim L, Yen TWF, Yang A, Grubbs EG, Patel D, Solórzano CC) Ann Surg Oncol 2018 Nov;25(12):3453-3459 11 Citations |
| 1 | Evaluation, Staging, and Surgical Management for Adrenocortical Carcinoma: An Update from the SSO Endocrine and Head and Neck Disease Site Working Group. (Dickson PV, Kim L, Yen TWF, Yang A, Grubbs EG, Patel D, Solórzano CC) Ann Surg Oncol 2018 Nov;25(12):3460-3468 22 Citations |
| 1 | Primary peritoneal hepatoid adenocarcinoma: a diagnostic and therapeutic conundrum in patients with gastrointestinal bleeding. (Inayat F, Zafar F, Lodhi HT, Ullah W) BMJ Case Rep 2018 Sep 18;2018 1 Citation |
| 1 | Considering the downregulation of Tpm1.6 and Tpm1.7 in squamous cell carcinoma of esophagus as a potent biomarker. (Zare M, Hadi F, Alivand MR) Per Med 2018 Sep;15(5):361-370 1 Citation |
| 1 | The prognostic significance of adrenocortical carcinomas identified incidentally. (Rossfeld KK, Maithel SK, Prescott J, Wang TS, Fields RC, Weber SM, Sicklick JK, Yopp AC, Duh QY, Solorzano CC, Votanopoulos KI, Hatzaras I, Poultsides GA, Shirley LA, and the U.S. Adrenocortical Carcinoma Study Group) J Surg Oncol 2018 Dec;118(7):1155-1162 6 Citations |
| 1 | Analysis of Circulating Tumor DNA and Clinical Correlates in Patients with Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma. (Kato S, Okamura R, Baumgartner JM, Patel H, Leichman L, Kelly K, Sicklick JK, Fanta PT, Lippman SM, Kurzrock R) Clin Cancer Res 2018 Dec 15;24(24):6248-6256 91 Citations |
| 1 | Hepatocellular Carcinoma After Fontan Operation: Multicenter Case Series. (Egbe AC, Poterucha JT, Warnes CA, Connolly HM, Baskar S, Ginde S, Clift P, Kogon B, Book WM, Walker N, Wagenaar L, Moe T, Oechslin E, Kay WA, Norris M, Gordon-Walker T, Dillman JR, Trout A, Anwar N, Hoskoppal A, Veldtman GR) Circulation 2018 Aug 14;138(7):746-748 77 Citations |
| 1 | Chronic p27Kip1 Induction by Dexamethasone Causes Senescence Phenotype and Permanent Cell Cycle Blockade in Lung Adenocarcinoma Cells Over-expressing Glucocorticoid Receptor. (Patki M, McFall T, Rosati R, Huang Y, Malysa A, Polin L, Fielder A, Wilson MR, Lonardo F, Back J, Li J, Matherly LH, Bepler G, Ratnam M) Sci Rep 2018 Oct 30;8(1):16006 8 Citations |
| 1 | Ductal Carcinoma in Situ Biomarkers in a Precision Medicine Era: Current and Future Molecular-Based Testing. (Shee K, Muller KE, Marotti J, Miller TW, Wells WA, Tsongalis GJ) Am J Pathol 2019 May;189(5):956-965 19 Citations |
| 1 | ASO Author Reflections: Circulating Tumor DNA in Peritoneal Carcinomatosis. (Baumgartner JM, Kurzrock R) Ann Surg Oncol 2018 Dec;25(Suppl 3):772-773 |
| 1 | SRC-3 inhibition blocks tumor growth of pancreatic ductal adenocarcinoma. (Song X, Chen H, Zhang C, Yu Y, Chen Z, Liang H, Van Buren G 2nd, McElhany AL, Fisher WE, Lonard DM, O'Malley BW, Wang J) Cancer Lett 2019 Feb 01;442:310-319 21 Citations |
| 1 | Correction to: The Emerging Roles of Steroid Hormone Receptors in Ductal Carcinoma in Situ (DCIS) of the Breast. (Villanueva H, Grimm SL, Dhamne S, Rajapakshe K, Visbal AP, Davis CM, Ehli EA, Hartig SM, Coarfa C, Edwards DP) J Mammary Gland Biol Neoplasia 2019 Mar;24(1):109-110 1 Citation |
| 1 | Patterns of Urachal Remnant Involvement by Urothelial Carcinoma: Intraluminal Noninvasive Spread Can Mimic a Deep-seated Bladder Invasion. (Han L, Gallan A, Paner GP) Am J Surg Pathol 2019 Apr;43(4):475-479 5 Citations |
| 1 | Neutrophil Gelatinase-associated Lipocalin as a Theragnostic Marker in Perihilar Cholangiocarcinoma. (Nair A, Ingram N, Verghese ET, Wijetunga I, Markham AF, Wyatt J, Prasad KR, Coletta PL) Anticancer Res 2018 Dec;38(12):6737-6744 6 Citations |
| 5 | A Serum-Induced Transcriptome and Serum Cytokine Signature Obtained at Diagnosis Correlates with the Development of Early Pancreatic Ductal Adenocarcinoma Metastasis. (Tsai S, McOlash L, Jia S, Zhang J, Simpson P, Kaldunski ML, Aldakkak M, Grewal J, Palen K, Dwinell MB, Johnson BD, Mackinnon A, Hessner MJ, Gershan JA) Cancer Epidemiol Biomarkers Prev 2019 Apr;28(4):680-689 2 Citations |
| 1 | Contemporary analysis of complications associated with biliary stents during neoadjuvant therapy for pancreatic adenocarcinoma. (Kim BJ, Prakash L, Narula N, Davis CH, Kim MP, Aloia TA, Vauthey JN, Lee JE, Katz MH, Tzeng CD) HPB (Oxford) 2019 Jun;21(6):662-668 10 Citations |
| 1 | Durvalumab for recurrent or metastatic head and neck squamous cell carcinoma: Results from a single-arm, phase II study in patients with ≥25% tumour cell PD-L1 expression who have progressed on platinum-based chemotherapy. (Zandberg DP, Algazi AP, Jimeno A, Good JS, Fayette J, Bouganim N, Ready NE, Clement PM, Even C, Jang RW, Wong S, Keilholz U, Gilbert J, Fenton M, Braña I, Henry S, Remenar E, Papai Z, Siu LL, Jarkowski A, Armstrong JM, Asubonteng K, Fan J, Melillo G, Mesía R) Eur J Cancer 2019 Jan;107:142-152 202 Citations |
| 1 | Carcinoma presenting as idiopathic anterior glottic webs: A case series. (Ramaswamy AT, Tian L, Bock JM, Klein AM, Pitman MJ) Laryngoscope 2019 Sep;129(9):2118-2120 1 Citation |
| 1 | Response to pembrolizumab in a patient with xeroderma pigmentosum and advanced squamous cell carcinoma (Steineck A, Krumm N, Sarthy JF, Pritchard CC, Chapman T, Stacey AW, Vitanza NA, Cole B) JCO Precision Oncology 2019;3:1-6 12 Citations |
| 1 | Esophageal pepsin and proton pump synthesis in barrett's esophagus and esophageal adenocarcinoma () Laryngoscope 2019 |
| 4 | Effect of Donor Race-Matching on Overall Survival for African-American Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma. (Silva JP, Maurina MN, Tsai S, Christians KK, Clarke CN, Mogal H, Saeian K, Gamblin TC) J Am Coll Surg 2019 Mar;228(3):245-254 8 Citations |
| 2 | Stereotactic body radiation therapy for hepatocellular carcinoma: Practice patterns, dose selection and factors impacting survival. (Robbins JR, Schmid RK, Hammad AY, Gamblin TC, Erickson BA) Cancer Med 2019 Mar;8(3):928-938 18 Citations |
| 1 | No Association Between Vitamin D Status and Risk of Barrett's Esophagus or Esophageal Adenocarcinoma: A Mendelian Randomization Study. (Dong J, Gharahkhani P, Chow WH, Gammon MD, Liu G, Caldas C, Wu AH, Ye W, Onstad L, Anderson LA, Bernstein L, Pharoah PD, Risch HA, Corley DA, Fitzgerald RC, Stomach and Esophageal Cancer Study Consortium, Iyer PG, Reid BJ, Lagergren J, Shaheen NJ, Vaughan TL, MacGregor S, Love S, Palles C, Tomlinson I, Gockel I, May A, Gerges C, Anders M, Böhmer AC, Becker J, Kreuser N, Thieme R, Noder T, Venerito M, Veits L, Schmidt T, Schmidt C, Izbicki JR, Hölscher AH, Lang H, Lorenz D, Schumacher B, Mayershofer R, Vashist Y, Ott K, Vieth M, Weismüller J, Nöthen MM, Moebus S, Knapp M, Peters WHM, Neuhaus H, Rösch T, Ell C, Jankowski J, Schumacher J, Neale RE, Whiteman DC, Thrift AP) Clin Gastroenterol Hepatol 2019 Oct;17(11):2227-2235.e1 18 Citations |
| 1 | Verrucous carcinoma: An unexpected finding arising from a burn scar. (Hannah CE, Weig EA, Collier S, Stone MS, Juma O, Mcharo JJ, Ferguson NN, Wanat KA) JAAD Case Rep 2019 Mar;5(3):225-227 4 Citations |
| 1 | Real-Time Targeted Genome Profile Analysis of Pancreatic Ductal Adenocarcinomas Identifies Genetic Alterations That Might Be Targeted With Existing Drugs or Used as Biomarkers. (Singhi AD, George B, Greenbowe JR, Chung J, Suh J, Maitra A, Klempner SJ, Hendifar A, Milind JM, Golan T, Brand RE, Zureikat AH, Roy S, Schrock AB, Miller VA, Ross JS, Ali SM, Bahary N) Gastroenterology 2019 Jun;156(8):2242-2253.e4 245 Citations |
| 1 | A competing risk nomogram to predict severe late toxicity after modern re-irradiation for squamous carcinoma of the head and neck. (Ward MC, Lee NY, Caudell JJ, Zajichek A, Awan MJ, Koyfman SA, Dunlap NE, Zakem SJ, Hassanzadeh C, Marcrom S, Boggs DH, Isrow D, Vargo JA, Heron DE, Siddiqui F, Bonner JA, Beitler JJ, Yao M, Trotti AM, Riaz N, Multi-Institution Re-Irradiation (MIRI) Collaborative) Oral Oncol 2019 Mar;90:80-86 34 Citations |
| 1 | Quantitative Non-Gaussian Intravoxel Incoherent Motion Diffusion-Weighted Imaging Metrics and Surgical Pathology for Stratifying Tumor Aggressiveness in Papillary Thyroid Carcinomas. (Núñez DA, Lu Y, Paudyal R, Hatzoglou V, Moreira AL, Oh JH, Stambuk HE, Mazaheri Y, Gonen M, Ghossein RA, Shaha AR, Tuttle RM, Shukla-Dave A) Tomography 2019 Mar;5(1):26-35 6 Citations |
| 1 | Oncological outcomes and pathological characteristics of cT1 upstaging to pT3a renal cell carcinoma compared with de novo pT3a tumors. (Senguttuvan Karthikeyan V, Mallya A, Sivaraman A, Galiano M, Rozet F, Cathala N, Barret E, Mombet A, Prapotnich D, Sanchez-Salas R, Cathelineau X) Actas Urol Esp (Engl Ed) 2019 Jun;43(5):234-240 1 Citation |
| 1 | Pathologic Response to Pretransplant Locoregional Therapy is Predictive of Patient Outcome After Liver Transplantation for Hepatocellular Carcinoma: Analysis From the US Multicenter HCC Transplant Consortium. (DiNorcia J, Florman SS, Haydel B, Tabrizian P, Ruiz RM, Klintmalm GB, Senguttuvan S, Lee DD, Taner CB, Verna EC, Halazun KJ, Hoteit M, Levine MH, Chapman WC, Vachharajani N, Aucejo F, Nguyen MH, Melcher ML, Tevar AD, Humar A, Mobley C, Ghobrial M, Nydam TL, Amundsen B, Markmann JF, Berumen J, Hemming AW, Langnas AN, Carney CA, Sudan DL, Hong JC, Kim J, Zimmerman MA, Rana A, Kueht ML, Jones CM, Fishbein TM, Markovic D, Busuttil RW, Agopian VG) Ann Surg 2020 Apr;271(4):616-624 79 Citations |
| 1 | Survival after Resection of Multiple Tumor Foci of Intrahepatic Cholangiocarcinoma. (Buettner S, Ten Cate DWG, Bagante F, Alexandrescu S, Marques HP, Lamelas J, Aldrighetti L, Gamblin TC, Maithel SK, Pulitano C, Margonis GA, Weiss M, Bauer TW, Shen F, Poultsides GA, Marsh JW, IJzermans JNM, Pawlik TM, Koerkamp BG) J Gastrointest Surg 2019 Nov;23(11):2239-2246 42 Citations |
| 1 | Hypercalcemia in Metaplastic Squamous Cell Carcinoma of the Breast. (Hardy BM, Cortina CS, Javidiparsijani S, Ghai R, Madrigrano A) Am J Case Rep 2019 Mar 20;20:366-369 6 Citations |
| 2 | Dickkopf-1 (DKK1) promotes tumor growth via Akt-phosphorylation and independently of Wnt-axis in Barrett's associated esophageal adenocarcinoma. (Lyros O, Lamprecht AK, Nie L, Thieme R, Götzel K, Gasparri M, Haasler G, Rafiee P, Shaker R, Gockel I) Am J Cancer Res 2019;9(2):330-346 |
| 1 | Anti-CD24 Antibody-Nitric Oxide Conjugate Selectively and Potently Suppresses Hepatic Carcinoma. (Sun F, Wang Y, Luo X, Ma Z, Xu Y, Zhang X, Lv T, Zhang Y, Wang M, Huang Z, Zhang J) Cancer Res 2019 Jul 01;79(13):3395-3405 51 Citations |
| 1 | Mucoepidermoid Carcinoma of the Parotid: Very Close Margins and Adjuvant Radiotherapy. (Zenga J, Yu Z, Parikh A, Chen JX, Lin DT, Emerick KS, Faquin WC, Varvares MA, Deschler DG) ORL J Otorhinolaryngol Relat Spec 2019;81(1):55-62 17 Citations |
| 1 | Preventive Effects by Black Raspberries of Endometrial Carcinoma Initiation and Promotion Induced by a High-Fat Diet. (Huang YW, Chen JH, Rader JS, Aguilera-Barrantes I, Wang LS) Mol Nutr Food Res 2019 Jun;63(12):e1900013 2 Citations |
| 1 | A Multiscale Map of the Stem Cell State in Pancreatic Adenocarcinoma. (Lytle NK, Ferguson LP, Rajbhandari N, Gilroy K, Fox RG, Deshpande A, Schürch CM, Hamilton M, Robertson N, Lin W, Noel P, Wartenberg M, Zlobec I, Eichmann M, Galván JA, Karamitopoulou E, Gilderman T, Esparza LA, Shima Y, Spahn P, French R, Lewis NE, Fisch KM, Sasik R, Rosenthal SB, Kritzik M, Von Hoff D, Han H, Ideker T, Deshpande AJ, Lowy AM, Adams PD, Reya T) Cell 2019 Apr 18;177(3):572-586.e22 112 Citations |
| 1 | Encapsulated and solid papillary carcinomas of the breast: Tumors in transition from in situ to invasive? (Solanki MH, Derylo AF, Visotcky AM, Jorns JM) Breast J 2019 May;25(3):539-541 5 Citations |
| 1 | Buccal Myomucosal Flap Reconstruction After Resection of Palatal Mucoepidermoid Carcinoma. (Kimia R, Shakir S, Jackson OA, Nguyen PD) Ann Plast Surg 2019 Nov;83(5):538-541 2 Citations |
| 1 | Mortalin (GRP75/HSPA9) promotes survival and proliferation of thyroid carcinoma cells (Dmytro Starenki, Nadiya Sosonkina, Seung-Keun Hong, Ricardo V Lloyd, Jong-In Park) International Journal of Molecular Sciences |
| 1 | Mortalin (GRP75/HSPA9) Promotes Survival and Proliferation of Thyroid Carcinoma Cells. (Starenki D, Sosonkina N, Hong SK, Lloyd RV, Park JI) Int J Mol Sci 2019 Apr 26;20(9) 44 Citations |
| 1 | Hepatocellular carcinoma up-regulated long non-coding RNA: a putative marker in multiple sclerosis. (Sayad A, Taheri M, Arsang-Jang S, Glassy MC, Ghafouri-Fard S) Metab Brain Dis 2019 Aug;34(4):1201-1205 12 Citations |
| 3 | Esophageal pepsin and proton pump synthesis in barrett's esophagus and esophageal adenocarcinoma. (Samuels TL, Altman KW, Gould JC, Kindel T, Bosler M, MacKinnon A, Hagen CE, Johnston N) Laryngoscope 2019 Dec;129(12):2687-2695 17 Citations |
| 4 | Downstaging Locally Advanced Cholangiocarcinoma Pre-Liver Transplantation: A Prospective Pilot Study. (Wong M, Kim J, George B, Eriksen C, Pearson T, Robbins J, Zimmerman MA, Hong JC) J Surg Res 2019 Oct;242:23-30 27 Citations |
| 1 | A Logistic Regression Model for Noninvasive Prediction of AFP-Negative Hepatocellular Carcinoma. (Luo CL, Rong Y, Chen H, Zhang WW, Wu L, Wei D, Wei XQ, Mei LJ, Wang FB) Technol Cancer Res Treat 2019 Jan 01;18:1533033819846632 19 Citations |
| 1 | Cutaneous metastasis of endometrial carcinoma: an unusual and dramatic presentation. (Bashline B, Danowski K, Ghaferi J, Lafond A) Cutis 2019 Apr;103(4):217-218 4 Citations |
| 1 | Microglandular Adenosis and Associated Invasive Carcinoma. (Kravtsov O, Jorns JM) Arch Pathol Lab Med 2020 Jan;144(1):42-46 17 Citations |
| 1 | Comprehensive genomic profiling of high-grade serous ovarian carcinoma from Chinese patients identifies co-occurring mutations in the Ras/Raf pathway with TP53. (Zhong F, Zhu T, Pan X, Zhang Y, Yang H, Wang X, Hu J, Han H, Mei L, Chen D, Wang K, Zhou X, Li X, Dong X) Cancer Med 2019 Jul;8(8):3928-3935 7 Citations |
| 1 | Clinical efficacy of TACE combined with Apatinib in the treatment of advanced hepatocellular carcinoma. (Zhu Y, Feng B, Mei L, Sun R, Guo C, Zhu J) J BUON 2019;24(2):608-614 27 Citations |
| 1 | Genomic distinctions between metastatic lower and upper tract urothelial carcinoma revealed through rapid autopsy. (Winters BR, De Sarkar N, Arora S, Bolouri H, Jana S, Vakar-Lopez F, Cheng HH, Schweizer MT, Yu EY, Grivas P, Lee JK, Kollath L, Holt SK, McFerrin L, Ha G, Nelson PS, Montgomery RB, Wright JL, Lam HM, Hsieh AC) JCI Insight 2019 May 30;5(13) 34 Citations |
| 1 | Prevalence of established and emerging biomarkers of immune checkpoint inhibitor response in advanced hepatocellular carcinoma (Ang C, Klempner SJ, Ali SM, Madison R, Ross JS, Severson EA, Fabrizio D, Goodman A, Kurzrock R, Suh J, Millis SZ) Oncotarget 1 June 2019;10(40):4018-4025 123 Citations |
| 1 | Epidemiological risk factors for adrenocortical carcinoma: A hospital-based case-control study. (Habra MA, Sukkari MA, Hasan A, Albousen Y, Elsheshtawi MA, Jimenez C, Campbell M, Karam JA, Graham PH, Hatia RI, Phan AT, Varghese J, Hassan MM) Int J Cancer 2020 Apr 01;146(7):1836-1840 13 Citations |
| 1 | Radiation therapy for pancreatic adenocarcinoma, a treatment option that must be considered in the management of a devastating malignancy. (Hall WA, Goodman KA) Radiat Oncol 2019 Jun 26;14(1):114 30 Citations |
| 1 | Beta-Secretase 1 (BACE1) is down-regulated in invasive ductal carcinoma of breast (Yaghoobi H, Azizi H, Banitalebi-Dehkordi M, Rezaei FM, Arsang-Jnag S, Taheri M, Ghafouri-Fard S) Reports of Biochemistry and Molecular Biology 1 July 2019;8(2):200-207 13 Citations |
| 1 | Prevalence of established and emerging biomarkers of immune checkpoint inhibitor response in advanced hepatocellular carcinoma. (Ang C, Klempner SJ, Ali SM, Madison R, Ross JS, Severson EA, Fabrizio D, Goodman A, Kurzrock R, Suh J, Millis SZ) Oncotarget 2019 Jun 18;10(40):4018-4025 123 Citations |
| 1 | Hepatocellular Carcinoma. (Duran SR, Jaquiss RDB) N Engl J Med 2019 Jul 04;381(1):e2 26 Citations |
| 1 | Features of synchronous versus metachronous metastasectomy in adrenal cortical carcinoma: Analysis from the US adrenocortical carcinoma database. (Prendergast KM, Smith PM, Tran TB, Postlewait LM, Maithel SK, Prescott JD, Pawlik TM, Wang TS, Glenn J, Hatzaras I, Shenoy R, Phay JE, Shirley LA, Fields RC, Jin LX, Weber SM, Salem A, Sicklick JK, Gad S, Yopp AC, Mansour JC, Duh QY, Seiser N, Votanopoulos KI, Levine EA, Poultsides GA, Solórzano CC, Kiernan CM) Surgery 2020 Feb;167(2):352-357 10 Citations |
| 2 | Evolving Trends for Selected Treatments of T1a Renal Cell Carcinoma. (Doolittle J, Piotrowski J, Zuk K, Jacobsohn K, Langenstroer P, See W, Johnson S) Urology 2019 Oct;132:136-142 27 Citations |
| 1 | Treatment of Hepatocellular Carcinoma: Time for a Paradigm Shift? (White SB) Radiology 2019 Sep;292(3):760-761 2 Citations |
| 1 | Exceptional response to chemotherapy followed by concurrent radiotherapy and immunotherapy in a male with primary retroperitoneal serous Adenocarcinoma: a case report and literature review. (Chae YK, Saleem N, Roh Y, Bilal H, Viveiros P, Sukhadia B, Lin X, Sheikh MM, Park LC) BMC Cancer 2019 Jul 30;19(1):748 6 Citations |
| 1 | Genetic profiling as a clinical tool in advanced parathyroid carcinoma (Kutahyalioglu M, Nguyen HT, Kwatampora L, Clarke C, Silva A, Ibrahim E, Waguespack SG, Cabanillas ME, Jimenez C, Hu MI, Sherman SI, Kopetz S, Broaddus R, Dadu R, Wanland K, Williams M, Zafereo M, Perrier N, Busaidy NL) Journal of Cancer Research and Clinical Oncology 1 August 2019;145(8):1977-1986 43 Citations |
| 1 | Molecular Profiling of Hepatocellular Carcinoma Using Circulating Cell-Free DNA. (Kaseb AO, Sánchez NS, Sen S, Kelley RK, Tan B, Bocobo AG, Lim KH, Abdel-Wahab R, Uemura M, Pestana RC, Qiao W, Xiao L, Morris J, Amin HM, Hassan MM, Rashid A, Banks KC, Lanman RB, Talasaz A, Mills-Shaw KR, George B, Haque A, Raghav KPS, Wolff RA, Yao JC, Meric-Bernstam F, Ikeda S, Kurzrock R) Clin Cancer Res 2019 Oct 15;25(20):6107-6118 64 Citations |
| 1 | Facility Type is Associated with Margin Status and Overall Survival of Patients with Resected Intrahepatic Cholangiocarcinoma. (Lee GC, Gamblin TC, Fong ZV, Ferrone CR, Goyal L, Lillemoe KD, Blaszkowsky LS, Tanabe KK, Qadan M) Ann Surg Oncol 2019 Nov;26(12):4091-4099 38 Citations |
| 1 | Tumor heterogeneity and acquired drug resistance in FGFR2-fusion-positive cholangiocarcinoma through rapid research autopsy. (Krook MA, Bonneville R, Chen HZ, Reeser JW, Wing MR, Martin DM, Smith AM, Dao T, Samorodnitsky E, Paruchuri A, Miya J, Baker KR, Yu L, Timmers C, Dittmar K, Freud AG, Allenby P, Roychowdhury S) Cold Spring Harb Mol Case Stud 2019 Aug;5(4) 68 Citations |
| 1 | Perioperative Gemcitabine + Erlotinib Plus Pancreaticoduodenectomy for Resectable Pancreatic Adenocarcinoma: ACOSOG Z5041 (Alliance) Phase II Trial. (Wei AC, Ou FS, Shi Q, Carrero X, O'Reilly EM, Meyerhardt J, Wolff RA, Kindler HL, Evans DB, Deshpande V, Misdraji J, Tamm E, Sahani D, Moore M, Newman E, Merchant N, Berlin J, Goff LW, Pisters P, Posner MC) Ann Surg Oncol 2019 Dec;26(13):4489-4497 21 Citations |
| 1 | Should We Be Doing Cytoreductive Surgery with HIPEC for Signet Ring Cell Appendiceal Adenocarcinoma? A Study from the US HIPEC Collaborative. (Levinsky NC, Morris MC, Wima K, Sussman JJ, Ahmad SA, Cloyd JM, Kimbrough C, Fournier K, Lee A, Dineen S, Dessureault S, Veerapong J, Baumgartner JM, Clarke C, Zaidi MY, Staley CA, Maithel SK, Leiting J, Grotz T, Lambert L, Hendrix RJ, Ronnekleiv-Kelly S, Pokrzywa C, Raoof M, Eng OS, Johnston FM, Greer J, Patel SH) J Gastrointest Surg 2020 Jan;24(1):155-164 26 Citations |
| 1 | Initial Experience With Staging Rectal Adenocarcinoma Using 7T Magnetic Resonance Imaging. (Blank J, Berger N, Knechtges P, Prost R, Peterson C, Ludwig K, Ridolfi T) J Surg Res 2020 Jan;245:434-440 2 Citations |
| 1 | Trastuzumab and pertuzumab in circulating tumor DNA ERBB2-amplified HER2-positive refractory cholangiocarcinoma. (Yarlagadda B, Kamatham V, Ritter A, Shahjehan F, Kasi PM) NPJ Precis Oncol 2019;3:19 34 Citations |
| 1 | Vanishing Papillary Thyroid Carcinoma: Morphological Changes After Fine-Needle Aspiration (Te Jose M, Hunt B, Magill SB) AACE Clinical Case Reports 1 September 2019;5(5):e298-e301 |
| 1 | VANISHING PAPILLARY THYROID CARCINOMA:
MORPHOLOGICAL CHANGES AFTER FINE-NEEDLE ASPIRATION (Maria Teresa Jose, MD; Bryn Hunt, MD; Steven B. Magill) AACE Clinical Case Reports AACE Clinical Case Rep. 2019;5:e298-e301 |
| 6 | Intermediate-grade carcinoma of the parotid and the impact of adjuvant radiation. (North L, Stadler M, Massey B, Campbell B, Shukla M, Awan M, Schultz CJ, Shreenivas A, Wong S, Graboyes E, Pipkorn P, Zenga J) Am J Otolaryngol 2019;40(6):102282 12 Citations |
| 1 | A Multimodal and Pathological Analysis of a Renal Cell Carcinoma Metastasis to the Thyroid Gland 11 Years Post Nephrectomy. (Geisbush TR, Dymon Z, Gabriel MS, Yedavalli V) J Radiol Case Rep 2019 Apr;13(4):1-9 3 Citations |
| 1 | Corrigendum to "A Rare Presentation of Cardiac Tamponade from Metastatic Urothelial Carcinoma of the Bladder". (Palam S, Kapoor R, Abdelkader A, Kulinski J) Case Rep Cardiol 2019;2019:8376360 |
| 1 | Targeting the vasopressin type-2 receptor for renal cell carcinoma therapy. (Sinha S, Dwivedi N, Tao S, Jamadar A, Kakade VR, Neil MO, Weiss RH, Enders J, Calvet JP, Thomas SM, Rao R) Oncogene 2020 Feb;39(6):1231-1245 33 Citations |
| 1 | Yttrium-90-Labeled Anti-Glypican 3 Radioimmunotherapy Halts Tumor Growth in an Orthotopic Xenograft Model of Hepatocellular Carcinoma. (Ludwig AD, Labadie KP, Seo YD, Hamlin DK, Nguyen HM, Mahadev VM, Yeung RS, Wilbur DS, Park JO) J Oncol 2019;2019:4564707 8 Citations |
| 7 | Management of Acute Cholecystitis during Neoadjuvant Therapy in Patients with Pancreatic Adenocarcinoma. (Jariwalla NR, Khan AH, Dua K, Christians KK, Clarke CN, Aldakkak M, George B, Tutton S, Rilling W, Erickson B, Evans DB, Tsai S) Ann Surg Oncol 2019 Dec;26(13):4515-4521 7 Citations |
| 6 | Intermediate-grade carcinoma of the parotid and the impact of adjuvant radiation (North L, Stadler M, Massey B, Campbell B, Shukla M, Awan M, Schultz CJ, Shreenivas A, Wong S, Graboyes E, Pipkorn P, Zenga J) American Journal of Otolaryngology - Head and Neck Medicine and Surgery November - December 2019;40(6) 12 Citations |
| 1 | Risk and Rate of Occult Contralateral Nodal Disease in Surgically Treated Patients With Human Papillomavirus-Related Squamous Cell Carcinoma of the Base of the Tongue. (Last AS, Pipkorn P, Chen S, Kallogjeri D, Zenga J, Rich JT, Paniello R, Zevallos J, Chernock R, Adkins D, Oppelt P, Gay H, Daly M, Thorstad W, Jackson RS) JAMA Otolaryngol Head Neck Surg 2020 Jan 01;146(1):50-56 25 Citations |
| 1 | Recent Trends in Squamous Cell Carcinoma of the Anus Incidence and Mortality in the United States, 2001-2015. (Deshmukh AA, Suk R, Shiels MS, Sonawane K, Nyitray AG, Liu Y, Gaisa MM, Palefsky JM, Sigel K) J Natl Cancer Inst 2020 Aug 01;112(8):829-838 216 Citations |
| 2 | Targeting the Stress-Induced Protein NUPR1 to Treat Pancreatic Adenocarcinoma. (Santofimia-Castaño P, Xia Y, Peng L, Velázquez-Campoy A, Abián O, Lan W, Lomberk G, Urrutia R, Rizzuti B, Soubeyran P, Neira JL, Iovanna J) Cells 2019 Nov 17;8(11) 34 Citations |
| 2 | White paper on pancreatic ductal adenocarcinoma from society of abdominal radiology's disease-focused panel for pancreatic ductal adenocarcinoma: Part I, AJCC staging system, NCCN guidelines, and borderline resectable disease. (Kulkarni NM, Soloff EV, Tolat PP, Sangster GP, Fleming JB, Brook OR, Wang ZJ, Hecht EM, Zins M, Bhosale PR, Arif-Tiwari H, Mannelli L, Kambadakone AR, Tamm EP) Abdom Radiol (NY) 2020 Mar;45(3):716-728 43 Citations |
| 2 | White paper on pancreatic ductal adenocarcinoma from society of abdominal radiology's disease-focused panel for pancreatic ductal adenocarcinoma: Part II, update on imaging techniques and screening of pancreatic cancer in high-risk individuals. (Kulkarni NM, Mannelli L, Zins M, Bhosale PR, Arif-Tiwari H, Brook OR, Hecht EM, Kastrinos F, Wang ZJ, Soloff EV, Tolat PP, Sangster G, Fleming J, Tamm EP, Kambadakone AR) Abdom Radiol (NY) 2020 Mar;45(3):729-742 23 Citations |
| 1 | Preclinical Assessment with Clinical Validation of Selinexor with Gemcitabine and Nab-Paclitaxel for the Treatment of Pancreatic Ductal Adenocarcinoma. (Azmi AS, Khan HY, Muqbil I, Aboukameel A, Neggers JE, Daelemans D, Mahipal A, Dyson G, Kamgar M, Al-Hallak MN, Tesfaye A, Kim S, Shidham V, M Mohammad R, Philip PA) Clin Cancer Res 2020 Mar 15;26(6):1338-1348 40 Citations |
| 1 | Molecular pathways and targeted therapy in cholangiocarcinoma. (Dabney RS, Khalife M, Shahid K, Phan AT) Clin Adv Hematol Oncol 2019 Nov;17(11):630-637 17 Citations |
| 3 | Initial Experience With Staging Rectal Adenocarcinoma Using 7T Magnetic Resonance Imaging (Blank J, Berger N, Knechtges P, Prost R, Peterson C, Ludwig K, Ridolfi T) Journal of Surgical Research January 2020;245:434-440 2 Citations |
| 1 | Development and validation of a genomic tool to predict seminal vesicle invasion in adenocarcinoma of the prostate (Hall WA, Fishbane N, Liu Y, Xu MJ, Davicioni E, Mahal BA, Den RB, Dess RT, Jackson WC, Wong AC, Schaeffer EM, Karnes RJ, Carroll PR, Cooperberg MR, Bismar TA, Kim HL, Klein EA, Davis JW, Ross AE, Tosoian JJ, Morgan TM, Mehra R, Salami SS, Nguyen PL, Lawton CAF, Spratt DE, Feng F) JCO Precision Oncology 2020;4:1228-1238 4 Citations |
| 1 | Efficacy of FGFR Inhibitors and Combination Therapies for Acquired Resistance in FGFR2-Fusion Cholangiocarcinoma. (Krook MA, Lenyo A, Wilberding M, Barker H, Dantuono M, Bailey KM, Chen HZ, Reeser JW, Wing MR, Miya J, Samorodnitsky E, Smith AM, Dao T, Martin DM, Ciombor KK, Hays J, Freud AG, Roychowdhury S) Mol Cancer Ther 2020 Mar;19(3):847-857 113 Citations |
| 1 | Vulvar basal cell carcinoma arising in the setting of repeated perilamp exposure. (McEnery-Stonelake ME, Clark MA, Vidimos AT) JAAD Case Rep 2020 Feb;6(2):103-105 2 Citations |
| 1 | Targeted therapy for advanced salivary gland carcinoma based on molecular profiling: results from MyPathway, a phase IIa multiple basket study. (Kurzrock R, Bowles DW, Kang H, Meric-Bernstam F, Hainsworth J, Spigel DR, Bose R, Burris H, Sweeney CJ, Beattie MS, Blotner S, Schulze K, Cuchelkar V, Swanton C) Ann Oncol 2020 Mar;31(3):412-421 95 Citations |
| 2 | The Role of Metastasectomy in Urothelial Carcinoma: Where Are We in 2020? (Lemke E, Sahasrabudhe D, Guancial E, Bylow K, Johnson S, Messing E, Kilari D) Clin Genitourin Cancer 2020 Aug;18(4):e478-e483 5 Citations |
| 1 | Evaluating the Utility of Routine Imaging in Squamous Cell Carcinoma of the Nail Unit. (Clark MA, Filitis D, Samie FH, Piliang M, Knackstedt TJ) Dermatol Surg 2020 Nov;46(11):1375-1381 10 Citations |
| 1 | Basal cell carcinoma: Management of advanced or metastatic cancer with checkpoint inhibitors and concurrent paradoxical development of new superficial tumors. (Cohen PR, Kurzrock R) J Am Acad Dermatol 2020 Jun;82(6):e253-e254 8 Citations |
| 1 | Salvage ipilimumab associated with a significant response in sarcomatoid renal cell carcinoma. (George G, Schmidt L, Tolat P, Riese M, Kilari D) J Immunother Cancer 2020 Feb;8(1) 4 Citations |
| 1 | Liver Transplantation Outcomes in a U.S. Multicenter Cohort of 789 Patients With Hepatocellular Carcinoma Presenting Beyond Milan Criteria. (Kardashian A, Florman SS, Haydel B, Ruiz RM, Klintmalm GB, Lee DD, Taner CB, Aucejo F, Tevar AD, Humar A, Verna EC, Halazun KJ, Chapman WC, Vachharajani N, Hoteit M, Levine MH, Nguyen MH, Melcher ML, Langnas AN, Carney CA, Mobley C, Ghobrial M, Amundsen B, Markmann JF, Sudan DL, Jones CM, Berumen J, Hemming AW, Hong JC, Kim J, Zimmerman MA, Nydam TL, Rana A, Kueht ML, Fishbein TM, Markovic D, Busuttil RW, Agopian VG) Hepatology 2020 Dec;72(6):2014-2028 82 Citations |
| 2 | Gross tumor size using the AJCC 8th ed. T staging criteria does not provide prognostic stratification for neoadjuvant treated pancreatic ductal adenocarcinoma. (Rowan DJ, Hartley CP, Aldakkak M, Christians KK, Evans DB, Tsai S, Hagen CE) Ann Diagn Pathol 2020 Jun;46:151485 5 Citations |
| 1 | Calcium Release-Activated Calcium (CRAC) Channel Inhibition Suppresses Pancreatic Ductal Adenocarcinoma Cell Proliferation and Patient-Derived Tumor Growth. (Khan HY, Mpilla GB, Sexton R, Viswanadha S, Penmetsa KV, Aboukameel A, Diab M, Kamgar M, Al-Hallak MN, Szlaczky M, Tesfaye A, Kim S, Philip PA, Mohammad RM, Azmi AS) Cancers (Basel) 2020 Mar 22;12(3) 28 Citations |
| 1 | Decrease in the Risk of Posttransplant Hepatocellular Carcinoma Recurrence After the Conversion to Prestorage Leukoreduction for Transfused Red Blood Cells. (Kwon JH, Han S, Jang JS, Lee KW, Ahn JH, Kim K, Jeon S, Gwak MS, Ko JS, Kim GS, Joh JW, Cho D) Transplantation 2021 Mar 01;105(3):577-585 8 Citations |
| 1 | Disparities in Pancreatic Ductal Adenocarcinoma-The Significance of Hispanic Ethnicity, Subgroup Analysis, and Treatment Facility on Clinical Outcomes. (Riner AN, Underwood PW, Yang K, Herremans KM, Cameron ME, Chamala S, Qiu P, George TJ, Permuth JB, Merchant NB, Trevino JG) Cancer Med 2020 Jun;9(12):4069-4082 18 Citations |
| 4 | Comparison of overall survival in gallbladder carcinoma at academic versus community cancer centers: An analysis of the National Cancer Data Base. (Liu C, Rein L, Clarke C, Mogal H, Tsai S, Christians KK, Gamblin TC) J Surg Oncol 2020 Aug;122(2):176-182 11 Citations |
| 1 | Identification of Serum miRNA Signature and Establishment of a Nomogram for Risk Stratification in Patients With Pancreatic Ductal Adenocarcinoma. (Kandimalla R, Shimura T, Mallik S, Sonohara F, Tsai S, Evans DB, Kim SC, Baba H, Kodera Y, Von Hoff D, Chen X, Goel A) Ann Surg 2022 Jan 01;275(1):e229-e237 17 Citations |
| 1 | CD105 is a prognostic marker and valid endothelial target for microbubble platforms in cholangiocarcinoma. (Nair A, Ingram N, Verghese ET, Wijetunga I, Markham AF, Wyatt J, Prasad KR, Coletta PL) Cell Oncol (Dordr) 2020 Oct;43(5):835-845 11 Citations |
| 2 | Gross tumor size using the AJCC 8th ed. T staging criteria does not provide prognostic stratification for neoadjuvant treated pancreatic ductal adenocarcinoma (Rowan DJ, Hartley CP, Aldakkak M, Christians KK, Evans DB, Tsai S, Hagen CE) Annals of Diagnostic Pathology June 2020;46 5 Citations |
| 1 | Yttrium-90 Radioembolization and Tumor Hypoxia: Gas-challenge BOLD Imaging in the VX2 Rabbit Model of Hepatocellular Carcinoma. (Gordon AC, White SB, Gates VL, Procissi D, Harris KR, Yang Y, Zhang Z, Li W, Lyu T, Huang X, Omary RA, Salem R, Lewandowski RJ, Larson AC) Acad Radiol 2021 Jun;28(6):849-858 7 Citations |
| 1 | An invited commentary on "Anatomic versus non-anatomic resection for hepatocellular carcinoma, do we have an answer? A meta-analysis" [Int. J. Surg. (2020) Epub ahead of print]: Does liver anatomy matter? (Maduekwe UN, Charles A) Int J Surg 2020 Jul;79:326 2 Citations |
| 1 | A novel hotspot and rare somatic mutation p.A138V, at TP53 is associated with poor survival of pancreatic ductal and periampullary adenocarcinoma patients. (Saha G, Singh R, Mandal A, Das S, Chattopadhyay E, Panja P, Roy P, DeSarkar N, Gulati S, Ghatak S, Ghosh S, Banerjee S, Roy B, Ghosh S, Chaudhuri D, Arora N, Biswas NK, Sikdar N) Mol Med 2020 Jun 17;26(1):59 15 Citations |
| 1 | Reply to "Effective therapy for advanced basal cell carcinoma". (Cohen PR, Kurzrock R) J Am Acad Dermatol 2022 Mar;86(3):e109 2 Citations |
| 1 | Diagnostic utility of high-risk human papillomavirus mRNA in situ hybridisation in squamous cell carcinoma of unknown primary in the head and neck and implementing American Society of Clinical Oncology guideline recommendations. (Daneshpajouhnejad P, Miller JA, Maleki Z) Cytopathology 2020 Nov;31(6):547-554 6 Citations |
| 2 | Analysis of Ugandan cervical carcinomas identifies human papillomavirus clade-specific epigenome and transcriptome landscapes. (Gagliardi A, Porter VL, Zong Z, Bowlby R, Titmuss E, Namirembe C, Griner NB, Petrello H, Bowen J, Chan SK, Culibrk L, Darragh TM, Stoler MH, Wright TC, Gesuwan P, Dyer MA, Ma Y, Mungall KL, Jones SJM, Nakisige C, Novik K, Orem J, Origa M, Gastier-Foster JM, Yarchoan R, Casper C, Mills GB, Rader JS, Ojesina AI, Gerhard DS, Mungall AJ, Marra MA) Nat Genet 2020 Aug;52(8):800-810 45 Citations |
| 1 | Evaluating the efficacy of enzalutamide and the development of resistance in a preclinical mouse model of type-I endometrial carcinoma. (Koivisto CS, Parrish M, Bonala SB, Ngoi S, Torres A, Gallagher J, Sanchez-Hodge R, Zeinner V, Nahhas GJ, Liu B, Cohn DE, Backes FJ, Goodfellow PJ, Chamberlin HM, Leone G) Neoplasia 2020 Oct;22(10):484-496 7 Citations |
| 1 | Hepatocellular carcinoma and the Fontan circulation: Clinical presentation and outcomes. (Possner M, Gordon-Walker T, Egbe AC, Poterucha JT, Warnes CA, Connolly HM, Ginde S, Clift P, Kogon B, Book WM, Walker N, Wagenaar LJ, Moe T, Oechslin E, Kay WA, Norris M, Dillman JR, Trout AT, Anwar N, Hoskoppal A, Broering DC, Bzeizi K, Veldtman G) Int J Cardiol 2021 Jan 01;322:142-148 42 Citations |
| 1 | Diffuse peritoneal carcinomatosis with ascites and disseminated bone marrow carcinomatosis as initial presentation of occult breast cancer. (Patwari A, Bhatlapenumarthi V) Breast J 2020 Nov;26(11):2233-2234 2 Citations |
| 2 | Upper gastrointestinal bleeding due to gastric metastasis of renal cell carcinoma. (Orosz E, Ali MA, Patel AV) Dig Liver Dis 2021 Oct;53(10):1354-1355 3 Citations |
| 1 | Sex-Specific Genetic Associations for Barrett's Esophagus and Esophageal Adenocarcinoma. (Dong J, Maj C, Tsavachidis S, Ostrom QT, Gharahkhani P, Anderson LA, Wu AH, Ye W, Bernstein L, Borisov O, Schröder J, Chow WH, Gammon MD, Liu G, Caldas C, Pharoah PD, Risch HA, May A, Gerges C, Anders M, Venerito M, Schmidt T, Izbicki JR, Hölscher AH, Schumacher B, Vashist Y, Neuhaus H, Rösch T, Knapp M, Krawitz P, Böhmer A, Iyer PG, Reid BJ, Lagergren J, Shaheen NJ, Corley DA, Gockel I, Fitzgerald RC, Stomach and Oesophageal Cancer Study (SOCS) consortium, Cook MB, Whiteman DC, Vaughan TL, Schumacher J, Thrift AP) Gastroenterology 2020 Dec;159(6):2065-2076.e1 18 Citations |
| 1 | Proliferative potential and response to nivolumab in clear cell renal cell carcinoma patients. (Zhang T, Pabla S, Lenzo FL, Conroy JM, Nesline MK, Glenn ST, Papanicolau-Sengos A, Burgher B, Giamo V, Andreas J, Wang Y, Bshara W, Madden KG, Shirai K, Dragnev K, Tafe LJ, Gupta R, Zhu J, Labriola M, McCall S, George DJ, Ghatalia P, Dayyani F, Edwards R, Park MS, Singh R, Jacob R, George S, Xu B, Zibelman M, Kurzrock R, Morrison C) Oncoimmunology 2020 Jun 10;9(1):1773200 12 Citations |
| 1 | Hepatocellular carcinomas can be Special AT-rich sequence-binding protein 2 positive: an important diagnostic pitfall. (Lee W, Li X, Chandan VS) Hum Pathol 2020 Nov;105:47-52 4 Citations |
| 1 | Incidence and significance of GATA3 positivity in gallbladder adenocarcinoma. (Guo W, Lee W, Lu Y, Li X, Chandan VS) Hum Pathol 2020 Dec;106:39-44 5 Citations |
| 1 | A Multi-biomarker Panel Including Delta Radiomics to Predict Distant Metastasis after Chemoradiation Therapy of Pancreatic Adenocarcinoma (H Nasief, WA Hall, C Zheng, S Tsai, BA Erickson, A Li) International Journal of Radiation Oncology, Biology, Physics 108 (3), S83 |
| 1 | Evaluating the efficacy of enzalutamide and the development of resistance in a preclinical mouse model of type-I endometrial carcinoma (Koivisto CS, Parrish M, Bonala SB, Ngoi S, Torres A, Gallagher J, Sanchez-Hodge R, Zeinner V, Nahhas GJ, Liu B, Cohn DE, Backes FJ, Goodfellow PJ, Chamberlin HM, Leone G) Neoplasia (United States) October 2020;22(10):484-496 7 Citations |
| 1 | Translating Biomarkers of Cholangiocarcinoma for Theranosis: A Systematic Review. (Wijetunga I, McVeigh LE, Charalambous A, Antanaviciute A, Carr IM, Nair A, Prasad KR, Ingram N, Coletta PL) Cancers (Basel) 2020 Sep 30;12(10) 5 Citations |
| 1 | Unique Genomic Landscape of High-Grade Neuroendocrine Cervical Carcinoma: Implications for Rethinking Current Treatment Paradigms. (Eskander RN, Elvin J, Gay L, Ross JS, Miller VA, Kurzrock R) JCO Precis Oncol 2020;4 26 Citations |
| 1 | Approach to the Patient with Unknown Primary Squamous Cell Carcinoma of the Head and Neck. (Moy J, Li R) Curr Treat Options Oncol 2020 Oct 06;21(12):93 7 Citations |
| 1 | The impact of HIPEC vs. EPIC for the treatment of mucinous appendiceal carcinoma: a study from the US HIPEC collaborative. (Leiting JL, Day CN, Harmsen WS, Cloyd JM, Abdel-Misih S, Fournier K, Lee AJ, Dineen S, Dessureault S, Veerapongh J, Baumgartner JM, Clarke C, Mogal H, Russell MC, Zaidi MY, Patel SH, Morris MC, Hendrix RJ, Lambert LA, Abbott DE, Pokrzywa C, Raoof M, Eng O, Johnston FM, Greer J, Grotz TE) Int J Hyperthermia 2020;37(1):1182-1188 7 Citations |
| 1 | Outcomes With First-Line PD-1/PD-L1 Inhibitor Monotherapy for Metastatic Renal Cell Carcinoma (mRCC): A Multi-Institutional Cohort (Barata P, Hatton W, Desai A, Koshkin V, Jaeger E, Manogue C, Cotogno P, Light M, Lewis B, Layton J, Sartor O, Basu A, Kilari D, Emamekhoo H, Bilen MA) Frontiers in Oncology 22 October 2020;10 12 Citations |
| 1 | Development and Validation of a Genomic Tool to Predict Seminal Vesicle Invasion in Adenocarcinoma of the Prostate. (Hall WA, Fishbane N, Liu Y, Xu MJ, Davicioni E, Mahal BA, Den RB, Dess RT, Jackson WC, Wong AC, Schaeffer EM, Karnes RJ, Carroll PR, Cooperberg MR, Bismar TA, Kim HL, Klein EA, Davis JW, Ross AE, Tosoian JJ, Morgan TM, Mehra R, Salami SS, Nguyen PL, Lawton CAF, Spratt DE, Feng F) JCO Precis Oncol 2020 Nov;4:1228-1238 4 Citations |
| 1 | Outcomes With First-Line PD-1/PD-L1 Inhibitor Monotherapy for Metastatic Renal Cell Carcinoma (mRCC): A Multi-Institutional Cohort. (Barata P, Hatton W, Desai A, Koshkin V, Jaeger E, Manogue C, Cotogno P, Light M, Lewis B, Layton J, Sartor O, Basu A, Kilari D, Emamekhoo H, Bilen MA) Front Oncol 2020;10:581189 12 Citations |
| 1 | BAP1-Mutated Clear Cell Renal Cell Carcinoma. (Gallan AJ, Parilla M, Segal J, Ritterhouse L, Antic T) Am J Clin Pathol 2021 Apr 26;155(5):718-728 40 Citations |
| 1 | Dual Checkpoint Blockade in a Neuroendocrine Carcinoma With Dual PD-L1/PD-L2 Amplification and High Tumor Mutational Burden. (Gong J, Patel S, Adashek JJ, Frishberg D, Guan M, Placencio-Hickok VR, Gangi A, Gresham G, Tuli R, Chae YK, Kurzrock R, Hendifar AE) JCO Precis Oncol 2020;4 1 Citation |
| 1 | Evaluation of Medium-Term Efficacy of Y90 Radiation Segmentectomy vs Percutaneous Microwave Ablation in Patients with Solitary Surgically Unresectable < 4 cm Hepatocellular Carcinoma: A Propensity Score Matched Study. (Arndt L, Villalobos A, Wagstaff W, Cheng B, Xing M, Ermentrout RM, Bercu Z, Cristescu M, Shah A, Wedd J, Majdalany BS, Magliocca JF, Sellers MT, Kokabi N) Cardiovasc Intervent Radiol 2021 Mar;44(3):401-413 15 Citations |
| 1 | Metastatic lobular carcinoma with signet-ring cells mimicking primary gastric signet-ring cell carcinoma (Michael K. Rooney, Wajeeha Rasool, Zain Rahman, Kaitlin W. Qualls, Alisha
Sharma, Randa Sharag Eldin, Nur Nabil, Solab Chitrakar, Dorota Filipiuk) Current Problems in Cancer: Case Reports |
| 1 | Multi-Center Analysis of Liver Transplantation for Combined Hepatocellular Carcinoma-Cholangiocarcinoma Liver Tumors. (Dageforde LA, Vachharajani N, Tabrizian P, Agopian V, Halazun K, Maynard E, Croome K, Nagorney D, Hong JC, Lee D, Ferrone C, Baker E, Jarnagin W, Hemming A, Schnickel G, Kimura S, Busuttil R, Lindemann J, Florman S, Holzner ML, Srouji R, Najjar M, Yohanathan L, Cheng J, Amin H, Rickert CA, Yang JD, Kim J, Pasko J, Chapman WC, Majella Doyle MB) J Am Coll Surg 2021 Apr;232(4):361-371 21 Citations |
| 2 | Early Bone Metastases are Associated with Worse Outcomes in Metastatic Urothelial Carcinoma (Nelson AA, Cronk RJ, Lemke EA, Szabo A, Khaki AR, Diamantopoulos LN, Grivas P, Nezami BG, MacLennan GT, Zhang T, Hoimes CJ) Bladder Cancer 2021;7(1):33-42 6 Citations |
| 1 | A New Prognostic Model in Patients with Advanced Urothelial Carcinoma Treated with First-line Immune Checkpoint Inhibitors. (Khaki AR, Li A, Diamantopoulos LN, Miller NJ, Carril-Ajuria L, Castellano D, De Kouchkovsky I, Koshkin V, Park J, Alva A, Bilen MA, Stewart T, Santos V, Agarwal N, Jain J, Zakharia Y, Morales-Barrera R, Devitt M, Nelson A, Hoimes CJ, Shreck E, Gartrell BA, Sankin A, Tripathi A, Zakopoulou R, Bamias A, Rodriguez-Vida A, Drakaki A, Liu S, Kumar V, Lythgoe MP, Pinato DJ, Murgic J, Fröbe A, Joshi M, Isaacsson Velho P, Hahn N, Alonso Buznego L, Duran I, Moses M, Barata P, Galsky MD, Sonpavde G, Yu EY, Shankaran V, Lyman GH, Grivas P) Eur Urol Oncol 2021 Jun;4(3):464-472 47 Citations |
| 1 | Primary pulmonary mucoepidermoid carcinoma: Cyto-histologic correlation and review of the literature. (Puzyrenko A, Shponka V, Sheinin Y, Giorgadze T, Nomani L) Ann Diagn Pathol 2021 Apr;51:151698 4 Citations |
| 1 | Atypical Cells in Peritoneal Cleft: A Pitfall in Diagnosis of Colorectal Adenocarcinoma. (Lee W, Chandan VS, Johnson C, Li X) Int J Surg Pathol 2021 Aug;29(5):506-509 |
| 1 | Association of total neoadjuvant therapy with favorable clinical outcomes in patients with locally advanced esophageal and gastroesophageal junction adenocarcinomas (LA-GEJ CA). (L Jurkowski, AV Shreenivas, S Chakrabarti, M Kamgar, JP Thomas,L Puckett, MShukla, E Gore, J Evans, CA Johnstone, M Gasparri, P Linsky, D Johnstone, K Dua, AH Khan, S Madhavan, A Szabo, B George) ournal of Clinical Oncology 39 (3_suppl), 231-231 |
| 1 | Foreign Body Granuloma Induced by Submucosal Lifting Agent Mimicking Adenoma or Colorectal Carcinoma (Ali, MD, M., Maloney-Patel, MD, N., & Zhou, MD, PhD) North American Journal of Medicine and Science Ali, MD, M., Maloney-Patel, MD, N., & Zhou, MD, PhD*, Z. (2021). Foreign Body Granuloma Induced by Submucosal Lifting Agent Mimicking Adenoma or Colorectal Carcinoma. North American Journal of Medicine and Science, 14(1). Retrieved from https://www.najms.com/index.php/najms/article/view/543 |
| 1 | Nasogastric tube feeding after transoral robotic surgery for oropharynx carcinoma. (Plonowska KA, Ochoa E, Zebolsky AL, Patel N, Hoppe KR, Ha PK, Heaton CM, Ryan WR) Am J Otolaryngol 2021;42(3):102857 6 Citations |
| 2 | Xanthomatous Dermal Changes in a Patient With Locally Advanced Basal Cell Carcinoma Treated Using Vismodegib. (Smith SDB, Clarke CN, Clark MA, Harker-Murray AK, Sokumbi O) Am J Dermatopathol 2021 Aug 01;43(8):585-587 1 Citation |
| 1 | Immune checkpoint inhibitors in advanced upper and lower tract urothelial carcinoma: a comparison of outcomes. (Esagian SM, Khaki AR, Diamantopoulos LN, Carril-Ajuria L, Castellano D, De Kouchkovsky I, Park JJ, Alva A, Bilen MA, Stewart TF, McKay RR, Santos VS, Agarwal N, Jain J, Zakharia Y, Morales-Barrera R, Devitt ME, Nelson A, Hoimes CJ, Shreck E, Gartrell BA, Sankin A, Tripathi A, Zakopoulou R, Bamias A, Rodriguez-Vida A, Drakaki A, Liu S, Kumar V, Lythgoe MP, Pinato DJ, Murgic J, Fröbe A, Joshi M, Isaacsson Velho P, Hahn N, Alonso Buznego L, Duran I, Moses M, Barata P, Galsky MD, Sonpavde G, Yu EY, Msaouel P, Koshkin VS, Grivas P) BJU Int 2021 Aug;128(2):196-205 23 Citations |
| 1 | Cumulative GRAS Score as a Predictor of Survival After Resection for Adrenocortical Carcinoma: Analysis From the U.S. Adrenocortical Carcinoma Database. (Baechle JJ, Marincola Smith P, Solórzano CC, Tran TB, Postlewait LM, Maithel SK, Prescott J, Pawlik T, Wang TS, Glenn J, Hatzaras I, Shenoy R, Phay JE, Shirley LA, Fields RC, Jin L, Abbott DE, Ronnekleiv-Kelly S, Sicklick JK, Yopp A, Mansour J, Duh QY, Seiser N, Votanopoulos K, Levine EA, Poultsides G, Kiernan CM) Ann Surg Oncol 2021 Oct;28(11):6551-6561 11 Citations |
| 1 | Cutaneous Metastatic Cancer: Carcinoma Hemorrhagiectoides Presenting as the Shield Sign. (Cohen PR, Kurzrock R) Cureus 2021 Jan 11;13(1):e12627 |
| 2 | The Utility of Preoperative Tumor Markers in Peritoneal Carcinomatosis from Primary Appendiceal Adenocarcinoma: an Analysis from the US HIPEC Collaborative. (Fackche N, Schmocker RK, Kubi B, Cloyd JM, Ahmed A, Grotz T, Leiting J, Fournier K, Lee AJ, Powers B, Dineen S, Veerapong J, Baumgartner JM, Clarke C, Gamblin TC, Patel SH, Dhar V, Hendrix RJ, Lambert L, Abbott DE, Pokrzywa C, Lafaro K, Lee B, Zaidi MY, Maithel SK, Johnston FM, Greer JB) J Gastrointest Surg 2021 Nov;25(11):2908-2919 7 Citations |
| 1 | Management of periocular cutaneous squamous cell carcinoma with perineural invasion: a case series and literature review. (Clark TJE, Harris GJ) Orbit 2022 Feb;41(1):34-43 4 Citations |
| 2 | Early Bone Metastases are Associated with Worse Outcomes in Metastatic Urothelial Carcinoma. (Nelson AA, Cronk RJ, Lemke EA, Szabo A, Khaki AR, Diamantopoulos LN, Grivas P, Nezami BG, MacLennan GT, Zhang T, Hoimes CJ) Bladder Cancer 2021;7(1):33-42 6 Citations |
| 1 | Early Bone Metastases are Associated with Worse Outcomes in Metastatic Urothelial Carcinoma (Nelson, Ariel A.; Cronk, Robert J.; Lemke, Emily A.; Szabo, Aniko; Khaki, Ali R., Diamantopoulos, Leonidas N.; Grivas, Petros; Nezami, Behtash Ghazi; MacLennan, Gregory T.;Zhang, Tian; Hoimes, Christopher J.) Bladder Cancer |
| 2 | Prognostic Outcomes of Signet Ring Cell Carcinoma of the Breast. (Mehdi M, Kong AL, Frebault J, Huang S, Huang CC, Cortina CS) J Surg Res 2021 Aug;264:138-148 7 Citations |
| 9 | Long-Term Outcomes of Dose-Escalated Pelvic Lymph Node Intensity-Modulated Radiation Therapy (IMRT) With a Simultaneous Hypofractionated Boost to the Prostate for Very High-Risk Adenocarcinoma of the Prostate: A Prospective Phase II Clinical Trial. (Hall WA, Bedi M, Kilari D, Bylow KA, Burfeind J, Johnstone C, Siker M, Currey A, See WA, Nelson A, Johnson S, Straza M, Lawton CAF) Pract Radiat Oncol 2021;11(6):527-533 4 Citations |
| 1 | A proposal to modify the 8th edition of the UICC staging system for pancreatic adenocarcinoma. (Matsumoto T, Okabayashi T, Sui K, Kimura J, Morita S, Iwata J, Iiyama T, Kubota K, Shimada Y) Langenbecks Arch Surg 2021 May;406(3):667-677 2 Citations |
| 2 | Metabolomic profiling of pancreatic adenocarcinoma reveals key features driving clinical outcome and drug resistance. (Kaoutari AE, Fraunhoffer NA, Hoare O, Teyssedou C, Soubeyran P, Gayet O, Roques J, Lomberk G, Urrutia R, Dusetti N, Iovanna J) EBioMedicine 2021 Apr;66:103332 28 Citations |
| 1 | Identification of a new TRAF6 inhibitor for the treatment of hepatocellular carcinoma. (Li N, Luo L, Wei J, Liu Y, Haque N, Huang H, Qi Y, Huang Z) Int J Biol Macromol 2021 Jul 01;182:910-920 10 Citations |
| 1 | Blood Salvage and Autotransfusion With Single Leukoreduction Does Not Increase the Risk of Tumor Recurrence After Liver Transplantation for Advanced Hepatocellular Carcinoma. (Kwon JH, Han S, Kim D, Kuk JH, Cho H, Kim S, Yang JD, Kim C, Kim JM, Choi GS, Joh JW, Ko JS, Gwak MS, Kim G) Ann Surg 2022 Dec 01;276(6):e842-e850 12 Citations |
| 1 | Metastatic renal cell carcinoma complicated by right atrial thrombus. (Jeelani HMA, Sheikh MM, Riaz A, Jain N, Tahir N, Ehsan H, Vemireddy L) Clin Case Rep 2021 Apr;9(4):2332-2335 2 Citations |
| 1 | The role of age in treatment decisions for oral cavity squamous cell carcinoma: Analysis of the National Cancer Database. (Barrett TF, Mazul AL, Stepan KO, Wood CB, Paniello RC, Zevallos JP, Massa S, Jackson RS, Schmitt NC, Zenga J, Kang SY, Pipkorn P, Rich JT, Puram SV) Oral Oncol 2021 Jul;118:105330 6 Citations |
| 1 | Impact of KRAS alterations in pancreatic ductal adenocarcinoma (PDAC). (M Mehdi, M Kamgar, B George, A Szabo, K Annunzio, BW Taylor, AV Shreenivas, S Chakrabarti, JP Thomas, S Tsai, KK Christians, DB Evans, C Clarke, WA Hall, B Erickson, G Ahmed, B Thapa) Journal of Clinical Oncology 39 (15_suppl), 4136-4136 |
| 1 | Clinical outcomes in pancreatic ductal adenocarcinoma (PDAC) patients with underlying autoimmune disease (AID). (G Ahmed, K Annunzio, A Szabo, D Eastwood, B Thapa, BW Taylor, S Tsai, KK Christians, C Clarke, DB Evans, WAdrian Hall, B Erickson, M Kamgar, B George) Journal of Clinical Oncology 39 (15_suppl), e16233-e16233 |
| 3 | Magnetic Resonance Guided Radiation Therapy for Pancreatic Adenocarcinoma, Advantages, Challenges, Current Approaches, and Future Directions. (Hall WA, Small C, Paulson E, Koay EJ, Crane C, Intven M, Daamen LA, Meijer GJ, Heerkens HD, Bassetti M, Rosenberg SA, Aitken K, Myrehaug S, Dawson LA, Lee P, Gani C, Chuong MD, Parikh PJ, Erickson BA) Front Oncol 2021;11:628155 28 Citations |
| 3 | Tumor Control Probability Modeling for Radiation Therapy of Keratinocyte Carcinoma. (Prior P, Awan MJ, Wilson JF, Li XA) Front Oncol 2021;11:621641 4 Citations |
| 1 | Comparative Genomic Analysis of Intrahepatic Cholangiocarcinoma: Biopsy Type, Ancestry, and Testing Patterns. (Israel MA, Danziger N, McGregor KA, Murugesan K, Gjoerup O, Sokol ES, Tukachinsky H, Kurzrock R, Kato S, Sicklick JK, Nimeiri HS, Oxnard GR, Ross JS) Oncologist 2021 Sep;26(9):787-796 31 Citations |
| 1 | Mixed High-Grade Neuroendocrine Carcinoma with Villous Adenoma in the Duodenum: A First Case Report (Ali, MD, M., Kahaleh, MD, M., & Zhou, MD, PhD) North American Journal of Medicine and Science Ali, MD, M., Kahaleh, MD, M., & Zhou, MD, PhD*, Z. (2021). Mixed High-Grade Neuroendocrine Carcinoma with Villous Adenoma in the Duodenum: A First Case Report. North American Journal of Medicine and Science, 14(1). Retrieved from https://najms.com/index.php/najms/article/view/544 |
| 1 | Synchronous Metastatic Clear Cell Renal Cell Carcinoma to the Gallbladder With Metachronous Contralateral Recurrence. (Pierce DP, Dahmen AS, Hernandez DJ) Cureus 2021 May 13;13(5):e15007 |
| 1 | Surgical Eligibility Does Not Imply Surgical Equity: Recommendations for Curative Treatment in Patients With Stage I/II Pancreatic Head Adenocarcinoma Differ by Age and Race. (Hester CA, Kothari AN, Mason M, Maxwell J, Ikoma N, Kim MP, Tzeng CD, Lee JE, Katz MHG, Cao HST) Ann Surg 2023 Feb 01;277(2):321-328 5 Citations |
| 1 | Dissection of PIK3CA Aberration for Cervical Adenocarcinoma Outcomes. (Chung TKH, Doran G, Cheung TH, Yim SF, Yu MY, Worley MJ Jr, Elias KM, Thorner AR, Pedamallu CS, Ojesina AI, Lau KM, Ducar MD, Wong RRY, Wang VW, Nag A, Wollison BM, Dalgarno A, Lee JHS, Yeung SY, Wong L, Horowitz NS, Davis MR, Leung SA, Mu Y, Mok SC, Chan PKS, Lawrence MS, Crum CP, Chiu RWK, Berkowitz RS, Wong YF) Cancers (Basel) 2021 Jun 28;13(13) 4 Citations |
| 1 | Immune checkpoint inhibitors in advanced upper and lower tract urothelial carcinoma: a comparison of outcomes (Esagian SM, Khaki AR, Diamantopoulos LN, Carril-Ajuria L, Castellano D, De Kouchkovsky I, Park JJ, Alva A, Bilen MA, Stewart TF, McKay RR, Santos VS, Agarwal N, Jain J, Zakharia Y, Morales-Barrera R, Devitt ME, Nelson A, Hoimes CJ, Shreck E, Gartrell BA, Sankin A, Tripathi A, Zakopoulou R, Bamias A, Rodriguez-Vida A, Drakaki A, Liu S, Kumar V, Lythgoe MP, Pinato DJ, Murgic J, Fröbe A, Joshi M, Isaacsson Velho P, Hahn N, Alonso Buznego L, Duran I, Moses M, Barata P, Galsky MD, Sonpavde G, Yu EY, Msaouel P, Koshkin VS, Grivas P) BJU International August 2021;128(2):196-205 23 Citations |
| 1 | Predictors of Successful Yttrium-90 Radioembolization Bridging or Downstaging in Patients with Hepatocellular Carcinoma. (Villalobos A, Wagstaff W, Guo M, Zhang J, Bercu Z, Whitmore MJ, Cristescu MM, Majdalany BS, Wedd J, Akce M, Magliocca J, Kokabi N) Can J Gastroenterol Hepatol 2021;2021:9926704 6 Citations |
| 2 | Paraneoplastic pemphigus secondary to neuroendocrine carcinoma. (Yee MD, Seline A, Young K, Wanat KA) JAAD Case Rep 2021 Sep;15:22-25 |
| 1 | Paraneoplastic pemphigus secondary to neuroendocrine carcinoma (Yee MD, Seline A, Young K, Wanat KA) JAAD Case Reports September 2021;15:22-25 |
| 1 | Outcomes of MR-guided stereotactic radiotherapy (SBRT) or yttrium-90 transarterial radioembolization for hepatocellular carcinoma treated at an urban liver transplant center.” (Liang E, Greer G, Burmeister C, Massa P, Dragovic J, Parikh P) |
| 1 | Recurrence of primary mucosal head and neck squamous cell carcinoma in solid organ transplant recipients.” (Gilbert M, Liang E, Siddiqui F. ) |
| 1 | Consensus-Based Recommendations on the Prevention of Squamous Cell Carcinoma in Solid Organ Transplant Recipients: A Delphi Consensus Statement. (Massey PR, Schmults CD, Li SJ, Arron ST, Asgari MM, Bouwes Bavinck JN, Billingsley E, Blalock TW, Blasdale K, Carroll BT, Carucci JA, Chong AH, Christensen SR, Chung CL, DeSimone JA, Ducroux E, Escutia-Muñoz B, Ferrándiz-Pulido C, Fox MC, Genders RE, Geusau A, Gjersvik P, Hanlon AM, Olasz Harken EB, Hofbauer GFL, Hopkins RS, Leitenberger JJ, Loss MJ, Del Marmol V, Mascaró JM Jr, Myers SA, Nguyen BT, Oliveira WRP, Otley CC, Proby CM, Rácz E, Ruiz-Salas V, Samie FH, Seçkin D, Shah SN, Shin TM, Shumack SP, Soon SL, Stasko T, Zavattaro E, Zeitouni NC, Zwald FO, Harwood CA, Jambusaria-Pahlajani A) JAMA Dermatol 2021 Oct 01;157(10):1219-1226 31 Citations |
| 2 | Evolution of Systemic Therapy in Metastatic Pancreatic Ductal Adenocarcinoma. (Kamgar M, Chakrabarti S, Shreenivas A, George B) Surg Oncol Clin N Am 2021 Oct;30(4):673-691 2 Citations |
| 2 | Pancreatic ductal adenocarcinomas associated with intraductal papillary mucinous neoplasms (IPMNs) versus pseudo-IPMNs: relative frequency, clinicopathologic characteristics and differential diagnosis. (Muraki T, Jang KT, Reid MD, Pehlivanoglu B, Memis B, Basturk O, Mittal P, Kooby D, Maithel SK, Sarmiento JM, Christians K, Tsai S, Evans D, Adsay V) Mod Pathol 2022 Jan;35(1):96-105 20 Citations |
| 1 | Genomic Characterization and Therapeutic Targeting of HPV Undetected Cervical Carcinomas. (Ruiz FJ, Sundaresan A, Zhang J, Pedamallu CS, Halle MK, Srinivasasainagendra V, Zhang J, Muhammad N, Stanley J, Markovina S, Tiwari HK, Grigsby PW, Krakstad C, Schwarz JK, Ojesina AI) Cancers (Basel) 2021 Sep 10;13(18) 19 Citations |
| 1 | 90-day hospitalization as a surrogate for overall survival in hepatocellular carcinoma (HCC) patients treated with magnetic resonance-guided liver stereotactic body radiation therapy: results of a single-center retrospective study”. (Liang E, Kirsch C, Gardey V, Burmeister C, Dragovic J, Parikh P) |
| 1 | Evolution of Systemic Therapy in Metastatic Pancreatic Ductal Adenocarcinoma (Kamgar M, Chakrabarti S, Shreenivas A, George B) Surgical Oncology Clinics of North America October 2021;30(4):673-691 2 Citations |
| 1 | Risk factors and survival outcomes for upstaging after inguinal lymph node dissection for cN1 penile squamous cell carcinoma. (Chakiryan NH, Dahmen A, Bandini M, Pederzoli F, Marandino L, Albersen M, Roussel E, Zhu Y, Ye DW, Ornellas AA, Catanzaro M, Hakenberg OW, Heidenreich A, Haidl F, Watkin N, Ager M, Briganti A, Salvioni R, Montorsi F, Necchi A, Spiess PE) Urol Oncol 2021 Dec;39(12):838.e7-838.e13 7 Citations |
| 7 | Updates and new directions in the use of radiation therapy for the treatment of pancreatic adenocarcinoma: dose, sensitization, and novel technology. (Hall WA, Kamgar M, Erickson BA, Ponce SB, Tsai S, Nevalainen MT, Christians KK, George B, Dua KS, Khan AH, Evans DB, Azmi AS) Cancer Metastasis Rev 2021 Sep;40(3):879-889 2 Citations |
| 1 | Genomic alterations associated with mutational signatures, DNA damage repair and chromatin remodeling pathways in cervical carcinoma. (Halle MK, Sundaresan A, Zhang J, Pedamallu CS, Srinivasasainagendra V, Blair J, Brooke D, Bertelsen BI, Woie K, Shrestha S, Tiwari H, Wong YF, Krakstad C, Ojesina AI) NPJ Genom Med 2021 Oct 07;6(1):82 17 Citations |
| 3 | Value of Neoadjuvant Radiation Therapy in the Management of Pancreatic Adenocarcinoma. (Hall WA, Dawson LA, Hong TS, Palta M, Herman JM, Evans DB, Tsai S, Ferrone CR, B Fleming J, Chang DT, Crane C, Koong AC, Oar A, Parikh P, Erickson B, Hoffe S, Goodman KA) J Clin Oncol 2021 Dec 01;39(34):3773-3777 23 Citations |
| 1 | Impact of tumor histology and socioeconomic factors on survival of patients suffering from malignant vascular tumors of liver and hepatocellular carcinomas: A SEER database analysis. (AV Shreenivas, GSG Murthy, B George, JP Thomas, S Chakrabarti, M Kamgar, PS Ritch) J Clin Oncol 38: 2020 (suppl; abstr e16612), 2020 ASCO Scientific Program, Online Publication; Virtual, May 2020 |
| 1 | Comprehensive genomic profiling in metastatic pancreatic adenocarcinoma, correlation with early death versus prolonged survival. (M Kamgar, G Dyson, AF Shields, AA Tesfaye, PA Philip, MN Al-Hallak) J Clin Oncol 37, 2019 (suppl 4; abstr 282), ASCO Gastrointestinal Cancer symposium, Poster Presentation; Saf Francisco, January 2019 |
| 1 | Comparison of fluoropyrimidine based (FP)and taxane based platinum doublets (TP) in frontline treatment of patients with metastatic gastroesophageal adenocarcinomas (mGEAC): A retrospective analysis. (H Ismail, A Mohamed, Y Song, N Abdallah, M Surapaneni, S Kim, M Kamgar, J Mettu, A Akhras, A Ahmed, PA Philip, AF Shields, AA Tesfaye) J Clin Oncol 35, 2017 (suppl; abstr e15604), AACO Annual Meeting, Online Publication; Chicago, June 2017 |
| 1 | The Association of Real-World CA 19-9 Level Monitoring Patterns and Clinical Outcomes Among Patients With Metastatic Pancreatic Ductal Adenocarcinoma. (George B, Kent M, Surinach A, Lamarre N, Cockrum P) Front Oncol 2021;11:754687 9 Citations |
| 1 | Germline Pathogenic Variants in Cancer Predisposition Genes Among Women With Invasive Lobular Carcinoma of the Breast. (Yadav S, Hu C, Nathanson KL, Weitzel JN, Goldgar DE, Kraft P, Gnanaolivu RD, Na J, Huang H, Boddicker NJ, Larson N, Gao C, Yao S, Weinberg C, Vachon CM, Trentham-Dietz A, Taylor JA, Sandler DR, Patel A, Palmer JR, Olson JE, Neuhausen S, Martinez E, Lindstrom S, Lacey JV, Kurian AW, John EM, Haiman C, Bernstein L, Auer PW, Anton-Culver H, Ambrosone CB, Karam R, Chao E, Yussuf A, Pesaran T, Dolinsky JS, Hart SN, LaDuca H, Polley EC, Domchek SM, Couch FJ) J Clin Oncol 2021 Dec 10;39(35):3918-3926 32 Citations |
| 1 | Examination for the Presence of an Oligo-Metastatic State in Patients with Newly Diagnosed Metastatic Pancreatic Adenocarcinoma Undergoing Systemic Chemotherapy. (Ortiz S, Visotcky A, Banerjee A, Aldakkak M, Tsai S, Evans DB, Christians K, Clarke CN, George B, Shreenivas A, Kamgar M, Chakrabarti S, Dua KS, Khan AH, Erickson BA, Hall WA) Int J Radiat Oncol Biol Phys 2021 Nov 01;111(3S):e66-e67 |
| 1 | Therapeutic Actionability of Circulating Cell-Free DNA Alterations in Carcinoma of Unknown Primary. (Kato S, Weipert C, Gumas S, Okamura R, Lee S, Sicklick JK, Saam J, Kurzrock R) JCO Precis Oncol 2021;5 |
| 1 | Enhanced metastatic risk assessment in cutaneous squamous cell carcinoma with the 40-gene expression profile test. (Ibrahim SF, Kasprzak JM, Hall MA, Fitzgerald AL, Siegel JJ, Kurley SJ, Covington KR, Goldberg MS, Farberg AS, Trotter SC, Reed K, Brodland DG, Koyfman SA, Somani AK, Arron ST, Wysong A) Future Oncol 2022 Mar;18(7):833-847 27 Citations |
| 1 | Adrenocorticotropic Hormone Secreting Pituitary Carcinoma: Rare, Durable Response to Concurrent Chemotherapy and Reirradiation With a Review of the Literature. (Orr M, Findling J, Zwagerman N, Connelly J, Albano K, Bovi J) Adv Radiat Oncol 2022;7(2):100813 1 Citation |
| 1 | Patterns of Adjuvant Chemotherapy Use and Association With Survival in Adults 80 Years and Older With Pancreatic Adenocarcinoma. (Mehtsun WT, McCleary NJ, Maduekwe UN, Wolpin BM, Schrag D, Wang J) JAMA Oncol 2022 Jan 01;8(1):88-95 16 Citations |
| 1 | Hepatocellular Carcinoma Cells Are Protected From Immunolysis by Mesenchymal Stromal Cells Through Indoleamine 2,3 Dioxygenase. (Chinnadurai R, Porter AP, Patel M, Lipat AJ, Forsberg MH, Rajan D, Hematti P, Capitini CM, Bruker C) Front Cell Dev Biol 2021;9:715905 6 Citations |
| 1 | A Rare Finding of Gastric Metastasis From Tonsillar Squamous Cell Carcinoma (Patel AV, Ali MA) Gastro Hep Advances January 2022;1(5):714-715 |
| 1 | Predictors of survival following liver transplantation for pediatric hepatoblastoma and hepatocellular carcinoma: Experience from the Society of Pediatric Liver Transplantation (SPLIT). (Boster JM, Superina R, Mazariegos GV, Tiao GM, Roach JP, Lovell MA, Greffe BS, Yanni G, Leung DH, Elisofon SA, McDiarmid SV, Gupta NA, Lobritto SJ, Lemoine C, Stoll JM, Vitola BE, Daniel JF, Sayed BA, Desai DM, Martin AE, Amin A, Anand R, Anderson SG, Sundaram SS) Am J Transplant 2022 May;22(5):1396-1408 28 Citations |
| 1 | NF2-mutated Renal Carcinomas Have Common Morphologic Features Which Overlap With Biphasic Hyalinizing Psammomatous Renal Cell Carcinoma: A Comprehensive Study of 14 Cases. (Paintal A, Tjota MY, Wang P, Fitzpatrick C, Wanjari P, Stadler WM, Gallan AJ, Segal J, Antic T) Am J Surg Pathol 2022 May 01;46(5):617-627 18 Citations |
| 1 | Analogs of the Heat Shock Protein 70 Inhibitor MKT-077 Suppress Medullary Thyroid Carcinoma Cells (Seung-Keun Hong, Dmytro Starenki, Oleta T Johnson, Jason E Gestwicki, Jong-In Park) International Journal of Molecular Sciences |
| 3 | Undifferentiated carcinoma with osteoclast-like giant cells: A pathologic-radiologic correlation of a rare histologic subtype of pancreatic ductal adenocarcinoma. (Jain PV, Griffin M, Hunt B, Ward E, Tsai S, Doucette S) Ann Diagn Pathol 2022 Apr;57:151884 3 Citations |
| 2 | Keratin 7 and ERBB2 Negative Mammary Paget Disease Without an Underlying in Situ and Invasive Carcinoma. (Ratiani M, Farooq A, Jorns J, Sheinin Y) Int J Surg Pathol 2022 Aug;30(5):590-592 1 Citation |
| 1 | Palliative radiation for bone metastases from hepatocellular carcinoma: practice patterns and the amount of remaining life spent receiving treatment. (Schmid RK, Johnstone CA, Robbins JR) Ann Palliat Med 2022 Jun;11(6):1900-1910 2 Citations |
| 1 | Gene expression profiling for metastatic risk in head and neck cutaneous squamous cell carcinoma. (Arron ST, Wysong A, Hall MA, Bailey CN, Covington KR, Kurley SJ, Goldberg MS, Kasprzak JM, Somani AK, Ibrahim SF, Brodland DG, Cleaver NJ, Maher IA, Xia Y, Koyfman SA, Newman JG) Laryngoscope Investig Otolaryngol 2022 Feb;7(1):135-144 9 Citations |
| 1 | Analogs of the Heat Shock Protein 70 Inhibitor MKT-077 Suppress Medullary Thyroid Carcinoma Cells. (Hong SK, Starenki D, Johnson OT, Gestwicki JE, Park JI) Int J Mol Sci 2022 Jan 19;23(3) 12 Citations |
| 1 | Non-phosphorylatable cyclin D1 mutant potentiates endometrial hyperplasia and drives carcinoma with Pten loss. (Yoshida A, Phillips-Mason P, Tarallo V, Avril S, Koivisto C, Leone G, Diehl JA) Oncogene 2022 Apr;41(15):2187-2195 5 Citations |
| 3 | Adrenocorticotropic Hormone Secreting Pituitary Carcinoma: Rare, Durable Response to Concurrent Chemotherapy and Reirradiation With a Review of the Literature (Orr M, Findling J, Zwagerman N, Connelly J, Albano K, Bovi J) Advances in Radiation Oncology 1 March 2022;7(2) 1 Citation |
| 2 | New Challenges in the Differential Diagnosis of High-Grade Triple-Negative Breast Cancer and Serous Carcinoma. (Puzyrenko A, Cortina CS, Jorns JM) Int J Surg Pathol 2022 Oct;30(7):728-733 1 Citation |
| 1 | Concurrent Inhibition of ERK and Farnesyltransferase Suppresses the Growth of HRAS Mutant Head and Neck Squamous Cell Carcinoma. (Javaid S, Schaefer A, Goodwin CM, Nguyen VV, Massey FL, Pierobon M, Gambrell-Sanders D, Waters AM, Lambert KN, Diehl JN, Hobbs GA, Wood KC, Petricoin EF, Der CJ, Cox AD) Mol Cancer Ther 2022 May 04;21(5):762-774 12 Citations |
| 1 | Photodynamic therapy for treatment of recurrent adenocarcinoma of the lung with tracheal oligometastasis. (Singh H, Benn BS, Jani C, Abdalla M, Kurman JS) Respir Med Case Rep 2022;37:101620 1 Citation |
| 1 | Adherence to Surveillance Endoscopies Posteradication of Barrett's Esophagus With High-grade Dysplasia or Carcinoma In Situ. (Um PS, Chan MQ, Hinton A, Haisley K, Perry KA, Balasubramanian G) J Clin Gastroenterol 2023 May-Jun 01;57(5):459-465 1 Citation |
| 1 | A Rare Finding of Gastric Metastasis From Tonsillar Squamous Cell Carcinoma. (Patel AV, Ali MA) Gastro Hep Adv 2022;1(5):714-715 |
| 1 | Clinicopathological Features and Surgical Outcomes of Small Bowel Metastasis from Renal Cell Carcinoma. (Kimura J, Okabayashi T, Sui K, Tabuchi M, Iwata J, Hata Y, Iiyama T, Ono N) Acta Med Okayama 2022 Apr;76(2):155-165 |
| 1 | Intraoperative Pancreatic Neck Margin Assessment During Pancreaticoduodenectomy for Pancreatic Adenocarcinoma in the Era of Neoadjuvant Therapy: A Multi-institutional Analysis from the Central Pancreatic Consortium. (Kelly KN, Macedo FI, Seaton M, Wilson G, Hammill C, Martin RC, Maduekwe UN, Kim HJ, Maithel SK, Abbott DE, Ahmad SA, Kooby DA, Merchant NB, Datta J) Ann Surg Oncol 2022 Sep;29(9):6004-6012 5 Citations |
| 1 | Baicalein: A review on its anti-cancer effects and mechanisms in lung carcinoma. (Chandrashekar N, Pandi A) J Food Biochem 2022 Sep;46(9):e14230 30 Citations |
| 1 | Comparison of Hepatic Arterial Infusion Pump Chemotherapy vs Resection for Patients With Multifocal Intrahepatic Cholangiocarcinoma. (Franssen S, Soares KC, Jolissaint JS, Tsilimigras DI, Buettner S, Alexandrescu S, Marques H, Lamelas J, Aldrighetti L, Gamblin TC, Maithel SK, Pulitano C, Margonis GA, Weiss MJ, Bauer TW, Shen F, Poultsides GA, Marsh JW, Cercek A, Kemeny N, Kingham TP, D'Angelica M, Pawlik TM, Jarnagin WR, Koerkamp BG) JAMA Surg 2022 Jul 01;157(7):590-596 37 Citations |
| 1 | First case report of neoadjuvant gemcitabine and S-1 for locally advanced unresectable duodenal adenocarcinoma. (Kimura J, Sui K, Tabuchi M, Murokawa T, Sakamoto S, Iwata J, Matsumoto M, Okabayashi T) Surg Case Rep 2022 May 19;8(1):98 |
| 3 | Palliative Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis: Is It Safe and Effective? (Strong EA, Livingston A, Gracz M, Peltier W, Tsai S, Christians K, Gamblin TC, Kersting K, Clarke CN) J Surg Res 2022 Oct;278:31-38 2 Citations |
| 2 | Thoracic Spinal Cord Compression Secondary to Metastatic Papillary Thyroid Carcinoma: An Unusual Oncological Phenomenon. (Saad EA, Abdalla M, Awadelkarim AM, Elkhider O, Agab M, Babkir A, Idris I, Filipiuk D) Cureus 2022 Apr;14(4):e24206 |
| 1 | Outcomes of Primary Mucosal Head and Neck Squamous Cell Carcinoma in Solid Organ Transplant Recipients. (Gilbert M, Liang E, Li P, Salgia R, Abouljoud M, Siddiqui F) Cureus 2022 Apr;14(4):e24305 |
| 1 | MEK-inhibitor (inh) and hydroxychloroquine (HCQ) in KRAS-mutated advanced pancreatic ductal adenocarcinoma (PDAC). (Mehdi M, Thalij SZ, Shreenivas AV, Chakrabarti S, Thomas JP, Christians KK, Evans DB, Hall WA, Erickson B, Thapa B, Ahmad G, Yazdanpanah O, Kurzrock R, Aldakkak M, Holden MB, George B, Tsai S, Oxencis C, McFall T, Kamgar M) Journal of Clinical Oncology Journal of Clinical Oncology 40, no. 16_suppl (June 01, 2022) e16260-e16260 |
| 1 | Microwave Ablation as Bridging to Liver Transplant for Patients with Hepatocellular Carcinoma: A Single-Center Retrospective Analysis. (Couillard AB, Knott EA, Zlevor AM, Mezrich JD, Cristescu MM, Agarwal P, Ziemlewicz TJ, Longhurst C, Lubner MG, Hinshaw JL, Said A, Laeseke PF, Lucey MR, Rice JP, Foley D, Al-Adra D, Lee FT Jr) J Vasc Interv Radiol 2022 Sep;33(9):1045-1053 9 Citations |
| 1 | Consideration of Management Techniques for Advanced Hepatocellular Carcinoma With Metastasis to the Right Atrium: A Case Report. (Warren BC, Yadav H, Campbell N, Colby S, Youngblood L) Cureus 2022 Apr;14(4):e24614 |
| 1 | Leptomeningeal disease in BRIP1-mutated pancreatic adenocarcinoma. (Yim E, Leung D) BMJ Case Rep 2022 Jun 08;15(6) 1 Citation |
| 1 | Preoperative therapy for pancreatic adenocarcinoma-precision beyond anatomy. (Seo YD, Katz MHG) Cancer 2022 Aug 15;128(16):3041-3056 22 Citations |
| 1 | Surgical outcomes and survival of adrenocortical carcinoma between children and adults. (Akinkuotu AC, Peace A, Maduekwe UN, Hayes AA) Am J Surg 2022 Oct;224(4):1090-1094 5 Citations |
| 1 | Systemic Therapy of Metastatic Pancreatic Adenocarcinoma: Current Status, Challenges, and Opportunities. (Chakrabarti S, Kamgar M, Mahipal A) Cancers (Basel) 2022 May 24;14(11) 16 Citations |
| 1 | Gallbladder carcinomas: review and updates on morphology, immunohistochemistry, and staging. (Lee W, Chandan VS) Hum Pathol 2023 Feb;132:149-157 3 Citations |
| 1 | Intraarterial Therapies for the Management of Hepatocellular Carcinoma (Garg T, Shrigiriwar A, Habibollahi P, Cristescu M, Liddell RP, Chapiro J, Inglis P, Camacho JC, Nezami N) Cancers July 2022;14(14) 15 Citations |
| 1 | Association Between Sites of Metastasis and Outcomes With Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma. (Makrakis D, Talukder R, Lin GI, Diamantopoulos LN, Dawsey S, Gupta S, Carril-Ajuria L, Castellano D, de Kouchkovsky I, Koshkin VS, Park JJ, Alva A, Bilen MA, Stewart TF, McKay RR, Tripathi N, Agarwal N, Vather-Wu N, Zakharia Y, Morales-Barrera R, Devitt ME, Cortellini A, Fulgenzi CAM, Pinato DJ, Nelson A, Hoimes CJ, Gupta K, Gartrell BA, Sankin A, Tripathi A, Zakopoulou R, Bamias A, Murgic J, Fröbe A, Rodriguez-Vida A, Drakaki A, Liu S, Lu E, Kumar V, Lorenzo GD, Joshi M, Isaacsson-Velho P, Buznego LA, Duran I, Moses M, Jang A, Barata P, Sonpavde G, Yu EY, Montgomery RB, Grivas P, Khaki AR) Clin Genitourin Cancer 2022 Oct;20(5):e440-e452 13 Citations |
| 1 | The Role of Stereotactic Ablative Body Radiotherapy in Renal Cell Carcinoma. (Ali M, Mooi J, Lawrentschuk N, McKay RR, Hannan R, Lo SS, Hall WA, Siva S) Eur Urol 2022 Dec;82(6):613-622 53 Citations |
| 1 | An Exosome-based Transcriptomic Signature for Noninvasive, Early Detection of Patients With Pancreatic Ductal Adenocarcinoma: A Multicenter Cohort Study. (Nakamura K, Zhu Z, Roy S, Jun E, Han H, Munoz RM, Nishiwada S, Sharma G, Cridebring D, Zenhausern F, Kim S, Roe DJ, Darabi S, Han IW, Evans DB, Yamada S, Demeure MJ, Becerra C, Celinski SA, Borazanci E, Tsai S, Kodera Y, Park JO, Bolton JS, Wang X, Kim SC, Von Hoff D, Goel A) Gastroenterology 2022 Nov;163(5):1252-1266.e2 72 Citations |
| 1 | Multi-omic analysis in carcinoma of unknown primary (CUP): therapeutic impact of knowing the unknown. (Kato S, Gumas S, Adashek JJ, Okamura R, Lee S, Sicklick JK, Kurzrock R) Mol Oncol 2024 Apr;18(4):956-968 7 Citations |
| 1 | GWAS meta-analysis of 16 790 patients with Barrett's oesophagus and oesophageal adenocarcinoma identifies 16 novel genetic risk loci and provides insights into disease aetiology beyond the single marker level. (Schröder J, Chegwidden L, Maj C, Gehlen J, Speller J, Böhmer AC, Borisov O, Hess T, Kreuser N, Venerito M, Alakus H, May A, Gerges C, Schmidt T, Thieme R, Heider D, Hillmer AM, Reingruber J, Lyros O, Dietrich A, Hoffmeister A, Mehdorn M, Lordick F, Stocker G, Hohaus M, Reim D, Kandler J, Müller M, Ebigbo A, Fuchs C, Bruns CJ, Hölscher AH, Lang H, Grimminger PP, Dakkak D, Vashist Y, May S, Görg S, Franke A, Ellinghaus D, Galavotti S, Veits L, Weismüller J, Dommermuth J, Benner U, Rösch T, Messmann H, Schumacher B, Neuhaus H, Schmidt C, Wissinowski TT, Nöthen MM, Wellcome Trust Case Control Consortium 2 (WTCCC2), Esophageal Adenocarcinoma Genetics Consortium (EAGLE), Barrett's and Esophageal Adenocarcinoma Consortium (BEACON), Dong J, Ong JS, Buas MF, Thrift AP, Vaughan TL, Tomlinson I, Whiteman DC, Fitzgerald RC, Jankowski J, Vieth M, Mayr A, Gharahkhani P, MacGregor S, Gockel I, Palles C, Schumacher J) Gut 2023 Apr;72(4):612-623 8 Citations |
| 1 | A Rare Case of Neck Sarcomatoid Squamous Cell Carcinoma With Brain Metastases. (Shah I, Razzak AN, Janardan A, Laing B, Zwagerman NT) Cureus 2022 Jun;14(6):e26179 |
| 1 | VITREOUS SEEDING OF RENAL CELL CARCINOMA IN A PATIENT RECEIVING CHECKPOINT INHIBITORS. (Dajani O, Wong A, Coleman A, Shepherd EA, Wind KP, MacCumber MW) Retin Cases Brief Rep 2023 Nov 01;17(6):699-701 |
| 1 | Carcinoma of unknown primary: Molecular tumor board-based therapy. (Shreenivas AV, Kato S, Hu J, Skefos C, Sicklick J, Kurzrock R) CA Cancer J Clin 2022 Nov;72(6):510-523 |
| 1 | Corrigendum to "The Role of Stereotactic Ablative Body Radiotherapy in Renal Cell Carcinoma" [Eur Urol 2022]. (Ali M, Mooi J, Lawrentschuk N, McKay RR, Hannan R, Lo SS, Hall WA, Siva S) Eur Urol 2022 Nov;82(5):e152 |
| 1 | DNA Damage Repair Classifier Defines Distinct Groups in Hepatocellular Carcinoma. (Smith MA, Van Alsten SC, Walens A, Damrauer JS, Maduekwe UN, Broaddus RR, Love MI, Troester MA, Hoadley KA) Cancers (Basel) 2022 Sep 01;14(17) 3 Citations |
| 2 | Phase 1 Randomized Trial of Stereotactic Body Radiation Therapy Followed by Nivolumab plus Ipilimumab or Nivolumab Alone in Advanced/Unresectable Hepatocellular Carcinoma. (Juloori A, Katipally RR, Lemons JM, Singh AK, Iyer R, Robbins JR, George B, Hall WA, Pitroda SP, Arif F, Fung J, Pillai A, Liao CY, Sharma M, Liauw SL) Int J Radiat Oncol Biol Phys 2023 Jan 01;115(1):202-213 41 Citations |
| 1 | Atlas of Dermatologic Diseases in Solid Organ Transplant Recipients, Book Chapter: Basal Cell Carcinoma (Editors:
Jane Tomimori, Walmar Roncalli Pereira de Oliveira, Carla Ferrándiz-Pulido, Marilia Marufuji Ogawa
Book Chapter: J. Fazio, EB Olasz Harken) |
| 1 | Association of the Time to Immune Checkpoint Inhibitor (ICI) Initiation and Outcomes With Second Line ICI in Patients With Advanced Urothelial Carcinoma. (Talukder R, Makrakis D, Lin GI, Diamantopoulos LN, Dawsey S, Gupta S, Carril-Ajuria L, Castellano D, de Kouchkovsky I, Jindal T, Koshkin VS, Park JJ, Alva A, Bilen MA, Stewart TF, McKay RR, Tripathi N, Agarwal N, Vather-Wu N, Zakharia Y, Morales-Barrera R, Devitt ME, Cortellini A, Fulgenzi CAM, Pinato DJ, Nelson A, Hoimes CJ, Gupta K, Gartrell BA, Sankin A, Tripathi A, Zakopoulou R, Bamias A, Murgic J, Fröbe A, Rodriguez-Vida A, Drakaki A, Liu S, Lu E, Kumar V, Lorenzo GD, Joshi M, Isaacsson-Velho P, Buznego LA, Duran I, Moses M, Barata P, Sonpavde G, Wright JL, Yu EY, Montgomery RB, Hsieh AC, Grivas P, Khaki AR) Clin Genitourin Cancer 2022 Dec;20(6):558-567 7 Citations |
| 2 | Postoperative surveillance of pancreatic ductal adenocarcinoma (PDAC) recurrence: practice pattern on standardized imaging and reporting from the society of abdominal radiology disease focus panel on PDAC. (Chu LC, Wang ZJ, Kambadakone A, Hecht EM, He J, Narang AK, Laheru DA, Arif-Tiwari H, Bhosale P, Bolan CW, Brook OR, Bezuidenhout AF, Do RKG, Galgano SJ, Goenka AH, Guimaraes AR, Hough DM, Kulkarni N, Le O, Luk L, Mannelli L, Rosenthal M, Sangster G, Shah ZK, Soloff EV, Tolat PP, Zins M, Fishman EK, Tamm EP, Zaheer A) Abdom Radiol (NY) 2023 Jan;48(1):318-339 7 Citations |
| 1 | Tissue Displacement Versus Two Primary Colorectal Carcinomas? A Case Report on the Utility of Comparative Sequencing. (Hong ES, Messersmith WA, Hammad H, Cornish TC, Aisner DL) JCO Precis Oncol 2022 Oct;6:e2200252 |
| 1 | Crucial conceptual concepts in the evaluation and management of advanced basal cell carcinoma. (Cohen PR, Kurzrock R) J Am Acad Dermatol 2023 Jan;88(1):e61-e62 2 Citations |
| 2 | Do Lymph Node Metastases Matter in Appendiceal Cancer with Peritoneal Carcinomatosis? A US HIPEC Collaborative Study. (Turner KM, Morris MC, Delman AM, Hanseman D, Johnston FM, Greer J, Walle KV, Abbott DE, Raoof M, Grotz TE, Fournier K, Dineen S, Veerapong J, Maduekwe U, Kothari A, Staley CA, Maithel SK, Lambert LA, Kim AC, Cloyd JM, Wilson GC, Sussman JJ, Ahmad SA, Patel SH) J Gastrointest Surg 2022 Dec;26(12):2569-2578 2 Citations |
| 1 | Retroperitoneal lipoma and bilateral renal cell carcinoma in a rare co-existence. (Rawashdeh B, Ayoub E, Demirag A) Int J Surg Case Rep 2022 Oct;99:107718 1 Citation |
| 3 | Annual cost-savings with the implementation of estrogen-receptor-only testing on Ductal Carcinoma in Situ specimens. (Gellings JA, Cortina CS, Jorns JM, Johnson MK, Huang CC, Kong AL) Am J Surg 2023 Feb;225(2):304-308 |
| 1 | Corrigendum to “The Role of Stereotactic Ablative Body Radiotherapy in Renal Cell Carcinoma” [Eur Urol 2022] (European Urology, (S030228382202468X), (10.1016/j.eururo.2022.06.017)) (Ali M, Mooi J, Lawrentschuk N, McKay RR, Hannan R, Lo SS, Hall WA, Siva S) European Urology November 2022;82(5):e152 |
| 1 | Real-world Practice Patterns and Safety of Concurrent Radiotherapy and Cabozantinib in Metastatic Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium. (Loo Gan C, Huang J, Pan E, Xie W, Schmidt AL, Labaki C, Meza L, Bouchard G, Li H, Jackson-Spence F, Sánchez-Ruiz C, Powles T, Kumar SA, Weise N, Hall WA, Rose BS, Beuselinck B, Suarez C, Pal SK, Choueiri TK, Heng DYC, McKay RR) Eur Urol Oncol 2023 Apr;6(2):204-211 6 Citations |
| 1 | Achieving a Cure Without Total Mesorectal Excision in Rectal Adenocarcinoma. (Hall WA, Smith JJ) J Clin Oncol 2023 Jan 10;41(2):173-180 9 Citations |
| 1 | Outcomes After Liver Transplantation With Incidental Cholangiocarcinoma. (Safdar NZ, Hakeem AR, Faulkes R, James F, Mason L, Masson S, Powell J, Rowe I, Shetty S, Jones R, Spiers HVM, Halliday N, Baker J, Thorburn D, Prasad R, Parker R) Transpl Int 2022;35:10802 7 Citations |
| 2 | Cabozantinib Safety With Different Anticoagulants in Patients With Renal Cell Carcinoma. (Shayeb AM, McManus HD, Urman D, Jani C, Zhang T, Dizman N, Meza L, Sivakumar A, Gan CL, Barata P, Bilen MA, Gao X, Heng D, Pal S, Narra R, Kilari D, Kaymakcalan MD, McGregor B, Choueiri TK, McKay RR) Clin Genitourin Cancer 2023 Feb;21(1):55-62 1 Citation |
| 1 | Evaluation of Adjuvant Chemotherapy Survival Outcomes Among Patients With Surgically Resected Pancreatic Carcinoma With Node-Negative Disease After Neoadjuvant Therapy. (Hammad AY, Hodges JC, AlMasri S, Paniccia A, Lee KK, Bahary N, Singhi AD, Ellsworth SG, Aldakkak M, Evans DB, Tsai S, Zureikat A) JAMA Surg 2023 Jan 01;158(1):55-62 16 Citations |
| 4 | A Randomized, Phase II, Clinical Trial of Preoperative Fractionated Radiation Therapy Versus Stereotactic Body Radiation Therapy for Resectable, Borderline Resectable, or Locally Advanced Type A Pancreatic Adenocarcinoma. (Saif A, Verbus E, Erickson B, Kamgar M, Tsai S, Evans D, Hernandez JM, Hall WA) Ann Surg Oncol 2023 Feb;30(2):688-690 1 Citation |
| 1 | State Variation in Squamous Cell Carcinoma of the Anus Incidence and Mortality, and Association With HIV/AIDS and Smoking in the United States. (Damgacioglu H, Lin YY, Ortiz AP, Wu CF, Shahmoradi Z, Shyu SS, Li R, Nyitray AG, Sigel K, Clifford GM, Jay N, Lopez VC, Barnell GM, Chiao EY, Stier EA, Ortiz-Ortiz KJ, Ramos-Cartagena JM, Sonawane K, Deshmukh AA) J Clin Oncol 2023 Feb 20;41(6):1228-1238 33 Citations |
| 1 | Correlation of Non-tumoral Liver Dose with Treatment-Related Adverse Events in Patients with Hepatocellular Carcinoma Treated with Glass-Based Yttrium-90 Radioembolization. (Webster LA, Villalobos A, Cheng B, Xing M, Majdalany BS, Bercu ZL, Cristescu MM, Brandon D, Schuster D, Baum Y, Loya MF, Kokabi N) Cardiovasc Intervent Radiol 2023 Jan;46(1):60-68 2 Citations |
| 3 | Management of Acute Liver Dysfunction Due to Budd-Chiari Syndrome in the Setting of Tumor Thrombus and Advanced Renal Cell Carcinoma. (Stevens-Haas C, Maniar V, Dietrich P, Langenstroer P, Joyce L, White S, Kilari D, Hong J, Johnson S) Urology 2023 Mar;173:32-33 |
| 1 | The role of liver transplant for intrahepatic cholangiocarcinoma: the UK NHSBT liver advisory group pilot programme (Hakeem AR, Isaac J, Thorburn D, Heaton N, Prasad R) Hepatoma Research 2023;9 2 Citations |
| 1 | Fibrolamellar carcinoma transcriptomic-based treatment prediction: complete response after nivolumab and ipilimumab. (Berger R, Dinstag G, Tirosh O, Schiff E, Kleiner D, Aldape KD, Ruppin E, Beker T, Kurzrock R) J Immunother Cancer 2022 Dec;10(12) 10 Citations |
| 1 | Rapid and Deep Response to Lorlatinib in Pancreatic High-Grade Neuroendocrine Carcinoma With a Treatment Emergent Novel KANK1-ALK Fusion. (Dayyani F, Lee W, Houshyar R, Fontaine P) JCO Precis Oncol 2023 Jan;7:e2200230 3 Citations |
| 1 | Smarcd3 is an epigenetic modulator of the metabolic landscape in pancreatic ductal adenocarcinoma. (Ferguson LP, Gatchalian J, McDermott ML, Nakamura M, Chambers K, Rajbhandari N, Lytle NK, Rosenthal SB, Hamilton M, Albini S, Wartenberg M, Zlobec I, Galván JA, Karamitopoulou E, Vavinskaya V, Wascher A, Lowy AM, Schürch CM, Puri PL, Bruneau BG, Hargreaves DC, Reya T) Nat Commun 2023 Jan 18;14(1):292 9 Citations |
| 1 | Primary Biliary Cholangitis, Liver Transplantation, and Hepatocellular Carcinoma: A Mini-review (Badi Rawashdeh, Allison Couillard, Aasem Rawshdeh, Hassan Aziz, James Esteban and Motaz Selim) Gene Expression |
| 1 | Evolution of the Targeted Therapy Landscape for Cholangiocarcinoma: Is Cholangiocarcinoma the ‘NSCLC’ of GI Oncology? (Gupta A, Kurzrock R, Adashek JJ) Cancers March 2023;15(5) 14 Citations |
| 1 | Evolution of the Targeted Therapy Landscape for Cholangiocarcinoma: Is Cholangiocarcinoma the 'NSCLC' of GI Oncology? (Gupta A, Kurzrock R, Adashek JJ) Cancers (Basel) 2023 Mar 03;15(5) 14 Citations |
| 1 | Systematic review of cholangiocarcinoma in Africa: epidemiology, management, and clinical outcomes. (Asombang AW, Chishinga N, Mohamed MF, Nkhoma A, Chipaila J, Nsokolo B, Manda-Mapalo M, Montiero JFG, Banda L, Dua KS) BMC Gastroenterol 2023 Mar 11;23(1):66 7 Citations |
| 1 | Cystic MED15::TFE3 translocation renal cell carcinoma: histologic mimicker of multilocular cystic renal neoplasm of low malignant potential with review of the literature. (Doytcheva K, Gallan AJ, Wang P, Wanjari P, Segal J, Antic T) Hum Pathol 2023 Jun;136:25-33 8 Citations |
| 1 | DKK1 is a predictive biomarker for response to DKN-01: Results of a phase 2 basket study in women with recurrent endometrial carcinoma. (Arend R, Dholakia J, Castro C, Matulonis U, Hamilton E, Jackson CG, LyBarger K, Goodman HM, Duska LR, Mahdi H, ElNaggar AC, Kagey MH, Liu A, Piper D, Barroilhet LM, Bradley W, Sachdev J, Sirard CA, O'Malley DM, Birrer M) Gynecol Oncol 2023 May;172:82-91 12 Citations |
| 3 | Resected cytokeratin-negative small cell lung carcinoma. (Jain PV, Thompson J, Sheinin Y) BMJ Case Rep 2023 Apr 03;16(4) |
| 1 | Evaluating the benefit of surgical resection for hepatocellular carcinoma with multifocality or intrahepatic vascular invasion. (Kothari AN, Massarweh NN, Flitcroft MA, Newhook T, Tzeng CD, Chun YS, Kaseb AO, Vauthey JN, Tran Cao HS) HPB (Oxford) 2023 Jul;25(7):758-765 2 Citations |
| 1 | Epigenetic Alterations from Barrett's Esophagus to Esophageal Adenocarcinoma. (Ergun P, Kipcak S, Bor S) Int J Mol Sci 2023 Apr 25;24(9) 3 Citations |
| 1 | AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma. (Singal AG, Llovet JM, Yarchoan M, Mehta N, Heimbach JK, Dawson LA, Jou JH, Kulik LM, Agopian VG, Marrero JA, Mendiratta-Lala M, Brown DB, Rilling WS, Goyal L, Wei AC, Taddei TH) Hepatology 2023 Dec 01;78(6):1922-1965 560 Citations |
| 1 | Use of Metformin and Survival in Patients with Hepatocellular Carcinoma (HCC) Undergoing Liver Directed Therapy: Analysis of a Nationwide Cancer Registry. (Mukherjee K, Elsayed M, Choksi E, Loya MF, Duszak R, Akce M, Majdalany BS, Bercu ZL, Cristescu M, Kokabi N) Cardiovasc Intervent Radiol 2023 Jul;46(7):870-879 1 Citation |
| 2 | Chemical Shift MRI Monitoring of Chemoembolization Delivery for Hepatocellular Carcinoma: Multicenter Feasibility of Initial Clinical Translation. (Gordon AC, Lewandowski RJ, Li W, Zhong X, Kannengiesser SAR, Miller FH, Salem R, Rilling WS, Larson AC, White SB) Radiol Imaging Cancer 2023 May;5(3):e220019 |
| 2 | Pathologic, immunologic, and clinical analysis of the microsatellite instability phenotype in endometrial carcinoma. (Mackinnon AC Jr, Johnson CM, Robin A, Christiansen L, Hanbazazh M, Summey RM, Chandrashaker D, Harada S, Bradley WH) Hum Pathol 2023 Sep;139:80-90 1 Citation |
| 1 | Phase 2 study of batiraxcept (AVB-S6-500, an AXL inhibitor) as monotherapy, in combination with cabozantinib (cabo), and in combination with cabo and nivolumab (nivo) in patients with advanced clear cell renal cell carcinoma (ccRCC). (Katy Beckermann, Matthew T Campbell, Naomi B. Haas, Moshe Chaim Ornstein, Xin Gao, Shifeng S. Mao, Hans J. Hammers, Saby George, Ariel Ann Nelson, Theodore Stewart Gourdin, Holavanahalli Keshava-Prasad, Arif Hussain, Christopher J. Hoimes, Hongxia Yan, Vanessa Esquibel, Gail McIntyre, Robert B. Geller, Martin H Voss, Brian I. Rini, Neil J. Shah) Journal of Clinical Oncology J Clin Oncol 41, 2023 (suppl 16; abstr 4534) |
| 1 | Pathological Outcomes of Patients With Advanced Renal Cell Carcinoma Who Receive Nephrectomy Following Immunotherapy. (Panian J, Saidian A, Hakimi K, Ajmera A, Anderson WJ, Barata P, Berg S, Signoretti S, Lee Chang S, D'Andrea V, George D, Dzimitrowicz H, El Zarif T, Emamekhoo H, Gross E, Kilari D, Lam E, Lashgari I, Psutka S, Rauterkus GP, Shabaik A, Thapa B, Wang L, Weise N, Yim K, Zhang T, Derweesh I, McKay RR) Oncologist 2024 Oct 03;29(10):870-877 3 Citations |
| 1 | Phase 2 study of batiraxcept (AVB-S6-500, an AXL inhibitor) as monotherapy, in combination with cabozantinib (cabo), and in combination with cabo and nivolumab (nivo) in patients with advanced clear cell renal cell carcinoma (ccRCC) (Katy Beckermann, Matthew T Campbell, Naomi B. Haas, Moshe Chaim Ornstein, Xin Gao, Shifeng S. Mao, Hans J. Hammers, Saby George, Ariel Ann Nelson, Theodore Stewart Gourdin, Holavanahalli Keshava-Prasad, Arif Hussain, Christopher J. Hoimes, Hongxia Yan, Vanessa Esquibel, Gail McIntyre, Robert B. Geller, Martin H Voss, Brian I. Rini, Neil J. Shah) J Clin Oncol J Clin Oncol 41, 2023 (suppl 16; abstr 4534) |
| 1 | Prospective Correlation of Magnetic Resonance Tumor Regression Grade With Pathologic Outcomes in Total Neoadjuvant Therapy for Rectal Adenocarcinoma. (Hall WA, Li J, You YN, Gollub MJ, Grajo JR, Rosen M, dePrisco G, Yothers G, Dorth JA, Rahma OE, Russell MM, Gross HM, Jacobs SA, Faller BA, George S, Al Baghdadi T, Haddock MG, Valicenti R, Hong TS, George TJ) J Clin Oncol 2023 Oct 10;41(29):4643-4651 14 Citations |
| 1 | Predicting futility of upfront surgery in perihilar cholangiocarcinoma: Machine learning analytics model to optimize treatment allocation. (Ratti F, Marino R, Olthof PB, Pratschke J, Erdmann JI, Neumann UP, Prasad R, Jarnagin WR, Schnitzbauer AA, Cescon M, Guglielmi A, Lang H, Nadalin S, Topal B, Maithel SK, Hoogwater FJH, Alikhanov R, Troisi R, Sparrelid E, Roberts KJ, Malagò M, Hagendoorn J, Malik HZ, Olde Damink SWM, Kazemier G, Schadde E, Charco R, de Reuver PR, Groot Koerkamp B, Aldrighetti L, Perihilar Cholangiocarcinoma Collaboration Group) Hepatology 2024 Feb 01;79(2):341-354 16 Citations |
| 1 | Outcomes of Consolidative Nephrectomy following Primary Immunotherapy in Advanced Renal Cell Carcinoma: A Multicenter Analysis. (Hakimi K, Saidian A, Panian J, Barata P, Berg S, Chang SL, Saliby RM, Dzimitrowicz H, Emamekhoo H, Gross E, Kilari D, Lam E, Nguyen M, Meagher M, Wang L, Rauterkus GP, D'Andrea V, Yim K, Psutka S, Thapa B, Weise N, Zhang T, McKay RR, Derweesh IH) Clin Genitourin Cancer 2023 Dec;21(6):694-702 1 Citation |
| 1 | Variation in treatment of intrahepatic cholangiocarcinoma: a nationwide multicentre study. (McClements J, Valle JW, Blackburn L, Brooks A, Prachalias A, Dasari BVM, Jones C, Harrison E, Malik H, Prasad KR, Sodergren M, Silva M, Kumar N, Shah N, Bhardwaj N, Nunes Q, Bhogal RH, Pandanaboyana S, Aroori S, Hamady Z, Gomez D, UK HPB Research Collaborative Group) Br J Surg 2023 Nov 09;110(12):1673-1676 3 Citations |
| 1 | Prostate Adenocarcinoma Metastasis to the Rectal Submucosa and Mesorectal Lymph Node on 18 F-PSMA PET/CT. (Segal E, Dababo N, Bhalla D, Bucklan D) Clin Nucl Med 2023 Oct 01;48(10):e506-e508 1 Citation |
| 1 | British Society of Gastroenterology guidelines for the diagnosis and management of cholangiocarcinoma. (Rushbrook SM, Kendall TJ, Zen Y, Albazaz R, Manoharan P, Pereira SP, Sturgess R, Davidson BR, Malik HZ, Manas D, Heaton N, Prasad KR, Bridgewater J, Valle JW, Goody R, Hawkins M, Prentice W, Morement H, Walmsley M, Khan SA) Gut 2023 Dec 07;73(1):16-46 32 Citations |
| 1 | Development of a blood-based extracellular vesicle classifier for detection of early-stage pancreatic ductal adenocarcinoma. (Hinestrosa JP, Sears RC, Dhani H, Lewis JM, Schroeder G, Balcer HI, Keith D, Sheppard BC, Kurzrock R, Billings PR) Commun Med (Lond) 2023 Oct 19;3(1):146 10 Citations |
| 2 | Incidence of Esophageal Adenocarcinoma, Mortality, and Esophagectomy in Barrett's Esophagus Patients Undergoing Endoscopic Eradication Therapy. (Smith ZL, Thorgerson AM, Dawson AZ, Wani S) Dig Dis Sci 2023 Dec;68(12):4439-4448 2 Citations |
| 2 | Novel targets in development for advanced renal cell carcinoma (Thapa B, Nelson A, Kilari D) Integrating Multidisciplinary Treatment for Advanced Renal Cell Carcinoma 1 November 2023:309-342 |
| 1 | Novel Targets in Development for Advanced Renal Cell Carcinoma (Bicky Thapa, Ariel Nelson & Deepak Kilari) Thapa, B., Nelson, A., Kilari, D. (2023). Novel Targets in Development for Advanced Renal Cell Carcinoma. In: McKay, R.R., Singer, E.A. (eds) Integrating Multidisciplinary Treatment for Advanced Renal Cell Carcinoma. Springer, Cham. https://doi.org/10.1007/978-3-031-40901-1_14 |
| 1 | Evaluation of Diagnostic Significance of Salivary miRNA-184 and miRNA-21 in Oral Squamous Cell Carcinoma and Oral Potentially Malignant Disorders. (Garg A, Urs AB, Koner BC, Augustine J, Guru SA) Head Neck Pathol 2023 Dec;17(4):961-968 3 Citations |
| 1 | Is chest imaging needed as part of pT1a renal cell carcinoma surveillance after surgical resection? (Charles D, Fitzgerald J, Landowski T, Cooper B, Yong R Jr, Everett R, See W, Jacobsohn K, Johnson S, Langenstroer P) Urol Oncol 2024 Jan;42(1):23.e1-23.e4 |
| 2 | Topical Treatment of Cutaneous Squamous Cell Carcinoma in Situ and the Impact of Clinical Risk Factors and Positive Histologic Margins at the Time of Diagnosis. (Calley BJ, Fazio J, Banerjee A, Clark MA) Dermatol Surg 2024 Mar 01;50(3):219-223 1 Citation |
| 1 | Immune checkpoint inhibitors in hepatocellular carcinoma: A review of current clinical trials. (Gamboa AC, Kooby DA, Maithel SK, Gamblin TC) J Surg Oncol 2024 Jan;129(1):63-70 2 Citations |
| 1 | Hepatocellular carcinoma in survivors after Fontan operation: a case-control study. (Kim YY, Lluri G, Haeffele C, Daugherty T, Krasuski RA, Serfas JD, de Freitas RA, Porlier A, Lubert AM, Wu FM, Valente AM, Krieger EV, Buber J, Rodriguez FH 3rd, Gaignard S, Saraf A, Hindes M, Earing MG, Lewis MJ, Rosenbaum MS, Zaidi AN, Hopkins K, Bradley EA, Cedars AM, Ko JL, Franklin WJ, Frederickson A, Ginde S, Grewal J, Nyman A, Min J, Schluger C, Rand E, Rosenthal BE, Hilscher M, Rychik J, Hoteit MA) Eur Heart J 2024 Apr 21;45(16):1477-1480 5 Citations |
| 10 | Characterization of an oligometastatic state in patients with metastatic pancreatic adenocarcinoma undergoing systemic chemotherapy. (de Ortiz de Choudens S, Visotcky A, Banerjee A, Aldakkak M, Tsai S, Evans DB, Christians KK, Clarke CN, George B, Shreenivas A, Kamgar M, Chakrabarti S, Dua KS, Khan AH, Madhavan S, Erickson BA, Hall WA) Cancer Med 2024 Jan;13(1):e6582 |
| 1 | New Insights on Liver-Directed Therapies in Hepatocellular Carcinoma. (Dalzell CG, Taylor AC, White SB) Cancers (Basel) 2023 Dec 08;15(24) 4 Citations |
| 1 | ASO Author Reflections: Liver Failure Dominates the Risk of Failure to Rescue After Surgery for Perihilar Cholangiocarcinoma (Olthof PB, Bouwense SAW, Dewulf M, Olde Damink SWM, Neumann UP, Koerkamp BG, Zonderhuis BM, van Laarhoven S, Troisi RI, Topal H, Topal B, Sutcliff R, Sultana A, Sparrelid E, Serenari M, Schnitzbauer AA, Schmelzle M, Schadde E, Ruzzenente A, Rolinger J, Roberts KJ, Ravaioli M, Ratti F, Quinn LM, Pratschke J, Prasad R, Porte RJ, Poletto E, Nota CLM, Nooijen LE, Nguyen TA, Nadalin S, Molenaar QI, Marino R, Margies R, Malik H, Malago MM, Maithel SK, Lodge P, Lang H, Kingham TP, Kazemier G, Jarnagin WR, Jansson H, Hoogwater FJH, Heil J, Hakeem A, Hagendoorn J, van Gulik TM, Guglielmi A, Gomez-Gavara C, Gilg S, Giglio MC, Geers J, Franken LC, Erdmann JI, Efanov M, Dopazo C, de Savornin Lohman E, de Reuver P, D’Angelica MI, Charco R, Cescon M, Capobianco I, Buettner S, de Boer MT, Benzing C, Bednarsch J, Bechstein WO, Bartsch F, Bartlett DM, Alikhanov R, Aldrighetti L) Annals of Surgical Oncology 2024 |
| 1 | Imaging and Biomarker Surveillance for Head and Neck Squamous Cell Carcinoma: A Systematic Review and American Radium Society Appropriate Use Criteria Statement. (Hanna GJ, Chang SS, Siddiqui F, Bain PA, Takiar V, Ward MC, Shukla ME, Hu KS, Robbins J, Witek ME, Bakst R, Chandra RA, Galloway T, Margalit DN) Int J Radiat Oncol Biol Phys 2024 Jul 01;119(3):786-802 |
| 1 | Clinical Outcomes After Personalized Dosimetry for 90Y Radioembolization of Advanced Hepatocellular Carcinoma: Defining the Role of a Device in a Pharma-Centric Landscape. (Soulen MC, Rilling WS) J Nucl Med 2024 Feb 01;65(2):270-271 2 Citations |
| 9 | Transcriptomic-Based Microenvironment Classification Reveals Precision Medicine Strategies for Pancreatic Ductal Adenocarcinoma. (George B, Kudryashova O, Kravets A, Thalji S, Malarkannan S, Kurzrock R, Chernyavskaya E, Gusakova M, Kravchenko D, Tychinin D, Savin E, Alekseeva L, Butusova A, Bagaev A, Shin N, Brown JH, Sethi I, Wang D, Taylor B, McFall T, Kamgar M, Hall WA, Erickson B, Christians KK, Evans DB, Tsai S) Gastroenterology 2024 May;166(5):859-871.e3 8 Citations |
| 1 | Scoring system for prediction of overall survival in patients with renal cell carcinoma T3aN0M0. (Suartz CV, Cordeiro MD, de Carvalho PA, Gallucci FP, Ribeiro-Filho LA, Cardili L, Sivaraman A, Audenet F, Mota JM, Nahas WC) BJUI Compass 2024 Mar;5(2):289-296 |
| 1 | Exploring miR-155-5p and miR-1246 as Diagnostic and Prognostic Markers in Oral Squamous cell carcinoma. (Maheswari R, Urs AB, Kumar P, Koner BC, Guru SA, Rawat G) Mol Biol Rep 2024 Feb 24;51(1):341 1 Citation |
| 1 | New phase 1 SURPASS trial cohort: Early-line ADP-A2M4CD8 T-cell receptor T-cell therapy plus pembrolizumab in urothelial carcinoma (David H Aggen, Alejandro Garcia, Jose M Saro Suarez, Amy Sauer, Sebastiano Cristiani, Francine Elizabeth Brophy, Sharon Streets, Elliot Norry, Ariel Ann Nelson, Deepak Kilari, Benjamin Garmezy, John A. Charlson, Jon Zugazagoitia, Emiliano Calvo, Irene Moreno, Victor Moreno, Christopher J. Hoimes, David S. Hong, Andres Cervantes) J Clin Oncol J Clin Oncol 42, 2024 (suppl 4; abstr TPS708) |
| 1 | Pancreatic Adenocarcinoma with Co-Occurrence of KRAS and EGFR Mutations: Case Report and Literature Review. (Mody J, Kamgar M) Case Rep Oncol 2024;17(1):399-406 1 Citation |
| 1 | ASO Author Reflections: Surgical Strategy for Perihilar Cholangiocarcinoma. (Olthof PB, Groot Koerkamp B, Perihilar Cholangiocarcinoma Collaboration Group) Ann Surg Oncol 2024 Jul;31(7):4454-4455 |
| 1 | Higher Postoperative Mortality and Inferior Survival After Right-Sided Liver Resection for Perihilar Cholangiocarcinoma: Left-Sided Resection is Preferred When Possible. (Olthof PB, Erdmann JI, Alikhanov R, Charco R, Guglielmi A, Hagendoorn J, Hakeem A, Hoogwater FJH, Jarnagin WR, Kazemier G, Lang H, Maithel SK, Malago M, Malik HZ, Nadalin S, Neumann U, Olde Damink SWM, Pratschke J, Ratti F, Ravaioli M, Roberts KJ, Schadde E, Schnitzbauer AA, Sparrelid E, Topal B, Troisi RI, Groot Koerkamp B, Perihilar Cholangiocarcinoma Collaboration Group) Ann Surg Oncol 2024 Jul;31(7):4405-4412 7 Citations |
| 1 | Intratumoral T-cell receptor repertoire composition predicts overall survival in patients with pancreatic ductal adenocarcinoma. (Pothuri VS, Hogg GD, Conant L, Borcherding N, James CA, Mudd J, Williams G, Seo YD, Hawkins WG, Pillarisetty VG, DeNardo DG, Fields RC) Oncoimmunology 2024;13(1):2320411 7 Citations |
| 1 | DNAJB1-PRKACA fusion neoantigens elicit rare endogenous T cell responses that potentiate cell therapy for fibrolamellar carcinoma. (Kirk AM, Crawford JC, Chou CH, Guy C, Pandey K, Kozlik T, Shah RK, Chung S, Nguyen P, Zhang X, Wang J, Bell M, Mettelman RC, Allen EK, Pogorelyy MV, Kim H, Minervina AA, Awad W, Bajracharya R, White T, Long D Jr, Gordon B, Morrison M, Glazer ES, Murphy AJ, Jiang Y, Fitzpatrick EA, Yarchoan M, Sethupathy P, Croft NP, Purcell AW, Federico SM, Stewart E, Gottschalk S, Zamora AE, DeRenzo C, Strome SE, Thomas PG) Cell Rep Med 2024 Mar 19;5(3):101469 2 Citations |
| 7 | Chemotherapy-free treatment targeting fusions and driver mutations in KRAS wild-type pancreatic ductal adenocarcinoma, a case series. (Mehdi M, Szabo A, Shreenivas A, Thomas JP, Tsai S, Christians KK, Evans DB, Clarke CN, Hall WA, Erickson B, Ahmed G, Thapa B, McFall T, George B, Kurzrock R, Kamgar M) Ther Adv Med Oncol 2024;16:17588359241253113 2 Citations |
| 2 | Intensity-Modulated Reirradiation Therapy With Nivolumab in Recurrent or Second Primary Head and Neck Squamous Cell Carcinoma: A Nonrandomized Controlled Trial. (Saba NF, Wong SJ, Nasti T, McCook-Veal AA, McDonald MW, Stokes WA, Anderson AM, Ekpenyong A, Rupji M, Abousaud M, Rudra S, Bates JE, Remick JS, Joshi NP, Woody NM, Awan M, Geiger JL, Shreenivas A, Samsa J, Ward MC, Schmitt NC, Patel MR, Higgins KA, Teng Y, Steuer CE, Shin DM, Liu Y, Ahmed R, Koyfman SA) JAMA Oncol 2024 Jul 01;10(7):896-904 1 Citation |
| 1 | Combination and Optimal Sequencing of Systemic and Locoregional Therapies in Hepatocellular Carcinoma: Proceedings from the Society of Interventional Radiology Foundation Research Consensus Panel. (Thornton LM, Abi-Jaoudeh N, Lim HJ, Malagari K, Spieler BO, Kudo M, Finn RS, Lencioni R, White SB, Kokabi N, Jeyarajah DR, Chaudhury P, Liu D) J Vasc Interv Radiol 2024 Jun;35(6):818-824 |
| 1 | Future patterns in burden and incidence of squamous cell carcinoma of the anus in the United States, 2001-2035. (Garg A, Damgacioglu H, Sigel K, Nyitray AG, Clifford GM, Curran T, Lazenby G, Meissner EG, Sterba K, Sonawane K, Deshmukh AA) J Natl Cancer Inst 2024 Sep 01;116(9):1508-1512 1 Citation |
| 2 | An Atypical Presentation of Giant Cutaneous Squamous Cell Carcinoma of the Nose Diagnostic and Treatment Challenges (Cherubin T, Pawar S, Zenga J, Kasprzak J) Wisconsin Medical Journal July 2024;123(3):243 |
| 1 | A UNIQUE AND CHALLENGING PRESENTATION OF METASTATIC DUCTAL CARCINOMA OF BREAST AS INTERSTITIAL LUNG DISEASE (Aurshina A, Ahmed M, Iftikhar H, Atiq I, Imtiaz M, Sheikh MM) Chest |
| 1 | Prospective Study of Non-Contrast, Abbreviated MRI for Hepatocellular Carcinoma Surveillance in Patients with Suboptimal Hepatic Visualisation on Ultrasound. (Vithayathil M, Qurashi M, Vicente PR, Alsafi A, Naik M, Graham A, Khan S, Lewis H, Dhar A, Smith B, Selvapatt N, Manousou P, Possamai L, Izadi H, Lim A, Tait P, Sharma R) Cancers (Basel) 2024 Jul 30;16(15) 1 Citation |
| 2 | A systematic review of sebaceous carcinoma of the breast from 2000-2023: A rare entity with high recurrence rates. (Cohen LN, Flanagan C, Kong AL, Cortina CS) Surg Oncol Insight 2024 Sep;1(3) |
| 1 | Guidelines Development Group for the British Society of Gastroenterology guidelines for the diagnosis and management of cholangiocarcinoma. (Khan SA, Rushbrook SM, Kendall TJ, Zen Y, Albazaz R, Manoharan P, Pereira SP, Sturgess R, Davidson BR, Malik HZ, Manas D, Heaton N, Prasad KR, Valle JW, Goody R, Hawkins M, Prentice W, Morement H, Walmsley M, Bridgewater J) Gut 2025 Feb 06;74(3):504-505 |
| 1 | Pleural complications in patients with renal cell carcinoma undergoing percutaneous cryoablation: A retrospective analysis of its incidence and risk factors. (Khatim I, Albaba I, Judson MA, Hu K, Ali S, Singh H, Syed K, Koo M, Yung T, Feustel P, Patel R, Siskin G, Chopra A) Am J Med Sci 2025 Mar;369(3):334-338 |
| 1 | Failure to Rescue After Resection of Perhilar Cholangiocarcinoma in an International Multicenter Cohort. (Olthof PB, Bouwense SAW, Bednarsch J, Dewulf M, Kazemier G, Maithel S, Jarnagin WR, Aldrighetti L, Roberts KJ, Troisi RI, Malago MM, Lang H, Alikhanov R, Ruzzenente A, Malik H, Charco R, Sparrelid E, Pratschke J, Cescon M, Nadalin S, Hagendoorn J, Schadde E, Hoogwater FJH, Schnitzbauer AA, Topal B, Lodge P, Olde Damink SWM, Neumann UP, Groot Koerkamp B, Perihilar Cholangiocarcinoma Collaboration Group) Ann Surg Oncol 2025 Mar;32(3):1762-1768 2 Citations |
| 3 | Immunohistochemistry in the Differential Diagnosis of Triple Negative Breast Carcinoma and High-grade Serous Carcinoma: Old and New Markers. (Jain PV, Molina M, Moh M, Bishop E, Rader JS, Jorns JM) Appl Immunohistochem Mol Morphol 2024 Nov-Dec 01;32(10):456-461 |
| 2 | Cutaneous metastases of colon adenocarcinoma. (Shah N, Ali MA, Patel AV) Dig Liver Dis 2025 Feb;57(2):636-637 |
| 1 | Role of Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC) in the Treatment of Peritoneal Carcinomatosis From Small Bowel Adenocarcinoma-A Systematic Review and Meta-Analysis. (Fernando DG, Sparapani R, Mogal H) J Surg Oncol 2024 Nov 17 |
| 1 | Non-clear cell renal cell carcinoma narrative review: where we are in 2024 (Pierro MJ, Gallan A, Kilari D) Translational Cancer Research 30 November 2024;13(11):6403-6412 |
| 1 | Oil Red O: A Useful Adjunctive Stain for Sebaceous Carcinoma of the Eyelid Margin. (Kasprzak JM, Popatia S, Aylward J, Wanat KA) Dermatol Surg 2025 Feb 01;51(2):207-208 |
| 1 | Best Practices for Delivering Neoadjuvant Therapy in Pancreatic Ductal Adenocarcinoma. (Cloyd JM, Sarna A, Arango MJ, Bates SE, Bhutani MS, Bloomston M, Chung V, Dotan E, Ferrone CR, Gambino PF, Goenka AH, Goodman KA, Hall WA, He J, Hogg ME, Jayaraman S, Kambadakone A, Katz MHG, Khorana AA, Ko AH, Koay EJ, Kooby DA, Krishna SG, Larsson LK, Lee RT, Maitra A, Massarweh NN, Mikhail S, Muzaffar M, O'Reilly EM, Palta M, Petzel MQB, Philip PA, Reyngold M, Santa Mina D, Sohal DPS, Sundaresan TK, Tsai S, Turner KL, Vreeland TJ, Walston S, Washington MK, Williams TM, Wo JY, Snyder RA) JAMA Surg 2025 Feb 01;160(2):172-180 |
| 1 | The Role of Dynamic Contrast Enhanced Magnetic Resonance Imaging in Evaluating Prostate Adenocarcinoma: A Partially-Blinded Retrospective Study of a Prostatectomy Patient Cohort With Whole Gland Histopathology Correlation and Application of PI-RADS or TNM Staging. (Sridhar S, Abouelfetouh Z, Codreanu I, Gupta N, Zhang S, Efstathiou E, Karolyi DK, Shen SS, LaViolette PS, Miles B, Martin DR) Prostate 2025 Apr;85(5):413-423 |
| 4 | Dual-center retrospective cohort analysis of high-risk cutaneous squamous cell carcinoma tumors. (Calley B, Trieglaff K, Boswell N, Vu A, Popatia S, Rivera DB, Tsafack UK, Banerjee A, Vaughn OA, Clark MA) Arch Dermatol Res 2025 Jan 20;317(1):300 |
| 1 | MEK inhibitor-based therapy in metastatic pancreatic adenocarcinoma with KRAS G12R alteration. (Auckley E, Ying G, Yohay S, Aldakkak M, Thalji SZ, Vakili P, Grahl J, Mayer B, Shahjehan F, Low SK, Evans DB, Christians KK, Seo YD, Erickson B, Hall WA, McFall T, Kurzrock R, George B, Kamgar M) Clin Oncol 43, 2025 (suppl 4; abstr 725), ASCO Gastrointestinal Cancer symposium, Poster Presentation; San Francisco, January 2025 |
| 1 | MEK inhibitor-based therapy in metastatic pancreatic adenocarcinoma with KRAS G12D or KRAS G12V alteration. (Yohay S, Ying G, Auckley E, Aldakkak M, Thalji SZ, Vakili P, Grahl J, Mayer B, Shahjehan F, Low SK, Evans DB, Christians KK, Seo YD, Erickson B, Hall WA, McFall T, Kurzrock R, George B, Kamgar M) Clin Oncol 43, 2025 (suppl 4; abstr 726), ASCO Gastrointestinal Cancer symposium, Poster Presentation; San Francisco, January 2025 |
| 1 | Correction: Targeting the vasopressin type-2 receptor for renal cell carcinoma therapy. (Sinha S, Dwivedi N, Tao S, Jamadar A, Kakade VR, O' Neil M, Weiss RH, Enders J, Calvet JP, Thomas SM, Rao R) Oncogene 2025 Mar;44(9):632-633 |
| 1 | Maximum Surgical Resection Followed by Radiation Therapy for the Management of Mucinous Adenocarcinoma of the Prostate. (Patel KR, Hall WA) Int J Radiat Oncol Biol Phys 2025 Mar 01;121(3):582 |
